Compounds > oxazolidin-2-one
Page last updated: 2024-09-23

oxazolidin-2-one

Description

Oxazolidinones: Derivatives of oxazolidin-2-one. They represent an important class of synthetic antibiotic agents. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

oxazolidin-2-one : An oxazolidinone that is 1,3-oxazolidine with an oxo substituent at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

oxazolidinone : An oxazolidine containing one or more oxo groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID73949
CHEMBL ID1867161
CHEBI ID1237
MeSH IDM0249955

Synonyms (60)

Synonym
carbamic acid, .gamma.-lactone
oxazolidin-2-one
nsc-38240
nsc38240
2-oxazolidone
1,3-oxazolidin-2-one
nsc35382
nsc-35382
wln: t5mvotj
oxazolidone
einecs 207-840-9
ai3-38980
nsc 35382
brn 0106251
carbamic acid, (2-hydroxyethyl)-, gamma-lactone
oxazolidinone
inchi=1/c3h5no2/c5-3-4-1-2-6-3/h1-2h2,(h,4,5
oxazolidine,2-one
497-25-6
2-oxazolidinone
C06695
2-oxazolidinone, 98%
smr000857362
MLS001335929
MLS001335930
O0188
AKOS000119963
51667-26-6
A827830
2h-oxazol-2-id-4-one;oxazolidin-2-one
CHEBI:1237 ,
HMS2231L03
4-27-00-02516 (beilstein handbook reference)
z4d49w92pp ,
unii-z4d49w92pp
oxazolidinones
FT-0613254
hydroxy-oxazoline
2-oxo-1,3-oxazolidine
oxazolodinone
oxazolidine-2-one
W-106010
CHEMBL1867161
carbamic acid, (2-hydroxyethyl)-, .gamma.-lactone
2-oxazolidine
2-oxotetrahydro-1,3-oxazole
mfcd00005268
DTXSID2074326
CS-W007548
2-oxazolidinon
F0001-1296
SY003480
Q425555
hydroxyoxazoline
STL183293
STR03231
AMY39498
C93484
EN300-19697
Z104474784

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
oxazolidinoneAn oxazolidine containing one or more oxo groups.
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency112.20200.354828.065989.1251AID504847
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency35.48130.050127.073689.1251AID588590
gemininHomo sapiens (human)Potency0.23440.004611.374133.4983AID624296; AID624297
VprHuman immunodeficiency virus 1Potency0.89131.584919.626463.0957AID651644
Rap guanine nucleotide exchange factor 4Homo sapiens (human)Potency39.81073.981146.7448112.2020AID720708
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (10)

Processvia Protein(s)Taxonomy
adaptive immune responseRap guanine nucleotide exchange factor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
calcium-ion regulated exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
positive regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of synaptic vesicle cycleRap guanine nucleotide exchange factor 4Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein-macromolecule adaptor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
small GTPase bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
cytosolRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4,186)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990212 (5.06)18.7374
1990's218 (5.21)18.2507
2000's1775 (42.40)29.6817
2010's1718 (41.04)24.3611
2020's263 (6.28)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials347 (7.93%)5.53%
Reviews542 (12.39%)6.00%
Case Studies563 (12.87%)4.05%
Observational9 (0.21%)0.25%
Other2,915 (66.61%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
daptomycin[no description available]medium2140
vancomycin[no description available]medium50244glycopeptideantibacterial drug;
antimicrobial agent;
bacterial metabolite
linezolid[no description available]medium2,286163acetamides;
morpholines;
organofluorine compound;
oxazolidinone		antibacterial drug;
protein synthesis inhibitor
anacetrapib[no description available]medium15831
aldosterone[no description available]medium5011beta-hydroxy steroid;
18-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
mineralocorticoid;
primary alpha-hydroxy ketone;
steroid aldehyde		human metabolite;
mouse metabolite
tedizolid[no description available]medium1280carbamate ester;
organofluorine compound;
oxazolidinone;
primary alcohol;
pyridines;
tetrazoles		antimicrobial agent;
drug metabolite;
protein synthesis inhibitor
tedizolid[no description available]medium1288carbamate ester;
organofluorine compound;
oxazolidinone;
primary alcohol;
pyridines;
tetrazoles		antimicrobial agent;
drug metabolite;
protein synthesis inhibitor
torcetrapib[no description available]medium400(trifluoromethyl)benzenes;
carbamate ester;
quinolines		anticholesteremic drug;
CETP inhibitor
dalcetrapib[no description available]medium430anilide
evacetrapib[no description available]medium250benzazepine
zolmitriptan[no description available]medium4260oxazolidinone;
tryptamines		anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
zolmitriptan[no description available]medium426109oxazolidinone;
tryptamines		anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
oxazoles[no description available]medium434611,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
isoxazoles[no description available]medium1568isoxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
azd0914[no description available]medium277
3-chloro-4,4-dimethyl-2-oxazolidinone[no description available]medium220
goitrin[no description available]medium4505-ethenyl-1,3-oxazolidine-2-thioneantiviral agent;
plant metabolite
palmidrol[no description available]medium30endocannabinoid;
N-(long-chain-acyl)ethanolamine;
N-(saturated fatty acyl)ethanolamine		anti-inflammatory drug;
anticonvulsant;
antihypertensive agent;
neuroprotective agent
chloramphenicol[no description available]medium330C-nitro compound;
carboxamide;
diol;
organochlorine compound		antibacterial drug;
antimicrobial agent;
Escherichia coli metabolite;
geroprotector;
Mycoplasma genitalium metabolite;
protein synthesis inhibitor
pyrazinamide[no description available]medium112monocarboxylic acid amide;
N-acylammonia;
pyrazines		antitubercular agent;
prodrug
isoniazid[no description available]medium193carbohydrazideantitubercular agent;
drug allergen
atorvastatin[no description available]medium125aromatic amide;
dihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrroles;
statin (synthetic)		environmental contaminant;
xenobiotic
lithium[no description available]medium50alkali metal atom
prednisolone[no description available]medium4011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
sumatriptan[no description available]medium12617sulfonamide;
tryptamines		serotonergic agonist;
vasoconstrictor agent
verapamil[no description available]medium40aromatic ether;
nitrile;
polyether;
tertiary amino compound
gold[no description available]medium30copper group element atom;
elemental gold
clomazone[no description available]medium770isoxazolidinone;
monochlorobenzenes		agrochemical;
carotenoid biosynthesis inhibitor;
environmental contaminant;
herbicide;
xenobiotic
formic acid[no description available]medium10monocarboxylic acidantibacterial agent;
astringent;
metabolite;
protic solvent;
solvent
radezolid[no description available]medium110
alanine[no description available]medium50alanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid		EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
florfenicol[no description available]medium130organochlorine compound;
organofluorine compound;
secondary alcohol;
secondary carboxamide;
sulfone		antimicrobial agent
thiamphenicol[no description available]medium150monocarboxylic acid amide;
sulfone		antimicrobial agent;
immunosuppressive agent
u 100480[no description available]medium273
furaltadon[no description available]medium990
cytarabine[no description available]medium10beta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside		antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
tetracycline[no description available]medium120
beta-lactams[no description available]medium290beta-lactam antibiotic allergen;
beta-lactam
enterobactin[no description available]medium10catechols;
crown compound;
macrotriolide;
polyphenol		bacterial metabolite;
siderophore
urea[no description available]medium140isourea;
monocarboxylic acid amide;
one-carbon compound		Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
carbamates[no description available]medium150amino-acid anion
cyanates[no description available]medium60
hydantoins[no description available]medium130imidazolidine-2,4-dione
acetaminophen[no description available]medium71acetamides;
phenols		antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
3-hydroxybutanal[no description available]medium50
serine[no description available]medium30L-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
buspirone[no description available]medium20azaspiro compound;
N-alkylpiperazine;
N-arylpiperazine;
organic heteropolycyclic compound;
piperidones;
pyrimidines		anxiolytic drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
sedative;
serotonergic agonist
levodopa[no description available]medium30amino acid zwitterion;
dopa;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid		allelochemical;
antidyskinesia agent;
antiparkinson drug;
dopaminergic agent;
hapten;
human metabolite;
mouse metabolite;
neurotoxin;
plant growth retardant;
plant metabolite;
prodrug
amantadine[no description available]medium10adamantanes;
primary aliphatic amine		analgesic;
antiparkinson drug;
antiviral drug;
dopaminergic agent;
NMDA receptor antagonist;
non-narcotic analgesic
oxidopamine[no description available]medium10benzenetriol;
catecholamine;
primary amino compound		drug metabolite;
human metabolite;
neurotoxin
rifampin[no description available]medium985cyclic ketal;
hydrazone;
N-iminopiperazine;
N-methylpiperazine;
rifamycins;
semisynthetic derivative;
zwitterion		angiogenesis inhibitor;
antiamoebic agent;
antineoplastic agent;
antitubercular agent;
DNA synthesis inhibitor;
EC 2.7.7.6 (RNA polymerase) inhibitor;
Escherichia coli metabolite;
geroprotector;
leprostatic drug;
neuroprotective agent;
pregnane X receptor agonist;
protein synthesis inhibitor
novobiocin[no description available]medium20carbamate ester;
ether;
hexoside;
hydroxycoumarin;
monocarboxylic acid amide;
monosaccharide derivative;
phenols		antibacterial agent;
antimicrobial agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Escherichia coli metabolite;
hepatoprotective agent
erythromycin[no description available]medium241cyclic ketone;
erythromycin
lipid a[no description available]medium10dodecanoate ester;
lipid A;
tetradecanoate ester		Escherichia coli metabolite
palladium[no description available]medium220metal allergen;
nickel group element atom;
platinum group metal atom
carbene[no description available]medium30carbene;
methanediyl
methanol[no description available]medium60alkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound		amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
methane[no description available]medium30alkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound		bacterial metabolite;
fossil fuel;
greenhouse gas
nitrofurantoin[no description available]medium150imidazolidine-2,4-dione;
nitrofuran antibiotic;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic		antibacterial drug;
antiinfective agent;
hepatotoxic agent
glycine[no description available]medium50alpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid		EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical
micafungin[no description available]medium20antibiotic antifungal drug;
echinocandin		antiinfective agent
meropenem[no description available]medium231alpha,beta-unsaturated monocarboxylic acid;
carbapenemcarboxylic acid;
organic sulfide;
pyrrolidinecarboxamide		antibacterial agent;
antibacterial drug;
drug allergen
ethambutol[no description available]medium130ethanolamines;
ethylenediamine derivative		antitubercular agent;
environmental contaminant;
xenobiotic
streptomycin[no description available]medium60antibiotic antifungal drug;
antibiotic fungicide;
streptomycins		antibacterial drug;
antifungal agrochemical;
antimicrobial agent;
antimicrobial drug;
bacterial metabolite;
protein synthesis inhibitor
levofloxacin[no description available]medium3019-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;
fluoroquinolone antibiotic;
quinolone antibiotic		antibacterial drug;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor
trimethoprim[no description available]medium30aminopyrimidine;
methoxybenzenes		antibacterial drug;
diuretic;
drug allergen;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
environmental contaminant;
xenobiotic
sodium hydroxide[no description available]medium10alkali metal hydroxide
oxazolidine[no description available]medium10oxazolidine
pa 824[no description available]medium120
azomycin[no description available]medium240C-nitro compound;
imidazoles		antitubercular agent
agelastatin a[no description available]medium280
opc-67683[no description available]medium51piperidines
bedaquiline[no description available]medium212aromatic ether;
naphthalenes;
organobromine compound;
quinolines;
tertiary alcohol;
tertiary amino compound		antitubercular agent;
ATP synthase inhibitor
moxifloxacin[no description available]medium493aromatic ether;
cyclopropanes;
fluoroquinolone antibiotic;
pyrrolidinopiperidine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone		antibacterial drug
metaxalone[no description available]medium283aromatic ether
streptogramin a[no description available]medium401,3-oxazoles;
cyclic ketone;
enamide;
lactam;
macrolide antibiotic;
macrolide;
pyrroline;
secondary alcohol;
secondary carboxamide;
tertiary carboxamide		antibacterial drug;
Mycoplasma genitalium metabolite
clarithromycin[no description available]medium263macrolide antibioticantibacterial drug;
environmental contaminant;
protein synthesis inhibitor;
xenobiotic
boron[no description available]medium20boron group element atom;
metalloid atom;
nonmetal atom		micronutrient
chitosan[no description available]medium80
dihydroergotamine[no description available]medium120ergot alkaloid;
semisynthetic derivative		dopamine agonist;
non-narcotic analgesic;
serotonergic agonist;
sympatholytic agent;
vasoconstrictor agent
abt-199[no description available]medium10aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
N-sulfonylcarboxamide;
oxanes;
pyrrolopyridine		antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
itraconazole[no description available]medium30aromatic ether;
conazole antifungal drug;
cyclic ketal;
dichlorobenzene;
dioxolane;
N-arylpiperazine;
triazole antifungal drug;
triazoles		EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
Hedgehog signaling pathway inhibitor;
P450 inhibitor
mdv 3100[no description available]medium10(trifluoromethyl)benzenes;
benzamides;
imidazolidinone;
monofluorobenzenes;
nitrile;
thiocarbonyl compound		androgen antagonist;
antineoplastic agent
tetrahydropapaverine[no description available]medium10aromatic ether;
benzylisoquinoline alkaloid;
benzyltetrahydroisoquinoline;
polyether;
secondary amino compound
lmt-28[no description available]medium80
nitroglycerin[no description available]medium41nitroglycerolexplosive;
muscle relaxant;
nitric oxide donor;
prodrug;
tocolytic agent;
vasodilator agent;
xenobiotic
metoprolol[no description available]medium10aromatic ether;
propanolamine;
secondary alcohol;
secondary amino compound		antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
geroprotector;
xenobiotic
progoitrin[no description available]medium70alkylglucosinolate
pyrazines[no description available]medium130diazine;
pyrazines		Daphnia magna metabolite
caryophyllene[no description available]medium10
metazachlor[no description available]medium20aromatic amide;
organochlorine compound;
pyrazoles		environmental contaminant;
herbicide;
xenobiotic
clindamycin[no description available]medium420
floxacillin[no description available]medium20penicillin allergen;
penicillin		antibacterial drug
n-methylaspartate[no description available]medium60amino dicarboxylic acid;
D-alpha-amino acid;
D-aspartic acid derivative;
secondary amino compound		neurotransmitter agent
3-amino-2-oxazolidinone[no description available]medium450oxazolidinone
carbamylhydrazine[no description available]medium120carbohydrazide;
monocarboxylic acid amide;
one-carbon compound;
ureas
1-aminohydantoin[no description available]medium70imidazolidine-2,4-dione
ta 0910[no description available]medium20oligopeptideanalgesic;
neuroprotective agent;
nootropic agent
glucose, (beta-d)-isomer[no description available]medium10D-glucopyranoseepitope;
mouse metabolite
leukotriene b4[no description available]medium10dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid		human metabolite;
mouse metabolite;
plant metabolite;
vasoconstrictor agent
metformin[no description available]medium10guanidinesenvironmental contaminant;
geroprotector;
hypoglycemic agent;
xenobiotic
tazobactam[no description available]medium30penicillanic acids;
triazoles		antiinfective agent;
antimicrobial agent;
EC 3.5.2.6 (beta-lactamase) inhibitor
cephalosporin c[no description available]medium563cephalosporinfungal metabolite
tigecycline[no description available]medium851
piperidines[no description available]medium692
rifapentine[no description available]medium50N-alkylpiperazine;
N-iminopiperazine;
rifamycins		antitubercular agent;
leprostatic drug
tedizolid phosphate[no description available]medium280carbamate ester;
organofluorine compound;
oxazolidinone;
phosphate monoester;
pyridines;
tetrazoles		antimicrobial agent;
prodrug;
protein synthesis inhibitor
tedizolid phosphate[no description available]medium286carbamate ester;
organofluorine compound;
oxazolidinone;
phosphate monoester;
pyridines;
tetrazoles		antimicrobial agent;
prodrug;
protein synthesis inhibitor
cycloserine[no description available]medium2324-amino-1,2-oxazolidin-3-one;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic;
zwitterion		antiinfective agent;
antimetabolite;
antitubercular agent;
metabolite;
NMDA receptor agonist
terizidone[no description available]medium192
triazoles[no description available]medium8981,2,3-triazole
benzoxazoles[no description available]medium1001,3-benzoxazoles;
mancude organic heterobicyclic parent
pectins[no description available]medium10D-galactopyranuronic acid
psilocybin[no description available]medium10organic phosphate;
tertiary amino compound;
tryptamine alkaloid		fungal metabolite;
hallucinogen;
prodrug;
serotonergic agonist
ketamine[no description available]medium30cyclohexanones;
monochlorobenzenes;
secondary amino compound		analgesic;
environmental contaminant;
intravenous anaesthetic;
neurotoxin;
NMDA receptor antagonist;
xenobiotic
lysergic acid diethylamide[no description available]medium10ergoline alkaloid;
monocarboxylic acid amide;
organic heterotetracyclic compound		dopamine agonist;
hallucinogen;
serotonergic agonist
capsaicin[no description available]medium41capsaicinoidnon-narcotic analgesic;
TRPV1 agonist;
voltage-gated sodium channel blocker
zucapsaicin[no description available]medium30methoxybenzenes;
phenols
pasireotide[no description available]medium10homodetic cyclic peptide;
peptide hormone		antineoplastic agent
betadex[no description available]medium100cyclodextrin
doripenem[no description available]medium40carbapenems
ciprofloxacin[no description available]medium392aminoquinoline;
cyclopropanes;
fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone;
zwitterion		antibacterial drug;
antiinfective agent;
antimicrobial agent;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
environmental contaminant;
topoisomerase IV inhibitor;
xenobiotic
fluconazole[no description available]medium40conazole antifungal drug;
difluorobenzene;
tertiary alcohol;
triazole antifungal drug		environmental contaminant;
P450 inhibitor;
xenobiotic
voriconazole[no description available]medium30conazole antifungal drug;
difluorobenzene;
pyrimidines;
tertiary alcohol;
triazole antifungal drug		P450 inhibitor
pazufloxacin[no description available]medium10quinolines
carbapenems[no description available]medium231
carbostyril[no description available]medium200monohydroxyquinoline;
quinolone		bacterial xenobiotic metabolite
ro13-9904[no description available]medium174
zithromax[no description available]medium141macrolide antibioticantibacterial drug;
environmental contaminant;
xenobiotic
amikacin[no description available]medium150alpha-D-glucoside;
amino cyclitol glycoside;
aminoglycoside;
carboxamide		antibacterial drug;
antimicrobial agent;
nephrotoxin
eletriptan[no description available]medium303indoles;
N-alkylpyrrolidine;
sulfone		non-steroidal anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
naratriptan[no description available]medium462heteroarylpiperidine;
sulfonamide;
tryptamines		serotonergic agonist;
vasoconstrictor agent
rizatriptan[no description available]medium587tryptaminesanti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
almotriptan[no description available]medium203indoles;
sulfonamide;
tertiary amine		non-steroidal anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
guanidine[no description available]medium50carboxamidine;
guanidines;
one-carbon compound
batzelladine a[no description available]medium10alkaloid;
carboxylic ester;
guanidines;
organic heterotricyclic compound;
pyrrolopyrimidine;
triazaacenaphthylene		anti-HIV-1 agent;
metabolite
tyramine[no description available]medium144monoamine molecular messenger;
primary amino compound;
tyramines		EC 3.1.1.8 (cholinesterase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter
eravacycline[no description available]medium20tetracyclines
virginiamycin[no description available]medium1101
telavancin[no description available]medium180glycopeptideantibacterial drug;
antimicrobial agent
quinupristin-dalfopristin[no description available]medium861organic molecular entity
omadacycline[no description available]medium20tetracyclines
haloxyfop[no description available]medium10aromatic ether;
monocarboxylic acid;
organochlorine compound;
organofluorine compound;
pyridines
fomesafen[no description available]medium20aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-sulfonylcarboxamide;
organofluorine compound;
phenols		agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
bay 11-7082[no description available]medium10nitrile;
sulfone		apoptosis inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor
carvedilol[no description available]medium10carbazoles;
secondary alcohol;
secondary amino compound		alpha-adrenergic antagonist;
antihypertensive agent;
beta-adrenergic antagonist;
cardiovascular drug;
vasodilator agent
isoproterenol[no description available]medium10catechols;
secondary alcohol;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
isopropyl myristate[no description available]medium10fatty acid ester
scopolamine hydrobromide[no description available]medium10
glutamic acid[no description available]medium50glutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical
pyrroles[no description available]medium333pyrrole;
secondary amine
adamantane[no description available]medium100adamantanes;
polycyclic alkane
uridine[no description available]medium20uridinesdrug metabolite;
fundamental metabolite;
human metabolite
sq-641[no description available]medium10
azd2563[no description available]medium260
sudoterb[no description available]medium30
imazethapyr[no description available]medium10aromatic carboxylic acid;
pyridines
bispyribac[no description available]medium20aromatic ether;
benzoic acids;
monocarboxylic acid;
pyrimidines		herbicide
corticosterone[no description available]medium4011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone		human metabolite;
mouse metabolite
methamphetamine[no description available]medium10amphetamines;
secondary amine		central nervous system stimulant;
environmental contaminant;
neurotoxin;
psychotropic drug;
xenobiotic
cp 94253[no description available]medium40pyrrolopyridine
methicillin[no description available]medium351penicillin allergen;
penicillin		antibacterial drug
eprazinone[no description available]medium53
ta-8995[no description available]medium30
carbon tetrachloride[no description available]medium40chlorocarbon;
chloromethanes		hepatotoxic agent;
refrigerant
pyochelin[no description available]medium10monocarboxylic acid;
phenols;
thiazolidines		metabolite;
siderophore
thiazoles[no description available]medium2201,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
tryptanthrine[no description available]medium10alkaloid antibiotic;
organic heterotetracyclic compound;
organonitrogen heterocyclic compound
ribavirin[no description available]medium101-ribosyltriazole;
aromatic amide;
monocarboxylic acid amide;
primary carboxamide		anticoronaviral agent;
antiinfective agent;
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
quinazolines[no description available]medium40azaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinazolines
arachidonic acid[no description available]medium10icosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid		Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite
4-benzyl-3-crotonyl-2-oxazolidinone[no description available]medium130
losartan potassium[no description available]medium30
medicarpin[no description available]medium10medicarpinplant metabolite
minocycline[no description available]medium912
miltefosine[no description available]medium10phosphocholines;
phospholipid		anti-inflammatory agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antiprotozoal drug;
apoptosis inducer;
immunomodulator;
protein kinase inhibitor
retapamulin[no description available]medium40carbotricyclic compound;
carboxylic ester;
cyclic ketone
phosphorylcholine[no description available]medium10phosphocholinesallergen;
epitope;
hapten;
human metabolite;
mouse metabolite
valnemulin[no description available]medium10carbotricyclic compound;
carboxylic ester;
cyclic ketone
tiamulin[no description available]medium30carbotricyclic compound;
carboxylic ester;
cyclic ketone;
organic sulfide;
secondary alcohol;
semisynthetic derivative;
tertiary amino compound;
tetracyclic diterpenoid		antibacterial drug
chlorantranilipole[no description available]medium10monochlorobenzenes;
organobromine compound;
pyrazole insecticide;
pyrazoles;
pyridines;
secondary carboxamide		ryanodine receptor agonist
technetium[no description available]medium20manganese group element atom
triphosphoric acid[no description available]medium10acyclic phosphorus acid anhydride;
phosphorus oxoacid
sulfuretin[no description available]medium101-benzofurans
clorgyline[no description available]medium170aromatic ether;
dichlorobenzene;
terminal acetylenic compound;
tertiary amino compound		antidepressant;
EC 1.4.3.4 (monoamine oxidase) inhibitor
lazabemide[no description available]medium10
toloxatone[no description available]medium320oxazolidinone;
primary alcohol;
toluenes
toloxatone[no description available]medium326oxazolidinone;
primary alcohol;
toluenes
benzofurans[no description available]medium50
pyrazolanthrone[no description available]medium10anthrapyrazole;
aromatic ketone;
cyclic ketone		antineoplastic agent;
c-Jun N-terminal kinase inhibitor;
geroprotector
endothelin-1[no description available]medium20
pyrimidinones[no description available]medium40
hydroxyl radical[no description available]medium10oxygen hydride;
oxygen radical;
reactive oxygen species
etodolac[no description available]medium10monocarboxylic acid;
organic heterotricyclic compound		antipyretic;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
furazolidone[no description available]medium420nitrofuran antibiotic;
oxazolidines		antibacterial drug;
antiinfective agent;
antitrichomonal drug;
EC 1.4.3.4 (monoamine oxidase) inhibitor
sodium glutamate[no description available]medium20monosodium glutamateflavouring agent
sinapinic acid[no description available]medium10sinapic acidMALDI matrix material;
plant metabolite
ammonium hydroxide[no description available]medium20azane;
gas molecular entity;
mononuclear parent hydride		EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant
fidaxomicin[no description available]medium40
cadazolid[no description available]medium163
thiourea[no description available]medium70one-carbon compound;
thioureas;
ureas		antioxidant;
chromophore
ethionamide[no description available]medium30pyridines;
thiocarboxamide		antilipemic drug;
antitubercular agent;
fatty acid synthesis inhibitor;
leprostatic drug;
prodrug
ezetimibe[no description available]medium51azetidines;
beta-lactam;
organofluorine compound		anticholesteremic drug;
antilipemic drug;
antimetabolite
lignans[no description available]medium20
probucol[no description available]medium30dithioketal;
polyphenol		anti-inflammatory drug;
anticholesteremic drug;
antilipemic drug;
antioxidant;
cardiovascular drug
leoligin[no description available]medium10
cem 101[no description available]medium31
papaverine[no description available]medium10benzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines		antispasmodic drug;
vasodilator agent
propargyl alcohol[no description available]medium20propynol;
terminal acetylenic compound;
volatile organic compound		antifungal agent;
Saccharomyces cerevisiae metabolite
nafcillin[no description available]medium70penicillin allergen;
penicillin		antibacterial drug
1-anilino-8-naphthalenesulfonate[no description available]medium30aminonaphthalene;
naphthalenesulfonic acid		fluorescent probe
tetradecanoylphorbol acetate[no description available]medium10acetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester		antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator
sq-23377[no description available]medium10cyclic ether;
enol;
polyunsaturated fatty acid;
very long-chain fatty acid		calcium ionophore;
metabolite
pentylenetetrazole[no description available]medium10organic heterobicyclic compound;
organonitrogen heterocyclic compound
proline[no description available]medium110amino acid zwitterion;
glutamine family amino acid;
L-alpha-amino acid;
proline;
proteinogenic amino acid		algal metabolite;
compatible osmolytes;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
butyraldehyde[no description available]medium10butanalsbiomarker;
Escherichia coli metabolite;
mouse metabolite
imipenem, anhydrous[no description available]medium140beta-lactam antibiotic allergen;
carbapenems;
zwitterion		antibacterial drug
avibactam[no description available]medium10azabicycloalkane;
hydroxylamine O-sulfonic acid;
monocarboxylic acid amide;
ureas		antibacterial drug;
antimicrobial agent;
EC 3.5.2.6 (beta-lactamase) inhibitor
sq 109[no description available]medium80
mocetinostat[no description available]medium40aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline		antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
hydroxyproline[no description available]medium104-hydroxyproline;
L-alpha-amino acid zwitterion		human metabolite;
mouse metabolite;
plant metabolite
transforming growth factor beta[no description available]medium21
gamma-cyclodextrin[no description available]medium10cyclodextrin
baclofen[no description available]medium21amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid;
monochlorobenzenes;
primary amino compound		central nervous system depressant;
GABA agonist;
muscle relaxant
clonidine[no description available]medium21clonidine;
imidazoline
ibuprofen[no description available]medium112monocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
tizanidine[no description available]medium11benzothiadiazole;
imidazoles		alpha-adrenergic agonist;
muscle relaxant
valine[no description available]medium30L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
trifazid[no description available]medium10
isopropyl palmitate[no description available]medium10fatty acid ester;
isopropyl ester		human metabolite
propionamide[no description available]medium10monocarboxylic acid amide;
primary fatty amide
metronidazole[no description available]medium200C-nitro compound;
imidazoles;
primary alcohol		antiamoebic agent;
antibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
environmental contaminant;
prodrug;
radiosensitizing agent;
xenobiotic
afn 1252[no description available]medium10
trimethoprim, sulfamethoxazole drug combination[no description available]medium482
dalteparin[no description available]medium20
tacrolimus[no description available]medium10macrolide lactambacterial metabolite;
immunosuppressive agent
potassium phosphate[no description available]medium10inorganic phosphate salt;
inorganic potassium salt
amoxicillin-potassium clavulanate combination[no description available]medium133
ofloxacin[no description available]medium3223-oxo monocarboxylic acid;
N-arylpiperazine;
N-methylpiperazine;
organofluorine compound;
oxazinoquinoline
etc-1002[no description available]medium10alpha,omega-dicarboxylic acidantilipemic drug;
EC 2.3.3.8 (ATP citrate synthase) inhibitor;
prodrug
bms201038[no description available]medium30(trifluoromethyl)benzenes;
benzamides;
fluorenes;
piperidines		anticholesteremic drug;
MTP inhibitor
oligonucleotides[no description available]medium40
interleukin-8[no description available]medium20
ru 66647[no description available]medium200
gentamicin[no description available]medium280
pseudoephedrine[no description available]medium11phenylethanolamines;
secondary alcohol;
secondary amino compound		anti-asthmatic drug;
bronchodilator agent;
central nervous system drug;
nasal decongestant;
plant metabolite;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
l 743,872[no description available]medium50
oxacillin[no description available]medium181penicillinantibacterial agent;
antibacterial drug
sb 269970[no description available]medium10sulfonamide
acetylcysteine[no description available]medium20acetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid		antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
paraquat[no description available]medium30organic cationgeroprotector;
herbicide
erythritol[no description available]medium40butane-1,2,3,4-tetrolantioxidant;
human metabolite;
plant metabolite
fosfomycin[no description available]medium120epoxide;
phosphonic acids		antimicrobial agent;
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor
cycloheximide[no description available]medium10antibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol		anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
fosmidomycin[no description available]medium30hydroxamic acid;
phosphonic acids		antimicrobial agent;
bacterial metabolite;
EC 1.1.1.267 (1-deoxy-D-xylulose-5-phosphate reductoisomerase) inhibitor
2-c-methylerythritol 4-phosphate[no description available]medium30tetritol phosphateEscherichia coli metabolite
allose[no description available]medium10allopyranose;
D-allose		antioxidant
glucosamine[no description available]medium90D-glucosamineEscherichia coli metabolite;
geroprotector;
mouse metabolite
frovatriptan[no description available]medium163carbazoles
fenitrothion[no description available]medium10C-nitro compound;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
insecticide
tebuconazole[no description available]medium20monochlorobenzenes;
tertiary alcohol;
triazoles
dimethoate[no description available]medium10monocarboxylic acid amide;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
atrazine[no description available]medium10chloro-1,3,5-triazine;
diamino-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
malathion[no description available]medium10diester;
ethyl ester;
organic thiophosphate
fipronil[no description available]medium10(trifluoromethyl)benzenes;
dichlorobenzene;
nitrile;
primary amino compound;
pyrazoles;
sulfoxide
cilastatin[no description available]medium20carboxamide;
L-cysteine derivative;
non-proteinogenic L-alpha-amino acid;
organic sulfide		EC 3.4.13.19 (membrane dipeptidase) inhibitor;
environmental contaminant;
protease inhibitor;
xenobiotic
cilastatin, imipenem drug combination[no description available]medium10
terbinafine[no description available]medium10acetylenic compound;
allylamine antifungal drug;
enyne;
naphthalenes;
tertiary amine		EC 1.14.13.132 (squalene monooxygenase) inhibitor;
P450 inhibitor;
sterol biosynthesis inhibitor
ceftobiprole[no description available]medium170cephalosporin;
thiadiazoles		antimicrobial agent
22-hydroxycholesterol[no description available]medium10cholanoid
1-deoxynojirimycin[no description available]medium202-(hydroxymethyl)piperidine-3,4,5-triol;
piperidine alkaloid		anti-HIV agent;
anti-obesity agent;
bacterial metabolite;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
hypoglycemic agent;
plant metabolite
cyclopentenone[no description available]medium20alicyclic ketone;
enone		Hsp70 inducer
cyclopentane[no description available]medium80cycloalkane;
cyclopentanes;
volatile organic compound		non-polar solvent
mupirocin[no description available]medium130alpha,beta-unsaturated carboxylic ester;
epoxide;
monocarboxylic acid;
oxanes;
secondary alcohol;
triol		antibacterial drug;
bacterial metabolite;
protein synthesis inhibitor
fusidic acid[no description available]medium14111alpha-hydroxy steroid;
3alpha-hydroxy steroid;
alpha,beta-unsaturated monocarboxylic acid;
steroid acid;
steroid antibiotic;
sterol ester		EC 2.7.1.33 (pantothenate kinase) inhibitor;
Escherichia coli metabolite;
protein synthesis inhibitor
titanium[no description available]medium70titanium group element atom
titanium dioxide[no description available]medium10titanium oxidesfood colouring
2-hydroxyethylhydrazine[no description available]medium30hydrazinesherbicide
hydrazine[no description available]medium90azane;
hydrazines		EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor
clofazimine[no description available]medium50monochlorobenzenes;
phenazines		dye;
leprostatic drug;
non-steroidal anti-inflammatory drug
trifluoromethanesulfonic acid[no description available]medium30one-carbon compound;
perfluoroalkanesulfonic acid
glycosides[no description available]medium70
3-amino-5-morpholinomethyl-2-oxazolidinone[no description available]medium120morpholines;
oxazolidinone		marine xenobiotic metabolite;
xenobiotic metabolite
oxadiazoles[no description available]medium70
phenyl acetate[no description available]medium70benzenes;
phenyl acetates
lovastatin[no description available]medium30delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring)		anticholesteremic drug;
antineoplastic agent;
Aspergillus metabolite;
prodrug
methyl jasmonate[no description available]medium10
rubimaillin[no description available]medium10benzochromene;
methyl ester;
phenols		acyl-CoA:cholesterol acyltransferase 2 inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
neuroprotective agent;
NF-kappaB inhibitor;
plant metabolite
naproxen[no description available]medium40methoxynaphthalene;
monocarboxylic acid		antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
propranolol[no description available]medium102naphthalenes;
propanolamine;
secondary amine		anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
colistin[no description available]medium30
diphenyldiselenide[no description available]medium10
ascorbic acid[no description available]medium41ascorbic acid;
vitamin C		coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent
acetonitrile[no description available]medium50aliphatic nitrile;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
NMR chemical shift reference compound;
polar aprotic solvent
phosphoric acid[no description available]medium20phosphoric acidsalgal metabolite;
fertilizer;
human metabolite;
NMR chemical shift reference compound;
solvent
lactic acid[no description available]medium502-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
cyclosporine[no description available]medium20
organophosphonates[no description available]medium30divalent inorganic anion;
phosphite ion
alanyl-glycyl-glycine[no description available]medium10oligopeptide
merrifield resin[no description available]medium10
aspirin[no description available]medium134benzoic acids;
phenyl acetates;
salicylates		anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
tinidazole[no description available]medium10imidazolesantiamoebic agent;
antibacterial drug;
antiparasitic agent;
antiprotozoal drug
gatifloxacin[no description available]medium191N-arylpiperazine;
organofluorine compound;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone		antiinfective agent;
antimicrobial agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
norfloxacin[no description available]medium40fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone		antibacterial drug;
DNA synthesis inhibitor;
environmental contaminant;
xenobiotic
spectinomycin[no description available]medium50cyclic acetal;
cyclic hemiketal;
cyclic ketone;
pyranobenzodioxin;
secondary alcohol;
secondary amino compound		antibacterial drug;
antimicrobial agent;
bacterial metabolite
oxalates[no description available]medium10
manganese[no description available]medium10elemental manganese;
manganese group element atom		Escherichia coli metabolite;
micronutrient
ampicillin[no description available]medium111beta-lactam antibiotic;
penicillin allergen;
penicillin		antibacterial drug
ranalexin[no description available]medium10
chondroitin sulfates[no description available]medium30
4-dimethylaminopyridine[no description available]medium10dialkylarylamine;
tertiary amino compound
4-aminopyridine[no description available]medium10aminopyridine;
aromatic amine		avicide;
orphan drug;
potassium channel blocker
cefoxitin[no description available]medium40beta-lactam antibiotic allergen;
cephalosporin;
cephamycin;
semisynthetic derivative		antibacterial drug
tobramycin[no description available]medium50amino cyclitol glycosideantibacterial agent;
antimicrobial agent;
toxin
methylprednisolone[no description available]medium306-methylprednisolone;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antiemetic;
environmental contaminant;
neuroprotective agent;
xenobiotic
eosine yellowish-(ys)[no description available]medium10organic sodium salt;
organobromine compound		fluorochrome;
histological dye
ferric chloride[no description available]medium10iron coordination entityastringent;
Lewis acid
chlorine[no description available]medium40halide anion;
monoatomic chlorine		cofactor;
Escherichia coli metabolite;
human metabolite
fullerene c60[no description available]medium20fullerenegeroprotector
diclofenac[no description available]medium30amino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound		antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
telcagepant[no description available]medium83
paramethadione[no description available]medium10oxazolidinoneanticonvulsant
furan[no description available]medium50furans;
mancude organic heteromonocyclic parent;
monocyclic heteroarene		carcinogenic agent;
hepatotoxic agent;
Maillard reaction product
3-isoxazolidone[no description available]medium150oxazolidinone
aminolevulinic acid[no description available]medium104-oxo monocarboxylic acid;
amino acid zwitterion;
delta-amino acid		antineoplastic agent;
dermatologic drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
methylcellulose[no description available]medium20
thyroxine[no description available]medium502-halophenol;
iodophenol;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
thyroxine zwitterion;
thyroxine		antithyroid drug;
human metabolite;
mouse metabolite;
thyroid hormone
gemifloxacin[no description available]medium201,8-naphthyridine derivative;
fluoroquinolone antibiotic;
monocarboxylic acid;
quinolone antibiotic		antibacterial drug;
antimicrobial agent;
topoisomerase IV inhibitor
kainic acid[no description available]medium30dicarboxylic acid;
L-proline derivative;
non-proteinogenic L-alpha-amino acid;
pyrrolidinecarboxylic acid		antinematodal drug;
excitatory amino acid agonist
d-alpha tocopherol[no description available]medium31alpha-tocopherolalgal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite
ceftobiprole medocaril[no description available]medium22
agar[no description available]medium40
sulbactam[no description available]medium51penicillanic acids
cefoperazone[no description available]medium30cephalosporinantibacterial drug
chlorophyll a[no description available]medium40chlorophyll;
methyl ester		cofactor
molinate[no description available]medium40azepanes;
monothiocarbamic ester		agrochemical;
antispermatogenic agent;
herbicide
orabase[no description available]medium10
berberine[no description available]medium10alkaloid antibiotic;
berberine alkaloid;
botanical anti-fungal agent;
organic heteropentacyclic compound		antilipemic drug;
antineoplastic agent;
antioxidant;
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor;
EC 1.21.3.3 (reticuline oxidase) inhibitor;
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
hypoglycemic agent;
metabolite;
potassium channel blocker
oritavancin[no description available]medium100disaccharide derivative;
glycopeptide;
semisynthetic derivative		antibacterial drug;
antimicrobial agent
alkenes[no description available]medium130
azides[no description available]medium40pseudohalide anionmitochondrial respiratory-chain inhibitor
niacin[no description available]medium81pyridine alkaloid;
pyridinemonocarboxylic acid;
vitamin B3		antidote;
antilipemic drug;
EC 3.5.1.19 (nicotinamidase) inhibitor;
Escherichia coli metabolite;
human urinary metabolite;
metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
galactosamine[no description available]medium10D-galactosamine;
primary amino compound		toxin
albendazole[no description available]medium10aryl sulfide;
benzimidazoles;
benzimidazolylcarbamate fungicide;
carbamate ester		anthelminthic drug;
microtubule-destabilising agent;
tubulin modulator
dextrothyroxine[no description available]medium10
gsk1322322[no description available]medium11
clopidogrel[no description available]medium10methyl ester;
monochlorobenzenes;
thienopyridine		anticoagulant;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
ticlopidine[no description available]medium10monochlorobenzenes;
thienopyridine		anticoagulant;
fibrin modulating drug;
hematologic agent;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
methysergide[no description available]medium40ergoline alkaloid
arginine[no description available]medium30arginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical
methyl carbonate[no description available]medium20carbonate esterreagent;
solvent
norvancomycin[no description available]medium10
dehydroalanine[no description available]medium102,3-dehydroamino acid;
alpha,beta-unsaturated monocarboxylic acid;
amino acid zwitterion;
enamine;
non-proteinogenic alpha-amino acid		alkylating agent;
human metabolite;
mouse metabolite
tryptophan[no description available]medium40erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan		antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
endomorphin 1[no description available]medium10oligopeptide
t0901317[no description available]medium10
lutein[no description available]medium10carotenolfood colouring;
plant metabolite
zeaxanthin[no description available]medium10carotenolantioxidant;
bacterial metabolite;
cofactor
chromium[no description available]medium10chromium group element atom;
metal allergen		micronutrient
ametryne[no description available]medium10diamino-1,3,5-triazine;
methylthio-1,3,5-triazine		environmental contaminant;
herbicide
fluorodeoxyglucose f18[no description available]medium102-deoxy-2-((18)F)fluoro-D-glucose;
2-deoxy-2-fluoro-aldehydo-D-glucose
sphingosine[no description available]medium10sphing-4-eninehuman metabolite;
mouse metabolite
pachastrissamine[no description available]medium10
gw 4064[no description available]medium10stilbenoid
plastoquinone[no description available]medium10plastoquinone
pheophytin a[no description available]medium10
citalopram[no description available]medium802-benzofurans;
cyclic ether;
nitrile;
organofluorine compound;
tertiary amino compound
paroxetine[no description available]medium30aromatic ether;
benzodioxoles;
organofluorine compound;
piperidines		antidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor
ketorolac[no description available]medium30amino acid;
aromatic ketone;
monocarboxylic acid;
pyrrolizines;
racemate		analgesic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
tetramethylpyrazine[no description available]medium10alkaloid;
pyrazines		antineoplastic agent;
apoptosis inhibitor;
bacterial metabolite;
neuroprotective agent;
platelet aggregation inhibitor;
vasodilator agent
kanamycin a[no description available]medium30kanamycinsbacterial metabolite
phosphorus[no description available]medium20monoatomic phosphorus;
nonmetal atom;
pnictogen		macronutrient
warfarin[no description available]medium21benzenes;
hydroxycoumarin;
methyl ketone
lead[no description available]medium10carbon group element atom;
elemental lead;
metal atom		neurotoxin
resazurin[no description available]medium20phenoxazine
rifamycins[no description available]medium50
xanthenes[no description available]medium20xanthene
valproic acid[no description available]medium30branched-chain fatty acid;
branched-chain saturated fatty acid		anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
cefixime[no description available]medium10
poloxalene[no description available]medium10epoxide
benzoxazolone[no description available]medium10benzoxazoleallelochemical;
phytoalexin
oxamide[no description available]medium10dicarboxylic acid diamide
oxamic acid[no description available]medium10dicarboxylic acid monoamideEscherichia coli metabolite
1-butyl-3-methylimidazolium tetrafluoroborate[no description available]medium10
fluorine[no description available]medium30diatomic fluorine;
gas molecular entity		NMR chemical shift reference compound
thiazolyl blue[no description available]medium10organic bromide saltcolorimetric reagent;
dye
garenoxacin[no description available]medium30aromatic ether;
cyclopropanes;
isoindoles;
organofluorine compound;
quinolinemonocarboxylic acid;
quinolone antibiotic		antibacterial drug;
non-steroidal anti-inflammatory drug
abt 492[no description available]medium10
indazoles[no description available]medium10indazole
alpha-aminopyridine[no description available]medium10
kibdelomycin[no description available]medium10
acetic acid[no description available]medium20monocarboxylic acidantimicrobial food preservative;
Daphnia magna metabolite;
food acidity regulator;
protic solvent
amoxicillin[no description available]medium170penicillin allergen;
penicillin		antibacterial drug
clavulanic acid[no description available]medium50oxapenamantibacterial drug;
anxiolytic drug;
bacterial metabolite;
EC 3.5.2.6 (beta-lactamase) inhibitor
thioridazine[no description available]medium20phenothiazines;
piperidines		alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist
rwj-416457[no description available]medium80
catechol[no description available]medium10catecholsallelochemical;
genotoxin;
plant metabolite
acrylic acid[no description available]medium10alpha,beta-unsaturated monocarboxylic acidmetabolite
madindoline a[no description available]medium10
adenosine[no description available]medium20adenosines;
purines D-ribonucleoside		analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
glucuronic acid[no description available]medium30D-glucuronic acidalgal metabolite
2,2'-dipyridyl[no description available]medium10bipyridinechelator;
ferroptosis inhibitor
propargyl bromide[no description available]medium10
pargyline[no description available]medium50aromatic amine
isothiocyanic acid[no description available]medium30hydracid;
one-carbon compound
iodine[no description available]medium30diatomic iodinenutrient
glucoraphanin[no description available]medium10sulfoxide;
thia-alkylglucosinolic acid
thiocyanate[no description available]medium10pseudohalide anion;
sulfur molecular entity		human metabolite
sulforaphane[no description available]medium10isothiocyanate;
sulfoxide		antineoplastic agent;
antioxidant;
EC 3.5.1.98 (histone deacetylase) inhibitor;
plant metabolite
sirolimus[no description available]medium10antibiotic antifungal drug;
cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
organic heterotricyclic compound;
secondary alcohol		antibacterial drug;
anticoronaviral agent;
antineoplastic agent;
bacterial metabolite;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
leucine[no description available]medium10amino acid zwitterion;
L-alpha-amino acid;
leucine;
proteinogenic amino acid;
pyruvate family amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
leucinol[no description available]medium10
aluminum[no description available]medium30boron group element atom;
elemental aluminium;
metal atom
aziridine[no description available]medium50azacycloalkane;
aziridines;
saturated organic heteromonocyclic parent		alkylating agent
GDC-0623[no description available]medium10hydroxamic acid ester;
imidazopyridine;
monofluorobenzenes;
organoiodine compound;
primary alcohol;
secondary amino compound;
substituted aniline		antineoplastic agent;
apoptosis inducer;
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
4-bromoaniline[no description available]medium10
alpha-asarone[no description available]medium10asaroneanticonvulsant;
GABA modulator
benzbromarone[no description available]medium101-benzofurans;
aromatic ketone		uricosuric drug
niacinamide[no description available]medium20pyridine alkaloid;
pyridinecarboxamide;
vitamin B3		anti-inflammatory agent;
antioxidant;
cofactor;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Escherichia coli metabolite;
geroprotector;
human urinary metabolite;
metabolite;
mouse metabolite;
neuroprotective agent;
Saccharomyces cerevisiae metabolite;
Sir2 inhibitor
thiophenes[no description available]medium130mancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound		non-polar solvent
4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol[no description available]medium10nitrosamine;
pyridines;
secondary alcohol		biomarker;
carcinogenic agent;
human urinary metabolite
jnj38877605[no description available]medium10quinolines
silver[no description available]medium30copper group element atom;
elemental silver		Escherichia coli metabolite
ethanolamine[no description available]medium10ethanolamines;
primary alcohol;
primary amine		Escherichia coli metabolite;
human metabolite;
mouse metabolite
propargylamine[no description available]medium10
1-methyl-3-ethylimidazolium[no description available]medium101-alkyl-3-methylimidazolium
triallate[no description available]medium10tertiary amine
naphthosultone[no description available]medium10
surotomycin[no description available]medium30
ridinilazole[no description available]medium20
zirconium[no description available]medium20titanium group element atom
didymin[no description available]medium10flavonoids;
glycoside
2-nitrobenzaldehyde[no description available]medium40benzaldehydes;
C-nitro compound
ethyl acetate[no description available]medium20acetate ester;
ethyl ester;
volatile organic compound		EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor;
metabolite;
polar aprotic solvent;
Saccharomyces cerevisiae metabolite
thioacetazone[no description available]medium20
1,4-dihydropyridine[no description available]medium10
dihydropyridines[no description available]medium10
2-methylpentane[no description available]medium10alkane
tetrahydrofuran[no description available]medium10cyclic ether;
oxolanes;
saturated organic heteromonocyclic parent;
volatile organic compound		polar aprotic solvent
toluene[no description available]medium10methylbenzene;
toluenes;
volatile organic compound		cholinergic antagonist;
fuel additive;
neurotoxin;
non-polar solvent
lithium bis(trimethylsilyl)amide[no description available]medium10
lff571[no description available]medium10
rep 3123[no description available]medium10
triethanolamine[no description available]medium10amino alcohol;
tertiary amino compound;
triol		buffer;
surfactant
diphenhydramine[no description available]medium40ether;
tertiary amino compound		anti-allergic agent;
antidyskinesia agent;
antiemetic;
antiparkinson drug;
antipruritic drug;
antitussive;
H1-receptor antagonist;
local anaesthetic;
muscarinic antagonist;
oneirogen;
sedative
furosemide[no description available]medium10chlorobenzoic acid;
furans;
sulfonamide		environmental contaminant;
loop diuretic;
xenobiotic
oxycodone[no description available]medium20organic heteropentacyclic compound;
semisynthetic derivative		antitussive;
mu-opioid receptor agonist;
opioid analgesic
famotidine[no description available]medium101,3-thiazoles;
guanidines;
sulfonamide		anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
ertapenem[no description available]medium60carbapenemcarboxylic acid;
pyrrolidinecarboxamide		antibacterial drug
ranbezolid[no description available]medium70
3-nitroso-2-oxazolidone[no description available]medium50
glycidamide[no description available]medium10
milrinone[no description available]medium10bipyridines;
nitrile;
pyridone		cardiotonic drug;
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
amiodarone[no description available]medium401-benzofurans;
aromatic ketone;
organoiodine compound;
tertiary amino compound		cardiovascular drug
acetylenedicarboxylic acid dimethyl ester[no description available]medium10
1,2-dioxetane[no description available]medium10
nickel[no description available]medium40metal allergen;
nickel group element atom		epitope;
micronutrient
n-glycolylneuraminic acid[no description available]medium10N-acylneuraminic acid
penicillin g[no description available]medium50penicillin allergen;
penicillin		antibacterial drug;
drug allergen;
epitope
da-7867[no description available]medium160
sparsomycin[no description available]medium40
malondialdehyde[no description available]medium10dialdehydebiomarker
mycobactin[no description available]medium10
indocyanine green[no description available]medium101,1-diunsubstituted alkanesulfonate;
benzoindole;
cyanine dye
midazolam[no description available]medium21imidazobenzodiazepine;
monofluorobenzenes;
organochlorine compound		anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative
diazepam[no description available]medium511,4-benzodiazepinone;
organochlorine compound		anticonvulsant;
anxiolytic drug;
environmental contaminant;
sedative;
xenobiotic
ketoconazole[no description available]medium42dichlorobenzene;
dioxolane;
ether;
imidazoles;
N-acylpiperazine;
N-arylpiperazine
imidazole[no description available]medium10imidazole
morpholine[no description available]medium20morpholines;
saturated organic heteromonocyclic parent		NMR chemical shift reference compound
leflunomide[no description available]medium10(trifluoromethyl)benzenes;
isoxazoles;
monocarboxylic acid amide		antineoplastic agent;
antiparasitic agent;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
hepatotoxic agent;
immunosuppressive agent;
non-steroidal anti-inflammatory drug;
prodrug;
pyrimidine synthesis inhibitor;
tyrosine kinase inhibitor
1,4-dioxane[no description available]medium10dioxane;
volatile organic compound		carcinogenic agent;
metabolite;
NMR chemical shift reference compound;
non-polar solvent
gabapentin[no description available]medium20gamma-amino acidanticonvulsant;
calcium channel blocker;
environmental contaminant;
xenobiotic
gamma-aminobutyric acid[no description available]medium80amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid		human metabolite;
neurotransmitter;
Saccharomyces cerevisiae metabolite;
signalling molecule
allylglycine[no description available]medium10
fluorides[no description available]medium20halide anion;
monoatomic fluorine
venlafaxine hydrochloride[no description available]medium60hydrochloride
cyclohexanol[no description available]medium70cyclohexanols;
secondary alcohol		solvent
mk-0524[no description available]medium10indolyl carboxylic acid
carbofuran[no description available]medium201-benzofurans;
carbamate ester		acaricide;
agrochemical;
avicide;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
nematicide
mannose[no description available]medium10D-aldohexose;
D-mannose;
mannopyranose		metabolite
calcium gluconate[no description available]medium10calcium saltnutraceutical
mannosamine[no description available]medium10D-mannosamine
methylthiouracil[no description available]medium20pyrimidone
cefditoren[no description available]medium20carboxylic acid;
cephalosporin		antibacterial drug
ergotamine[no description available]medium142peptide ergot alkaloidalpha-adrenergic agonist;
mycotoxin;
non-narcotic analgesic;
oxytocic;
serotonergic agonist;
vasoconstrictor agent
n-heptane[no description available]medium10alkane;
volatile organic compound		non-polar solvent;
plant metabolite
phenylalanine[no description available]medium20amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
phenylalanine;
proteinogenic amino acid		algal metabolite;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
Escherichia coli metabolite;
human xenobiotic metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
piperazine[no description available]medium30azacycloalkane;
piperazines;
saturated organic heteromonocyclic parent		anthelminthic drug
1,4-thioxane[no description available]medium10
sulfamic acid[no description available]medium20sulfamic acids
piracetam[no description available]medium20organonitrogen compound;
organooxygen compound
levetiracetam[no description available]medium20pyrrolidin-2-onesanticonvulsant;
environmental contaminant;
xenobiotic
dalfopristin[no description available]medium160
4-butyrolactone[no description available]medium30butan-4-olidemetabolite;
neurotoxin
eperezolid[no description available]medium371
dichlorodicyanobenzoquinone[no description available]medium10
simvastatin[no description available]medium11delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
statin (semi-synthetic)		EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
ferroptosis inducer;
geroprotector;
prodrug
iclaprim[no description available]medium20aminopyrimidine;
chromenes;
cyclopropanes
acetone[no description available]medium20ketone body;
methyl ketone;
propanones;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent
anisomycin[no description available]medium10monohydroxypyrrolidine;
organonitrogen heterocyclic antibiotic		anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
antiparasitic agent;
bacterial metabolite;
DNA synthesis inhibitor;
protein synthesis inhibitor
preussin[no description available]medium10
aztreonam[no description available]medium85
threonine[no description available]medium10amino acid zwitterion;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
threonine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
ceratinamine[no description available]medium10
metoclopramide[no description available]medium62benzamides;
monochlorobenzenes;
substituted aniline;
tertiary amino compound		antiemetic;
dopaminergic antagonist;
environmental contaminant;
gastrointestinal drug;
xenobiotic
fumarates[no description available]medium20butenedioate;
C4-dicarboxylate		human metabolite;
metabolite;
Saccharomyces cerevisiae metabolite
laurocapram[no description available]medium10
propylene glycol[no description available]medium10glycol;
propane-1,2-diols		allergen;
human xenobiotic metabolite;
mouse metabolite;
protic solvent
deet[no description available]medium10benzamides;
monocarboxylic acid amide		environmental contaminant;
insect repellent;
xenobiotic
sulfur[no description available]medium60chalcogen;
nonmetal atom		macronutrient
creatine[no description available]medium10glycine derivative;
guanidines;
zwitterion		geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent;
nutraceutical
mitomycin[no description available]medium10mitomycinalkylating agent;
antineoplastic agent
hydrogen carbonate[no description available]medium20carbon oxoanioncofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
temocillin[no description available]medium10penicillin
benzaldehyde[no description available]medium20benzaldehydesEC 3.1.1.3 (triacylglycerol lipase) inhibitor;
EC 3.5.5.1 (nitrilase) inhibitor;
flavouring agent;
fragrance;
odorant receptor agonist;
plant metabolite
melatonin[no description available]medium10acetamides;
tryptamines		anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger
fibrin[no description available]medium10peptide
icodextrin[no description available]medium10
phosphatidylcholines[no description available]medium101,2-diacyl-sn-glycero-3-phosphocholine
clofibric acid[no description available]medium10aromatic ether;
monocarboxylic acid;
monochlorobenzenes		anticholesteremic drug;
antilipemic drug;
antineoplastic agent;
herbicide;
marine xenobiotic metabolite;
PPARalpha agonist
sisomicin[no description available]medium10amino cyclitol glycoside;
aminoglycoside antibiotic;
beta-L-arabinoside;
monosaccharide derivative
achn 490[no description available]medium10
caffeine[no description available]medium31purine alkaloid;
trimethylxanthine		adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
monensin[no description available]medium10cyclic hemiketal;
monocarboxylic acid;
polyether antibiotic;
spiroketal		antifungal agent;
coccidiostat;
ionophore
diltiazem[no description available]medium215-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetateantihypertensive agent;
calcium channel blocker;
vasodilator agent
cefazolin[no description available]medium40beta-lactam antibiotic allergen;
cephalosporin;
tetrazoles;
thiadiazoles		antibacterial drug
probenecid[no description available]medium11benzoic acids;
sulfonamide		uricosuric drug
cimetidine[no description available]medium61aliphatic sulfide;
guanidines;
imidazoles;
nitrile		adjuvant;
analgesic;
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
butalbital[no description available]medium10barbituratesanalgesic;
sedative
methadone[no description available]medium20benzenes;
diarylmethane;
ketone;
tertiary amino compound
carisoprodol[no description available]medium20carbamate estermuscle relaxant
phenylthiourea[no description available]medium10thioureasEC 1.14.18.1 (tyrosinase) inhibitor
propylthiouracil[no description available]medium10pyrimidinethioneantidote to paracetamol poisoning;
antimetabolite;
antioxidant;
antithyroid drug;
carcinogenic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
hormone antagonist
azetidine[no description available]medium10azacycloalkane;
azetidines;
saturated organic heteromonocyclic parent
tubulysin d[no description available]medium10carboxylic acid;
diester
gulose[no description available]medium10D-aldohexose;
D-gulose;
gulopyranose
tubulysin u[no description available]medium10
tubulysin v[no description available]medium10
galactose[no description available]medium10
cefuroxime[no description available]medium50carbamate ester;
cephalosporin
peramivir[no description available]medium10
rhodium[no description available]medium20cobalt group element atom
streptogramin b[no description available]medium30cyclodepsipeptideantibacterial drug;
antimicrobial agent;
bacterial metabolite
pregabalin[no description available]medium10gamma-amino acidanticonvulsant;
calcium channel blocker
valdecoxib[no description available]medium10isoxazoles;
sulfonamide		antipyretic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
ziprasidone[no description available]medium101,2-benzisothiazole;
indolones;
organochlorine compound;
piperazines		antipsychotic agent;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
psychotropic drug;
serotonergic antagonist
quinupristin[no description available]medium210cyclodepsipeptide
tricalcium phosphate[no description available]medium10calcium phosphate
cefepime[no description available]medium70cephalosporin;
oxime O-ether		antibacterial drug
1-hydroxy-3-amino-2-pyrrolidone[no description available]medium10
mci 9038[no description available]medium20peptide
sodium persulfate[no description available]medium10
azauracil[no description available]medium101,2,4-triazines;
nucleobase analogue		antimetabolite
azetidyl-2-carboxylic acid[no description available]medium10azetidine-2-carboxylic acid
uracil[no description available]medium10pyrimidine nucleobase;
pyrimidone		allergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
succinobucol[no description available]medium20benzoate ester;
phenols
darapladib[no description available]medium20
varespladib[no description available]medium10aromatic ether;
benzenes;
dicarboxylic acid monoamide;
indoles;
monocarboxylic acid;
primary carboxamide		anti-inflammatory drug;
antidote;
EC 3.1.1.4 (phospholipase A2) inhibitor
d-4f peptide[no description available]medium10
rvx 208[no description available]medium10
piperacillin[no description available]medium50penicillin allergen;
penicillin		antibacterial drug
penicillanic acid[no description available]medium40penicillanic acids
potassium chloride[no description available]medium10inorganic chloride;
inorganic potassium salt;
potassium salt		fertilizer
piperacillin, tazobactam drug combination[no description available]medium20
dicloxacillin[no description available]medium21dichlorobenzene;
penicillin		antibacterial drug
ruthenium[no description available]medium40iron group element atom;
platinum group metal atom
sorbinil[no description available]medium10azaspiro compound;
chromanes;
imidazolidinone;
organofluorine compound;
oxaspiro compound		antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor
nadp[no description available]medium10
imidazolidines[no description available]medium10azacycloalkane;
imidazolidines;
saturated organic heteromonocyclic parent
lactose[no description available]medium20lactose
sultamicillin[no description available]medium31penicillanic acid ester
sertraline[no description available]medium40dichlorobenzene;
secondary amino compound;
tetralins		antidepressant;
serotonin uptake inhibitor
chlorine[no description available]medium30diatomic chlorine;
gas molecular entity		bleaching agent
azelaic acid[no description available]medium10alpha,omega-dicarboxylic acid;
dicarboxylic fatty acid		antibacterial agent;
antineoplastic agent;
dermatologic drug;
plant metabolite
2-aminocyclobutanecarboxylic acid[no description available]medium10
sulfamerazine[no description available]medium20pyrimidines;
sulfonamide antibiotic;
sulfonamide		antiinfective agent;
drug allergen
sulfenamide[no description available]medium20
prednisone[no description available]medium2011-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
immunosuppressive agent;
prodrug
reserpine[no description available]medium20alkaloid ester;
methyl ester;
yohimban alkaloid		adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic
5-hydroxytryptophan[no description available]medium10hydroxytryptophanhuman metabolite;
neurotransmitter
aminosalicylic acid[no description available]medium10aminobenzoic acid;
phenols		antitubercular agent
stearylamine[no description available]medium20primary aliphatic aminefilm-forming compound
oxazolone[no description available]medium40
imidazolone[no description available]medium10organonitrogen heterocyclic compound
nxl 103[no description available]medium10
puerarin[no description available]medium10C-glycosyl compound;
isoflavonoid
quizalofop[no description available]medium10aromatic ether;
monocarboxylic acid;
organochlorine compound;
quinoxaline derivative
aminoimidazole carboxamide[no description available]medium10aminoimidazole;
monocarboxylic acid amide		mouse metabolite
diflufenican[no description available]medium10(trifluoromethyl)benzenes;
aromatic ether;
pyridinecarboxamide		carotenoid biosynthesis inhibitor;
environmental contaminant;
herbicide;
xenobiotic
devrinol[no description available]medium10aromatic ether;
monocarboxylic acid amide;
naphthalenes
carbendazim[no description available]high10benzimidazole fungicide;
benzimidazoles;
benzimidazolylcarbamate fungicide;
carbamate ester		antifungal agrochemical;
antinematodal drug;
metabolite;
microtubule-destabilising agent
iprodione[no description available]medium10benzenes;
dichlorophenyl dicarboximide fungicide;
imidazole fungicide;
imidazolidine-2,4-dione;
ureas		antifungal agrochemical;
nematicide
isoproturon[no description available]medium103-(3,4-substituted-phenyl)-1,1-dimethylureaagrochemical;
environmental contaminant;
herbicide;
xenobiotic
thifensulfuron methyl[no description available]medium101,3,5-triazines;
methyl ester;
N-sulfonylurea;
thiophenes		agrochemical;
environmental contaminant;
herbicide;
xenobiotic
azoxystrobin[no description available]medium10aryloxypyrimidine;
enoate ester;
enol ether;
methoxyacrylate strobilurin antifungal agent;
methyl ester;
nitrile		antifungal agrochemical;
environmental contaminant;
mitochondrial cytochrome-bc1 complex inhibitor;
quinone outside inhibitor;
xenobiotic
mesosulfuron-methyl[no description available]medium10
quinoxalines[no description available]medium20mancude organic heterobicyclic parent;
naphthyridine;
ortho-fused heteroarene
ozone[no description available]medium10elemental molecule;
gas molecular entity;
reactive oxygen species;
triatomic oxygen		antiseptic drug;
disinfectant;
electrophilic reagent;
greenhouse gas;
mutagen;
oxidising agent;
tracer
osteum[no description available]medium10organic molecular entity
oleic acid[no description available]medium10octadec-9-enoic acidantioxidant;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite;
solvent
glycerol[no description available]medium20alditol;
triol		algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
n-vinyl-2-pyrrolidinone[no description available]medium20pyrrolidin-2-ones
limonene[no description available]medium10cycloalkene;
p-menthadiene		human metabolite
eucalyptol[no description available]medium10
diphenyliodonium[no description available]medium10
zinc chloride[no description available]medium10inorganic chloride;
zinc molecular entity		astringent;
disinfectant;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
Lewis acid
sperm motility inhibitor 2[no description available]medium30
samarium[no description available]medium30f-block element atom;
lanthanoid atom
iodine[no description available]medium40halide anion;
monoatomic iodine		human metabolite
licochalcone e[no description available]medium20
aziridine-2-carboxylic acid[no description available]medium10
nifursol[no description available]medium30carbohydrazide;
dinitrophenol;
nitrofuran antibiotic
digoxin[no description available]medium11cardenolide glycoside;
steroid saponin		anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
epitope
arbekacin[no description available]medium40aminoglycoside;
kanamycins		antibacterial agent;
antibacterial drug;
antimicrobial agent;
protein synthesis inhibitor
dibekacin[no description available]medium40kanamycinsantibacterial agent;
protein synthesis inhibitor
chloroquine[no description available]medium10aminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound		anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
cyanine dye 3[no description available]medium10
carbocyanines[no description available]medium10cyanine dye;
organic iodide salt		fluorochrome
n-acetylneuraminic acid[no description available]medium50N-acetylneuraminic acidsantioxidant;
bacterial metabolite;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
human metabolite;
mouse metabolite
dapsone[no description available]medium11substituted aniline;
sulfone		anti-inflammatory drug;
antiinfective agent;
antimalarial;
leprostatic drug
phosphine[no description available]medium10mononuclear parent hydride;
phosphanes;
phosphine		carcinogenic agent;
fumigant insecticide
meperidine[no description available]medium20ethyl ester;
piperidinecarboxylate ester;
tertiary amino compound		antispasmodic drug;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
acetaldehyde[no description available]medium10aldehydecarcinogenic agent;
EC 3.5.1.4 (amidase) inhibitor;
electron acceptor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
mutagen;
oxidising agent;
Saccharomyces cerevisiae metabolite;
teratogenic agent
triflic anhydride[no description available]medium10organosulfonic anhydride
galactose[no description available]medium10D-galactose;
galactopyranose		Escherichia coli metabolite;
mouse metabolite
methylene chloride[no description available]medium30chloromethanes;
volatile organic compound		carcinogenic agent;
polar aprotic solvent;
refrigerant
carbonates[no description available]medium40carbon oxoanion
ach 702[no description available]medium10
acetamide[no description available]medium20acetamides;
carboximidic acid;
monocarboxylic acid amide;
N-acylammonia
trifluralin[no description available]medium10(trifluoromethyl)benzenes;
C-nitro compound;
substituted aniline		agrochemical;
environmental contaminant;
herbicide;
xenobiotic
phenylacetylene[no description available]medium10benzenes
acetylene[no description available]medium20alkyne;
gas molecular entity;
terminal acetylenic compound
cathepsin g[no description available]medium10
cefaclor anhydrous[no description available]medium30cephalosporinantibacterial drug;
drug allergen
histidine[no description available]medium40amino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
n(6)-cyclopentyladenosine[no description available]medium10
nitrofurazone[no description available]medium90
methylphenyl carbinol[no description available]medium10aromatic alcoholmouse metabolite
pirinixic acid[no description available]medium10aryl sulfide;
organochlorine compound;
pyrimidines
bay x 1005[no description available]medium10
tbc-11251[no description available]medium10benzodioxoles
cardiovascular agents[no description available]medium10
cysteine[no description available]medium30cysteiniumfundamental metabolite
stannic chloride[no description available]medium10
atomoxetine hydrochloride[no description available]medium10hydrochlorideadrenergic uptake inhibitor;
antidepressant
1,8-diazabicyclo(5.4.0)undec-7-ene[no description available]medium10
butenolide[no description available]medium10butenolide
3-hydroxyflavone[no description available]medium10flavonols;
monohydroxyflavone
picrotoxin[no description available]medium10
s20098[no description available]medium10acetamides
1h-tetrazole[no description available]medium10one-carbon compound;
tetrazole
benzyne[no description available]medium10aryne;
benzyne
methylene blue[no description available]medium10organic chloride saltacid-base indicator;
antidepressant;
antimalarial;
antimicrobial agent;
antioxidant;
cardioprotective agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 4.6.1.2 (guanylate cyclase) inhibitor;
fluorochrome;
histological dye;
neuroprotective agent;
physical tracer
amitriptyline[no description available]medium70carbotricyclic compound;
tertiary amine		adrenergic uptake inhibitor;
antidepressant;
environmental contaminant;
tropomyosin-related kinase B receptor agonist;
xenobiotic
sanguinine[no description available]medium10benzazepine
puromycin[no description available]medium40puromycinsantiinfective agent;
antimicrobial agent;
antineoplastic agent;
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor;
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor;
nucleoside antibiotic;
protein synthesis inhibitor
lypressin[no description available]medium10cyclic peptide
terlipressin[no description available]medium10polypeptide
sodium cyanate[no description available]medium10cyanate salt;
one-carbon compound
substance p[no description available]medium10peptideneurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent
pregnanolone[no description available]medium203-hydroxy-5beta-pregnan-20-one;
3alpha-hydroxy steroid		human metabolite;
intravenous anaesthetic;
sedative
anpirtoline[no description available]medium10aryl sulfide
methylphenidate[no description available]medium20beta-amino acid ester;
methyl ester;
piperidines
mifepristone[no description available]medium203-oxo-Delta(4) steroid;
acetylenic compound;
tertiary amino compound		abortifacient;
contraceptive drug;
hormone antagonist;
synthetic oral contraceptive
allyl cyanide[no description available]medium10aliphatic nitrile;
olefinic compound		antifeedant;
neurotoxin;
plant metabolite
indole-3-carbinol[no description available]medium10indolyl alcoholantineoplastic agent;
plant metabolite
kaempferol[no description available]medium107-hydroxyflavonol;
flavonols;
tetrahydroxyflavone		antibacterial agent;
geroprotector;
human blood serum metabolite;
human urinary metabolite;
human xenobiotic metabolite;
plant metabolite
nitrites[no description available]medium10monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species		human metabolite
nitrates[no description available]medium10monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
carnitine[no description available]medium10amino-acid betainehuman metabolite;
mouse metabolite
choline[no description available]medium10cholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
4-acetylphenyloxooxazolidinylmethylacetamide[no description available]medium150
androstenedione[no description available]medium1017-oxo steroid;
3-oxo-Delta(4) steroid;
androstanoid		androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
tetrindole[no description available]medium10racemateantidepressant;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
serotonergic agonist
pirlindole[no description available]medium10carbazoles
tyrosine[no description available]medium10amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine		EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
monoiodotyrosine[no description available]medium10amino acid zwitterion;
L-tyrosine derivative;
monoiodotyrosine;
non-proteinogenic L-alpha-amino acid		EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor;
human metabolite;
mouse metabolite
glycidyl nitrate[no description available]medium10
cocaine[no description available]medium10benzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid		adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
lidocaine[no description available]medium10benzenes;
monocarboxylic acid amide;
tertiary amino compound		anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic
cloxacillin[no description available]medium20penicillin allergen;
penicillin;
semisynthetic derivative		antibacterial agent;
antibacterial drug
bromide[no description available]medium20halide anion;
monoatomic bromine
chlorpheniramine[no description available]medium10monochlorobenzenes;
pyridines;
tertiary amino compound		anti-allergic agent;
antidepressant;
antipruritic drug;
H1-receptor antagonist;
histamine antagonist;
serotonin uptake inhibitor
acetylglucosamine[no description available]medium10N-acetyl-D-glucosamineepitope
cefadroxil anhydrous[no description available]medium43cephalosporinantibacterial drug
sodium acetate, anhydrous[no description available]medium10organic sodium saltNMR chemical shift reference compound
mirtazapine[no description available]medium20benzazepine;
tetracyclic antidepressant		alpha-adrenergic antagonist;
anxiolytic drug;
H1-receptor antagonist;
histamine antagonist;
oneirogen;
serotonergic antagonist
mianserin[no description available]medium20dibenzoazepineadrenergic uptake inhibitor;
alpha-adrenergic antagonist;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
H1-receptor antagonist;
histamine agonist;
sedative;
serotonergic antagonist
miconazole[no description available]medium10dichlorobenzene;
ether;
imidazoles
troleandomycin[no description available]medium10acetate ester;
epoxide;
macrolide antibiotic;
monosaccharide derivative;
polyketide;
semisynthetic derivative		EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitor;
xenobiotic
droperidol[no description available]medium10aromatic ketone;
benzimidazoles;
organofluorine compound		anaesthesia adjuvant;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic
topiramate[no description available]medium30cyclic ketal;
ketohexose derivative;
sulfamate ester		anticonvulsant;
sodium channel blocker
D-fructopyranose[no description available]medium30cyclic hemiketal;
D-fructose;
fructopyranose		sweetening agent
salmeterol xinafoate[no description available]medium10naphthoic acid
albuterol[no description available]medium10phenols;
phenylethanolamines;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
environmental contaminant;
xenobiotic
trimethylsilanol[no description available]medium10
thiouracil[no description available]medium10nucleobase analogue;
thiocarbonyl compound		antithyroid drug;
metabolite
ddt[no description available]medium10benzenoid aromatic compound;
chlorophenylethane;
monochlorobenzenes;
organochlorine insecticide		bridged diphenyl acaricide;
carcinogenic agent;
endocrine disruptor;
persistent organic pollutant
phenothiazine[no description available]medium10phenothiazineferroptosis inhibitor;
plant metabolite;
radical scavenger
cortisone[no description available]medium1011-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		human metabolite;
mouse metabolite
framycetin[no description available]medium30aminoglycosideallergen;
antibacterial drug;
Escherichia coli metabolite
pemoline[no description available]medium101,3-oxazolescentral nervous system stimulant
amobarbital[no description available]medium10barbiturates
o-carbamylserine[no description available]medium10
phentolamine[no description available]medium10imidazoles;
phenols;
substituted aniline;
tertiary amino compound		alpha-adrenergic antagonist;
vasodilator agent
pyrimidine[no description available]medium10diazine;
pyrimidines		Daphnia magna metabolite
sulfanilamide[no description available]medium10substituted aniline;
sulfonamide antibiotic;
sulfonamide		antibacterial agent;
drug allergen;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
ketanserin[no description available]medium40aromatic ketone;
organofluorine compound;
piperidines;
quinazolines		alpha-adrenergic antagonist;
antihypertensive agent;
cardiovascular drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
serotonergic antagonist
salicylic acid[no description available]medium10monohydroxybenzoic acidalgal metabolite;
antifungal agent;
antiinfective agent;
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor;
keratolytic drug;
plant hormone;
plant metabolite
phenobarbital[no description available]medium20barbituratesanticonvulsant;
drug allergen;
excitatory amino acid antagonist;
sedative
barbituric acid[no description available]medium10barbituratesallergen;
xenobiotic
radium[no description available]medium10alkaline earth metal atom
pyridine[no description available]medium50azaarene;
mancude organic heteromonocyclic parent;
monocyclic heteroarene;
pyridines		environmental contaminant;
NMR chemical shift reference compound
epiaustraline[no description available]medium10
2-aminopurine[no description available]medium102-aminopurines;
nucleobase analogue		antimetabolite
acyclovir[no description available]medium102-aminopurines;
oxopurine		antimetabolite;
antiviral drug
brl 42810[no description available]medium102-aminopurines;
acetate ester		antiviral drug;
prodrug
lysine[no description available]medium10aspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid		algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
acetylsalicylic acid lysinate[no description available]medium10
trifluoperazine[no description available]medium10N-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines		antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug
amphotericin b[no description available]medium10antibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic		antiamoebic agent;
antiprotozoal drug;
bacterial metabolite
thioacetamide[no description available]medium30thiocarboxamidehepatotoxic agent
ethylene[no description available]medium10alkene;
gas molecular entity		plant hormone;
refrigerant
thiamorpholine[no description available]medium10saturated organic heteromonocyclic parent;
thiomorpholines
moclobemide[no description available]medium157benzamides;
monochlorobenzenes;
morpholines		antidepressant;
environmental contaminant;
xenobiotic
fluvoxamine[no description available]medium10(trifluoromethyl)benzenes;
5-methoxyvalerophenone O-(2-aminoethyl)oxime		antidepressant;
anxiolytic drug;
serotonin uptake inhibitor
beta-naphthoflavone[no description available]medium10extended flavonoid;
naphtho-gamma-pyrone;
organic heterotricyclic compound		aryl hydrocarbon receptor agonist
isopentenyl pyrophosphate[no description available]medium10prenol phosphateantigen;
antioxidant;
epitope;
Escherichia coli metabolite;
mouse metabolite;
phosphoantigen
brassinolide[no description available]medium1022-hydroxy steroid;
23-hydroxy steroid;
2alpha-hydroxy steroid;
3alpha-hydroxy steroid;
brassinosteroid		plant growth stimulator;
plant hormone
methampicillin[no description available]medium10monochlorobenzenes;
tertiary alcohol;
triazoles		brassinosteroid biosynthesis inhibitor
risperidone[no description available]medium101,2-benzoxazoles;
heteroarylpiperidine;
organofluorine compound;
pyridopyrimidine		alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
psychotropic drug;
second generation antipsychotic;
serotonergic antagonist
ephedrine[no description available]medium21phenethylamine alkaloid;
phenylethanolamines		bacterial metabolite;
environmental contaminant;
nasal decongestant;
plant metabolite;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
trimethadione[no description available]medium70oxazolidinoneanticonvulsant;
geroprotector
metribuzin[no description available]medium101,2,4-triazines;
cyclic ketone;
organic sulfide		agrochemical;
environmental contaminant;
herbicide;
xenobiotic
metobromuron[no description available]medium10ureas
dinoprost[no description available]medium10monocarboxylic acid;
prostaglandins Falpha		human metabolite;
mouse metabolite
5-carboxamidotryptamine[no description available]medium20tryptamines
gr 127935[no description available]medium301,2,4-oxadiazole;
benzamides;
N-alkylpiperazine;
N-arylpiperazine
fluoxetine[no description available]medium41(trifluoromethyl)benzenes;
aromatic ether;
secondary amino compound
temporin[no description available]medium10
mlv 6976[no description available]medium100
vitamin b 6[no description available]medium20
singlet oxygen[no description available]medium10chalcogen;
monoatomic oxygen;
nonmetal atom		macronutrient
benzoin[no description available]medium10benzoins;
secondary alpha-hydroxy ketone		EC 3.1.1.1 (carboxylesterase) inhibitor
meclizine[no description available]medium10diarylmethane
2,3-diaminopropionic acid[no description available]medium10alanine derivative;
amino acid zwitterion;
beta-amino acid;
diamino acid;
non-proteinogenic alpha-amino acid		Escherichia coli metabolite
beta-alanine[no description available]medium10amino acid zwitterion;
beta-amino acid		agonist;
fundamental metabolite;
human metabolite;
inhibitor;
neurotransmitter
gigantecin[no description available]medium10
cyclobenzaprine[no description available]medium10carbotricyclic compoundantidepressant;
muscle relaxant;
tranquilizing drug
tolfenamic acid[no description available]medium20aminobenzoic acid;
organochlorine compound;
secondary amino compound		EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
salicylates[no description available]medium20monohydroxybenzoateplant metabolite
bupropion[no description available]medium10aromatic ketone;
monochlorobenzenes;
secondary amino compound		antidepressant;
environmental contaminant;
xenobiotic
cefotaxime[no description available]medium101,3-thiazoles;
cephalosporin;
oxime O-ether		antibacterial drug;
drug allergen
benzimidazole[no description available]medium10benzimidazole;
polycyclic heteroarene
benzotriazole[no description available]medium10benzotriazolesenvironmental contaminant;
xenobiotic
proadifen[no description available]medium20diarylmethane
dimethylnitrosamine[no description available]medium10nitrosaminegeroprotector;
mutagen
hydroxylamine[no description available]medium10hydroxylaminesalgal metabolite;
bacterial xenobiotic metabolite;
EC 1.1.3.13 (alcohol oxidase) inhibitor;
EC 4.2.1.22 (cystathionine beta-synthase) inhibitor;
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor;
nitric oxide donor;
nucleophilic reagent
beta carotene[no description available]medium10carotenoid beta-end derivative;
cyclic carotene		antioxidant;
biological pigment;
cofactor;
ferroptosis inhibitor;
human metabolite;
mouse metabolite;
plant metabolite;
provitamin A
deoxyglucose[no description available]medium10
hymenidin[no description available]medium10
metsulfuron methyl[no description available]medium101,3,5-triazines;
benzoate ester;
N-sulfonylurea		environmental contaminant;
herbicide;
xenobiotic
quinclorac[no description available]medium10monocarboxylic acid;
organochlorine compound;
quinolinemonocarboxylic acid		agrochemical;
herbicide;
synthetic auxin
cinnamyl alcohol[no description available]medium10cinnamyl alcoholplant metabolite
brofaromine[no description available]medium70
cyproheptadine[no description available]medium10piperidines;
tertiary amine		anti-allergic agent;
antipruritic drug;
gastrointestinal drug;
H1-receptor antagonist;
serotonergic antagonist
pyrrolidonecarboxylic acid[no description available]medium105-oxoproline;
L-proline derivative;
non-proteinogenic L-alpha-amino acid		algal metabolite
styrene[no description available]medium10styrenes;
vinylarene;
volatile organic compound		mouse metabolite;
mutagen;
plant metabolite
hyaluronoglucosaminidase[no description available]medium10
triethylamine[no description available]medium10tertiary amine
acetohydroxamic acid[no description available]medium10acetohydroxamic acids;
carbohydroximic acid		algal metabolite;
EC 3.5.1.5 (urease) inhibitor
fludarabine[no description available]medium10purine nucleoside
vidarabine[no description available]medium10beta-D-arabinoside;
purine nucleoside		antineoplastic agent;
bacterial metabolite;
nucleoside antibiotic
barium[no description available]medium10alkaline earth metal atom;
elemental barium
pteridic acid a[no description available]medium10
platensimycin[no description available]medium10aromatic amide;
cyclic ether;
cyclic ketone;
dihydroxybenzoic acid;
monocarboxylic acid amide;
polycyclic cage		antibacterial agent;
antimicrobial agent;
bacterial metabolite;
EC 2.3.1.85 (fatty acid synthase) inhibitor
levoleucovorin[no description available]medium105-formyltetrahydrofolic acidantineoplastic agent;
metabolite
methotrexate[no description available]medium10dicarboxylic acid;
monocarboxylic acid amide;
pteridines		abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
lutetium[no description available]medium10d-block element atom;
lanthanoid atom
scandium[no description available]medium10d-block element atom;
rare earth metal atom;
scandium group element atom
3'-hydroxy-5'-(4-isobutylpiperazinyl)benzoxazinorifamycin[no description available]medium10phenoxazine
benthiocarb[no description available]medium20monochlorobenzenes;
monothiocarbamic ester
ethidium[no description available]medium10phenanthridinesfluorochrome;
intercalator
pyronine[no description available]medium10iminium salt;
organic chloride salt		histological dye
carbonyl cyanide m-chlorophenyl hydrazone[no description available]medium10hydrazone;
monochlorobenzenes;
nitrile		antibacterial agent;
geroprotector;
ionophore
ag 1879[no description available]medium10aromatic amine;
monochlorobenzenes;
pyrazolopyrimidine		beta-adrenergic antagonist;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector
cephalexin[no description available]medium10beta-lactam antibiotic allergen;
cephalosporin;
semisynthetic derivative		antibacterial drug
7432 s[no description available]medium10cephalosporin;
dicarboxylic acid		antibacterial drug
hydroxyurea[no description available]medium10one-carbon compound;
ureas		antimetabolite;
antimitotic;
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
genotoxin;
immunomodulator;
radical scavenger;
teratogenic agent
pyridoxine[no description available]medium21hydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
vitamin B6		cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
glycolipids[no description available]medium10
phenylalanine-beta-naphthylamide[no description available]medium10amino acid amide;
L-phenylalanine derivative;
N-(2-naphthyl)carboxamide		chromogenic compound
alpha-chymotrypsin[no description available]medium10
chloroacetyl chloride[no description available]medium10acyl halide
rotenone[no description available]medium10organic heteropentacyclic compound;
rotenones		antineoplastic agent;
metabolite;
mitochondrial NADH:ubiquinone reductase inhibitor;
phytogenic insecticide;
piscicide;
toxin
antimycin a[no description available]medium10amidobenzoic acid
duloxetine hydrochloride[no description available]medium10duloxetine hydrochlorideantidepressant
3-fluoroalanine[no description available]medium10
pyrophosphate[no description available]medium10diphosphate ion
fluoxydine[no description available]medium10
thiazoline-2-thione[no description available]medium10
thiazolidines[no description available]medium10thiazolidine
epoetin alfa[no description available]medium10
sulfamethoxazole[no description available]medium20isoxazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antibacterial agent;
antiinfective agent;
antimicrobial agent;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
epitope;
P450 inhibitor;
xenobiotic
tosufloxacin[no description available]medium101,8-naphthyridine derivative;
amino acid;
aminopyrrolidine;
monocarboxylic acid;
organofluorine compound;
primary amino compound;
quinolone antibiotic;
tertiary amino compound
methyl chloride[no description available]medium10chloromethanes;
methyl halides		marine metabolite;
mutagen;
refrigerant
nifuroxazide[no description available]medium10benzoic acids
kynuramine[no description available]medium10kynurenamines;
primary amino compound		metabolite
ticarcillin[no description available]medium20penicillin allergen;
penicillin		antibacterial drug
cellobiose[no description available]medium10cellobioseepitope
2-pyrrolecarboxylic acid[no description available]medium10pyrrolecarboxylic acidplant metabolite
acrylamide[no description available]medium10acrylamides;
N-acylammonia;
primary carboxamide		alkylating agent;
carcinogenic agent;
Maillard reaction product;
mutagen;
neurotoxin
indole[no description available]medium10indole;
polycyclic heteroarene		Escherichia coli metabolite
phenylpiperazine[no description available]medium10
2-piperidone[no description available]medium10delta-lactam;
piperidones		EC 1.2.1.88 (L-glutamate gamma-semialdehyde dehydrogenase) inhibitor
ethyl carbonate[no description available]medium10carbonate ester
diethyl pyrocarbonate[no description available]medium10acyclic carboxylic anhydride
nojirimycin[no description available]medium10amino monosaccharide;
hydroxypiperidine
adinazolam[no description available]medium10triazolobenzodiazepineanticonvulsant;
antidepressant;
anxiolytic drug;
sedative
troglitazone[no description available]medium10chromanes;
thiazolidinone		anticoagulant;
anticonvulsant;
antineoplastic agent;
antioxidant;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
hypoglycemic agent;
platelet aggregation inhibitor;
vasodilator agent
zidovudine[no description available]medium10azide;
pyrimidine 2',3'-dideoxyribonucleoside		antimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
hydrogen[no description available]medium20elemental hydrogen;
elemental molecule;
gas molecular entity		antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
atenolol[no description available]medium20ethanolamines;
monocarboxylic acid amide;
propanolamine		anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
sympatholytic agent;
xenobiotic
cetirizine[no description available]medium10ether;
monocarboxylic acid;
monochlorobenzenes;
piperazines		anti-allergic agent;
environmental contaminant;
H1-receptor antagonist;
xenobiotic
flunarizine[no description available]medium20diarylmethane
ly 163892[no description available]medium10carbacephem;
zwitterion		antibacterial drug;
antimicrobial agent
arabitol[no description available]medium10arabinitol
benzene[no description available]medium10aromatic annulene;
benzenes;
volatile organic compound		carcinogenic agent;
environmental contaminant;
non-polar solvent
phenol[no description available]medium10phenolsantiseptic drug;
disinfectant;
human xenobiotic metabolite;
mouse metabolite
lopinavir[no description available]medium20amphetamines;
dicarboxylic acid diamide		anticoronaviral agent;
antiviral drug;
HIV protease inhibitor
tamoxifen[no description available]medium10stilbenoid;
tertiary amino compound		angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
biotin[no description available]medium10biotins;
vitamin B7		coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite
indomethacin[no description available]medium10aromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole		analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
antimicrobial peptide ib-367[no description available]medium10
tropaeolin oo[no description available]medium10
bromthymol blue[no description available]medium102,1-benzoxathiole;
arenesulfonate ester;
organobromine compound;
polyphenol;
sultone		acid-base indicator;
dye;
two-colour indicator
mecysteine[no description available]medium10L-cysteinyl ester;
primary amino compound;
thiol		mucolytic
technetium tc 99m exametazime[no description available]medium10
tert-butylacrylamide[no description available]medium10
3-(trimethoxysilyl)propyl methacrylate[no description available]medium10
nitrobenzene[no description available]medium10nitroarene;
nitrobenzenes
aspartic acid[no description available]medium10aspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
mouse metabolite;
neurotransmitter
hygromycin a[no description available]medium10hydroxycinnamic acidmetabolite
hygromycin b[no description available]medium20
n,n'-dibutylurea[no description available]medium10
citronellal[no description available]medium10aldehyde;
monoterpenoid		antifungal agent;
metabolite
trifluoroacetic acid[no description available]medium10fluoroalkanoic acidhuman xenobiotic metabolite;
NMR chemical shift reference compound;
reagent
selenium[no description available]medium20chalcogen;
nonmetal atom		micronutrient
disulfoton[no description available]medium10organic thiophosphate;
organothiophosphate insecticide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
morphine[no description available]medium20morphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound		anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
triiodothyronine[no description available]medium402-halophenol;
amino acid zwitterion;
iodophenol;
iodothyronine		human metabolite;
mouse metabolite;
thyroid hormone
amphetamine[no description available]medium10primary amine
cimoxatone[no description available]medium263
md 780236[no description available]medium120
selegiline[no description available]medium91selegiline;
terminal acetylenic compound		geroprotector
dimethyl sulfoxide[no description available]medium20sulfoxide;
volatile organic compound		alkylating agent;
antidote;
Escherichia coli metabolite;
geroprotector;
MRI contrast agent;
non-narcotic analgesic;
polar aprotic solvent;
radical scavenger
md 770222[no description available]medium62
bilirubin[no description available]medium10biladienes;
dicarboxylic acid		antioxidant;
human metabolite;
mouse metabolite
sulfachlorpyridazine[no description available]medium10organochlorine compound;
pyridazines;
sulfonamide		antibacterial drug;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor
methoxyhydroxyphenylglycol[no description available]medium54methoxybenzenes;
phenols
3-methoxy-4-hydroxyphenylglycol sulfate[no description available]medium22alcohol;
phenols
desoxycorticosterone[no description available]medium1020-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
mineralocorticoid;
primary alpha-hydroxy ketone		human metabolite;
mouse metabolite
tranylcypromine[no description available]medium402-phenylcyclopropan-1-amine
nifurtimox[no description available]medium10nitrofuran antibiotic
allylamine[no description available]medium21alkylamine
2-(3,4-dimethoxyphenyl)-3-fluoroallylamine[no description available]medium21
6-benzoyl benzoxazolinone[no description available]medium40
ethylnitrosourea[no description available]medium30N-nitrosoureasalkylating agent;
carcinogenic agent;
genotoxin;
mutagen
1-(2-hydroxyethyl)-1-nitrosourea[no description available]medium30
n-(2-hydroxypropyl)-n-nitrosourea[no description available]medium20
iproniazid[no description available]medium20carbohydrazide;
pyridines
histamine[no description available]medium10aralkylamino compound;
imidazoles		human metabolite;
mouse metabolite;
neurotransmitter
aflatoxin b1[no description available]medium20aflatoxin;
aromatic ether;
aromatic ketone		carcinogenic agent;
human metabolite
phenethylamine[no description available]medium30alkaloid;
aralkylamine;
phenylethylamine		Escherichia coli metabolite;
human metabolite;
mouse metabolite
caroxazone[no description available]medium10benzoxazine
pentafluorobenzoyl chloride[no description available]medium10acyl chloride;
perfluorinated compound		chromatographic reagent
harmaline[no description available]medium40harmala alkaloidoneirogen
hydroxyindoleacetic acid[no description available]medium41indole-3-acetic acidsdrug metabolite;
human metabolite;
mouse metabolite
desipramine[no description available]medium10dibenzoazepine;
secondary amino compound		adrenergic uptake inhibitor;
alpha-adrenergic antagonist;
antidepressant;
cholinergic antagonist;
drug allergen;
EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
serotonin uptake inhibitor
dinitrochlorobenzene[no description available]medium10C-nitro compound;
monochlorobenzenes		allergen;
epitope;
sensitiser
glutathione disulfide[no description available]medium10glutathione derivative;
organic disulfide		Escherichia coli metabolite;
mouse metabolite
bromhexine[no description available]medium10organobromine compound;
substituted aniline;
tertiary amino compound		mucolytic
ambroxol[no description available]medium10aromatic amine
ifosfamide[no description available]medium10ifosfamidesalkylating agent;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
xenobiotic
2-chloroethylamine[no description available]medium10
1-cyano-3-butene[no description available]medium10
piperidine-4-sulfonic acid[no description available]medium20
gaboxadol[no description available]medium20oxazole
muscimol[no description available]medium40alkaloid;
isoxazoles;
primary amino compound		fungal metabolite;
GABA agonist;
oneirogen;
psychotropic drug
phenylephrine[no description available]medium10phenols;
phenylethanolamines;
secondary amino compound		alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent
terbutaline[no description available]medium10phenylethanolamines;
resorcinols		anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
hypoglycemic agent;
sympathomimetic agent;
tocolytic agent
dechloroethylcyclophosphamide[no description available]medium10phosphorodiamide
nornitrogen mustard[no description available]medium30nitrogen mustard
4-ketocyclophosphamide[no description available]medium10nitrogen mustard
carboxyphosphamide[no description available]medium10nitrogen mustard
tylosin[no description available]medium10
apramycin[no description available]medium102-deoxystreptamine derivative;
aminoglycoside;
organic heterobicyclic compound		antibacterial drug;
antimicrobial agent
lincomycin[no description available]medium20carbohydrate-containing antibiotic;
L-proline derivative;
monocarboxylic acid amide;
pyrrolidinecarboxamide;
S-glycosyl compound		antimicrobial agent;
bacterial metabolite
oxytetracycline, anhydrous[no description available]medium20
imipramine[no description available]medium11dibenzoazepineadrenergic uptake inhibitor;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
piroxicam[no description available]medium11benzothiazine;
monocarboxylic acid amide;
pyridines		analgesic;
antirheumatic drug;
cyclooxygenase 1 inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
mexiletine[no description available]medium11aromatic ether;
primary amino compound		anti-arrhythmia drug
4-toluenesulfonyl chloride[no description available]medium10
26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3[no description available]medium10
calcitriol[no description available]medium10D3 vitamins;
hydroxycalciol;
triol		antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical
guanine[no description available]medium102-aminopurines;
oxopurine;
purine nucleobase		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pentafluorophenylisothiocyanate[no description available]medium10
trovafloxacin[no description available]medium50
tremorine[no description available]medium10N-alkylpyrrolidine
pentobarbital[no description available]medium20barbituratesGABAA receptor agonist
brl 28500[no description available]medium10
n-formylmethionine[no description available]medium10L-methionine derivative;
N-formyl amino acid;
proteinogenic amino acid		metabolite
homocysteine[no description available]medium10amino acid zwitterion;
homocysteine;
serine family amino acid		fundamental metabolite;
mouse metabolite
homocysteic acid[no description available]medium10homocysteic acidNMDA receptor agonist
ritanserin[no description available]medium10organofluorine compound;
piperidines;
thiazolopyrimidine		antidepressant;
antipsychotic agent;
anxiolytic drug;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
serotonergic antagonist
hydrochlorothiazide[no description available]medium11benzothiadiazine;
organochlorine compound;
sulfonamide		antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
ng-nitroarginine methyl ester[no description available]medium10alpha-amino acid ester;
L-arginine derivative;
methyl ester;
N-nitro compound		EC 1.14.13.39 (nitric oxide synthase) inhibitor
timolol[no description available]medium10timololanti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
8-hydroxy-2-(di-n-propylamino)tetralin[no description available]medium20phenols;
tertiary amino compound;
tetralins		serotonergic antagonist
cp 93129[no description available]medium10pyrrolopyridine
lorazepam[no description available]medium11benzodiazepine
methiothepin[no description available]medium10aryl sulfide;
dibenzothiepine;
N-alkylpiperazine;
tertiary amino compound		antipsychotic agent;
dopaminergic antagonist;
geroprotector;
serotonergic antagonist
2-methyl-5-ht[no description available]medium10tryptaminesserotonergic agonist
dihydroergotoxine[no description available]medium10
lisuride[no description available]medium10monocarboxylic acid amideantidyskinesia agent;
antiparkinson drug;
dopamine agonist;
serotonergic agonist
3,4-dihydroxyphenylglycol[no description available]medium20catechols;
tetrol		metabolite;
mouse metabolite
3,4-dihydroxyphenylglycol[no description available]medium22catechols;
tetrol		metabolite;
mouse metabolite
dexfenfluramine[no description available]medium10fenfluramineappetite depressant;
serotonergic agonist;
serotonin uptake inhibitor
furafylline[no description available]medium10oxopurine
theophylline[no description available]medium10dimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
omeprazole[no description available]medium10aromatic ether;
benzimidazoles;
pyridines;
sulfoxide
bufotenin[no description available]medium10tertiary amine;
tryptamine alkaloid		coral metabolite;
hallucinogen
cyclic gmp[no description available]medium103',5'-cyclic purine nucleotide;
guanyl ribonucleotide		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
laurencin[no description available]medium10
tetraethylammonium[no description available]medium10quaternary ammonium ion
iberiotoxin[no description available]medium10
alosetron[no description available]medium10imidazoles;
pyridoindole		antiemetic;
gastrointestinal drug;
serotonergic antagonist
dizocilpine maleate[no description available]medium30maleate salt;
tetracyclic antidepressant		anaesthetic;
anticonvulsant;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist
6-cyano-7-nitroquinoxaline-2,3-dione[no description available]medium10quinoxaline derivative
benzothiazole[no description available]medium10benzothiazolesenvironmental contaminant;
plant metabolite;
xenobiotic
cyfluthrin[no description available]medium10
isoprene[no description available]medium10alkadiene;
hemiterpene;
volatile organic compound		plant metabolite
pentane[no description available]medium10alkane;
volatile organic compound		non-polar solvent;
refrigerant
cellulose[no description available]medium20glycoside
diethylhexyl phthalate[no description available]medium10diester;
phthalate ester		androstane receptor agonist;
apoptosis inhibitor;
plasticiser
evernimicin[no description available]medium30
dextromethorphan[no description available]medium216-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthreneantitussive;
environmental contaminant;
neurotoxin;
NMDA receptor antagonist;
oneirogen;
prodrug;
xenobiotic
phenylpropanolamine[no description available]medium11amphetamines;
phenethylamine alkaloid		plant metabolite
cellulose triacetate[no description available]medium10
2,6-dichloro-4-nitrophenol[no description available]medium10
ranitidine[no description available]medium10C-nitro compound;
furans;
organic sulfide;
tertiary amino compound		anti-ulcer drug;
drug allergen;
environmental contaminant;
H2-receptor antagonist;
xenobiotic
pentachlorophenol[no description available]medium10aromatic fungicide;
chlorophenol;
organochlorine pesticide;
pentachlorobenzenes		human xenobiotic metabolite
nitrophenols[no description available]medium10
atovaquone[no description available]medium10hydroxy-1,2-naphthoquinone
proguanil[no description available]medium10biguanides;
monochlorobenzenes		antimalarial;
antiprotozoal drug;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
naphthoquinones[no description available]medium10
titanium tetrachloride[no description available]medium10
tin[no description available]medium10carbon group element atom;
elemental tin;
metal atom		micronutrient
trazodone[no description available]medium10monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
triazolopyridine		adrenergic antagonist;
antidepressant;
anxiolytic drug;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor
diphenhydramine hydrochloride[no description available]medium10hydrochloride;
organoammonium salt		anti-allergic agent;
antiemetic;
antiparkinson drug;
antipruritic drug;
H1-receptor antagonist;
local anaesthetic;
muscarinic antagonist;
sedative
meglitinide[no description available]medium10
indoramin[no description available]medium10tryptamines
2,4-thiazolidinedione[no description available]medium10thiazolidenedione
mobic[no description available]medium101,3-thiazoles;
benzothiazine;
monocarboxylic acid amide		analgesic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
rwj 54428[no description available]medium10
docosanol[no description available]medium10docosanol;
long-chain primary fatty alcohol		antiviral drug;
plant metabolite
ritonavir[no description available]medium101,3-thiazoles;
carbamate ester;
carboxamide;
L-valine derivative;
ureas		antiviral drug;
environmental contaminant;
HIV protease inhibitor;
xenobiotic
insulin glargine[no description available]medium10
quinuclidines[no description available]medium10quinuclidines;
saturated organic heterobicyclic parent
heme[no description available]medium10
cefamandole[no description available]medium10cephalosporin;
semisynthetic derivative		antibacterial drug
mefloquine[no description available]medium10
thiomuscimol[no description available]medium10
oxyquinoline[no description available]medium10monohydroxyquinolineantibacterial agent;
antifungal agrochemical;
antiseptic drug;
iron chelator
enalkiren[no description available]medium10peptide
phenylmethylsulfonyl fluoride[no description available]medium10acyl fluorideserine proteinase inhibitor
a 74273[no description available]medium10
homovanillic acid[no description available]medium41guaiacols;
monocarboxylic acid		human metabolite;
mouse metabolite
bicuculline[no description available]medium20benzylisoquinoline alkaloid;
isoquinoline alkaloid;
isoquinolines		agrochemical;
central nervous system stimulant;
GABA-gated chloride channel antagonist;
GABAA receptor antagonist;
neurotoxin
rb 6145[no description available]medium10
debrisoquin[no description available]medium10carboxamidine;
isoquinolines		adrenergic agent;
antihypertensive agent;
human metabolite;
sympatholytic agent
apomorphine[no description available]medium10aporphine alkaloidalpha-adrenergic drug;
antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
emetic;
serotonergic drug
angiotensin ii[no description available]medium10amino acid zwitterion;
angiotensin II		human metabolite
allyl isothiocyanate[no description available]medium10alkenyl isothiocyanate;
isothiocyanate		antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
lachrymator;
metabolite
glucobrassicin[no description available]medium10indolyl carbohydrate;
indolylmethylglucosinolic acid
tamolarizine[no description available]medium10
dup 105[no description available]medium70
paldimycin[no description available]medium10
3,4-dihydroxyphenylacetic acid[no description available]medium30catechols;
dihydroxyphenylacetic acid		human metabolite
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid[no description available]medium10
kynurenic acid[no description available]medium10monohydroxyquinoline;
quinolinemonocarboxylic acid		G-protein-coupled receptor agonist;
human metabolite;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist;
Saccharomyces cerevisiae metabolite
diphenylborinic acid[no description available]medium10
glafenine[no description available]medium10aminoquinoline;
carboxylic ester;
glycol;
organochlorine compound;
secondary amino compound		inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2-amino-7-phosphonoheptanoic acid[no description available]medium10
2-amino-5-phosphonovalerate[no description available]medium10non-proteinogenic alpha-amino acidNMDA receptor antagonist
4-amino-3-hydroxybutyric acid[no description available]medium103-hydroxy monocarboxylic acid;
amino acid zwitterion;
gamma-amino acid
bicuculline methochloride[no description available]medium10
calcium hypochlorite[no description available]medium30calcium salt;
inorganic calcium salt		bleaching agent
sr 95191[no description available]medium10
salsolinol[no description available]medium101-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diolhuman urinary metabolite
n-(2-aminoethyl)-4-chlorobenzamide hydrochloride[no description available]medium10
amiflamine[no description available]medium20
bromine[no description available]medium10diatomic bromine
1-nitroso-5,6-dihydrouracil[no description available]medium10
acetoxime[no description available]medium10ketoxime
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine[no description available]medium10methylpyridines;
phenylpyridine;
tetrahydropyridine		neurotoxin
caloreen[no description available]medium10
phenazopyridine[no description available]medium10diaminopyridine;
monoazo compound		anticoronaviral agent;
carcinogenic agent;
local anaesthetic;
non-narcotic analgesic
ppi-0903[no description available]medium1501,3-thiazoles;
cephalosporin;
iminium betaine;
organic phosphoramidate;
oxime O-ether;
thiadiazoles		antibacterial drug;
antimicrobial agent;
prodrug
oxybutynin[no description available]medium71acetylenic compound;
carboxylic ester;
racemate;
tertiary alcohol;
tertiary amino compound		antispasmodic drug;
calcium channel blocker;
local anaesthetic;
muscarinic antagonist;
muscle relaxant;
parasympatholytic
humulene[no description available]medium10alpha-humulene
sucrose[no description available]medium10glycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
trolamine salicylate[no description available]medium31
rome[no description available]medium212-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-olEC 2.7.1.91 (sphingosine kinase) inhibitor
isomethyleugenol[no description available]medium140isomethyleugenol
curcumin[no description available]medium10aromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
fusarium[no description available]medium40
eye[no description available]medium10
glyphosate[no description available]medium10glycine derivative;
phosphonic acid		agrochemical;
EC 2.5.1.19 (3-phosphoshikimate 1-carboxyvinyltransferase) inhibitor;
herbicide
benzothiazide[no description available]medium10benzothiadiazine;
sulfonamide		antihypertensive agent;
diuretic
phenylephrine hydrochloride[no description available]medium21hydrochloride
exudates[no description available]medium10
cucurbitaceae[no description available]medium10
egg white[no description available]medium10
2-propanol[no description available]medium10secondary alcohol;
secondary fatty alcohol		protic solvent
alpha-hydroxyglutarate[no description available]low002-hydroxydicarboxylic acid;
dicarboxylic fatty acid		metabolite;
mouse metabolite
alpha-isopropylmalate[no description available]low002-hydroxy carboxylic acid;
3-hydroxy carboxylic acid;
dicarboxylic acid		metabolite
acetoacetic acid[no description available]low003-oxo fatty acid;
ketone body		metabolite
3-hydroxybenzyl alcohol[no description available]low00hydroxybenzyl alcohol;
phenols		metabolite
n-carbamoyl-beta-alanine[no description available]low00beta-alanine derivativemetabolite;
mouse metabolite
ethylene glycol[no description available]low00ethanediol;
glycol		metabolite;
mouse metabolite;
solvent;
toxin
acetoin[no description available]low00methyl ketone;
secondary alpha-hydroxy ketone		metabolite
benzyl alcohol[no description available]low00benzyl alcoholsantioxidant;
fragrance;
metabolite;
solvent
carbon monoxide[no description available]low00carbon oxide;
gas molecular entity;
one-carbon compound		biomarker;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
human metabolite;
ligand;
metabolite;
mitochondrial respiratory-chain inhibitor;
mouse metabolite;
neurotoxin;
neurotransmitter;
P450 inhibitor;
probe;
signalling molecule;
vasodilator agent
4-hydroxymandelic acid[no description available]low002-hydroxy carboxylic acid;
phenols		metabolite
aminoethylphosphonic acid[no description available]low00phosphonic acids;
primary amino compound;
zwitterion		human metabolite;
metabolite;
mouse metabolite
hydrogen sulfide[no description available]low00gas molecular entity;
hydracid;
mononuclear parent hydride;
sulfur hydride		Escherichia coli metabolite;
genotoxin;
metabolite;
signalling molecule;
toxin;
vasodilator agent
4-aminophenol[no description available]low00aminophenolallergen;
metabolite
n(1)-acetylspermidine[no description available]low00acetylspermidineEscherichia coli metabolite;
metabolite
aminocaproic acid[no description available]low00amino acid zwitterion;
epsilon-amino acid;
omega-amino fatty acid		antifibrinolytic drug;
hematologic agent;
metabolite
dihydrouracil[no description available]low00pyrimidoneEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
dihydroxyacetone[no description available]low00ketotriose;
primary alpha-hydroxy ketone		antifungal agent;
Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
dimethylamine[no description available]low00methylamines;
secondary aliphatic amine		metabolite
glycolic acid[no description available]low002-hydroxy monocarboxylic acid;
primary alcohol		keratolytic drug;
metabolite
hydantoin-5-propionic acid[no description available]low00imidazolidine-2,4-dione;
monocarboxylic acid		metabolite;
mouse metabolite
orotic acid[no description available]low00pyrimidinemonocarboxylic acidEscherichia coli metabolite;
metabolite;
mouse metabolite
oxaloacetic acid[no description available]low00C4-dicarboxylic acid;
oxo dicarboxylic acid		geroprotector;
metabolite
porphobilinogen[no description available]low00aralkylamino compound;
dicarboxylic acid;
pyrroles		Escherichia coli metabolite;
metabolite;
mouse metabolite
1-propanol[no description available]low00propan-1-ols;
short-chain primary fatty alcohol		metabolite;
protic solvent
trimethyloxamine[no description available]low00tertiary amine oxideEscherichia coli metabolite;
metabolite;
osmolyte
6-hydroxymelatonin[no description available]low00acetamides;
tryptamines		metabolite;
mouse metabolite
n-acetylphenylalanine[no description available]low00N-acetyl-amino acid;
phenylalanine derivative		antidepressant;
metabolite
n-acetyltryptophan[no description available]low00N-acetyl-amino acid;
tryptophan derivative		metabolite
arecoline[no description available]low00enoate ester;
methyl ester;
pyridine alkaloid;
tetrahydropyridine		metabolite;
muscarinic agonist
aristolochic acid i[no description available]low00aristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound		carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
dibutyl phthalate[no description available]low00diester;
phthalate ester		EC 3.2.1.20 (alpha-glucosidase) inhibitor;
environmental contaminant;
metabolite;
plasticiser;
teratogenic agent
hydroxymethyltolbutamide[no description available]low00benzyl alcohols;
sulfonamide;
ureas		metabolite
methyl salicylate[no description available]low00benzoate ester;
methyl ester;
salicylates		flavouring agent;
insect attractant;
metabolite
myristicin[no description available]low00organic molecular entitymetabolite
phenmetrazine[no description available]low00morpholinesmetabolite;
sympathomimetic agent
phenylbutazone[no description available]low00pyrazolidinesantirheumatic drug;
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor;
metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
safrole[no description available]low00benzodioxolesflavouring agent;
insecticide;
metabolite;
plant metabolite
2,2'-thiodiethanol[no description available]low00aliphatic sulfide;
diol		antineoplastic agent;
antioxidant;
metabolite;
solvent
sorbitol[no description available]low00glucitolcathartic;
Escherichia coli metabolite;
food humectant;
human metabolite;
laxative;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite;
sweetening agent
alloxan[no description available]low00pyrimidonehyperglycemic agent;
metabolite
thymidine[no description available]low00pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
glutamine[no description available]low00amino acid zwitterion;
glutamine family amino acid;
glutamine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
n-methyltryptamine[no description available]low00tryptamine alkaloid;
tryptamines		metabolite
4-deoxypyridoxine[no description available]low00hydroxymethylpyridine;
methylpyridines;
monohydroxypyridine		metabolite
17-alpha-hydroxyprogesterone[no description available]low0017alpha-hydroxy-C21-steroid;
17alpha-hydroxy steroid;
tertiary alpha-hydroxy ketone		human metabolite;
metabolite;
mouse metabolite;
progestin
mannitol[no description available]low00mannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
phenacyl bromide[no description available]low00acetophenones;
alpha-bromoketone		metabolite
trichloroacetic acid[no description available]low00monocarboxylic acid;
organochlorine compound		carcinogenic agent;
metabolite;
mouse metabolite
n-methylacetamide[no description available]low00acetamides;
monocarboxylic acid amide		metabolite
bis(4-hydroxyphenyl)sulfone[no description available]low00bisphenol;
sulfone		endocrine disruptor;
metabolite
7-amino-4-hydroxy-2-naphthalenesulfonic acid[no description available]low00aminonaphthalenesulfonic acid;
naphthols		metabolite
methyl benzoate[no description available]low00benzoate ester;
methyl ester		insect attractant;
metabolite
2-dichlorobenzene[no description available]low00dichlorobenzenehepatotoxic agent;
metabolite
2,4-diaminotoluene[no description available]low00aminotoluenemetabolite
sulfosalicylic acid[no description available]low00arenesulfonic acid;
benzoic acids;
phenols		metabolite
ethyl lactate[no description available]low00ethyl ester;
lactate ester;
secondary alcohol		metabolite
furaldehyde[no description available]low00aldehyde;
furans		Maillard reaction product;
metabolite
thiophene-2-carboxaldehyde[no description available]low00aldehyde;
thiophenes		metabolite
alpha-resorcylic acid[no description available]low00dihydroxybenzoic acid;
resorcinols		metabolite
methylenebis(chloroaniline)[no description available]low00chloroanilinemetabolite
2-phenylethyl acetate[no description available]low00acetate estermetabolite;
Saccharomyces cerevisiae metabolite
dibenzyl ether[no description available]low00benzyl ethermetabolite
ethyl propionate[no description available]low00propanoate estermetabolite
ethyl oenanthate[no description available]low00fatty acid ethyl estermetabolite
ethyl caprylate[no description available]low00fatty acid ethyl ester;
octanoate ester		metabolite
ethyl laurate[no description available]low00fatty acid ethyl estermetabolite
acetic anhydride[no description available]low00acyclic carboxylic anhydridemetabolite;
reagent
ethyl isovalerate[no description available]low00fatty acid ethyl ester;
olefinic compound		metabolite
n-butyl n-butyrate[no description available]low00butyrate estermetabolite
ethyl decanoate[no description available]low00decanoate ester;
fatty acid ethyl ester		metabolite
methyl octanoate[no description available]low00fatty acid methyl ester;
octanoate ester		metabolite
2-octanone[no description available]low00methyl ketonemetabolite
hexylamine[no description available]low00primary aliphatic aminemetabolite
lauric acid methyl ester[no description available]low00dodecanoate ester;
fatty acid methyl ester		metabolite
octylamine[no description available]low00primary aliphatic aminemetabolite
n-decyl alcohol[no description available]low00decanol;
primary alcohol		metabolite;
pheromone;
protic solvent
methyl palmitate[no description available]low00fatty acid methyl estermetabolite
maltol[no description available]low004-pyranonesmetabolite
chloranil[no description available]low001,4-benzoquinones;
organochlorine compound		EC 2.7.1.33 (pantothenate kinase) inhibitor;
metabolite
dibenzoylmethane[no description available]low00aromatic ketone;
beta-diketone		antimutagen;
antineoplastic agent;
metabolite
methyl anthranilate[no description available]low00benzoate esterflavouring agent;
metabolite
benzyl acetate[no description available]low00acetate ester;
benzyl ester		metabolite
dibenzyl disulfide[no description available]low00organic aromatic compound;
organic disulfide		metabolite
mequinol[no description available]low00methoxybenzenes;
phenols		metabolite
gamma-resorcylic acid[no description available]low00dihydroxybenzoic acidmetabolite
5-methylpyrazole-3-carboxylic acid[no description available]low00monocarboxylic acid;
pyrazoles		metabolite
4-trifluoromethylaniline[no description available]low00(trifluoromethyl)benzenes;
substituted aniline		metabolite
methylguanidine[no description available]low00guanidinesEC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite;
uremic toxin
liriodenine[no description available]low00alkaloid antibiotic;
cyclic ketone;
organic heteropentacyclic compound;
oxacycle;
oxoaporphine alkaloid		antifungal agent;
antimicrobial agent;
antineoplastic agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
plumbagin[no description available]low00hydroxy-1,4-naphthoquinone;
phenols		anticoagulant;
antineoplastic agent;
immunological adjuvant;
metabolite
imperatorin[no description available]low00psoralensEC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite
osthol[no description available]low00botanical anti-fungal agent;
coumarins		metabolite
Dillapiole[no description available]low00benzodioxolesmetabolite
coumaran[no description available]low001-benzofuransmetabolite
1,3-propanediol[no description available]low00propane-1,3-diolsmetabolite;
protic solvent
tridecanedioic acid[no description available]low00alpha,omega-dicarboxylic acidmetabolite
physcione[no description available]low00dihydroxyanthraquinoneanti-inflammatory agent;
antibacterial agent;
antifungal agent;
antineoplastic agent;
apoptosis inducer;
hepatoprotective agent;
metabolite
apiole[no description available]low00benzodioxolesmetabolite
flavone[no description available]low00flavonesmetabolite;
nematicide
cetyl palmitate[no description available]low00hexadecanoate estermetabolite
n-amyl butyrate[no description available]low00butyrate estermetabolite
3-aminobutyric acid[no description available]low00amino acid zwitterion;
beta-amino acid;
monocarboxylic acid		metabolite
methyl lactate[no description available]low00lactate ester;
methyl ester		metabolite
paeonol[no description available]low00methoxybenzenes;
phenols		metabolite
2,2-dimethylbutyric acid[no description available]low00dimethylbutyric acidmetabolite
2-chloroacrylic acid[no description available]low00alpha,beta-unsaturated monocarboxylic acid;
chlorocarboxylic acid		metabolite
galactitol[no description available]low00hexitolEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
1-methyluracil[no description available]low00nucleobase analogue;
pyrimidone		metabolite
2-pyrrolidone[no description available]low00pyrrolidin-2-onesmetabolite;
polar solvent
n-ethylacetamide[no description available]low00acetamidesmetabolite
6-methyluracil[no description available]low00pyrimidonemetabolite
3-methylglutaric acid[no description available]low00alpha,omega-dicarboxylic acidmetabolite
amyl acetate[no description available]low00acetate estermetabolite
dibenzothiophene 5-oxide[no description available]low00dibenzothiophenesmetabolite
2-acetamidoethanethiol[no description available]low00acetamidesmetabolite
2-hydroxyquinoxaline[no description available]low00hydroxyquinoxalinemetabolite
3,4-dihydroxyacetophenone[no description available]low00acetophenones;
catechols;
dihydroxyacetophenone		metabolite
methyl hippurate[no description available]low00glycine derivative;
methyl ester		metabolite
isobarbaloin[no description available]low00anthracenes;
C-glycosyl compound;
cyclic ketone;
phenols		laxative;
metabolite
vincamine[no description available]low00alkaloid ester;
hemiaminal;
methyl ester;
organic heteropentacyclic compound;
vinca alkaloid		antihypertensive agent;
metabolite;
vasodilator agent
methyl tert-butyl ether[no description available]low00etherfuel additive;
metabolite;
non-polar solvent
4-octylphenol[no description available]low00phenolsmetabolite;
surfactant;
xenoestrogen
dronabinol[no description available]low00benzochromene;
diterpenoid;
phytocannabinoid;
polyketide		cannabinoid receptor agonist;
epitope;
hallucinogen;
metabolite;
non-narcotic analgesic
phenethyl isothiocyanate[no description available]low00isothiocyanateantineoplastic agent;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
metabolite
2-methoxy-1,4-naphthoquinone[no description available]low001,4-naphthoquinones;
enol ether		antimicrobial agent;
metabolite;
plant metabolite
aviprin[no description available]low00furanocoumarinmetabolite
hydroxyphenytoin[no description available]low00imidazolidine-2,4-dione;
phenols		metabolite
squaric acid[no description available]low00alicyclic ketone;
carbon oxoacid		metabolite
methyl methanethiosulfonate[no description available]low00sulfonic acid derivative;
thiosulfonate ester		metabolite
arabinofuranosyluracil[no description available]low00N-glycosyl compoundmetabolite
6-aminonicotinic acid[no description available]low00aminonicotinic acid;
aminopyridine;
aromatic amine		metabolite
2,3-hexanedione[no description available]low00alpha-diketonemetabolite
tabersonine[no description available]low00alkaloid ester;
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound		antineoplastic agent;
metabolite
3,3-dimethylglutarate[no description available]low00alpha,omega-dicarboxylic acidmetabolite
raspberry ketone[no description available]low00methyl ketone;
phenols		androgen antagonist;
cosmetic;
flavouring agent;
fragrance;
hepatoprotective agent;
metabolite
laurolitsine[no description available]low00aporphine alkaloid;
aromatic ether;
phenols		HIV-1 integrase inhibitor;
metabolite
helenalin[no description available]low00cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
secondary alcohol;
sesquiterpene lactone		anti-inflammatory agent;
antineoplastic agent;
metabolite;
plant metabolite
diethyl malate[no description available]low00malate estermetabolite
glucoheptonate[no description available]low00carbohydrate acid;
monocarboxylic acid		metabolite
deslanoside[no description available]low0012beta-hydroxy steroid;
14beta-hydroxy steroid;
cardenolide glycoside;
tetrasaccharide derivative		anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
metabolite
streptozocin[no description available]low00N-acylglucosamine;
N-nitrosoureas		antimicrobial agent;
antineoplastic agent;
DNA synthesis inhibitor;
metabolite
pedalitin[no description available]low00monomethoxyflavone;
tetrahydroxyflavone		EC 1.17.3.2 (xanthine oxidase) inhibitor;
metabolite
ethyl nonanoate[no description available]low00fatty acid ethyl estermetabolite
ethyl hexanoate[no description available]low00fatty acid ethyl ester;
hexanoate ester		metabolite
butyl acetate[no description available]low00acetate estermetabolite
isoamyl acetate[no description available]low00acetate estermetabolite;
Saccharomyces cerevisiae metabolite
ribostamycin[no description available]low00amino cyclitol glycoside;
aminoglycoside antibiotic		antibacterial drug;
antimicrobial agent;
metabolite
tramadol[no description available]low002-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanoladrenergic uptake inhibitor;
antitussive;
capsaicin receptor antagonist;
delta-opioid receptor agonist;
kappa-opioid receptor agonist;
metabolite;
mu-opioid receptor agonist;
muscarinic antagonist;
nicotinic antagonist;
NMDA receptor antagonist;
opioid analgesic;
serotonergic antagonist;
serotonin uptake inhibitor
6-pentylpyrone[no description available]low002-pyranonesmetabolite
paclitaxel[no description available]low00taxane diterpenoid;
tetracyclic diterpenoid		antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
4-methylhistamine[no description available]low00aralkylamino compound;
imidazoles		histamine agonist;
metabolite
perfosfamide[no description available]low00nitrogen mustard;
organochlorine compound;
peroxol;
phosphorodiamide		alkylating agent;
antineoplastic agent;
drug allergen;
immunosuppressive agent;
metabolite
castanospermine[no description available]low00indolizidine alkaloidanti-HIV-1 agent;
anti-inflammatory agent;
EC 3.2.1.* (glycosidase) inhibitor;
metabolite
pravastatin[no description available]low003-hydroxy carboxylic acid;
carbobicyclic compound;
carboxylic ester;
hydroxy monocarboxylic acid;
secondary alcohol;
statin (semi-synthetic)		anticholesteremic drug;
environmental contaminant;
metabolite;
xenobiotic
3-methyl-2-butenal[no description available]low00enalmetabolite
ethyl 3-hydroxybutyrate[no description available]low00fatty acid ethyl estermetabolite
4,5-dimethyl-3-hydroxy-2(5h)-furanone[no description available]low00butenolidemetabolite
n-methylnicotinamide[no description available]low00pyridinecarboxamidemetabolite
3-aminoisobutyric acid[no description available]low00amino acid zwitterion;
beta-amino acid		metabolite
platanic acid[no description available]low00hydroxy monocarboxylic acid;
methyl ketone;
pentacyclic triterpenoid		anti-HIV agent;
metabolite
2'-deoxyuridylic acid[no description available]low00deoxyuridine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-monophosphate		Escherichia coli metabolite;
metabolite;
mouse metabolite
gallocatechol[no description available]low00gallocatechinantioxidant;
metabolite;
radical scavenger
1-methylinosine[no description available]low00inosinesmetabolite
dihydrobetulinic acid[no description available]low00hydroxy monocarboxylic acid;
pentacyclic triterpenoid		anti-HIV agent;
antileishmanial agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
metabolite
bergenin[no description available]low00trihydroxybenzoic acidmetabolite
2-methoxyestradiol[no description available]low0017beta-hydroxy steroid;
3-hydroxy steroid		angiogenesis modulating agent;
antimitotic;
antineoplastic agent;
human metabolite;
metabolite;
mouse metabolite
3'-cmp[no description available]low00cytidine 3'-phosphate;
pyrimidine ribonucleoside 3'-monophosphate		Escherichia coli metabolite;
metabolite;
mouse metabolite
xanthoxyletin[no description available]low00coumarinsmetabolite
pinocembrin[no description available]low00(2S)-flavan-4-one;
dihydroxyflavanone		antineoplastic agent;
antioxidant;
metabolite;
neuroprotective agent;
vasodilator agent
orsellinic acid[no description available]low00dihydroxybenzoic acid;
resorcinols		fungal metabolite;
marine metabolite;
metabolite
isoimperatorin[no description available]low00psoralensEC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite
rotenolone[no description available]low00organic molecular entitymetabolite
seselin[no description available]low00coumarinsmetabolite
perillene[no description available]low00furans;
monoterpenoid		fragrance;
metabolite;
semiochemical
glycine methyl ester[no description available]low00glycinyl estermetabolite
hexadecanamide[no description available]low00primary fatty amidemetabolite
benzocyclobutene[no description available]low00carbobicyclic compoundmetabolite
9-methyladenine[no description available]low00methyladeninemetabolite
n'-methyl-2-pyridone-5-carboxamide[no description available]low00methylpyridines;
pyridinecarboxamide;
pyridone		metabolite;
mouse metabolite
1,3-dimethyluracil[no description available]low00pyrimidonemetabolite
3-methoxysalicylic acid[no description available]low00methoxysalicylic acidmetabolite
1,3-dimethyluric acid[no description available]low00oxopurinemetabolite
leucyltyrosine[no description available]low00dipeptidemetabolite
3-methylxanthine[no description available]low003-methylxanthinemetabolite
leucyl-glycyl-glycine[no description available]low00tripeptidemetabolite
acetylleucine[no description available]low00L-leucine derivative;
N-acetyl-L-amino acid		metabolite
n-benzoylalanine, (dl-ala)-isomer[no description available]low00alanine derivative;
N-acyl-amino acid		metabolite
dipropylacetamide[no description available]low00fatty amidegeroprotector;
metabolite;
teratogenic agent
masoprocol[no description available]low00nordihydroguaiaretic acidantineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite
7-methyladenine[no description available]low00methyladeninemetabolite
acetylisoniazid[no description available]low00carbohydrazidemetabolite
illimaquinone[no description available]low00monohydroxy-1,4-benzoquinones;
prenylquinone		metabolite
coptisine[no description available]low00alkaloidmetabolite
betulin[no description available]low00diol;
pentacyclic triterpenoid		analgesic;
anti-inflammatory agent;
antineoplastic agent;
antiviral agent;
metabolite
narciclasine[no description available]low00phenanthridinesmetabolite
lividomycin[no description available]low00lividomycinsmetabolite
dmp 323[no description available]low00diazepanone;
ureas		anti-HIV agent;
metabolite
eupolauridine[no description available]low00naphthyridine derivativemetabolite
zaluzanin C[no description available]low00gamma-lactone;
guaiane sesquiterpenoid;
organic heterotricyclic compound;
secondary alcohol;
sesquiterpene lactone		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite
2-aminonicotinic acid[no description available]low00aminonicotinic acid;
aminopyridine		metabolite
(-)-catechin[no description available]low00catechinmetabolite
dehydrocostus lactone[no description available]low00gamma-lactone;
guaiane sesquiterpenoid;
organic heterotricyclic compound;
sesquiterpene lactone		antimycobacterial drug;
antineoplastic agent;
apoptosis inducer;
cyclooxygenase 2 inhibitor;
metabolite;
trypanocidal drug
Tormentic acid[no description available]low00triterpenoidmetabolite
pinobanksin[no description available]low00secondary alpha-hydroxy ketone;
trihydroxyflavanone		antimutagen;
antioxidant;
metabolite
sigmoidin a[no description available]low004'-hydroxyflavanones;
tetrahydroxyflavanone		anti-inflammatory agent;
anti-obesity agent;
antibacterial agent;
metabolite;
radical scavenger
xanthosine 5'-triphosphate[no description available]low00purine ribonucleoside 5'-monophosphate;
xanthosine 5'-phosphate		Escherichia coli metabolite;
metabolite;
mouse metabolite
monotropein[no description available]low00beta-D-glucoside;
cyclopentapyran;
iridoid monoterpenoid;
monocarboxylic acid;
monosaccharide derivative		anti-inflammatory agent;
metabolite
glycyl-histidyl-lysine[no description available]low00tripeptidechelator;
hepatoprotective agent;
metabolite;
vulnerary
homoeriodictyol[no description available]low003'-methoxyflavanones;
4'-hydroxyflavanones;
monomethoxyflavanone;
trihydroxyflavanone		flavouring agent;
metabolite
arjunolic acid[no description available]low00hydroxy monocarboxylic acid;
pentacyclic triterpenoid		antibacterial agent;
antifungal agent;
antioxidant;
metabolite
monoethyl phthalate[no description available]low00ethyl ester;
phthalic acid monoester		metabolite
methylimidazoleacetic acid[no description available]low00imidazoles;
monocarboxylic acid		GABA agonist;
metabolite
2-(2-aminoethyl)pyridine[no description available]low00aminoalkylpyridine;
primary amine		histamine agonist;
metabolite
xanthurenic acid 8-methyl ether[no description available]low00aromatic ether;
monohydroxyquinoline;
quinolinemonocarboxylic acid		carcinogenic agent;
metabolite;
mouse metabolite
methyl orsellinate[no description available]low00hydroxybenzoic acidmetabolite
2,2-di(4-methacryloxyphenyl)propane[no description available]low00bisphenol;
enoate ester		metabolite
sofosbuvir[no description available]low00aminopyrimidine;
aromatic carboxylic acid;
nucleobase analogue;
pyrimidone		metabolite
3-methyluracil[no description available]low00nucleobase analogue;
pyrimidone		metabolite
1-methylcytosine[no description available]low00aminopyrimidine;
methylcytosine;
pyrimidone		metabolite
leucyl-alanine[no description available]low00dipeptidemetabolite
leucyl-leucyl-leucine[no description available]low00tripeptidemetabolite
3,4-dihydroxyphenylethanol[no description available]low00catechols;
primary alcohol		antineoplastic agent;
antioxidant;
metabolite
3,7-dimethyluric acid[no description available]low00oxopurinemetabolite;
mouse metabolite
alanylproline[no description available]low00dipeptide zwitterion;
dipeptide		metabolite
d-biotin-d-sulfoxide[no description available]low00biotins;
sulfoxide		metabolite
biotin sulfone[no description available]low00biotins;
sulfone		metabolite
asperuloside[no description available]low00acetate ester;
beta-D-glucoside;
gamma-lactone;
iridoid monoterpenoid;
monosaccharide derivative		metabolite
primin[no description available]low001,4-benzoquinonesallergen;
antifeedant;
antimicrobial agent;
hapten;
metabolite
2-(hydroxymethyl)anthraquinone[no description available]low00anthraquinonemetabolite
tyrosylleucine[no description available]low00dipeptidemetabolite
o-methylserine[no description available]low00L-serine derivative;
non-proteinogenic L-alpha-amino acid		metabolite
cinchonine[no description available]low00(8xi)-cinchonan-9-ol;
cinchona alkaloid		metabolite
aucubin[no description available]low00organic molecular entitymetabolite
catalpol[no description available]low00organic molecular entitymetabolite
2-methylhistamine[no description available]low00aralkylamino compound;
imidazoles		histamine agonist;
metabolite
2-methylhippuric acid[no description available]low00N-acylglycinemetabolite
taraxerol[no description available]low00pentacyclic triterpenoid;
secondary alcohol		metabolite
alpha-peltatin[no description available]low00furonaphthodioxole;
gamma-lactone;
lignan;
organic heterotetracyclic compound;
phenols		antineoplastic agent;
metabolite
3-acetyllupeol[no description available]low00organic molecular entitymetabolite
lupenone[no description available]low00triterpenoidmetabolite
glycyltryptophan[no description available]low00dipeptidemetabolite
monocerin[no description available]low00hydroxybenzoic acidmetabolite
propionyl-coenzyme a[no description available]low00acyl-CoAEscherichia coli metabolite;
metabolite;
mouse metabolite
alpha-hydroxyisocaproic acid[no description available]low002-hydroxy fatty acid;
branched-chain fatty acid		metabolite
totarol[no description available]low00diterpenoidmetabolite
taraxerone[no description available]low00scalarane sesterterpenoidmetabolite
prunin protein, prunus[no description available]low00(2S)-flavan-4-one;
4'-hydroxyflavanones;
dihydroxyflavanone;
flavanone 7-O-beta-D-glucoside;
monosaccharide derivative		antibacterial agent;
antilipemic drug;
hypoglycemic agent;
metabolite
uvaol[no description available]low00triterpenoidmetabolite
glycyltyrosine[no description available]low00dipeptidemetabolite
glycylleucine[no description available]low00dipeptide zwitterion;
dipeptide		metabolite
alanyltyrosine[no description available]low00dipeptidemetabolite
glycyl-l-phenylalanine[no description available]low00dipeptide zwitterion;
dipeptide		human metabolite;
metabolite
digoxigenin-mono(digitoxoside)[no description available]low00cardenolide glycoside;
digitoxoside;
monosaccharide derivative;
steroid saponin		metabolite
thiazolidine-4-carboxylic acid, (r)-isomer[no description available]low00thiazolidinemonocarboxylic acid;
thioproline		geroprotector;
metabolite
5,6-dihydrothymine[no description available]low00pyrimidonehuman metabolite;
metabolite;
mouse metabolite
dehydroabietic acid[no description available]low00abietane diterpenoid;
carbotricyclic compound;
monocarboxylic acid		allergen;
metabolite
palmitone[no description available]low00dialkyl ketoneanticonvulsant;
metabolite
1-methylthymine[no description available]low00methylthyminemetabolite
imidazoleacetic acid[no description available]low00imidazoles;
monocarboxylic acid		metabolite;
mouse metabolite
1-methylguanosine[no description available]low00methylguanosinemetabolite
alanylphenylalanine[no description available]low00dipeptidemetabolite
murrayanine[no description available]low00carbazolesmetabolite
girinimbine[no description available]low00carbazolesmetabolite
tryptophylglycine[no description available]low00dipeptidemetabolite
canthin-6-one[no description available]low00enone;
indole alkaloid;
organic heterotetracyclic compound		antimycobacterial drug;
metabolite
glycylaspartic acid[no description available]low00dipeptidemetabolite
4-methylhippuric acid[no description available]low00N-acylglycinemetabolite
delta(9)-tetrahydrocannabinolic acid[no description available]low00benzochromene;
diterpenoid;
hydroxy monocarboxylic acid;
phytocannabinoid;
polyketide		anti-inflammatory agent;
biomarker;
metabolite;
neuroprotective agent
3-methylhippuric acid[no description available]low00N-acylglycinemetabolite
n-glycylglutamic acid[no description available]low00dipeptidemetabolite
n-caproylglycine[no description available]low00N-acylglycinemetabolite
diosgenin[no description available]low003beta-sterol;
hexacyclic triterpenoid;
sapogenin;
spiroketal		antineoplastic agent;
antiviral agent;
apoptosis inducer;
metabolite
s-2-aminoethyl cysteine[no description available]low00L-cysteine thioether;
non-proteinogenic L-alpha-amino acid		EC 5.4.3.2 (lysine 2,3-aminomutase) inhibitor;
metabolite;
protein synthesis inhibitor
4-hydroxycyclophosphamide[no description available]low00nitrogen mustard;
organochlorine compound;
phosphorodiamide		alkylating agent;
metabolite
alpha-glutamyltryptophan[no description available]low00dipeptideangiogenesis modulating agent;
antineoplastic agent;
immunomodulator;
metabolite
malabaricone c[no description available]low00butanonemetabolite
loliolide[no description available]low00benzofuransmetabolite
tuberostemonine[no description available]low00alkaloidmetabolite
pyrrole-3-carboxylic acid[no description available]low00pyrrolecarboxylic acidmetabolite;
Penicillium metabolite
histidylglycine[no description available]low00dipeptidemetabolite
histidinoalanine[no description available]low00dipeptide zwitterion;
dipeptide		metabolite
cinchonidine[no description available]low00(8xi)-cinchonan-9-ol;
cinchona alkaloid		metabolite
quillaic acid[no description available]low00aldehyde;
hydroxy monocarboxylic acid;
pentacyclic triterpenoid		anti-inflammatory agent;
metabolite
p-methoxy-n-methylphenethylamine[no description available]low00aromatic ether;
secondary amino compound		metabolite
ecgonine methyl ester[no description available]low00methyl ester;
tertiary amino compound;
tropane alkaloid		analgesic;
central nervous system depressant;
metabolite;
mouse metabolite;
opioid analgesic;
peripheral nervous system drug
n-acetylcytidine[no description available]low00acetamides;
cytidines;
secondary carboxamide		metabolite
4-hydroxydebrisoquin[no description available]low00carboxamidine;
isoquinolines;
secondary alcohol		metabolite
hypotaurine[no description available]low00aminosulfinic acid;
zwitterion		human metabolite;
metabolite;
mouse metabolite
hc toxin[no description available]low00homodetic cyclic peptide;
tetrapeptide		antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
metabolite;
phytotoxin
epicatechin gallate[no description available]low00catechin;
gallate ester;
polyphenol		EC 3.2.1.1 (alpha-amylase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
versiconal hemiacetal acetate[no description available]low00acetate ester;
anthrafuran;
lactol;
palmitoyl amino acid;
polyphenol		metabolite
selenodiglutathione[no description available]low00glutathione derivative;
thioselenide		Escherichia coli metabolite;
metabolite
coprine[no description available]low00cyclopropanes;
dicarboxylic acid monoamide;
L-glutamine derivative;
non-proteinogenic L-alpha-amino acid		EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
metabolite;
mycotoxin
aristolochic acid ii[no description available]low00aristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound		carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
exp3174[no description available]low00biphenylyltetrazole;
imidazoles;
organochlorine compound		metabolite
ribonolactone[no description available]low00butan-4-olide;
ribonolactone		metabolite
sulfamethoxazole hydroxylamine[no description available]low00isoxazoles;
sulfonamide		allergen;
metabolite
androsterone glucuronide[no description available]low00beta-D-glucosiduronic acid;
steroid glucosiduronic acid		human metabolite;
metabolite;
mouse metabolite
tephrosin[no description available]low00aromatic ether;
cyclic ketone;
organic heteropentacyclic compound;
rotenones		antineoplastic agent;
metabolite;
pesticide
sapintoxin d[no description available]low00phorbol ester;
tertiary alpha-hydroxy ketone		fluorescent probe;
metabolite
amarogentin[no description available]low00monosaccharide derivative;
secoiridoid glycoside		EC 5.99.1.2 (DNA topoisomerase) inhibitor;
metabolite
taraxasterol[no description available]low00pentacyclic triterpenoid;
secondary alcohol		anti-inflammatory agent;
metabolite
asiatic acid[no description available]low00monocarboxylic acid;
pentacyclic triterpenoid;
triol		angiogenesis modulating agent;
metabolite
flavoglaucin[no description available]low00hydroquinonesmetabolite
1-(6-hydroxy-2-isopropenyl-1-benzofuran-5-yl)-1-ethanone[no description available]low00benzofuransmetabolite
dioscin[no description available]low00hexacyclic triterpenoid;
spiroketal;
spirostanyl glycoside;
trisaccharide derivative		anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 1.14.18.1 (tyrosinase) inhibitor;
hepatoprotective agent;
metabolite
maculosin[no description available]low00dipeptide;
homodetic cyclic peptide;
phenols;
pyrrolopyrazine		metabolite
n(4)-methylcytosine[no description available]low00aminopyrimidine;
methylcytosine;
pyrimidone		metabolite
n-acetylputrescine[no description available]low00N-monoacetylalkane-alpha,omega-diamine;
N-substituted putrescine		metabolite;
mouse metabolite
4'-demethylpodophyllotoxin[no description available]low00furonaphthodioxole;
organic heterotetracyclic compound;
phenols		metabolite
lysicamine[no description available]low00alkaloid antibiotic;
oxoaporphine alkaloid		metabolite
celastrol[no description available]low00monocarboxylic acid;
pentacyclic triterpenoid		anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
procyanidin b2[no description available]low00biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin		antioxidant;
metabolite
aromadedrin[no description available]low004'-hydroxyflavanones;
dihydroflavonols;
secondary alpha-hydroxy ketone;
tetrahydroxyflavanone		metabolite
3-methylthymine[no description available]low00methylthymine;
pyrimidone		metabolite
tyrosyl-glycyl-glycine[no description available]low00tripeptide zwitterion;
tripeptide		metabolite
cyclic adp-ribose[no description available]low00cyclic purine nucleotide;
nucleotide-sugar		metabolite;
ryanodine receptor agonist
glycylglutamine[no description available]low00dipeptide zwitterion;
dipeptide		metabolite;
protective agent
alanylglutamine[no description available]low00dipeptide zwitterion;
dipeptide		metabolite
naadp[no description available]low00nicotinic acid dinucleotidecalcium channel agonist;
metabolite;
signalling molecule
procyanidin b5[no description available]low00biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin		metabolite
proanthocyanidin a2[no description available]low00hydroxyflavan;
proanthocyanidin		angiogenesis modulating agent;
anti-HIV agent;
antioxidant;
metabolite
dihydrosanguinarine[no description available]low00benzophenanthridine alkaloidantifungal agent;
metabolite
tetrahydrocurcumin[no description available]low00beta-diketone;
diarylheptanoid;
polyphenol		metabolite
eriodictyol 7-glucuronide[no description available]low003'-hydroxyflavonoid;
beta-D-glucosiduronic acid		EC 1.1.1.21 (aldehyde reductase) inhibitor;
metabolite
beta-lipotropin, gln(9)-[no description available]low00catechols;
crown compound;
macrocyclic lactone		bacterial metabolite;
metabolite
4-nitrososulfamethoxazole[no description available]low00isoxazoles;
nitroso compound;
sulfonamide		allergen;
metabolite
protosappanin a[no description available]low00catecholsmetabolite
3,3'-neotrehalosadiamine[no description available]low00amino disaccharide;
glycosyl glycoside derivative		antimicrobial agent;
metabolite
salvinorin a[no description available]low00organic heterotricyclic compound;
organooxygen compound		metabolite;
oneirogen
cyanidin[no description available]low005-hydroxyanthocyanidinantioxidant;
metabolite;
neuroprotective agent
yakuchinone-a[no description available]low00ketone;
monomethoxybenzene;
phenols		antineoplastic agent;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite
marsupsin[no description available]low001-benzofurans;
aromatic ether;
polyphenol		antilipemic drug;
hypoglycemic agent;
metabolite
6,6'-bieckol[no description available]low00aromatic ether;
oxacycle;
phlorotannin		anti-HIV-1 agent;
metabolite;
radical scavenger
3-methylcytosine[no description available]low00aminopyrimidine;
methylcytosine;
pyrimidone		metabolite
eckol[no description available]low00phlorotanninantioxidant;
metabolite
procyanidin b3[no description available]low00biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin		anti-inflammatory agent;
antioxidant;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
metabolite
aclacinomycin[no description available]low00aminoglycoside;
anthracycline;
deoxy hexoside;
methyl ester;
monosaccharide derivative;
phenols;
polyketide;
tertiary alcohol;
tetracenequinones;
zwitterion		antimicrobial agent;
antineoplastic agent;
metabolite
phenylalanylarginine[no description available]low00dipeptidemetabolite
prolylarginine[no description available]low00dipeptidemetabolite
5-methoxytryptophan[no description available]low00L-alpha-amino acid zwitterion;
L-tryptophan derivative		metabolite
phenylalanylglutamate[no description available]low00dipeptidemetabolite
aspartylglycine[no description available]low00dipeptidemetabolite
aspartylglutamate[no description available]low00dipeptidemetabolite
5-hydroxypipecolic acid[no description available]low00piperidinemonocarboxylic acidmetabolite
prolyl-tyrosine[no description available]low00dipeptidemetabolite
histidylproline[no description available]low00dipeptide zwitterion;
dipeptide		metabolite
phenylalanyl-glycyl-glycine[no description available]low00tripeptidemetabolite
leucylarginine[no description available]low00dipeptidemetabolite
pendolmycin[no description available]low00indolesmetabolite
atractylenolide iii[no description available]low00naphthofuranmetabolite
malvidin[no description available]low005-hydroxyanthocyanidinbiological pigment;
metabolite
5-hydroxytryptoline[no description available]low00beta-carbolinesmetabolite
perlolyrine[no description available]low00organic molecular entitymetabolite
endocrocin[no description available]low00monocarboxylic acid;
phenols;
trihydroxyanthraquinone		metabolite
sulochrin[no description available]low00benzophenones;
carboxylic ester;
phenols		metabolite
i-677[no description available]low00L-serine derivative;
non-proteinogenic L-alpha-amino acid		antimetabolite;
antimicrobial agent;
antineoplastic agent;
metabolite
isohomovanillic acid[no description available]low00aromatic ether;
phenols;
phenylacetic acids		metabolite
4-amino-2-methoxypyrimidine[no description available]low00aminopyrimidine;
aromatic ether;
methylcytosine		metabolite
asimilobine[no description available]low00aporphine alkaloidmetabolite
aristolochic acid D[no description available]low00aristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound		carcinogenic agent;
metabolite;
nephrotoxin;
toxin
leukodopachrome[no description available]low00hydroxy monocarboxylic acid;
indoles		metabolite
ampelopsin[no description available]low00dihydromyricetin;
secondary alpha-hydroxy ketone		antineoplastic agent;
antioxidant;
metabolite
pinusolide[no description available]low00diterpene lactonemetabolite
2,4,5-trihydroxypentanoic acid gamma-lactone[no description available]low00ribonolactonemetabolite
hydroxysitosterol[no description available]low003beta-hydroxy-Delta(5)-steroid;
7alpha-hydroxy steroid		metabolite;
plant metabolite
jolkinolide a[no description available]low00diterpene lactonemetabolite
jolkinolide b[no description available]low00diterpene lactonemetabolite
1-o-hexadecyl-2-lyso-glycero-3-phosphorylcholine[no description available]low001-alkyl-sn-glycero-3-phosphocholine;
lysophosphatidylcholine O-16:0		metabolite
isovitexin[no description available]low00C-glycosyl compound;
trihydroxyflavone		EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
dopamine quinone[no description available]low001,2-benzoquinones;
primary amino compound		metabolite
platycodin d[no description available]low00triterpenoid saponinmetabolite
frenolicin b[no description available]low00benzoisochromanequinone;
p-quinones		metabolite
4-oxopentanal[no description available]low00ketoaldehydemetabolite
my 12-62c[no description available]low00monohydroxyquinoline;
quinolone		antibacterial agent;
iron chelator;
metabolite;
signalling molecule
3,4-dihydroxyphenylpyruvic acid[no description available]low002-oxo monocarboxylic acidmetabolite
proximadiol[no description available]low00eudesmane sesquiterpenoidmetabolite
aristolochic acid c[no description available]low00aristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound		carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
phenylacetyl-coenzyme a[no description available]low00acyl-CoAEscherichia coli metabolite;
metabolite;
mouse metabolite
taxusin[no description available]low00acetate ester;
carbotricyclic compound;
taxane diterpenoid		metabolite
confertin[no description available]low00cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
pseudoguaianolide		anti-inflammatory agent;
metabolite;
plant metabolite
beta-methylcrotonylglycine[no description available]low00N-acylglycinemetabolite
tracheloside[no description available]low00glycoside;
lignan		metabolite
maytenonic acid[no description available]low00triterpenoidmetabolite
procyanidin C1[no description available]low00hydroxyflavan;
polyphenol;
proanthocyanidin		anti-inflammatory agent;
antioxidant;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
lipoxygenase inhibitor;
metabolite
3-methyleneindolenine[no description available]low00indolesmetabolite
isopulegol[no description available]low00p-menthane monoterpenoidmetabolite
kadsurin[no description available]low00tanninmetabolite
lysylproline[no description available]low00dipeptidemetabolite
5-o-methylembelin[no description available]low00enol ether;
monohydroxy-1,4-benzoquinones		antileishmanial agent;
antineoplastic agent;
hepatitis C protease inhibitor;
metabolite
dihydrodaidzein[no description available]low00hydroxyisoflavanonemetabolite
4'-o-methylepigallocatechin[no description available]low00catechinmetabolite
corynoline[no description available]low00benzophenanthridine alkaloid;
cyclic acetal;
isoquinolines;
organic heterohexacyclic compound;
secondary alcohol		antineoplastic agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
hepatoprotective agent;
metabolite
limonin[no description available]low00epoxide;
furans;
hexacyclic triterpenoid;
lactone;
limonoid;
organic heterohexacyclic compound		inhibitor;
metabolite;
volatile oil component
dichamanetin[no description available]low00diarylheptanoidmetabolite
brevianamide f[no description available]low00dipeptide;
indoles;
pyrrolopyrazine		metabolite
ergolide[no description available]low00acetate ester;
cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
sesquiterpene lactone		anti-inflammatory agent;
antineoplastic agent;
metabolite;
NF-kappaB inhibitor;
plant metabolite
4-sulfocatechol[no description available]low00dihydroxybenzenesulfonic acidmetabolite
histidylleucine[no description available]low00dipeptide zwitterion;
dipeptide		metabolite
7-methoxyheptaphylline[no description available]low00carbazolesmetabolite
phenylalanylserine[no description available]low00dipeptidemetabolite
phellamurin[no description available]low004'-hydroxyflavanones;
beta-D-glucoside;
dihydroflavonols;
flavanone glycoside;
monosaccharide derivative;
trihydroxyflavanone		metabolite
prolylglutamic acid[no description available]low00dipeptidemetabolite
nantenine[no description available]low00oxoaporphine alkaloidmetabolite
hydrastine[no description available]low00isoquinolinesmetabolite
butyrylcarnitine[no description available]low00O-butanoylcarnitine;
saturated fatty acyl-L-carnitine		metabolite
2-hydroxyestradiol[no description available]low0017beta-hydroxy steroid;
2-hydroxy steroid		carcinogenic agent;
human metabolite;
metabolite;
mouse metabolite;
prodrug
aromaticin[no description available]low00cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
sesquiterpene lactone		anti-inflammatory agent;
metabolite;
plant metabolite
acivicin[no description available]low00isoxazoles;
non-proteinogenic L-alpha-amino acid;
organochlorine compound		antileishmanial agent;
antimetabolite;
antimicrobial agent;
antineoplastic agent;
EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor;
glutamine antagonist;
metabolite
n-methylcorydaldine[no description available]low00quinolonemetabolite
2-amino-3,3-dimethylbutanoic acid[no description available]low00non-proteinogenic alpha-amino acidmetabolite
pentabromopseudilin[no description available]low00pyrrolesmetabolite
rocaglamide[no description available]low00monocarboxylic acid amide;
monomethoxybenzene;
organic heterotricyclic compound		antileishmanial agent;
antineoplastic agent;
metabolite
dentatin[no description available]low00coumarinsmetabolite
acronine[no description available]low00acridone derivatives;
alkaloid		antineoplastic agent;
metabolite
enmein[no description available]low00delta-lactonemetabolite
5-aminonicotinic acid[no description available]low00aminonicotinic acid;
aminopyridine;
aromatic amine		metabolite
pomolic acid[no description available]low00triterpenoidmetabolite
aglafoline[no description available]low00methyl ester;
organic heterotricyclic compound		metabolite;
platelet aggregation inhibitor
isomaltose[no description available]low00glycosylglucosehuman metabolite;
metabolite;
mouse metabolite
deoxyglucose[no description available]low002-deoxy-D-glucosemetabolite
vestitone[no description available]low00(3R)-2'-hydroxyisoflavanones;
hydroxyisoflavanone;
methoxyisoflavanone		antibacterial agent;
metabolite
pantetheine[no description available]low00pantetheines;
thiol		human metabolite;
metabolite;
mouse metabolite
salicin[no description available]low00aromatic primary alcohol;
aryl beta-D-glucoside;
benzyl alcohols		antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
taxifolin[no description available]low00taxifolinmetabolite
fucose[no description available]low00deoxygalactosemetabolite
saponarin[no description available]low00C-glycosyl compound;
dihydroxyflavone;
glycosyloxyflavone;
monosaccharide derivative		metabolite
hippeastrine[no description available]low00delta-lactone;
indole alkaloid;
organic heteropentacyclic compound;
secondary alcohol		antineoplastic agent;
metabolite
cyanidin 3-o-beta-d-glucopyranoside[no description available]low00anthocyanin cation;
beta-D-glucoside;
monosaccharide derivative		metabolite
silychristin[no description available]low001-benzofurans;
aromatic ether;
flavonolignan;
polyphenol;
secondary alpha-hydroxy ketone		lipoxygenase inhibitor;
metabolite;
prostaglandin antagonist;
radical scavenger
peonidin[no description available]low005-hydroxyanthocyanidinantineoplastic agent;
antioxidant;
apoptosis inducer;
metabolite
convallatoxin[no description available]low0014beta-hydroxy steroid;
19-oxo steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
steroid aldehyde;
steroid lactone		metabolite;
vasodilator agent
furostanol i[no description available]low00beta-D-glucoside;
cyclic hemiketal;
pentacyclic triterpenoid;
steroid saponin;
trisaccharide derivative		metabolite
decursinol[no description available]low00cyclic ether;
delta-lactone;
organic heterotricyclic compound;
secondary alcohol		analgesic;
antineoplastic agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite
abyssinone v[no description available]low004'-hydroxyflavanones;
phenols;
trihydroxyflavanone		metabolite
davidigenin[no description available]low00dihydrochalcones;
polyphenol		anti-allergic agent;
anti-asthmatic agent;
antioxidant;
metabolite
farrerol[no description available]low00organic molecular entitymetabolite
naringin[no description available]low00(2S)-flavan-4-one;
4'-hydroxyflavanones;
dihydroxyflavanone;
disaccharide derivative;
neohesperidoside		anti-inflammatory agent;
antineoplastic agent;
metabolite
isonaringin[no description available]low00(2S)-flavan-4-one;
4'-hydroxyflavanones;
dihydroxyflavanone;
disaccharide derivative;
rutinoside		anti-inflammatory agent;
antioxidant;
metabolite
cleomiscosin a[no description available]low00aromatic ether;
delta-lactone;
organic heterotricyclic compound;
phenols;
primary alcohol		anti-inflammatory agent;
metabolite
vicenin ii[no description available]low00C-glycosyl compound;
trihydroxyflavone		metabolite
eugeniin[no description available]low00beta-D-glucoside;
ellagitannin;
gallate ester;
lactone		anti-HSV-1 agent;
antifungal agent;
antineoplastic agent;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
knipholone[no description available]low00aromatic ketone;
dihydroxyanthraquinone;
methoxybenzenes;
methyl ketone;
polyphenol;
resorcinols		antineoplastic agent;
antioxidant;
antiplasmodial drug;
leukotriene antagonist;
metabolite
alpha bitter acid[no description available]low00aromatic ketone;
cyclic ketone;
diketone;
tertiary alpha-hydroxy ketone;
triol		antibacterial drug;
antioxidant;
cyclooxygenase 2 inhibitor;
metabolite
acanthoside b[no description available]low00beta-D-glucosidemetabolite
chlorpromazine n-oxide[no description available]low00organochlorine compound;
phenothiazines;
tertiary amine oxide		metabolite
3-hydroxyaspartic acid, (threo-l)-isomer[no description available]low003-hydroxy-L-aspartic acidmetabolite
cyclo(l-phe-l-pro)[no description available]low00organic molecular entitymetabolite
surfactin c[no description available]low00cyclodepsipeptide;
lipopeptide antibiotic;
macrocyclic lactone		antibacterial agent;
antifungal agent;
antineoplastic agent;
antiviral agent;
metabolite;
platelet aggregation inhibitor;
surfactant
petunidin-3-glucoside[no description available]low00anthocyanin cation;
aromatic ether;
beta-D-glucoside		antioxidant;
metabolite
malvidin-3-glucoside[no description available]low00anthocyanin cation;
aromatic ether;
beta-D-glucoside		metabolite
dioncophylline a[no description available]low00biaryl;
isoquinoline alkaloid;
isoquinolines;
methoxynaphthalene;
methylnaphthalenes;
naphthalenes		antifungal agent;
antimalarial;
metabolite;
molluscicide
dioncophylline c[no description available]low00aromatic ether;
biaryl;
isoquinoline alkaloid;
isoquinolines;
methoxynaphthalene;
methylnaphthalenes;
naphthols		antimalarial;
antiplasmodial drug;
metabolite
latrunculin a[no description available]low00cyclic hemiketal;
macrolide;
oxabicycloalkane;
thiazolidinone		actin polymerisation inhibitor;
metabolite;
toxin
aglucovancomycin b[no description available]low00cyclic ether;
heterodetic cyclic peptide;
peptide antibiotic;
peptide zwitterion;
polyphenol		metabolite
(S)-ATPA[no description available]low00isoxazoles;
non-proteinogenic L-alpha-amino acid		metabolite
epothilone a[no description available]low00epothilone;
epoxide		antineoplastic agent;
metabolite;
microtubule-stabilising agent;
tubulin modulator
alitretinoin[no description available]low00retinoic acidantineoplastic agent;
keratolytic drug;
metabolite;
retinoid X receptor agonist
isoleucylvaline[no description available]low00dipeptidemetabolite
afimoxifene[no description available]low00phenols;
tertiary amino compound		antineoplastic agent;
estrogen receptor antagonist;
metabolite
3-hydroxyhippuric acid[no description available]low00N-acylglycine;
phenols		metabolite
12-deoxyphorbol 13-acetate[no description available]low00phorbol estermetabolite
conidendrin[no description available]low00lignanmetabolite
bevirimat[no description available]low00dicarboxylic acid monoester;
monocarboxylic acid;
pentacyclic triterpenoid		HIV-1 maturation inhibitor;
metabolite
azaserine[no description available]low00carboxylic ester;
diazo compound;
L-serine derivative;
non-proteinogenic L-alpha-amino acid		antifungal agent;
antimetabolite;
antimicrobial agent;
antineoplastic agent;
glutamine antagonist;
immunosuppressive agent;
metabolite
16beta,17-dihydroxy-ent-kaurane-19-oic acid[no description available]low00bridged compound;
diol;
ent-kaurane diterpenoid;
hydroxy monocarboxylic acid;
primary alcohol;
tertiary alcohol		anti-HIV agent;
metabolite
glycyrin[no description available]low00aromatic ether;
coumarins;
hydroxyisoflavans		antibacterial agent;
metabolite;
plant metabolite
reynosin[no description available]low00organic heterotricyclic compound;
sesquiterpene lactone		metabolite
moronic acid[no description available]low00pentacyclic triterpenoidanti-HIV agent;
anti-HSV-1 agent;
metabolite
maltitol[no description available]low00alpha-D-glucoside;
glycosyl alditol		laxative;
metabolite;
sweetening agent
Phe-Tyr[no description available]low00dipeptidemetabolite
2-acetyl-1-pyrroline[no description available]low00acylimine;
methyl ketone;
pyrroline		flavouring agent;
Maillard reaction product;
metabolite
methyl indole-3-carboxylate[no description available]low00indoles;
methyl ester		metabolite
camalexin[no description available]low001,3-thiazoles;
indole phytoalexin		metabolite
komaroviquinone[no description available]low00bridged compound;
lactol;
p-quinones;
tetracyclic diterpenoid		metabolite;
trypanocidal drug
2-hydroxycinnamic acid[no description available]low002-coumaric acid;
phenols		antioxidant;
metabolite
16-epivincamine[no description available]low00alkaloidmetabolite
diethyl fumarate[no description available]low00diestermetabolite
isoliquiritigenin[no description available]low00chalconesantineoplastic agent;
biological pigment;
EC 1.14.18.1 (tyrosinase) inhibitor;
GABA modulator;
geroprotector;
metabolite;
NMDA receptor antagonist
1-acetyl-beta-carboline[no description available]low00harmala alkaloidmetabolite
propolin c[no description available]low004'-hydroxyflavanones;
tetrahydroxyflavanone		metabolite;
radical scavenger
xanthohumol[no description available]low00aromatic ether;
chalcones;
polyphenol		anti-HIV-1 agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitor;
metabolite
butylidenephthalide[no description available]low002-benzofurans;
gamma-lactone		EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hypoglycemic agent;
metabolite
malonyl coenzyme a[no description available]low00malonyl-CoAsEC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitor;
Escherichia coli metabolite;
metabolite;
mouse metabolite
imidazol-1-ylacetic acid[no description available]low00imidazolyl carboxylic acidmetabolite
captax[no description available]low00aryl thiol;
benzothiazoles		carcinogenic agent;
metabolite
n-acetyltryptophan[no description available]low00L-tryptophan derivative;
N-acetyl-L-amino acid		metabolite
cinnamoylglycine[no description available]low00N-acylglycinemetabolite
n-benzoylalanine[no description available]low00N-acyl-L-alanine;
N-benzoylalanine		metabolite
isoferulic acid[no description available]low00ferulic acidsantioxidant;
biomarker;
metabolite
oxypeucadanin, (r)-(+)-isomer[no description available]low00furanocoumarinmetabolite
allylthiourea[no description available]low00thioureasmetabolite
n-glycylalanine[no description available]low00dipeptidemetabolite
caryophyllene oxide[no description available]low00epoxidemetabolite
fumonisin b1[no description available]low00diester;
fumonisin;
primary amino compound;
triol		carcinogenic agent;
metabolite
olivetolic acid[no description available]low00benzoic acids;
monocarboxylic acid;
polyketide;
resorcinols		metabolite
hirsutine, (16e,20beta)-isomer[no description available]low00alkaloidmetabolite
Ganodermanontriol[no description available]low00triterpenoidmetabolite
dieckol[no description available]low00aromatic ether;
oxacycle;
phlorotannin		anticoagulant;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
metabolite;
radical scavenger
glycylproline[no description available]low00dipeptide zwitterion;
dipeptide		metabolite
tamoxifen n-oxide[no description available]low00aromatic ether;
tertiary amine oxide		anti-estrogen;
metabolite
7-deacetylgedunin[no description available]low00cyclic terpene ketone;
delta-lactone;
enone;
epoxide;
furans;
limonoid;
pentacyclic triterpenoid		anti-inflammatory agent;
antimalarial;
metabolite;
plant metabolite
galactose-6-phosphate[no description available]low00D-galactose 6-phosphatemetabolite
nicotine n-glucuronide[no description available]low00iminium betaine;
N-glycosylpyridine		metabolite
isorhyncophylline[no description available]low00indolizinesmetabolite
cysteinylproline[no description available]low00dipeptidemetabolite
glycyllysine[no description available]low00dipeptidemetabolite
methionyltryptophan[no description available]low00dipeptidemetabolite
ascorbigen[no description available]low00indolyl carbohydratemetabolite
pimeloyl-coenzyme a[no description available]low00omega-carboxyacyl-CoAmetabolite
1-salicylate glucuronide[no description available]low00benzoic acids;
beta-D-glucosiduronic acid		metabolite
isoschaftoside[no description available]low00C-glycosyl compound;
trihydroxyflavone		metabolite
croomine[no description available]low00alkaloidmetabolite
3-hydroxyflavanone[no description available]low003'-hydroxyflavanones;
monohydroxyflavanone		metabolite
ungeremine[no description available]low00organic molecular entitymetabolite
seryl-proline[no description available]low00dipeptidemetabolite
4-hydroxy-5-methyl-3(2h)-furanone[no description available]low00cyclic ketone;
enol;
furans		metabolite
annomontine[no description available]low00alkaloid;
aminopyrimidine;
beta-carbolines		antiparasitic agent;
metabolite
8-hydroxymanzamine a[no description available]low00alkaloid;
beta-carbolines;
isoquinolines		anti-HSV-2 agent;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
metabolite
ginkgetin[no description available]low00biflavonoid;
hydroxyflavone;
methoxyflavone;
ring assembly		anti-HSV-1 agent;
antineoplastic agent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
metabolite
calceolarioside b[no description available]low00hydroxycinnamic acidmetabolite
eupatilin[no description available]low00dihydroxyflavone;
trimethoxyflavone		anti-inflammatory agent;
anti-ulcer drug;
antineoplastic agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
metabolite
quercetin 3-o-glucuronide[no description available]low00beta-D-glucosiduronic acid;
quercetin O-glycoside		antidepressant;
antioxidant;
metabolite
australifungin[no description available]low00carbobicyclic compound;
enol;
enone;
secondary alcohol		antifungal agent;
EC 2.3.1.24 (sphingosine N-acyltransferase) inhibitor;
HIV-1 integrase inhibitor;
metabolite
catechin gallate[no description available]low00flavans;
gallate ester;
polyphenol		metabolite
sterigmatocystin[no description available]low00sterigmatocystinsmetabolite
3,7-dimethoxy-5,3',4'-trihydroxyflavone[no description available]low00dimethoxyflavone;
trihydroxyflavone		EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor;
metabolite
apigenin[no description available]low00trihydroxyflavoneantineoplastic agent;
metabolite
7,3'-dihydroxy-4'-methoxyisoflavone[no description available]low004'-methoxyisoflavones;
7-hydroxyisoflavones		antioxidant;
metabolite
vomifoliol[no description available]low00(6S)-vomifoliolmetabolite;
phytotoxin
feruloyltyramine[no description available]low00tyraminesmetabolite
luteolin-7-glucuronide[no description available]low00glycosyloxyflavone;
luteolin O-glucuronoside;
monosaccharide derivative;
trihydroxyflavone		metabolite
chrysoeriol[no description available]low00monomethoxyflavone;
trihydroxyflavone		antineoplastic agent;
antioxidant;
metabolite
quercetin 3-o-methyl ether[no description available]low00monomethoxyflavone;
tetrahydroxyflavone		antimicrobial agent;
metabolite
dexmedetomidine[no description available]low00trihydroxyflavone;
trimethoxyflavone		antineoplastic agent;
metabolite
apigetrin[no description available]low00beta-D-glucoside;
dihydroxyflavone;
glycosyloxyflavone;
monosaccharide derivative		antibacterial agent;
metabolite;
non-steroidal anti-inflammatory drug
rutin[no description available]low00disaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone		antioxidant;
metabolite
6-ketoprostaglandin e1[no description available]low00prostaglandins Emetabolite;
platelet aggregation inhibitor
lipoxin a4[no description available]low00hydroxy polyunsaturated fatty acid;
lipoxin;
long-chain fatty acid		human metabolite;
metabolite
harmine[no description available]low00harmala alkaloidanti-HIV agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
metabolite
naringenin chalcone[no description available]low00chalcones;
polyphenol		anti-allergic agent;
anti-inflammatory agent;
metabolite
cornexistin[no description available]low00cyclic dicarboxylic anhydride;
organic heterobicyclic compound;
secondary alpha-hydroxy ketone		herbicide;
metabolite
isobavachalcone[no description available]low00chalcones;
polyphenol		antibacterial agent;
metabolite;
platelet aggregation inhibitor
daphnoretin[no description available]low00aromatic ether;
hydroxycoumarin		antineoplastic agent;
antiviral agent;
metabolite
Rhynchophylline[no description available]low00indolizinesmetabolite
esculin[no description available]low00beta-D-glucoside;
hydroxycoumarin		antioxidant;
metabolite
mammeisin[no description available]low00neoflavonoidmetabolite
ostruthin[no description available]low00terpene lactonemetabolite
costunolide[no description available]low00germacranolide;
heterobicyclic compound		anthelminthic drug;
antiinfective agent;
antineoplastic agent;
antiparasitic agent;
antiviral drug;
metabolite
caryophyllene[no description available]low00beta-caryophyllenefragrance;
insect attractant;
metabolite;
non-steroidal anti-inflammatory drug
phaseic acid[no description available]low00alpha,beta-unsaturated monocarboxylic acid;
apo carotenoid sesquiterpenoid		metabolite
agathisflavone[no description available]low00biaryl;
biflavonoid;
hydroxyflavone		antineoplastic agent;
antiviral agent;
hepatoprotective agent;
metabolite
cupressuflavone[no description available]low00biflavonoid;
hydroxyflavone;
ring assembly		EC 3.4.21.37 (leukocyte elastase) inhibitor;
metabolite;
radical scavenger
fisetin[no description available]low003'-hydroxyflavonoid;
7-hydroxyflavonol;
tetrahydroxyflavone		anti-inflammatory agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
metabolite;
plant metabolite
genkwanin[no description available]low00dihydroxyflavone;
monomethoxyflavone		metabolite
bellidifolin[no description available]low00polyphenol;
xanthones		EC 3.1.1.7 (acetylcholinesterase) inhibitor;
hypoglycemic agent;
metabolite
demethylbellidifolin[no description available]low00tetrol;
xanthones		antioxidant;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite;
mutagen;
radical scavenger
hinokiflavone[no description available]low00aromatic ether;
biflavonoid;
hydroxyflavone		antineoplastic agent;
metabolite;
neuroprotective agent
euxanthone[no description available]low00phenols;
xanthones		metabolite;
plant metabolite
3-methylquercetin[no description available]low007-hydroxyflavonol;
monomethoxyflavone;
tetrahydroxyflavone		anticoagulant;
EC 1.14.18.1 (tyrosinase) inhibitor;
metabolite
norswertianolin[no description available]low00beta-D-glucoside;
xanthones		EC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite
swerchirin[no description available]low00aromatic ether;
phenols;
xanthones		hypoglycemic agent;
metabolite
isoscutellarein[no description available]low00tetrahydroxyflavonemetabolite
kaempferide[no description available]low007-hydroxyflavonol;
monomethoxyflavone;
trihydroxyflavone		antihypertensive agent;
metabolite
morin[no description available]low007-hydroxyflavonol;
pentahydroxyflavone		angiogenesis modulating agent;
anti-inflammatory agent;
antibacterial agent;
antihypertensive agent;
antineoplastic agent;
antioxidant;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
hepatoprotective agent;
metabolite;
neuroprotective agent
norwogonin[no description available]low00trihydroxyflavoneantioxidant;
metabolite
orientin[no description available]low003'-hydroxyflavonoid;
C-glycosyl compound;
tetrahydroxyflavone		antioxidant;
metabolite
patuletin[no description available]low00flavonols;
monomethoxyflavone;
pentahydroxyflavone		analgesic;
antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
lipoxygenase inhibitor;
metabolite
rhamnetin[no description available]low00monomethoxyflavone;
tetrahydroxyflavone		anti-inflammatory agent;
antioxidant;
metabolite
robustaflavone[no description available]low00biflavonoid;
hydroxyflavone;
ring assembly		anti-HBV agent;
antineoplastic agent;
antioxidant;
metabolite
scutellarein[no description available]low00tetrahydroxyflavonemetabolite
tamarixetin[no description available]low007-hydroxyflavonol;
monomethoxyflavone;
tetrahydroxyflavone		antioxidant;
metabolite
tricetin[no description available]low00pentahydroxyflavoneantineoplastic agent;
metabolite
tricin[no description available]low003'-methoxyflavones;
dimethoxyflavone;
trihydroxyflavone		EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
metabolite
astringin[no description available]low00beta-D-glucoside;
monosaccharide derivative;
polyphenol;
stilbenoid		antineoplastic agent;
antioxidant;
metabolite
polydatin[no description available]low00beta-D-glucoside;
monosaccharide derivative;
polyphenol;
stilbenoid		anti-arrhythmia drug;
antioxidant;
geroprotector;
hepatoprotective agent;
metabolite;
nephroprotective agent;
potassium channel modulator
epsilon-viniferin[no description available]low001-benzofurans;
polyphenol;
stilbenoid		metabolite
irilone[no description available]low00hydroxyisoflavone;
organic heterotricyclic compound;
oxacycle		antineoplastic agent;
immunomodulator;
metabolite
caffeic acid phenethyl ester[no description available]low00alkyl caffeate esteranti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
antioxidant;
antiviral agent;
immunomodulator;
metabolite;
neuroprotective agent
licoisoflavone a[no description available]low007-hydroxyisoflavonesmetabolite
prunetin[no description available]low007-methoxyisoflavones;
hydroxyisoflavone		anti-inflammatory agent;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor;
metabolite
wedelolactone[no description available]low00aromatic ether;
coumestans;
delta-lactone;
polyphenol		antineoplastic agent;
apoptosis inducer;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
hepatoprotective agent;
metabolite
rottlerin[no description available]low00aromatic ketone;
benzenetriol;
chromenol;
enone;
methyl ketone		anti-allergic agent;
antihypertensive agent;
antineoplastic agent;
apoptosis inducer;
K-ATP channel agonist;
metabolite
syringetin[no description available]low003',5'-dimethoxyflavone;
3'-methoxyflavones;
7-hydroxyflavonol;
dimethoxyflavone;
tetrahydroxyflavone		metabolite;
platelet aggregation inhibitor
10-deoxymethynolide[no description available]low00macrolidemetabolite
4',7-dihydroxyflavone[no description available]low00dihydroxyflavonemetabolite
rhoifolin[no description available]low00dihydroxyflavone;
glycosyloxyflavone;
neohesperidoside		metabolite
veronicastroside[no description available]low00disaccharide derivative;
glycosyloxyflavone;
neohesperidoside;
trihydroxyflavone		antibacterial agent;
metabolite
quercimeritrin[no description available]low00beta-D-glucoside;
flavonols;
monosaccharide derivative;
quercetin O-glucoside;
tetrahydroxyflavone		antioxidant;
metabolite
josamycin[no description available]low00acetate ester;
aldehyde;
disaccharide derivative;
glycoside;
macrolide antibiotic;
tertiary alcohol;
tertiary amino compound		antibacterial drug;
metabolite
n,n-dimethylsphingenine[no description available]low00aminodiol;
sphingoid;
tertiary amino compound		EC 2.7.1.91 (sphingosine kinase) inhibitor;
metabolite
4-hydroxyestradiol[no description available]low004-hydroxy steroidmetabolite
9-hydroxy-10,12-octadecadienoic acid[no description available]low00HODE;
octadecadienoic acid		human metabolite;
metabolite;
mouse metabolite;
plant metabolite
9-oxo-10,12-octadecadienoic acid[no description available]low00enone;
oxooctadecadienoic acid		metabolite
13-oxo-9,11-octadecadienoic acid[no description available]low0013-oxo-9,11-octadecadienoic acid;
oxo fatty acid		metabolite
13,14-dihydro-15-ketoprostaglandin d2[no description available]low00prostaglandins Dmetabolite
15-keto-13,14-dihydroprostaglandin f2alpha[no description available]low00ketone;
prostaglandins Falpha		metabolite
2,3-dinor-6-ketoprostaglandin f1alpha[no description available]low004-oxo monocarboxylic acid;
prostanoid;
secondary alcohol		metabolite
ergosta-7,22-dien-3-ol, (3beta,5alpha,6alpha,22e)-isomer[no description available]low003beta-sterolanti-HSV-1 agent;
antifungal agent;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
metabolite
calcifediol[no description available]low00D3 vitamins;
diol;
hydroxycalciol		bone density conservation agent;
human metabolite;
metabolite;
mouse metabolite;
nutraceutical
cyclosporine[no description available]low00homodetic cyclic peptideanti-asthmatic drug;
anticoronaviral agent;
antifungal agent;
antirheumatic drug;
carcinogenic agent;
dermatologic drug;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
geroprotector;
immunosuppressive agent;
metabolite
oleyl alcohol[no description available]low00fatty alcohol 18:1;
long-chain primary fatty alcohol		metabolite;
nonionic surfactant
fortimicin a[no description available]low00amino cyclitol glycoside;
aminoglycoside antibiotic;
diol;
monocarboxylic acid amide;
primary amino compound		antibacterial agent;
metabolite
3',4',7-trihydroxyisoflavone[no description available]low007-hydroxyisoflavonesantineoplastic agent;
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor;
metabolite
6,7,4'-trihydroxyisoflavone[no description available]low007-hydroxyisoflavonesanti-inflammatory agent;
antimutagen;
EC 1.14.18.1 (tyrosinase) inhibitor;
metabolite;
PPARalpha agonist;
PPARgamma agonist
15-deoxy-delta(12,14)-prostaglandin j2[no description available]low00prostaglandins Jelectrophilic reagent;
insulin-sensitizing drug;
metabolite
cytochalasin b[no description available]low00cytochalasin;
lactam;
lactone;
organic heterotricyclic compound		actin polymerisation inhibitor;
metabolite;
mycotoxin;
platelet aggregation inhibitor
ciguatoxins[no description available]low00ciguatoxinmetabolite
12-hydroxy-5,8,10-heptadecatrienoic acid[no description available]low00hydroxy polyunsaturated fatty acid;
long-chain fatty acid;
trienoic fatty acid		metabolite
bisdemethoxycurcumin[no description available]low00beta-diketone;
diarylheptanoid;
enone;
polyphenol		EC 3.2.1.1 (alpha-amylase) inhibitor;
metabolite
clausine e[no description available]low00carbazolesmetabolite
ethyl caffeate[no description available]low00alkyl caffeate ester;
ethyl ester;
hydroxycinnamic acid		anti-inflammatory agent;
antineoplastic agent;
metabolite
heptaphylline[no description available]low00carbazolesmetabolite
pellitorine[no description available]low00fatty amidemetabolite
andrographolide[no description available]low00carbobicyclic compound;
gamma-lactone;
labdane diterpenoid;
primary alcohol;
secondary alcohol		anti-HIV agent;
anti-inflammatory drug;
antineoplastic agent;
metabolite
isorhamnetin-3-o-galactoside[no description available]low00beta-D-galactoside;
glycosyloxyflavone;
monomethoxyflavone;
monosaccharide derivative;
trihydroxyflavone		metabolite
isorhamnetin 3-o-glucoside[no description available]low00beta-D-glucoside;
glycosyloxyflavone;
monomethoxyflavone;
monosaccharide derivative;
trihydroxyflavone		metabolite
kaempferol-3-o-rutinoside[no description available]low00disaccharide derivative;
kaempferol O-glucoside;
rutinoside;
trihydroxyflavone		metabolite;
plant metabolite;
radical scavenger
ligustilide[no description available]low00butenolidemetabolite
7,4'-dihydroxy-3'-methoxyisoflavone[no description available]low007-hydroxyisoflavones;
methoxyisoflavone		antiplasmodial drug;
metabolite
sappanchalcone[no description available]low00catechols;
chalcones;
monomethoxybenzene		anti-allergic agent;
anti-inflammatory agent;
antioxidant;
metabolite
methyl brevifolincarboxylate[no description available]low00cyclic ketone;
delta-lactone;
organic heterotricyclic compound;
phenols		EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
metabolite;
platelet aggregation inhibitor;
radical scavenger;
vasodilator agent
3-deoxysappanchalcone[no description available]low00chalcones;
monomethoxybenzene;
phenols		metabolite
nostocarboline[no description available]low00alkaloid;
beta-carbolines;
organic cation;
organochlorine compound		antimalarial;
EC 3.1.1.8 (cholinesterase) inhibitor;
metabolite
ergosterol-5,8-peroxide[no description available]low003beta-sterol;
ergostanoid;
organic peroxide;
phytosterols		antimycobacterial drug;
antineoplastic agent;
metabolite;
trypanocidal drug
3-(4-hydroxy-3-methoxyphenyl)-n-(2-(4-hydroxy-3-methoxyphenyl)ethyl)-2-propenamide[no description available]low00hydroxycinnamic acidmetabolite
macluraxanthone b[no description available]low00phenols;
xanthones		anti-HIV agent;
antineoplastic agent;
metabolite
flavokawain b[no description available]low00chalcones;
dimethoxybenzene;
phenols		anti-inflammatory agent;
antileishmanial agent;
antineoplastic agent;
apoptosis inducer;
metabolite
alternariol[no description available]low00benzochromenone;
phenols		EC 3.1.1.8 (cholinesterase) inhibitor;
metabolite;
mycotoxin
cis-3-hexenyl acetate[no description available]low00acetate ester;
olefinic compound		metabolite
pipercallosidine[no description available]low00alkaloid;
benzodioxoles;
enamide;
secondary carboxamide		apoptosis inducer;
metabolite;
plant metabolite
n-(4-hydroxy-beta-phenethyl)-4-hydroxycinnamide[no description available]low00hydroxycinnamic acidmetabolite
7-hydroxyisoflavone[no description available]low007-hydroxyisoflavonesEC 1.14.14.14 (aromatase) inhibitor;
metabolite
flazin[no description available]low00harmala alkaloidmetabolite
11-hydroxynoracronycine[no description available]low00acridinesmetabolite
jaceosidin[no description available]low00dimethoxyflavone;
trihydroxyflavone		anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
metabolite
5,7,3'-trihydroxy-3,4'-dimethoxyflavone[no description available]low00dimethoxyflavone;
trihydroxyflavone		antineoplastic agent;
metabolite
salutaridine[no description available]low00morphinane alkaloidanti-HBV agent;
metabolite
cytochalasin e[no description available]low00cytochalasan alkaloidmetabolite
artocarpin lectin[no description available]low00monomethoxyflavone;
trihydroxyflavone		antineoplastic agent;
metabolite
bleomycin[no description available]low00bleomycinantineoplastic agent;
metabolite
1,7-dihydroxy-4-methoxyxanthone[no description available]low00aromatic ether;
phenols;
xanthones		metabolite;
plant metabolite
demethoxycurcumin[no description available]low00beta-diketone;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
antineoplastic agent;
metabolite
bergamottin[no description available]low00furanocoumarinmetabolite
alanyl-alanyl-alanine[no description available]low00tripeptidemetabolite
24-ethyl-4-cholesten-3-one[no description available]low00C29-steroid;
steroid		metabolite
myricetin 3-o-glucuronide[no description available]low00monosaccharide derivative;
myricetin O-glucuronide;
pentahydroxyflavone		metabolite
phenylalanylalanine[no description available]low00dipeptide zwitterion;
dipeptide		metabolite
alpinumisoflavone[no description available]low00isoflavanonesmetabolite
alpha-aspartylalanine[no description available]low00dipeptidemetabolite
arglabin[no description available]low00epoxide;
gamma-lactone;
organic heterotetracyclic compound;
sesquiterpene lactone		antineoplastic agent;
metabolite
ap 10[no description available]low00diterpene lactonemetabolite
quercetin 7-rhamnoside[no description available]low00alpha-L-rhamnoside;
flavonols;
monosaccharide derivative;
quercetin O-glycoside;
tetrahydroxyflavone		metabolite
albonoursin[no description available]low002,5-diketopiperazinesmetabolite
oroidin[no description available]low00pyrroles;
secondary carboxamide		metabolite
monorden[no description available]low00cyclic ketone;
enone;
epoxide;
macrolide antibiotic;
monochlorobenzenes;
phenols		antifungal agent;
metabolite;
tyrosine kinase inhibitor
apratoxin a[no description available]low001,3-thiazoles;
apratoxin		antineoplastic agent;
metabolite
(-)-catechin-3-O-gallate[no description available]low00flavans;
gallate ester;
polyphenol		metabolite
aspartyllysine[no description available]low00dipeptidemetabolite
arginyllysine[no description available]low00dipeptidemetabolite
latrunculin b[no description available]low00cyclic hemiketal;
macrolide;
oxabicycloalkane;
thiazolidinone		actin polymerisation inhibitor;
metabolite;
toxin
falcarindiol[no description available]low00organic molecular entitymetabolite
dehydroergosterol[no description available]low003beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
ergostanoid;
phytosterols		biomarker;
metabolite
n-oleoylglycine[no description available]low00fatty amide;
N-acylglycine 18:1		metabolite
rhizoxin[no description available]low001,3-oxazoles;
epoxide;
macrolide antibiotic		antimitotic;
antineoplastic agent;
metabolite
manoalide[no description available]low00butenolide;
lactol;
sesterterpenoid		EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
metabolite
concanamycin a[no description available]medium00carbamate ester;
concanamycin		antifungal agent;
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor;
metabolite
n(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid[no description available]low00enoate ester;
methyl ester;
monocarboxylic acid amide		metabolite
thunberginol f[no description available]low00catechols;
gamma-lactone;
isobenzofuranone		metabolite;
plant metabolite
pyracrenic acid[no description available]low00triterpenoidmetabolite
eicosa-11,14-dienoic acid, (z,z)-isomer[no description available]low00icosadienoic acidmetabolite
yuanhuadine[no description available]low00diterpenoidmetabolite
tiglylglycine[no description available]low00N-acylglycinemetabolite
rhodiocyanoside a[no description available]low00aliphatic nitrile;
beta-D-glucoside;
cyanogenic glycoside;
monosaccharide derivative		anti-allergic agent;
metabolite
(2E,4E)-N-isobutyl-2,4-dodecadienamide[no description available]low00fatty amidemetabolite
mycothiazole[no description available]low00thiazolesmetabolite
13-oxo-9,11-octadecadienoic acid[no description available]low0013-oxo-9,11-octadecadienoic acidmetabolite;
mouse metabolite
linderalactone[no description available]low00butenolidemetabolite
pros-methylimidazoleacetic acid[no description available]low00imidazolyl carboxylic acidmetabolite
cellobionic acid[no description available]low00carbohydrate acid;
disaccharide		metabolite
pseudopteroxazole[no description available]low00tetralinsmetabolite
sophoraflavanone a[no description available]low00(2S)-flavan-4-one;
4'-hydroxyflavanones;
trihydroxyflavanone		antibacterial agent;
antineoplastic agent;
metabolite
panduratin a[no description available]low00diarylheptanoidmetabolite
stigmasterol 3-o-beta-d-glucopyranoside[no description available]low00beta-D-glucoside;
monosaccharide derivative;
phytosterols;
steroid saponin		metabolite
17-hydroxyjolkinolide b[no description available]low00diterpene lactonemetabolite
corosolic acid[no description available]low00triterpenoidmetabolite
cyclo(prolyl-valyl)[no description available]low00piperazinonemetabolite
phenylalanylglycine[no description available]low00dipeptidemetabolite
leucyl-phenylalanine[no description available]low00dipeptidemetabolite
glutamylalanine[no description available]low00dipeptidemetabolite
glutaminyl-glycine[no description available]low00dipeptidemetabolite
methionylglycine[no description available]low00dipeptidemetabolite
valylleucine[no description available]low00dipeptidemetabolite
phenylalanyl-valine[no description available]low00dipeptidemetabolite
cyclo(glycyltryptophyl)[no description available]low00indolesmetabolite
alanylglycine[no description available]low00dipeptide zwitterion;
dipeptide		metabolite
valyltyrosine[no description available]low00dipeptidemetabolite
alpha-glutamyltryptophan[no description available]low00dipeptidemetabolite
lysylglutamic acid[no description available]low00dipeptidemetabolite
methionylglutamic acid[no description available]low00dipeptidemetabolite
seryl-histidine[no description available]low00dipeptidemetabolite
arginyl-glutamine[no description available]low00dipeptidemetabolite
phenylalanylproline[no description available]low00dipeptidemetabolite
lysylglycine[no description available]low00dipeptidemetabolite
glycylhistidine[no description available]low00dipeptide zwitterion;
dipeptide		metabolite
kopsinine[no description available]low00indole alkaloidmetabolite
cyclo(leucyl-phenylalanyl)[no description available]low002,5-diketopiperazinesmetabolite
prolylisoleucine[no description available]low00dipeptidemetabolite
isoleucyl-tyrosine[no description available]low00dipeptidemetabolite
prolyl-serine[no description available]low00dipeptidemetabolite
grayanotoxin i[no description available]low00acetate ester;
pentol;
secondary alcohol;
tertiary alcohol;
tetracyclic diterpenoid		antihypertensive agent;
metabolite;
neuromuscular agent;
phytotoxin
19-norandrosterone[no description available]low0017-oxo steroidmetabolite
s-allylcysteine[no description available]low00L-alpha-amino acid zwitterion;
S-hydrocarbyl-L-cysteine		antineoplastic agent;
metabolite
oleandrigenin[no description available]low0014beta-hydroxy steroid;
3beta-hydroxy steroid;
steroid ester		EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
metabolite
valyl-prolyl-proline[no description available]low00tripeptidemetabolite
prolylvaline[no description available]low00dipeptidemetabolite
palbinone[no description available]low0016-oxo steroidmetabolite
pseurotin[no description available]low00azaspiro compound;
lactam;
oxaspiro compound		metabolite
gambogic acid[no description available]low00pyranoxanthonesmetabolite
xenovulene a[no description available]low00cyclic ether;
enone;
organic heterotetracyclic compound;
sesquiterpenoid		GABA antagonist;
metabolite
fr 148083[no description available]low00aromatic ether;
macrolide;
phenols;
secondary alcohol;
secondary alpha-hydroxy ketone		antibacterial agent;
antineoplastic agent;
metabolite;
NF-kappaB inhibitor
LL-Z1640-1[no description available]low00macrolide;
resorcinols		metabolite
9-methoxycanthin-6-one[no description available]low00aromatic ether;
indole alkaloid;
organic heterotetracyclic compound		antineoplastic agent;
antiplasmodial drug;
metabolite
n-acetylcarnosine[no description available]low00dipeptidemetabolite
cholest-5-en-3-one[no description available]low003-oxo-Delta(5)-steroid;
cholestanoid		metabolite
kaempferol 3-O-beta-L-glucopyranoside[no description available]low00beta-L-glucoside;
flavonols;
kaempferol O-glucoside;
monosaccharide derivative;
trihydroxyflavone		metabolite
rubraxanthone[no description available]low00aromatic ether;
polyphenol;
xanthones		antibacterial agent;
antineoplastic agent;
metabolite
ubiquinol[no description available]low00polyprenylhydroquinone;
ubiquinol		biomarker;
metabolite
landomycin a[no description available]low00oligosaccharidemetabolite
ancistroealaine a[no description available]low00aromatic ether;
biaryl;
isoquinoline alkaloid;
isoquinolines;
methoxynaphthalene;
methylnaphthalenes		antileishmanial agent;
antiplasmodial drug;
metabolite;
trypanocidal drug
cerberin[no description available]low00acetate ester;
cardenolide glycoside;
monosaccharide derivative		antineoplastic agent;
metabolite
actein[no description available]low00triterpenoidmetabolite
araloside a[no description available]low00triterpenoid saponinmetabolite
ageladine a[no description available]low00alkaloid;
aromatic amine;
imidazopyridine;
organobromine compound;
pyrroles		angiogenesis inhibitor;
antineoplastic agent;
matrix metalloproteinase inhibitor;
metabolite
corynoxine b[no description available]low00indolizinesmetabolite
kaempferol 7-o-glucoside[no description available]low00beta-D-glucoside;
flavonols;
kaempferol O-glucoside;
monosaccharide derivative;
trihydroxyflavone		metabolite;
plant metabolite;
radical scavenger
delphinidin 3-sambubioside[no description available]low00anthocyanidin 3-O-beta-D-sambubiosideapoptosis inducer;
metabolite
nodosin[no description available]low00delta-lactonemetabolite
protylonolide[no description available]low00diol;
enone;
macrolide		metabolite
arisugacin[no description available]low00aromatic ether;
delta-lactone;
enone;
organic heterotetracyclic compound;
tertiary alcohol		antimicrobial agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite;
Penicillium metabolite
nymphaeol c[no description available]low004'-hydroxyflavanones;
tetrahydroxyflavanone		metabolite;
radical scavenger
thonningianin a[no description available]low00tanninmetabolite
cephalostatin i[no description available]low00oxo steroidmetabolite
papyriflavonol a[no description available]low003'-hydroxyflavonoid;
flavonols;
pentahydroxyflavone		EC 1.14.18.1 (tyrosinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
metabolite
lactonamycin[no description available]low00gamma-lactone;
organic heterohexacyclic compound;
phenols;
trideoxyhexose derivative		antibacterial agent;
antimicrobial agent;
metabolite
myrsinoic acid b[no description available]low001-benzofurans;
monocarboxylic acid		anti-inflammatory agent;
EC 4.4.1.11 (methionine gamma-lyase) inhibitor;
metabolite
betulone[no description available]low00triterpenoidmetabolite
eckstolonol[no description available]low00organic heteropentacyclic compound;
oxacycle;
phlorotannin		metabolite;
radical scavenger
manassantin b[no description available]low00benzodioxoles;
dimethoxybenzene;
lignan;
oxolanes;
secondary alcohol		antineoplastic agent;
metabolite
gitaloxin[no description available]low00cardenolide glycosidemetabolite
paeonilide[no description available]low00benzoate estermetabolite
dihydroxanthohumol[no description available]low00aromatic ether;
dihydrochalcones;
polyphenol		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite
corynoxine[no description available]low00indolizinesmetabolite
7-phloroeckol[no description available]low00aromatic ether;
phlorotannin		antioxidant;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
metabolite
(+)-lyoniresinol-3-alpha-O-beta-D-glucopyranoside[no description available]low00beta-D-glucoside;
dimethoxybenzene;
lignan;
monosaccharide derivative;
polyphenol;
primary alcohol;
tetralins		antibacterial agent;
antifungal agent;
metabolite
Sphaeropsidin C[no description available]low00tricyclic diterpenoidmetabolite
kelampayoside a[no description available]low00glycosidemetabolite
3,5-dimethoxy-4-hydroxybenzyl alcohol-4-O-beta-D-glucopyranoside[no description available]low00aromatic ether;
benzyl alcohols;
beta-D-glucoside;
monosaccharide derivative;
primary alcohol		antineoplastic agent;
metabolite
2,3-dihydro-3beta-methoxy withaferin A[no description available]low0027-hydroxy steroid;
4-hydroxy steroid;
delta-lactone;
epoxy steroid;
ergostanoid;
primary alcohol;
secondary alcohol;
withanolide		metabolite;
plant metabolite
nigranoic acid[no description available]low00dicarboxylic acid;
tetracyclic triterpenoid		antineoplastic agent;
HIV-1 reverse transcriptase inhibitor;
metabolite
esculeoside a[no description available]low00azaspiro compound;
oxaspiro compound;
saponin;
steroid alkaloid;
steroid saponin		antineoplastic agent;
metabolite
aerothionin[no description available]low00isoxazolesmetabolite
artemisic acid[no description available]low00carbobicyclic compound;
monocarboxylic acid;
octahydronaphthalenes;
sesquiterpenoid		metabolite
26-deoxyactein[no description available]low00triterpenoidmetabolite
5-formylcytosine[no description available]low00aminopyrimidine;
heteroarenecarbaldehyde;
nucleobase analogue;
pyrimidone		metabolite
migrastatin[no description available]low00ether;
macrolide antibiotic;
piperidones;
secondary alcohol		antineoplastic agent;
metabolite
Lyngbic acid[no description available]low00long-chain fatty acidmetabolite
2,3,6,8-tetrahydroxy-1-(3-methylbut-2-enyl)-5-(2-methylbut-3-en-2-yl)-9h-xanthen-9-one[no description available]low00polyphenol;
xanthones		anti-inflammatory agent;
antineoplastic agent;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
metabolite
bielschowskysin[no description available]low00acetate ester;
cyclic acetal;
diterpenoid;
gamma-lactone;
organic heterohexacyclic compound		antimalarial;
antineoplastic agent;
metabolite
procyanidin b1[no description available]low00biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin		anti-inflammatory agent;
EC 3.4.21.5 (thrombin) inhibitor;
metabolite
cyclo(tyrosyl-tyrosyl)[no description available]low00cyclo(tyrosyl-tyrosyl)metabolite
spiculoic acid a[no description available]low00carbobicyclic compound;
cyclic ketone;
oxo monocarboxylic acid;
styrenes		antineoplastic agent;
metabolite
myrocin a[no description available]low00tertiary alcoholmetabolite
3'-o-methylepicatechin[no description available]low00catechinmetabolite
episilvestrol[no description available]low00dioxanes;
ether;
methyl ester;
organic heterotricyclic compound		antineoplastic agent;
metabolite
protopanaxatriol[no description available]low0012beta-hydroxy steroid;
3beta-hydroxy-4,4-dimethylsteroid;
3beta-hydroxy steroid;
6alpha-hydroxy steroid;
sapogenin;
tetracyclic triterpenoid		metabolite
laurinterol[no description available]low00organobromine compound;
phenols;
sesquiterpenoid		antibacterial agent;
apoptosis inducer;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
metabolite
Pseudopterosin G-J aglycone[no description available]low00diterpenoidmetabolite
ceratamine a[no description available]low00alkaloid;
aromatic ether;
cyclic ketone;
organic heterobicyclic compound;
organobromine compound;
secondary amino compound;
tertiary amine		antimitotic;
metabolite
liphagal[no description available]low00aldehyde;
cyclic ether;
meroterpenoid;
organic heterotetracyclic compound;
polyphenol		EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
metabolite
pulsatilla saponin d[no description available]low00triterpenoidmetabolite
diversonol[no description available]low00phenols;
tertiary alcohol		antibacterial agent;
metabolite
neotuberostemonine[no description available]low00alkaloidmetabolite
drymaritin[no description available]low00enol ether;
enone;
indole alkaloid;
organic heterotetracyclic compound		anti-HIV agent;
metabolite
lyoniresinol[no description available]low00dimethoxybenzene;
lignan;
polyphenol;
primary alcohol;
tetralins		antineoplastic agent;
metabolite
silvestrol[no description available]low00dioxanes;
ether;
methyl ester;
organic heterotricyclic compound		antineoplastic agent;
metabolite
ginsenoside ro[no description available]low00triterpenoid saponinmetabolite
diosgenin glucoside[no description available]low00hexacyclic triterpenoid;
monosaccharide derivative;
spiroketal;
sterol 3-beta-D-glucoside		metabolite
pyripyropene a[no description available]low00organic heterotetracyclic compound;
sesquiterpenoid		acyl-CoA:cholesterol acyltransferase 2 inhibitor;
metabolite
3-epioleanolic acid[no description available]low00triterpenoidmetabolite
leucylproline[no description available]low00dipeptide zwitterion;
dipeptide		metabolite
R-(-)-actinodaphnine[no description available]low00aporphine alkaloidmetabolite
cytotrienin a[no description available]low00cyclopropanecarboxylate ester;
ether;
hydroquinones;
lactam;
macrocycle;
secondary alcohol		antibacterial agent;
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
metabolite
methylamphotericin b[no description available]low00macrolide;
methyl ester;
monosaccharide derivative		antifungal agent;
antiinfective agent;
metabolite
2'-methoxykurarinone[no description available]low004'-hydroxyflavanones;
dihydroxyflavanone;
dimethoxyflavanone		antineoplastic agent;
metabolite
verproside[no description available]low00glycosidemetabolite
verminoside[no description available]low00hydroxycinnamic acidmetabolite
minecoside[no description available]low00hydroxycinnamic acidmetabolite
(R)-(+)-6',7'-dihydroxybergamottin[no description available]low00furanocoumarinmetabolite
lapidilectine b[no description available]low00indolyl carboxylic acidmetabolite
alloin[no description available]low00anthracenes;
C-glycosyl compound;
cyclic ketone;
phenols		laxative;
metabolite
longipinene[no description available]low00alpha-longipinenemetabolite
parkeol[no description available]low003beta-hydroxy-4,4-dimethylsteroid;
3beta-sterol;
tetracyclic triterpenoid		metabolite
rutundic acid[no description available]low00triterpenoidmetabolite
a-factor (streptomyces)[no description available]low00butan-4-olide;
primary alcohol		metabolite
taraxasteryl acetate[no description available]low00triterpenoidmetabolite
chikusetsu saponin iva[no description available]low00triterpenoid saponinmetabolite
xestoaminol c[no description available]low00amino alcohol;
sphingoid		metabolite
malyngamide A[no description available]low00dicarboximidemetabolite
simalikalactone D[no description available]low00cyclic ether;
delta-lactone;
enone;
organic heteropentacyclic compound;
quassinoid;
secondary alcohol;
secondary alpha-hydroxy ketone;
triol		antimalarial;
antineoplastic agent;
antiviral agent;
metabolite
friedelane[no description available]low00triterpenemetabolite
shamixanthone[no description available]low00cyclic ketone;
phenols;
pyranoxanthene		metabolite
17,18-epoxy-5,8,11,14-eicosatetraenoic acid[no description available]low00EpETEmetabolite
chaetominine[no description available]low00indole alkaloid;
lactam;
organic heterotetracyclic compound;
quinazolines		metabolite
schweinfurthin g[no description available]low00cyclic ether;
organic heterotricyclic compound;
resorcinols;
stilbenoid		antineoplastic agent;
metabolite
salmon calcitonin[no description available]low00heterodetic cyclic peptide;
peptide hormone;
polypeptide		bone density conservation agent;
metabolite
complestatin[no description available]low00cyclic ether;
heterodetic cyclic peptide;
indoles;
organic heterobicyclic compound;
organochlorine compound;
peptide antibiotic;
polyphenol		anti-HIV-1 agent;
antimicrobial agent;
HIV-1 integrase inhibitor;
metabolite
neuroprotectin a[no description available]low00cyclic ether;
heterodetic cyclic peptide;
indoles;
organochlorine compound;
polyphenol		HIV-1 integrase inhibitor;
metabolite
alx-0600[no description available]low00polypeptideantioxidant;
glucagon-like peptide-2 receptor agonist;
metabolite;
protective agent
schweinfurthin f[no description available]low00cyclic ether;
organic heterotricyclic compound;
resorcinols;
stilbenoid		metabolite
antrocamphin a[no description available]low00methoxybenzenesanti-inflammatory agent;
metabolite
respirantin[no description available]low00benzamides;
cyclodepsipeptide;
formamides;
phenols		antimicrobial agent;
antineoplastic agent;
metabolite
streptobiosamine[no description available]low00amino disaccharidemetabolite
interiotherin b[no description available]low00aromatic ether;
fatty acid ester;
lignan;
organic heteropentacyclic compound;
oxacycle		anti-HIV agent;
metabolite
succinyladenosine[no description available]low00adenosines;
amino dicarboxylic acid;
L-aspartic acid derivative		metabolite
6-tuliposide a[no description available]low006-O-acyl-D-glucose;
homoallylic alcohol		allergen;
metabolite
glycochenodeoxycholate-3-sulfate[no description available]low007alpha-hydroxy steroid;
bile acid glycine conjugate;
steroid sulfate		metabolite
wewakazole[no description available]low00cyclic peptidemetabolite
spongia-13(16),14-dien-19-oic acid[no description available]low00cyclic ether;
monocarboxylic acid;
tetracyclic diterpenoid		androgen antagonist;
metabolite
Icariside E4[no description available]low00benzofuransmetabolite
lucidenic acid n[no description available]low00cyclic terpene ketone;
dioxo monocarboxylic acid;
secondary alcohol;
tetracyclic triterpenoid		antineoplastic agent;
EC 3.1.1.8 (cholinesterase) inhibitor;
metabolite
dihydroagarofuran[no description available]low00bridged compound;
cyclic ether;
eudesmane sesquiterpenoid;
organic heterotricyclic compound		metabolite
23-epi-26-deoxyactein[no description available]low00triterpenoidmetabolite
23-hydroxybetulinic acid[no description available]low00triterpenoidmetabolite
(1S,3aR,4S,6S,6aS,9aS,9bS)-9a-isocyano-6-(2-isocyano-2-methylpropyl)-1,4-dimethyl-7-methylidene-2,3,3a,4,5,6,6a,8,9,9b-decahydro-1H-phenalene[no description available]low00diterpenoidmetabolite
bromophycolide a[no description available]low00diterpenoid;
macrolide;
organobromine compound;
phenols;
tertiary alcohol		anti-HIV agent;
antibacterial agent;
antifungal agent;
antimalarial;
antineoplastic agent;
metabolite
2-acetamidoglucal[no description available]low00acetamides;
glycal derivative		metabolite
diorcinol[no description available]low00aromatic ether;
phenols		fungal metabolite;
marine metabolite;
metabolite
caribenol a[no description available]low00organic heterotetracyclic compound;
terpene lactone;
tertiary alcohol		antimalarial;
antitubercular agent;
metabolite
halisulfate 1[no description available]low00organic molecular entitymetabolite
6-O-feruloylcatalpol[no description available]low00hydroxycinnamic acidmetabolite
grassypeptolide[no description available]low00cyclodepsipeptide;
macrocycle		antineoplastic agent;
metabolite
essramycin[no description available]low00triazolopyrimidinesmetabolite
ainsliadimer a[no description available]low00sesquiterpene lactone;
spiro compound		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite
salvileucalin b[no description available]low00bridged compound;
diterpenoid;
furans;
gamma-lactone		antineoplastic agent;
metabolite
ciliatamide a[no description available]low00caprolactams;
lipopeptide		antileishmanial agent;
metabolite
etnangien[no description available]low00hydroxy monocarboxylic acid;
macrolide antibiotic		antibacterial agent;
metabolite
latrunculol a[no description available]low00macrolidemetabolite
N-trans-sinapoyltyramine[no description available]low00hydroxycinnamic acidmetabolite
lycojapodine a[no description available]low00alkaloid;
bridged compound;
cyclic ketone;
lactone;
organic heterotetracyclic compound		anti-HIV-1 agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite
epi-maslinic acid[no description available]low00dihydroxy monocarboxylic acid;
pentacyclic triterpenoid		anti-inflammatory agent;
metabolite
eoxin c4[no description available]low00eoxin;
leukotriene		metabolite
brartemicin[no description available]low00benzoate ester;
glycosyl glycoside derivative;
resorcinols		antimicrobial agent;
metabolite
Majusculamide AB[no description available]low00amino acid amidemetabolite
7,8-dihydroxyflavanone[no description available]low00dihydroxyflavanoneantineoplastic agent;
metabolite
antcin a[no description available]low00ergostanoidmetabolite
integric acid[no description available]low00carboxylic ester;
cyclic ketone;
dioxo monocarboxylic acid;
enal;
enone;
eremophilane sesquiterpenoid		HIV-1 integrase inhibitor;
metabolite
vanilloloside[no description available]low00glycosidemetabolite
2,3-dihydro-3beta-O-sulfate withaferin A[no description available]low0027-hydroxy steroid;
4-hydroxy steroid;
delta-lactone;
epoxy steroid;
ergostanoid;
primary alcohol;
steroid sulfate;
withanolide		antineoplastic agent;
metabolite;
plant metabolite
dicranin[no description available]low00acetylenic fatty acid;
long-chain fatty acid;
straight-chain fatty acid;
trienoic fatty acid		antibacterial agent;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
metabolite
leachianone a[no description available]low004'-hydroxyflavanones;
monomethoxyflavanone;
trihydroxyflavanone		antimalarial;
antineoplastic agent;
metabolite
hordatine a[no description available]low00aromatic ether;
benzofurans;
dicarboxylic acid diamide;
guanidines;
phenols		adrenergic antagonist;
metabolite
englerin a[no description available]low00cinnamate ester;
glycolate ester;
guaiane sesquiterpenoid		antineoplastic agent;
metabolite
monanchocidin[no description available]low00organic molecular entitymetabolite
eurycomanone[no description available]low00cyclic ether;
delta-lactone;
enone;
organic heteropentacyclic compound;
pentol;
quassinoid;
secondary alcohol;
secondary alpha-hydroxy ketone;
tertiary alcohol		antimalarial;
antineoplastic agent;
metabolite
sphaeropsidin a[no description available]low00gamma-lactonemetabolite
gardenoside[no description available]low00beta-D-glucoside;
cyclopentapyran;
enoate ester;
methyl ester;
monosaccharide derivative;
tertiary alcohol		metabolite
landomycin d[no description available]low00anthraquinonemetabolite
3alpha,12alpha-dihydroxy-4alpha-methylergosta-8,24(28)-dien-7,11-dione-26-oic acid[no description available]low0011-oxo steroid;
12alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7-oxo steroid;
monocarboxylic acid;
secondary alpha-hydroxy ketone;
steroid acid		antineoplastic agent;
metabolite
antcin k[no description available]low00bile acidmetabolite
3alpha-hydroxy-4alpha-methylergosta-8,24(28)-dien-7,11-dione-26-oic acid[no description available]low0011-oxo steroid;
3alpha-hydroxy steroid;
7-oxo steroid;
monocarboxylic acid;
steroid acid		antineoplastic agent;
cholinergic antagonist;
metabolite;
serotonergic antagonist
shizukaol B[no description available]low00triterpenoidmetabolite
shizukaol f[no description available]low00triterpenoidmetabolite
calicheamicin gamma(1)i[no description available]low00calicheamicin;
enediyne antibiotic;
organoiodine compound		antineoplastic agent;
metabolite
staphyloxanthin[no description available]low00apo carotenoid triterpenoid;
D-aldohexose derivative;
fatty acid ester;
triol;
xanthophyll		antioxidant;
biological pigment;
metabolite;
virulence factor
sm 1 peptide[no description available]low00acetate ester;
ergot alkaloid		metabolite
mycocyclosin[no description available]low002,5-diketopiperazines;
organic heterotetracyclic compound;
polyphenol		metabolite
callipeltin a[no description available]low00cyclodepsipeptide;
guanidines;
lactone;
oligopeptide;
phenols		anti-HIV-1 agent;
antifungal agent;
metabolite
vinylamycin[no description available]low00cyclodepsipeptide;
macrocycle;
primary alcohol		antibacterial agent;
antimicrobial agent;
metabolite
promegestone[no description available]low00terpene lactonemetabolite
lancifodilactone g[no description available]low00cyclic ether;
diol;
enol;
gamma-lactone;
oxaspiro compound;
triterpenoid		anti-HIV agent;
metabolite
rediocide a[no description available]low00diterpenoid;
epoxide;
ortho ester;
terpene lactone		insecticide;
metabolite
lasiokaurin[no description available]low00kaurane diterpenoidmetabolite
longikaurin a[no description available]low00kaurane diterpenoidmetabolite
ponicidin[no description available]low00dioxanesmetabolite
(Z)-6,6',7,3'a-Diligustilide[no description available]low00butenolidemetabolite
suvanine[no description available]low00organic molecular entitymetabolite
shizukaol d[no description available]low00triterpenoidmetabolite
thailandepsin a[no description available]low00cyclodepsipeptidemetabolite
nordidemnin b[no description available]low00didemninmetabolite
4-formylaminooxyvinylglycine[no description available]low00non-proteinogenic alpha-amino acidmetabolite
platycoside e[no description available]low00triterpenoid saponinmetabolite
leuconoxine[no description available]low00alkaloidmetabolite
epidermin[no description available]low00macrocycle;
type A lantibiotic		antibacterial agent;
metabolite
surfactin A[no description available]low00cyclodepsipeptide;
lipopeptide antibiotic;
macrocyclic lactone		antibacterial agent;
antifungal agent;
antineoplastic agent;
antiviral agent;
metabolite;
surfactant
myriaporone 3[no description available]low00beta-hydroxy ketone;
epoxide;
lactol;
oxanes;
primary alcohol;
secondary alcohol		antineoplastic agent;
metabolite
avenacoside b[no description available]low00beta-D-glucoside;
hexacyclic triterpenoid;
spiroketal;
steroid saponin;
tetrasaccharide derivative		metabolite
3-methylglutarylcarnitine[no description available]low00O-methylglutarylcarnitinemetabolite
pivaloylcarnitine[no description available]low00C5-acylcarnitinemetabolite
7,8-dihydroneopterin[no description available]low00dihydropterin;
neopterins		Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
guanosine monophosphate[no description available]low00guanosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate		biomarker;
Escherichia coli metabolite;
metabolite;
mouse metabolite
2-amino-4-oxo-6-acetyl-7,8-dihydro-3h,9h-pyrimidodiazepine[no description available]low00methyl ketone;
pyrimidodiazepine		metabolite
dyspropterin[no description available]low00biopterins;
tetrahydropterin		human metabolite;
metabolite;
mouse metabolite
2'-o-methylguanosine[no description available]low00methylguanosinemetabolite
allopurinol riboside[no description available]low00nucleoside analoguemetabolite
norclozapine[no description available]low00dibenzodiazepine;
organochlorine compound;
piperazines		delta-opioid receptor agonist;
metabolite;
serotonergic antagonist
7-methylguanosine[no description available]low00methylguanosine;
organic cation		metabolite
3'-o-methylguanosine[no description available]low00methylguanosinemetabolite
primapterin[no description available]low00biopterinsmetabolite
7-methylinosine[no description available]low00inosines;
organic cation		metabolite
marineosin a[no description available]low00azaspiro compound;
ether;
macrocycle;
oxaspiro compound;
pyrroles		antineoplastic agent;
metabolite
marineosin b[no description available]low00azaspiro compound;
ether;
macrocycle;
oxaspiro compound;
pyrroles		antineoplastic agent;
metabolite
dimethadione[no description available]low00oxazolidinone
vinclozolin[no description available]low00dicarboximide;
dichlorobenzene;
olefinic compound;
oxazolidinone
dichlozolinate[no description available]low00dicarboximide;
dichlorobenzene;
ethyl ester;
oxazolidinone
oxadixyl[no description available]low00anilide fungicide;
aromatic amide;
carbohydrazide;
ether;
oxazolidinone		agrochemical
famoxadone[no description available]low00aromatic ether;
carbohydrazide;
oxazolidinone
2-oxa-4-azatetracyclo[6.3.1.16,10.01,5]tridecan-3-one[no description available]low00oxazolidinone
rivaroxaban[no description available]low00aromatic amide;
lactam;
monocarboxylic acid amide;
morpholines;
organochlorine compound;
oxazolidinone;
thiophenes		anticoagulant;
EC 3.4.21.6 (coagulation factor Xa) inhibitor
bendiocarb[no description available]low00benzodioxoles;
carbamate ester		agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
bethanechol[no description available]low00carbamate ester;
quaternary ammonium ion		muscarinic agonist
chlorphenesin carbamate[no description available]low00carbamate ester;
monochlorobenzenes;
secondary alcohol		muscle relaxant
chlorpropham[no description available]low00benzenes;
carbamate ester;
monochlorobenzenes		herbicide;
plant growth retardant
distigmine[no description available]low00carbamate ester;
pyridinium ion		EC 3.1.1.8 (cholinesterase) inhibitor;
muscarinic agonist
ethinamate[no description available]low00carbamate ester;
terminal acetylenic compound		sedative
felbamate[no description available]low00carbamate esteranticonvulsant;
neuroprotective agent
fenbendazole[no description available]low00aryl sulfide;
benzimidazoles;
carbamate ester		antinematodal drug
mebendazole[no description available]low00aromatic ketone;
benzimidazoles;
carbamate ester		antinematodal drug;
microtubule-destabilising agent;
tubulin modulator
methocarbamol[no description available]low00aromatic ether;
carbamate ester;
secondary alcohol
methomyl[no description available]low00aliphatic sulfide;
carbamate ester		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
nematicide;
xenobiotic
nocodazole[no description available]low00aromatic ketone;
benzimidazoles;
carbamate ester;
thiophenes		antimitotic;
antineoplastic agent;
microtubule-destabilising agent;
tubulin modulator
entinostat[no description available]low00benzamides;
carbamate ester;
primary amino compound;
pyridines;
substituted aniline		antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
oxibendazole[no description available]low00benzimidazoles;
carbamate ester
phosalone[no description available]low001,3-benzoxazoles;
carbamate ester;
organochlorine insecticide;
organothiophosphate insecticide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor
propoxur[no description available]low00aromatic ether;
carbamate ester		acaricide;
agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
1,6-bis(cyclohexyloximinocarbonyl)hexane[no description available]low00carbamate ester;
organonitrogen compound
ronidazole[no description available]low00C-nitro compound;
carbamate ester;
imidazoles		antiparasitic agent;
antiprotozoal drug
urethane[no description available]low00carbamate esterfungal metabolite;
mutagen
ici 204,219[no description available]low00carbamate ester;
indoles;
N-sulfonylcarboxamide		anti-asthmatic agent;
leukotriene antagonist
carbachol[no description available]low00ammonium salt;
carbamate ester		cardiotonic drug;
miotic;
muscarinic agonist;
nicotinic acetylcholine receptor agonist;
non-narcotic analgesic
demecarium[no description available]low00carbamate ester;
quaternary ammonium ion
physostigmine[no description available]low00carbamate ester;
indole alkaloid		antidote to curare poisoning;
EC 3.1.1.8 (cholinesterase) inhibitor;
miotic
carbaryl[no description available]low00carbamate ester;
naphthalenes		acaricide;
agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
plant growth retardant
emylcamate[no description available]low00carbamate ester
barban[no description available]low00acetylenic compound;
carbamate ester;
monochlorobenzenes		herbicide
hexapropymate[no description available]low00carbamate ester
diperodon[no description available]low00carbamate ester
uraline[no description available]low00carbamate ester
bethanechol chloride[no description available]low00carbamate ester;
chloride salt;
quaternary ammonium salt		muscarinic agonist
methyl carbamate[no description available]low00carbamate ester
metolcarb[no description available]low00carbamate esteracaricide;
agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
aminocarb[no description available]low00carbamate ester;
toluenes		acaricide;
agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
molluscicide
methiocarb[no description available]low00aryl sulfide;
carbamate ester;
methyl sulfide		acaricide;
agrochemical;
avicide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide;
molluscicide;
xenobiotic
mecarbam[no description available]low00carbamate ester;
organic thiophosphate;
organothiophosphate insecticide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
isoprocarb[no description available]low00carbamate esteragrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
methiocarb sulfoxide[no description available]low00carbamate ester;
sulfoxide		marine xenobiotic metabolite
asulam[no description available]low00carbamate ester;
primary amino compound;
substituted aniline;
sulfonamide		agrochemical;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
herbicide;
xenobiotic
bpmc[no description available]low00carbamate esteragrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
herbicide;
insecticide
tybamate[no description available]low00carbamate ester
lobendazole[no description available]low00benzimidazoles;
carbamate ester
nitrosocarbaryl[no description available]low00carbamate ester;
naphthalenes;
nitroso compound		carcinogenic agent;
mutagen
propham[no description available]low00benzenes;
carbamate ester		herbicide;
plant growth retardant
desmedipham[no description available]low00carbamate esteragrochemical;
environmental contaminant;
herbicide;
xenobiotic
phenmedipham[no description available]low00carbamate esterenvironmental contaminant;
herbicide;
xenobiotic
parbendazole[no description available]low00benzimidazoles;
carbamate ester
vinyl carbamate[no description available]low00carbamate ester
metergoline[no description available]low00carbamate ester;
ergoline alkaloid		dopamine agonist;
geroprotector;
serotonergic antagonist
benomyl[no description available]low00aromatic amide;
benzimidazole fungicide;
benzimidazoles;
benzimidazolylcarbamate fungicide;
carbamate ester		acaricide;
anthelminthic drug;
antifungal agrochemical;
microtubule-destabilising agent;
tubulin modulator
carbimazole[no description available]low001,3-dihydroimidazole-2-thiones;
carbamate ester		antithyroid drug;
prodrug
formetanate[no description available]low00carbamate esteracaricide;
agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
pirimicarb[no description available]low00aminopyrimidine;
carbamate ester;
tertiary amino compound		agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
propamocarb[no description available]low00carbamate ester;
carbamate fungicide;
tertiary amino compound		antifungal agrochemical;
environmental contaminant;
xenobiotic
moricizine[no description available]low00carbamate ester;
morpholines;
phenothiazines		anti-arrhythmia drug
croneton[no description available]low00carbamate esteragrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
flubendazole[no description available]low00aromatic ketone;
benzimidazoles;
carbamate ester;
organofluorine compound		antinematodal drug;
teratogenic agent
ciclobendazole[no description available]low00benzimidazoles;
carbamate ester
oxfendazole[no description available]low00benzimidazoles;
carbamate ester;
sulfoxide		antinematodal drug
dibutylaminosulfenylcarbofuran[no description available]low001-benzofurans;
carbamate ester		acaricide;
agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
nematicide
diaziquone[no description available]low001,4-benzoquinones;
aziridines;
carbamate ester;
enamine		alkylating agent;
antineoplastic agent
deltanit[no description available]low001-benzofurans;
carbamate ester		agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
fenoxycarb[no description available]low00aromatic ether;
carbamate ester		environmental contaminant;
insecticide;
juvenile hormone mimic;
xenobiotic
bambuterol hydrochloride[no description available]low00carbamate ester;
hydrochloride;
phenylethanolamines		anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
prodrug;
sympathomimetic agent
bambuterol[no description available]low00carbamate ester;
phenylethanolamines		anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
prodrug;
sympathomimetic agent;
tocolytic agent
benfuracarb[no description available]low001-benzofurans;
carbamate ester;
ethyl ester		agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
irinotecan[no description available]low00carbamate ester;
delta-lactone;
N-acylpiperidine;
pyranoindolizinoquinoline;
ring assembly;
tertiary alcohol;
tertiary amino compound		antineoplastic agent;
apoptosis inducer;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug
capecitabine[no description available]low00carbamate ester;
cytidines;
organofluorine compound		antimetabolite;
antineoplastic agent;
prodrug
3-iodo-2-propynylbutylcarbamate[no description available]low00acetylenic compound;
carbamate ester;
carbamate fungicide;
organoiodine compound		antifungal agrochemical;
environmental contaminant;
xenobiotic
amprenavir[no description available]low00carbamate ester;
sulfonamide;
tetrahydrofuryl ester		antiviral drug;
HIV protease inhibitor
cyclarbamate[no description available]low00carbamate ester
carbobenzoxyvalylphenylalanine aldehyde[no description available]low00aldehyde;
carbamate ester;
dipeptide		antileishmanial agent;
apoptosis inhibitor;
EC 3.4.22.52 (calpain-1) inhibitor;
EC 3.4.22.53 (calpain-2) inhibitor;
EC 3.4.23.46 (memapsin 2) inhibitor
rivastigmine[no description available]low00carbamate ester;
tertiary amino compound		cholinergic drug;
EC 3.1.1.8 (cholinesterase) inhibitor;
neuroprotective agent
diethofencarb[no description available]low00aromatic ether;
carbamate ester;
carbanilate fungicide		antifungal agrochemical
ezogabine[no description available]low00carbamate ester;
organofluorine compound;
secondary amino compound;
substituted aniline		anticonvulsant;
potassium channel modulator
thiobenzyl benzyloxycarbonyl-l-lysinate[no description available]low00benzyl ester;
carbamate ester;
L-lysine derivative;
primary amino compound;
thiocarboxylic ester
N-(4-methoxyphenyl)carbamic acid propan-2-yl ester[no description available]low00carbamate ester
darunavir[no description available]low00carbamate ester;
furofuran;
sulfonamide		antiviral drug;
HIV protease inhibitor
N-(3-chlorophenyl)carbamic acid 2-pyridinylmethyl ester[no description available]low00carbamate ester
N-[3-(ethoxycarbonylamino)-2,2-dimethylpropyl]carbamic acid ethyl ester[no description available]low00carbamate ester
nsc-89199[no description available]low00carbamate ester;
organochlorine compound;
steroid phosphate
estramustine[no description available]low0017beta-hydroxy steroid;
carbamate ester;
organochlorine compound		alkylating agent;
antineoplastic agent;
radiation protective agent
N-(4-fluorophenyl)carbamic acid (2-oxo-1H-pyridin-3-yl) ester[no description available]low00carbamate ester
N-phenylcarbamic acid 2-phenoxyethyl ester[no description available]low00carbamate ester
o-(chloroacetylcarbamoyl)fumagillol[no description available]low00carbamate ester;
organochlorine compound;
semisynthetic derivative;
sesquiterpenoid;
spiro-epoxide		angiogenesis inhibitor;
antineoplastic agent;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
methionine aminopeptidase 2 inhibitor;
retinoic acid receptor alpha antagonist
benzyloxycarbonylleucyl-leucyl-leucine aldehyde[no description available]low00amino aldehyde;
carbamate ester;
tripeptide		proteasome inhibitor
N-[2-[(3-chloroanilino)-oxomethoxy]ethyl]carbamic acid propan-2-yl ester[no description available]low00carbamate ester
N-[4-(2-pyrimidinylsulfamoyl)phenyl]carbamic acid methyl ester[no description available]low00carbamate ester
N-(4-phenylmethoxyphenyl)carbamic acid methyl ester[no description available]low00carbamate ester
N-methyl-N-phenylcarbamic acid (4-tert-butylphenyl) ester[no description available]low00carbamate ester
ethyl 4-{N-[(4-chlorophenyl)sulfonyl]-N-methylglycyl}piperazine-1-carboxylate[no description available]low00carbamate ester;
sulfonamide
N-(4-chlorophenyl)carbamic acid 2-pyridinylmethyl ester[no description available]low00carbamate ester
N-(4-chlorophenyl)carbamic acid [1-(4-chlorophenyl)-4-triazolyl]methyl ester[no description available]low00carbamate ester
N-phenylcarbamic acid [5-(2-chlorophenyl)-3-isoxazolyl]methyl ester[no description available]low00carbamate ester
3,3,3-trifluoro-2-hydroxy-2-[4-[methoxycarbonyl(methyl)amino]phenyl]propanoic acid methyl ester[no description available]low00carbamate ester
thiophanate[no description available]low00benzimidazole precursor fungicide;
carbamate ester;
carbamate fungicide;
thioureas		antifungal agrochemical
thiophanate[no description available]low00benzimidazole precursor fungicide;
carbamate ester;
carbamate fungicide;
thioureas		antifungal drug
maytansine[no description available]low00alpha-amino acid ester;
carbamate ester;
epoxide;
maytansinoid;
organic heterotetracyclic compound;
organochlorine compound		antimicrobial agent;
antimitotic;
antineoplastic agent;
plant metabolite;
tubulin modulator
geldanamycin[no description available]low001,4-benzoquinones;
ansamycin;
carbamate ester;
organic heterobicyclic compound		antimicrobial agent;
antineoplastic agent;
antiviral agent;
cysteine protease inhibitor;
Hsp90 inhibitor
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin[no description available]low001,4-benzoquinones;
ansamycin;
carbamate ester;
secondary amino compound;
tertiary amino compound		Hsp90 inhibitor
l 685458[no description available]low00carbamate ester;
monocarboxylic acid amide;
peptide;
secondary alcohol		EC 3.4.23.46 (memapsin 2) inhibitor;
peptidomimetic
z-val-ala-asp(ome)-fluoromethylketone[no description available]low00carbamate ester;
organofluorine compound;
tripeptide		apoptosis inhibitor;
protease inhibitor
pyrachlostrobin[no description available]low00aromatic ether;
carbamate ester;
carbanilate fungicide;
methoxycarbanilate strobilurin antifungal agent;
monochlorobenzenes;
pyrazoles		antifungal agrochemical;
environmental contaminant;
mitochondrial cytochrome-bc1 complex inhibitor;
xenobiotic
s 1006[no description available]low001,3-thiazoles;
carbamate ester;
carboxylic acid;
cephalosporin;
enamide;
secondary carboxamide		antibacterial drug
kalimantacin a[no description available]low00alpha,beta-unsaturated monocarboxylic acid;
carbamate ester;
fatty acid derivative;
secondary carboxamide		antibacterial agent;
antimicrobial agent;
bacterial metabolite
tanespimycin[no description available]low001,4-benzoquinones;
ansamycin;
carbamate ester;
organic heterobicyclic compound;
secondary amino compound		antineoplastic agent;
apoptosis inducer;
Hsp90 inhibitor
methiazole[no description available]low00benzimidazoles;
carbamate ester
iprovalicarb[no description available]low00amino acid amide;
carbamate ester;
valine derivative
givinostat[no description available]low00carbamate ester
cay 10499[no description available]low00carbamate ester
vorapaxar[no description available]low00carbamate ester;
lactone;
naphthofuran;
organofluorine compound;
pyridines		cardiovascular drug;
platelet aggregation inhibitor;
protease-activated receptor-1 antagonist
ki16425[no description available]low00carbamate ester;
isoxazoles;
monocarboxylic acid;
monochlorobenzenes;
organic sulfide
bay 63-2521[no description available]low00aminopyrimidine;
carbamate ester;
organofluorine compound;
pyrazolopyridine		antihypertensive agent;
soluble guanylate cyclase activator
bay 60-4552[no description available]low00aminopyrimidine;
carbamate ester;
monofluorobenzenes;
pyrazolopyridine		antihypertensive agent;
drug metabolite;
soluble guanylate cyclase activator;
vasodilator agent
wyosine[no description available]low00carbamate ester;
methyl ester;
nucleoside analogue
mk-7009[no description available]low00azamacrocycle;
carbamate ester;
cyclopropanes;
N-sulfonylcarboxamide;
pyrrolidinecarboxamide		antiviral drug;
hepatitis C protease inhibitor
N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]-oxomethyl]-5-isoxazolyl]phenyl]carbamic acid tert-butyl ester[no description available]low00carbamate ester
cobicistat[no description available]low001,3-thiazoles;
carbamate ester;
monocarboxylic acid amide;
morpholines;
ureas		P450 inhibitor
bms-790052[no description available]low00biphenyls;
carbamate ester;
carboxamide;
imidazoles;
valine derivative		antiviral drug;
nonstructural protein 5A inhibitor
4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl ester[no description available]low00carbamate ester
grazoprevir[no description available]low00aromatic ether;
azamacrocycle;
carbamate ester;
cyclopropanes;
lactam;
N-sulfonylcarboxamide;
quinoxaline derivative		antiviral drug;
hepatitis C protease inhibitor;
hepatoprotective agent
vericiguat[no description available]low00aminopyrimidine;
carbamate ester;
organofluorine compound;
pyrazolopyridine		antihypertensive agent;
soluble guanylate cyclase activator;
vasodilator agent
abt-267[no description available]low00aromatic amide;
carbamate ester;
dipeptide;
pyrrolidines		antiviral drug;
hepatitis C virus nonstructural protein 5A inhibitor
saxitoxin[no description available]low00alkaloid;
carbamate ester;
guanidines;
ketone hydrate;
paralytic shellfish toxin;
pyrrolopurine		cyanotoxin;
marine metabolite;
neurotoxin;
sodium channel blocker;
toxin
ledipasvir[no description available]low00azaspiro compound;
benzimidazole;
bridged compound;
carbamate ester;
carboxamide;
fluorenes;
imidazoles;
L-valine derivative;
N-acylpyrrolidine;
organofluorine compound		antiviral drug;
hepatitis C protease inhibitor
gs-5816[no description available]low00carbamate ester;
ether;
imidazoles;
L-valine derivative;
N-acylpyrrolidine;
organic heteropentacyclic compound;
ring assembly		antiviral drug;
hepatitis C virus nonstructural protein 5A inhibitor
mk-8742[no description available]low00carbamate ester;
imidazoles;
L-valine derivative;
N-acylpyrrolidine;
organic heterotetracyclic compound;
ring assembly		antiviral drug;
hepatitis C virus nonstructural protein 5A inhibitor;
hepatoprotective agent
ConditionIndicatedRelationship StrengthStudiesTrials
2019 Novel Coronavirus Disease0low10
2019 Novel Coronavirus Infection0low10
2019-nCoV Disease0low10
2019-nCoV Infection0low10
A-alphalipoprotein Neuropathy0low10
Abdominal Abscess0low30
Abdominal Migraine0medium24572
Abscess0medium161
Abscess, Abdominal0low30
Abscess, Amebic0low10
Abscess, Epidural0medium51
Abscess, Extradural0medium51
Abscess, Hepatic0low30
Abscess, Intra-Abdominal0low30
Abscess, Intracranial, Subdural0low30
Abscess, Pulmonary0low40
Abscess, Retropharyngeal0low10
Abscesses, Pulmonary0low40
Absence Seizure0low40
Absence Seizure Disorder0low10
Absence Seizures0low40
Absence Status0low10
Acanthamebiasis0low10
Acanthamoeba Infection0low10
Acanthamoeba Meningoencephalitis0low10
Acathisia, Drug-Induced0medium22
Ache0medium168
Acid Aspiration Syndrome0low10
Acidosis, Lactic0low250
Acinetobacter Infections0low10
Acne Inversa0low10
Actinobacillus Infections0low10
Actinomyces Infections0low10
Actinomycetales Infections0low50
Actinomycete Infections0low50
Actinomycetoma0low50
Actinomycosis0low10
Action Tremor0low20
Active Hyperemia0low10
Acute Anterior Wall Myocardial Infarction0low10
Acute Confusional Migraine0medium24572
Acute Confusional Senile Dementia0low10
Acute Coronary Syndrome0low30
Acute Disease0medium4918
Acute Edematous Pancreatitis0low30
Acute Hypercapnic Respiratory Failure0low20
Acute Hypoxemic Respiratory Failure0low20
Acute Idiopathic Facial Neuropathy0low20
Acute Inflammatory Facial Neuropathy0low20
Acute Kidney Failure0medium91
Acute Kidney Injury0medium91
Acute Kidney Insufficiency0medium91
Acute Liver Injury, Drug-Induced0low70
Acute Lymphoid Leukemia0low30
Acute Myelogenous Leukemia0low80
Acute Myeloid Leukemia0low80
Acute Myeloid Leukemia with Maturation0low80
Acute Myeloid Leukemia without Maturation0low80
Acute Necrotizing Pancreatitis0low30
Acute Onset Aura Migraine0medium75
Acute Pain0medium21
Acute Pancreatitis0low30
Acute Post-operative Pain0low10
Acute Post-Traumatic Stress Disorder0low10
Acute Postoperative Pain0low10
Acute Q Fever0low10
Acute Renal Failure0medium91
Acute Renal Injury0medium91
Acute Renal Insufficiency0medium91
Acute Respiratory Distress Syndrome0low30
ADDH0low30
Adenitis0low10
Adenocarcinoma Of Kidney0low10
Adenocarcinoma, Renal0low10
Adenocarcinoma, Renal Cell0low10
Adhesions, Tissue0low40
Adhesive Capsulitis0low10
Adhesive Capsulitis of the Shoulder0low10
Adiadochokinesis0medium11
Adipocere0low10
Adjuvant Arthritis0low30
Adrenal Cancer0low10
Adrenal Gland Cancer0low10
Adrenal Gland Neoplasms0low10
Adrenal Neoplasm0low10
Adult Respiratory Distress Syndrome0low30
Adult-Onset Still Disease0low10
Adult-Onset Still's Disease0low10
Adverse Drug Event0medium174
Adverse Drug Reaction0medium174
African Sleeping Sickness0low30
African Trypanosomiasis0low30
Age-Related Memory Disorders0low10
Age-Related Osteoporosis0low10
Aggression0medium51
Aging0medium63
Agoraphobia0medium11
Agranulocytosis0low20
AIDS-Related Opportunistic Infections0low20
Airflow Obstruction, Chronic0low30
Airway Obstruction0low10
Akathisia, Drug-Induced0medium22
Akathisia, Tardive0medium22
Akinetic Petit Mal0low10
Alcohol Abuse0low30
Alcohol Abuse, Nervous System0low10
Alcohol Addiction0low30
Alcohol Dependence0low30
Alcohol Drinking0low30
Alcohol Related Neurodevelopmental Disorder0low10
Alcohol Use Disorder0low30
Alcohol-Induced Disorders, Nervous System0low10
Alcohol-Related Birth Defects0low10
Alcoholic Intoxication, Chronic0low30
Alcoholism0low30
Aldosteronism0low10
Algor Mortis0low10
ALL, Childhood0low30
Allergic Contact Dermatitis0low10
Allergic Cutaneous Angiitis0low10
Allergic Cutaneous Vasculitis0low10
Allergic Reaction0low30
Allergy0low30
Allergy, Drug0low60
Allodynia0low10
Allodynia, Mechanical0low10
Allodynia, Tactile0low10
Allodynia, Thermal0low10
Alloxan Diabetes0low30
Alogia0low10
Alpha High Density Lipoprotein Deficiency Disease0low10
Altered Level of Consciousness0low10
Alzheimer Dementia0low10
Alzheimer Disease0low10
Alzheimer Disease, Early Onset0low10
Alzheimer Disease, Late Onset0low10
Alzheimer Sclerosis0low10
Alzheimer Syndrome0low10
Alzheimer Type Senile Dementia0low10
Alzheimer-Type Dementia (ATD)0low10
Alzheimer's Disease0low10
Alzheimer's Disease, Focal Onset0low10
Alzheimer's Diseases0low10
Amaurosis0low40
Amebiasis0low10
Amebic Meningoencephalitis0low10
Ameboma0low10
Amentia0low10
American Trypanosomiasis0low30
Amoebiasis0low10
Amphetamine Abuse0low10
Amphetamine Addiction0low10
Amphetamine Dependence0low10
Amphetamine-Related Disorders0low10
Analphalipoproteinemia0low10
Anankastic Personality0medium11
Anaplastic Oligodendroglioma0low10
Anasarca0low20
Anemia0medium282
Anemia, Aplastic0low30
Anemia, Hemolytic0low10
Anemia, Hemolytic, Acquired0low10
Anemia, Hypoplastic0low30
Anemia, Microangiopathic0low10
Anemia, Refractory0low10
Anemia, Sickle Cell0low10
Anemia, Sideroblastic0low40
Anepia0low10
Anesthesia0low40
Aneurysm, Thoracic Aortic0low10
Angiitis, Allergic Cutaneous0low10
Angiitis, Hypersensitivity0low10
Angina at Rest0low10
Angina Pectoris, Unstable0low10
Angina Pectoris, Variant0low10
Angina, Preinfarction0low10
Angina, Unstable0low10
Angioblastic Meningioma0low20
Angiogenesis, Pathologic0low10
Angiogenesis, Pathological0low10
Angiomatous Meningioma0low20
ANLL0low80
Anorectal Diseases0medium11
Anorectal Disorders0medium11
Anoxemia0low40
Anoxia0low40
Anterior Cervical Pain0low10
Anterior Choroidal Artery Infarction0low10
Anterior Circulation Transient Ischemic Attack0low10
Anterior Neck Pain0low10
Anterior Optic Neuritis0low20
Anterior Wall Myocardial Infarction0low10
Anterolateral Myocardial Infarction0low10
Anteroseptal Myocardial Infarction0low10
Anthrax0low20
Anti-MuSK Myasthenia Gravis0low20
Anti-Phospholipid Antibody Syndrome0low10
Anti-Phospholipid Syndrome0low10
Antibiotic-Associated Colitis0low70
Antiphospholipid Antibody Syndrome0low10
Antiphospholipid Syndrome0low10
Anuria0low10
Anxiety0low20
Aortic Aneurysm, Thoracic0low10
Aortic Aneurysm, Thoracoabdominal0low10
Aortic Coarctation0low10
Aphasia0low10
Aphasia, Acquired0low10
Aphasia, Ageusic0low10
Aphasia, Auditory Discriminatory0low10
Aphasia, Commisural0low10
Aphasia, Functional0low10
Aphasia, Global0low10
Aphasia, Graphomotor0low10
Aphasia, Intellectual0low10
Aphasia, Mixed0low10
Aphasia, Post-Ictal0low10
Aphasia, Post-Traumatic0low10
Aphasia, Progressive0low10
Aphasia, Semantic0low10
Aphasia, Syntactical0low10
Apical Ballooning Syndrome0low10
Aplasia Pure Red Cell0low30
Aplastic Anaemia0low30
Aplastic Anemia0low30
Apolipoprotein B-100, Familial Defective0medium52
Apolipoprotein B-100, Familial Ligand-Defective0medium52
Apoplexy0low50
Aqueductal Stenosis0low50
ARDS, Human0low30
Arrhythmia0medium22
Arrhythmias, Cardiac0medium22
Arrythmia0medium22
Arterial Diseases, Carotid0low10
Arterial Diseases, Common Carotid0low10
Arterial Diseases, External Carotid0low10
Arterial Diseases, Internal Carotid0low10
Arterial Hyperemia0low10
Arterial Inflammation0low10
Arterial Obstructive Diseases0low10
Arterial Occlusive Diseases0low10
Arteriosclerosis, Coronary0low30
Arteritis0low10
Arthritides, Bacterial0medium211
Arthritis0medium31
Arthritis, Adjuvant0low30
Arthritis, Adjuvant-Induced0low30
Arthritis, Bacterial0medium211
Arthritis, Collagen-Induced0low30
Arthritis, Degenerative0low50
Arthritis, Experimental0low30
Arthritis, Infectious0medium211
Arthritis, Rheumatoid0low20
Arthritis, Septic0medium211
Arthritis, Suppurative0medium211
Arthritis, Viral0medium211
Arthropathies0low50
Arthroses0low50
Arthrosis0low50
Aspergilloses, Bronchopulmonary0low10
Aspergillosis, Bronchopulmonary0low10
Aspiration Pneumonia0low10
Asthenia0low10
Asthma0low60
Asthma, Bronchial0low60
Astrocytoma, Grade IV0low10
Asymmetric Diabetic Proximal Motor Neuropathy0medium22
Asymptomatic Conditions0low10
Asymptomatic Diseases0low10
Asymptomatic States0low10
Asystole0low10
Ataxia0low20
Ataxia, Appendicular0low20
Ataxia, Cerebellar0medium11
Ataxia, Limb0low20
Ataxia, Motor0low20
Ataxia, Sensory0low20
Ataxia, Truncal0low20
Ataxias, Hereditary0medium31
Ataxy0low20
Atherogenesis0medium212
Atheroma0low10
Atheromatous Plaque0low10
Atheromatous Plaques0low10
Atherosclerosis0medium212
Atherosclerosis, Coronary0low30
Atherosclerotic Disease, Carotid0low10
Atherosclerotic Plaque0low10
Atherosclerotic Plaques0low10
Atonic Absence Seizure0low40
Atonic Absence Seizures0low40
Atonic Seizure0low40
Atonic Seizures0low40
Atrial Fibrillation0low10
Atrial Septal Defect0low10
Atrial Septal Defect Ostium Primum0low10
Atrial Septal Defects0low10
Atrioventricular Nodal Re-Entrant Tachycardia0low10
Atrioventricular Reentrant Tachycardia0low10
Atrophy, Muscle0low10
Attention Deficit Disorder0low30
Attention Deficit Disorder with Hyperactivity0low30
Attention Deficit Disorders with Hyperactivity0low30
Attention Deficit Hyperactivity Disorder0low30
Attention Deficit Hyperactivity Disorders0low30
Attention Deficit-Hyperactivity Disorder0low30
Atypical Cluster Headache0medium275
Atypical Mycobacterial Infection, Disseminated0low240
Atypical Mycobacterial Infection, Familial Disseminated0low240
Atypical Mycobacteriosis, Familial0low240
Atypical Mycobacteriosis, Familial Disseminated0low240
Atypical Mycobacterium Infections0low240
Auditory Hyperesthesia0medium22
Aura0medium81
Auricular Fibrillation0low10
Autoimmune Diabetes0low10
Autosomal Recessive Chronic Granulomatous Disease0low10
Awakening Epilepsy0medium81
B-Cell Chronic Lymphocytic Leukemia0low30
B-Cell Leukemia, Chronic0low30
B-Cell Lymphoma0low10
B-Cell Malignancy, Low-Grade0low30
B-Lymphocytic Leukemia, Chronic0low30
Bacillus anthracis Infection0low20
Back Ache0low10
Back Pain0low10
Back Pain with Radiation0low10
Back Pain without Radiation0low10
Backache0low10
Bacteremia0medium887
Bacterial Arthritides0medium211
Bacterial Arthritis0medium211
Bacterial Disease0medium683
Bacterial Endocarditides0medium851
Bacterial Endocarditides, Subacute0low20
Bacterial Endocarditis0medium851
Bacterial Endocarditis, Subacute0low20
Bacterial Eye Infections0low70
Bacterial Infection0medium683
Bacterial Infections0medium683
Bacterial Infections, Central Nervous System0low30
Bacterial Infections, Gram-Negative0medium253
Bacterial Infections, Gram-Positive0medium43834
Bacterial Meningitides0medium361
Bacterial Meningitis0medium361
Bacterial Ocular Infections0low70
Bacterial Pneumonia0medium5610
Bacterial Skin Diseases0medium6522
Bacteriuria0low10
Bacteroides Infections0low20
Balamuthia Infection0low10
Balamuthia mandrillaris CNS Infection0low10
Balamuthia mandrillaris Meningoencephalitis0low10
Basilar Artery Migraine0medium75
Basilar Migraine0medium75
Basilar-Type Migraine0medium75
Bed Sores0low20
Bedsore0low20
Behavior Disorders0low20
Bell Palsy0low20
Bell's Palsy0low20
Benign Cerebellar Neoplasms0low10
Benign Meningeal Neoplasms0low10
Benign Meningioma0low20
Benign Neoplasms0medium121
Benign Neoplasms, Brain0low20
Besnier-Boeck Disease0low10
Besnier-Boeck-Schaumann Syndrome0low10
Bewilderment0low10
Bilateral Blindness0low40
Bilateral Deafness0low10
Bilateral Headache0medium183
Bile Duct Obstruction, Extrahepatic0low10
Bile Duct Obstruction, Intrahepatic0low10
Biliary or Urinary Stones0low10
Biliary Stasis, Extrahepatic0low10
Biliary Stasis, Intrahepatic0low10
Biliary Tract Diseases0low10
Bilirubinemia0low10
Bladder Cancer0low10
Bladder Diseases0low10
Bladder Neoplasms0low10
Bladder Tumors0low10
Bleeding0low20
Blindness0low40
Blindness, Acquired0low40
Blindness, Bilateral0low40
Blindness, Complete0low40
Blindness, Hysterical0low40
Blindness, Legal0low40
Blindness, Monocular0low40
Blindness, Transient0low40
Blindness, Unilateral0low40
Blood Clot0low30
Blood Diseases0medium81
Blood Poisoning0medium505
Blood Pressure, High0medium91
Bloodstream Infection0medium505
Blunt Injuries0low10
Body Weight0medium194
Boeck Disease0low10
Boeck's Disease0low10
Boeck's Sarcoid0low10
Bone Cancer0low10
Bone Diseases0low10
Bone Diseases, Infectious0low70
Bone Inflammation0low10
Bone Loss, Age-Related0low10
Bone Malalignment0low10
Bone Malposition0low10
Bone Marrow Diseases0low40
Bone Misalignment0low10
Bone Neoplasms0low10
Bovine Diseases0low10
Brachial Paresis0low10
Bradyarrhythmia0low20
Bradyarrhythmias0low20
Bradycardia0low20
Brain Abscess0low160
Brain Abscess, Child0low160
Brain Abscess, Multiple0low160
Brain Abscess, Pyogenic0low160
Brain Abscess, Sterile0low160
Brain Cancer0low20
Brain Damage, Chronic0low10
Brain Diseases0medium51
Brain Disorders0medium51
Brain Dysfunction, Minimal0low30
Brain Emboli0low20
Brain Embolism0low20
Brain Inflammation0medium71
Brain Injuries, Traumatic0low30
Brain Ischemia0low20
Brain Metastases0low20
Brain Neoplasm, Primary0low20
Brain Neoplasms0low20
Brain Neoplasms, Benign0low20
Brain Neoplasms, Malignant0low20
Brain Neoplasms, Malignant, Primary0low20
Brain Neoplasms, Primary Malignant0low20
Brain Stem Ischemia, Transient0low10
Brain Stem Transient Ischemic Attack0low10
Brain TIA0low10
Brain Tumor, Primary0low20
Brain Tumor, Recurrent0low20
Brain Tumors0low20
Brainstem Ischemia, Transient0low10
Brainstem Transient Ischemic Attack0low10
Breast Cancer0low20
Breast Carcinoma0low20
Breast Neoplasms0low20
Breast Tumors0low20
Breathlessness0low10
Bright Disease0low10
Broken Heart Syndrome0low10
Bronchial Asthma0low60
Bronchial Diseases0low10
Bronchial Pneumonia0low20
Bronchopneumonia0low20
Bronchopulmonary Aspergilloses0low10
Bronchopulmonary Aspergillosis0low10
Bruxism, Nocturnal0low10
Buckley Syndrome0low10
Burns0medium71
Bursitis0low10
Buruli Ulcer0low20
Buruli Ulcer Disease0low20
C gattii Infection0low10
C neoformans Infection0low10
C. gattii Infection0low10
C. neoformans Infection0low10
Cadaver0low10
Calculi0low10
Cancer0medium121
Cancer of Bladder0low10
Cancer of Bone0low10
Cancer of Brain0low20
Cancer of Breast0low20
Cancer of Colon0low10
Cancer of Intestines0low10
Cancer of Kidney0low30
Cancer of Larynx0low10
Cancer of Liver0low50
Cancer of Lung0low10
Cancer of Prostate0low10
Cancer of Stomach0low10
Cancer of the Adrenal Gland0low10
Cancer of the Bladder0low10
Cancer of the Bone0low10
Cancer of the Brain0low20
Cancer of the Breast0low20
Cancer of the Colon0low10
Cancer of the Intestines0low10
Cancer of the Kidney0low30
Cancer of the Larynx0low10
Cancer of the Liver0low50
Cancer of the Lung0low10
Cancer of the Prostate0low10
Cancer of the Stomach0low10
Cancer of the Uterus0low10
Cancer of Uterus0low10
Cancer, Hepatocellular0low50
Candida Infection0low20
Candidiasis0low20
Candidiasis, Invasive0low10
Caprine Diseases0low10
Capsulitis0low10
Capsulitis, Adhesive0low10
Carcinoma, Hepatocellular0low20
Carcinoma, Hypernephroid0low10
Carcinoma, Renal Cell0low10
Cardiac Arrest0low10
Cardiac Arrhythmia0medium22
Cardiac Arrhythmias0medium22
Cardiac Diseases0low40
Cardiac Disorders0low40
Cardiac Dysrhythmia0medium22
Cardiac Failure0low10
Cardiometabolic Syndrome0low20
Cardiopulmonary Arrest0low10
Cardiovascular Diseases0medium322
Cardiovascular Stroke0medium101
Caries, Dental0low10
Carious Dentin0low10
Carious Lesions0low10
Carotid Artery Diseases0low10
Carotid Artery Disorders0low10
Carotid Atherosclerosis0low10
Carotid Atherosclerotic Disease0low10
Carotid Circulation Transient Ischemic Attack0low10
Catatonic Rigidity0low30
Catheter-Associated Infections0medium92
Catheter-Related Infections0medium92
Cattle Diseases0low10
Cellulitis0medium133
Cellulitis, Orbital0low10
Central Hypothyroidism0low30
Central Nervous System Bacterial Infections0low30
Central Nervous System Disease0low40
Central Nervous System Diseases0low40
Central Nervous System Disorder0low40
Central Nervous System Disorders0low40
Central Nervous System Disorders, Intracranial0medium51
Central Nervous System Infection0medium41
Central Nervous System Infections0medium41
Central Nervous System Intracranial Disorders0medium51
Central Nervous System Origin Vertigo0medium31
Central Nervous System Protozoal Infections0low10
Centrala nervsystemets sjukdomar@sv0low40
Cephalalgia0medium183
Cephalgia0medium183
Cephalgia Syndromes0low10
Cephalgia, Vascular0low10
Cephalodynia0medium183
Cerebellar Ataxia0medium11
Cerebellar Ataxia, Early Onset0medium31
Cerebellar Ataxia, Late Onset0medium31
Cerebellar Cancer0low10
Cerebellar Degenerations, Primary0medium31
Cerebellar Diseases0low20
Cerebellar Disorders0low20
Cerebellar Dysfunction0low20
Cerebellar Dysmetria0medium11
Cerebellar Hemiataxia0medium11
Cerebellar Incoordination0medium11
Cerebellar Neoplasms0low10
Cerebellar Neoplasms, Benign0low10
Cerebellar Neoplasms, Malignant0low10
Cerebellar Neoplasms, Primary0low10
Cerebellar Syndromes0low20
Cerebellar Tumors0low10
Cerebellum Diseases0low20
Cerebral Abscess0low160
Cerebral Convexity Meningioma0low20
Cerebral Emboli0low20
Cerebral Embolism0low20
Cerebral Infarct0low10
Cerebral Infarction0low10
Cerebral Infarction, Left Hemisphere0low10
Cerebral Infarction, Right Hemisphere0low10
Cerebral Ischemia0low20
Cerebral Ischemia, Transient0low10
Cerebral Nocardiosis0medium321
Cerebral Protozoal Infections0low10
Cerebral Stroke0low50
Cerebral Ventriculitis0low10
Cerebral Ventriculomegaly0low50
Cerebral, Left Hemisphere, Infarction0low10
Cerebral, Right Hemisphere, Infarction0low10
Cerebromeningitis0low30
Cerebrovascular Accident0low50
Cerebrovascular Accident, Acute0low50
Cerebrovascular Apoplexy0low50
Cerebrovascular Stroke0low50
Cervical Migraine Syndrome0medium24572
Cervical Pain0low10
Cervicalgia0low10
Cervicodynia0low10
Chagas Disease0low30
Chagas' Disease0low30
Chemical and Drug Induced Liver Injury0low70
Chemical Dependence0low30
Chemically-Induced Liver Toxicity0low70
Chest Pain0medium21
Chicken Pox0low10
Chickenpox0low10
Childhood Absence Epilepsy0low10
Choking0low10
Cholangitis0low10
Cholera Infantum0low20
Cholestasis, Extrahepatic0low10
Cholestasis, Intrahepatic0low10
Cholesterol Thesaurismosis0low10
Choroby OUN@pl0low40
Chromophil Renal Cell Carcinoma0low10
Chromophobe Renal Cell Carcinoma0low10
Chronic Airflow Obstruction0low30
Chronic Cluster Headache0medium275
Chronic Daily Headache0low10
Chronic Disease0medium193
Chronic Encephalopathy0low10
Chronic Granulomatous Disease0low10
Chronic Granulomatous Disease, Atypical0low10
Chronic Granulomatous Disease, X-Linked0low10
Chronic Headache0low10
Chronic Illness0medium193
Chronic Kidney Failure0medium195
Chronic Lymphocytic Leukemia0low30
Chronic Obstructive Airway Disease0low30
Chronic Obstructive Lung Disease0low30
Chronic Obstructive Pulmonary Disease0low30
Chronic Obstructive Pulmonary Diseases0low30
Chronic Paroxysmal Hemicrania0low10
Chronic Post-operative Pain0low10
Chronic Post-surgical Pain0low10
Chronic Post-Traumatic Stress Disorder0low10
Chronic Postoperative Pain0low10
Chronic Postsurgical Pain0low10
Chronic Q Fever0low10
Chronically Ill0medium193
Chylopericardium0low10
Ciliary Neuralgia0medium275
Cirrhoses, Experimental Liver0low20
Cirrhosis0low20
Cirrhosis, Experimental Liver0low20
Cirrhosis, Liver0low40
Clasp-Knife Spasticity0medium11
Classic Migraine0medium75
Classical Migraine0medium75
Claustrophobia0low10
Clear Cell Meningioma0low20
Clear Cell Renal Carcinoma0low10
Clear Cell Renal Cell Carcinoma0low10
Clonic Seizure0low40
Clonic Seizures0low40
Clostridioides difficile Infection0medium193
Clostridioides Infections0medium193
Clostridioides perfringens Food Poisoning0medium193
Clostridioides perfringens Infections0medium193
Clostridioides sordellii Infection0medium193
Clostridium difficile Infection0medium193
Clostridium difficile Infections0medium193
Clostridium Enterocolitis0low70
Clostridium Infections0medium193
Clostridium perfringens Food Poisoning0medium193
Clostridium perfringens Infections0medium193
Clostridium sordellii Infection0medium193
Clostridium sordellii Infections0medium193
Cluster Headache0medium275
Cluster Headache Syndrome0medium275
CNS Disease0low40
CNS Diseases0low40
CNS Disorders, Intracranial0medium51
CNS Infections0medium41
CNS Origin Vertigo0medium31
CNS Protozoal Infections0low10
Co-infection0low100
COAD0low30
Coarctation of Aorta0low10
Coarctation of Aorta Dominant0low10
Coarctation of the Aorta0low10
Coarse Tremor0low20
Cocaine Abuse0low10
Cocaine Addiction0low10
Cocaine Dependence0low10
Cocaine-Related Disorders0low10
Coccidioides immitis Infection0low20
Coccidioidomycosis0low20
Cognitive Decline0low10
Cognitive Dysfunction0low10
Cognitive Impairments0low10
Cogwheel Rigidity0low30
Coinfection0low100
Colitis0low10
Colitis, Granulomatous0low20
Colitis, Pseudomembranous0low70
Collagen Arthritis0low30
Collecting Duct Carcinoma0low10
Collecting Duct Carcinoma (Kidney)0low10
Collecting Duct Carcinoma of the Kidney0low10
Colon Cancer0low10
Colon Neoplasms0low10
Colonic Cancer0low10
Colonic Diseases, Functional0low10
Colonic Neoplasms0low10
Common Carotid Artery Diseases0low10
Common Migraine0medium75
Communicable Diseases0low20
Communicable Diseases, Emerging0low20
Communicable Diseases, Re-Emerging0low20
Communicable Diseases, Reemerging0low20
Communicating Hydrocephalus0low50
Community Acquired Infection0medium574
Community-Acquired Infection0medium574
Community-Acquired Infections0medium574
Complex Partial Epilepsy0low10
Complex Partial Seizure0low40
Complex Partial Seizure Disorder0low10
Complex Partial Seizures0low40
Complex Partial Status Epilepticus0low10
Complicated Migraine0medium75
Complication, Intraoperative0low10
Complication, Peroperative0low10
Complication, Postoperative0medium303
Complications of Diabetes Mellitus0medium61
Complications, Infectious Pregnancy0low30
Complications, Pregnancy0low10
Concomitant Strabismus0low10
Condition, Preneoplastic0low30
Conditions, Preneoplastic0low30
Confusion0low10
Confusion, Post-Ictal0low10
Confusion, Reactive0low10
Confusional State0low10
Congenital Familial Lymphedema0low10
Congenital Hereditary Lymphedema0low10
Congenital Hydrocephalus0low50
Congestive Heart Failure0low10
Conjugate Nystagmus0low10
Conn Syndrome0low10
Conn's Syndrome0low10
Consciousness Disorders0low10
Consciousness, Level Altered0low10
Consciousness, Level Depressed0low10
Constriction, Pathologic0low10
Constriction, Pathological0low10
Contact Dermatitis0low10
Continuous Tremor0low20
Convergence Nystagmus0low10
Convergent Comitant Strabismus0low10
Convulsion0low40
Convulsion, Non-Epileptic0low40
Convulsions0low40
Convulsions, Grand Mal0low10
Convulsive Seizure0low40
Convulsive Seizures0low40
Coordination Impairment0low20
COPD0low30
Corneal Ulcer0low20
Coronary Arteriosclerosis0low30
Coronary Artery Disease0low30
Coronary Artery Vasospasm0low30
Coronary Atherosclerosis0low30
Coronary Disease0medium155
Coronary Heart Disease0medium155
Coronary Vasospasm0low30
Coronavirus Disease 20190low10
Coronavirus Disease-190low10
Corpse0low10
Corticostriatal-Spinal Degeneration0medium31
Corynebacterium Infections0low20
COVID-190low10
COVID-19 Pandemic0low10
COVID-19 Pandemics0low10
COVID-19 Virus Disease0low10
COVID-19 Virus Infection0low10
COVID190low10
Coxiella burnetii Fever0low10
Coxiella burnetii Infection0low10
Coxiella burnetii Vector-Borne Disease0low10
Cranial Epidural Abscess0medium51
Cranial Extradural Abscess0medium51
Cranial Nerve II Diseases0low250
Cranial Nerve II Disorder0low250
Cranial Nerve V Diseases0low10
Cranial Pain0medium183
Crescendo Transient Ischemic Attacks0low10
Critical Illness0medium369
Critically Ill0medium369
Crohn Disease0low20
Crohn's Disease0low20
Crohn's Enteritis0low20
Cronobacter Infections0low10
Cross Infection0medium18019
Cruor0low10
Crural Paresis0low10
Cruveilhier-Baumgarten Syndrome0low10
Cryptococcosis0low10
Cryptococcus gattii Infection0low10
Cryptococcus Infection0low10
Cryptococcus Infections0low10
Cryptococcus neoformans Infection0low10
Cryptogenic Fibrosing Alveolitis0low10
Cryptogenic Partial Complex Epilepsy0low10
Cryptogenic Tonic-Clonic Epilepsy0low10
Cutaneous Allergic Vasculitis0low10
Cutaneous Fistula0low10
Cutaneous Leukocytoclastic Angiitis0low10
Cutaneous Leukocytoclastic Vasculitis0low10
Cutaneous T-Cell Lymphoma0low10
CVA (Cerebrovascular Accident)0low50
Cystic Fibrosis0medium213
Cystic Fibrosis of Pancreas0medium213
Cystitis0low10
Cytochrome B-Negative Granulomatous Disease, Chronic, X-Linked0low10
Cytochrome B-Positive Granulomatous Disease, Chronic, X-Linked0low10
Darkness Tremor0low20
Day Blindness0low30
Deafness Bilateral0low10
Deafness, Transitory0low10
Decay, Dental0low10
Decerebrate Posturing0low30
Decerebrate State0low30
Decorticate Rigidity0low30
Decorticate State0low30
Decubitus Ulcer0low20
Deficiency, Oxygen0low40
Deficiency, Vitamin D0low10
Dehiscence, Surgical Wound0low10
Dehydration0low20
Dejerine-Lichtheim Phenomenon0low10
Delayed Onset Post-Traumatic Stress Disorder0low10
Delirium0low10
Delirium of Mixed Origin0low10
Dementia0low10
Dementia Praecox0medium31
Dementia, Alzheimer Type0low10
Dementia, Presenile0low10
Dementia, Primary Senile Degenerative0low10
Dementia, Senile0low10
Dental Caries0low10
Dental Decay0low10
Dental Focal Infection0low10
Dental Focal Infections0low10
Dental White Spot0low10
Dental White Spots0low10
Dentin Hypersensitivity0low10
Dentin Sensitivity0low10
Dentine Hypersensitivity0low10
Dentine Sensitivity0low10
Depressed Level of Consciousness0low10
Depression0medium111
Depression, Endogenous0medium72
Depression, Involutional0low20
Depression, Neurotic0medium72
Depression, Unipolar0medium72
Depressive Disorder0medium72
Depressive Disorder, Major0low20
Depressive Syndrome0medium72
Dermatitis0low10
Dermatitis Medicamentosa0low40
Dermatitis Venenata0low10
Dermatitis, Adverse Drug Reaction0low40
Dermatitis, Allergic Contact0low10
Dermatitis, Allergic Eczematous0low10
Dermatitis, Contact0low10
Dermatitis, Contact, Allergic0low10
Dermatomycoses0low10
Dermatomycosis0low10
Dermatophyte Infection0low10
Dermatoses0medium52
Dermatosis0medium52
Diabetes Complications0medium61
Diabetes Mellitus0low30
Diabetes Mellitus, Adult-Onset0medium81
Diabetes Mellitus, Brittle0low10
Diabetes Mellitus, Experimental0low30
Diabetes Mellitus, Insulin-Dependent0low10
Diabetes Mellitus, Insulin-Dependent, 10low10
Diabetes Mellitus, Juvenile-Onset0low10
Diabetes Mellitus, Ketosis-Prone0low10
Diabetes Mellitus, Ketosis-Resistant0medium81
Diabetes Mellitus, Maturity-Onset0medium81
Diabetes Mellitus, Non Insulin Dependent0medium81
Diabetes Mellitus, Non-Insulin-Dependent0medium81
Diabetes Mellitus, Noninsulin Dependent0medium81
Diabetes Mellitus, Noninsulin-Dependent0medium81
Diabetes Mellitus, Slow-Onset0medium81
Diabetes Mellitus, Stable0medium81
Diabetes Mellitus, Sudden-Onset0low10
Diabetes Mellitus, Type 10low10
Diabetes Mellitus, Type 20medium81
Diabetes Mellitus, Type I0low10
Diabetes Mellitus, Type II0medium81
Diabetes-Related Complications0medium61
Diabetes, Autoimmune0low10
Diabetic Amyotrophy0medium22
Diabetic Angiopathies0low10
Diabetic Asymmetric Polyneuropathy0medium22
Diabetic Autonomic Neuropathy0medium22
Diabetic Complications0medium61
Diabetic Feet0medium112
Diabetic Foot0medium112
Diabetic Mononeuropathy0medium22
Diabetic Mononeuropathy Simplex0medium22
Diabetic Neuralgia0medium22
Diabetic Neuropathies0medium22
Diabetic Neuropathy, Painful0medium22
Diabetic Polyneuropathy0medium22
Diabetic Vascular Complications0low10
Diabetic Vascular Diseases0low10
Diagnosis, Psychiatric0low20
Diarrhea0medium102
Diathesis0low40
Diffuse Well-Differentiated Lymphocytic Lymphoma0low30
Digestive System Diseases0low10
Digestive System Disorders0low10
Disc, Herniated0low10
Discitis0low40
Disease0low20
Disease Exacerbation0low20
Disease Models, Animal0medium1022
Disease Progression0low20
Disease Susceptibility0low40
Disease, Pulmonary0low30
Diseases of Immune System0low10
Diseases of Pharynx0medium11
Diseases, Peripheral Vascular0low30
Diseases, Pulmonary0low30
Disk Prolapse0low10
Disk, Herniated0low10
Diskitis0low40
Disorder, Complex Partial Seizures0low10
Disorientation0low10
Disrupted In B-Cell Malignancy0low30
Dissociated Nystagmus0low10
Dissociated Vertical Deviation0low10
Dizziness0medium54
Dizzyness0medium54
Doenu00E7as do Sistema Nervoso Central@pt0low40
Dropsy0low20
Drug Abuse0low30
Drug Abuse, Intravenous0low10
Drug Abuse, Parenteral0low10
Drug Addiction0low30
Drug Allergy0low60
Drug Dependence0low30
Drug Eruptions0low40
Drug Habituation0low30
Drug Hypersensitivity0low60
Drug Overdose0low60
Drug Side Effects0medium174
Drug Toxicity0medium174
Drug Use Disorders0low30
Drug Withdrawal Symptoms0medium31
Drug-Induced Acute Liver Injury0low70
Drug-Induced Akathisia0medium22
Drug-Induced Liver Disease0low70
Drug-Induced Liver Injury0low70
Drug-Related Side Effects and Adverse Reactions0medium174
Dyscoordination0low20
Dysesthesia0medium11
Dysgeusia0low10
Dyskinesia, Drug-Induced0low10
Dyskinesia, Medication-Induced0low10
Dyslipidemia0medium296
Dyslipidemias0medium296
Dyslipoproteinemias0medium296
Dysmenorrhea0medium11
Dysmetabolic Syndrome X0low20
Dysmetria0medium11
Dysphasia0low10
Dysphasia, Global0low10
Dyspnea0low10
Dyssynergia0low20
E coli Infections0low30
E. coli Infection0low30
Early Onset Alzheimer Disease0low10
Early Onset Cerebellar Ataxia0medium31
Early Onset Lymphedema0low10
Ecthyma0low10
Eczema, Contact0low10
Edema0low20
Edema-Proteinuria-Hypertension Gestosis0low10
Edema, Fetal0low10
Edema, Pulmonary0low10
Edemas, Pulmonary0low10
Electrocardiogram QT Prolonged0medium32
Electrolytes0low10
Electron Transport Chain Deficiencies, Mitochondrial0low30
Elevated Cholesterol0medium186
Embolism, Brain0low20
Embolism, Intracranial0low20
Embolism, Pulmonary0low40
Embolisms, Pulmonary0low40
Emergencies0low10
Emesis0medium21
Empyema0low10
Empyema, Pleural0low10
Empyema, Subdural0low30
Empyema, Thoracic0low10
Encephalitis0medium71
Encephalitis, Rasmussen0medium71
Encephalomeningitis0low30
Encephalon Diseases0medium51
Encephalopathy0medium51
Encephalopathy, Chronic0low10
Encephalopathy, Hepatic0low10
Encephalopathy, Hepatocerebral0low10
Encephalopathy, Hypertensive0low10
Encephalopathy, Ischemic0low20
Encephalopathy, Portal-Systemic0low10
Encephalopathy, Portosystemic0low10
Encephalopathy, Toxic0low50
Encephalopathy, Traumatic0low30
End-Stage Kidney Disease0medium195
End-Stage Renal Disease0medium195
Endocarditides, Bacterial0medium851
Endocarditides, Subacute Bacterial0low20
Endocarditis0low40
Endocarditis Lenta0low20
Endocarditis, Bacterial0medium851
Endocarditis, Subacute Bacterial0low20
Endophthalmitis0medium91
Endotoxemia0low20
Endotoxin Shock0low90
Enfermedades del Sistema Nervioso Central@es0low40
Enteritis0low20
Enteritis, Granulomatous0low20
Enteritis, Pseudomembranous0low70
Enteritis, Regional0low20
Enterobacteriaceae Infections0low10
Enterobacterial Infections0low10
Enterocolitis0low20
Enterocolitis, Pseudomembranous0low70
Enterovirus Infections0low10
Eosinophilia0low30
Eosinophilia, Pulmonary0low10
Eosinophilia, Tropical0low30
Eosinophilias, Pulmonary0low10
Eosinophilic Pneumonia0low10
EPH Complex0low10
EPH Gestosis0low10
EPH Toxemias0low10
Epidural Abscess0medium51
Epidural Abscess, Intracranial0medium51
Epidural Abscess, Spinal0medium51
Epilepsy0medium81
Epilepsy Juvenile Absence0low10
Epilepsy, Absence0low10
Epilepsy, Absence, Atypical0low10
Epilepsy, Complex Partial0low10
Epilepsy, Cryptogenic0medium81
Epilepsy, Cryptogenic, Partial Complex0low10
Epilepsy, Grand Mal0low10
Epilepsy, Major0low10
Epilepsy, Minor0low10
Epilepsy, Petit Mal0low10
Epilepsy, Psychic Equivalent0low10
Epilepsy, Psychomotor0low10
Epilepsy, Symptomatic, Partial Complex0low10
Epilepsy, Tonic-Clonic0low10
Epilepsy, Tonic-Clonic, Cryptogenic0low10
Epilepsy, Tonic-Clonic, Familial0low10
Epilepsy, Tonic-Clonic, Symptomatic0low10
Epileptic Seizure0low40
Epileptic Seizures0low40
Epileptiform Neuralgia0low20
Episodic Cluster Headache0medium275
Episodic Paroxysmal Hemicrania0low10
Erysipelothrix Infections0low10
Erythema0medium11
Erythrocyte Aplasia0low30
Escherichia coli Infections0low30
Esophagotracheal Fistula0low10
ESRD0medium195
Ethanol Abuse0low30
Ethanol Induced Nervous System Disorders0low10
Ethanol-Induced Disorders, Nervous System0low10
Ethanol-Induced Nervous System Disorders0low10
Ethyl Alcohol Abuse Neurologic Syndromes0low10
Eumycetoma0low50
Ewing Sarcoma0low10
Ewing Tumor0low10
Ewing's Sarcoma0low10
Ewing's Tumor0low10
Exanthem0low30
Exanthema0low30
Experimental Diabetes Mellitus0low30
Experimental Hepatoma0low20
Experimental Hepatomas0low20
Experimental Leukemia0low20
Experimental Leukemias0low20
Experimental Liver Cirrhoses0low20
Experimental Liver Cirrhosis0low20
Experimental Liver Neoplasms0low20
Experimental Lung Inflammation0medium193
Experimental Neoplasms0low20
Experimental Pneumococcal Meningitis0low60
Extensively Drug-Resistant Tuberculosis0medium464
Extensor Rigidity0low30
External Carotid Artery Diseases0low10
External Fistula0low10
Extrahepatic Cholestasis0low10
Extrapyramidal Rigidity0low30
Extravascular Hemolysis0low10
Extremely Drug-Resistant Tuberculosis0medium464
Eye Diseases0low10
Eye Disorders0low10
Eye Infections, Bacterial0low70
Eyelid Diseases0low10
Facial Injuries0low10
Facial Neuropathy, Idiopathic Acute0low20
Facial Neuropathy, Inflammatory, Acute0low20
Facial Paralysis, Idiopathic0low20
Facial Spasm, Unilateral0low20
Factitious Disorders0low10
FAE (Fetal Alcohol Effects)0low10
Familial Alzheimer Disease (FAD)0low10
Familial Atrial Fibrillation0low10
Familial Combined Hyperlipoproteinemia0medium52
Familial Dementia0low10
Familial Hemiplegic Migraine0medium75
Familial Idiopathic Pulmonary Fibrosis0low10
Familial Non-Immune Hydrops Fetalis0low10
Familial Spinocerebellar Degenerations0medium31
Familial Tonic-Clonic Epilepsy0low10
Fasciitis, Necrotizing0low10
Fascitis, Necrotizing0low10
FASD0low10
Fasting Hypoglycemia0low20
Fatigable Positional Nystagmus0low10
Fatty Liver0low10
Fatty Streak, Arterial0low10
Female Genitourinary Diseases0medium11
Female Urogenital Diseases0medium11
Fetal Alcohol Spectrum Disorder0low10
Fetal Alcohol Spectrum Disorders0low10
Fetal Alcohol Syndrome0low10
Fetal Cerebral Ventriculomegaly0low50
Fetal Edema0low10
Fetal Hydrops0low10
Fever0medium91
Fibroatheroma0low10
Fibroatheromatous Plaques0low10
Fibrocystic Disease of Pancreas0medium213
Fibrocystic Pulmonary Dysplasia0low10
Fibroid0low10
Fibroid Tumor0low10
Fibroid Uterus0low10
Fibroids, Uterine0low10
Fibroma, Uterine0low10
Fibromyoma0low10
Fibrosing Alveolitis, Cryptogenic0low10
Fibrosis0low20
Fibrosis, Liver0low40
Fibrous Meningioma0low20
Fifth Cranial Nerve Diseases0low10
Fine Tremor0low20
Finger Injuries0low10
Fistula0low10
Focal Infection, Dental0low10
Focal Infections, Dental0low10
Focal Onset Alzheimer's Disease0low10
Foot Diseases0medium32
Foot Ulcer0medium21
Foot Ulcer, Diabetic0medium112
Foreign Bodies0low40
Foreign Objects0low40
Foreign-Body Reaction0low20
Formication0medium11
Foster-Kennedy Syndrome0low250
Fothergill Disease0low20
Fournier Disease0low10
Fournier Gangrene0low10
Fournier's Disease0low10
Fournier's Gangrene0low10
Fractures, Closed0low10
Fractures, Compound0low10
Fractures, Occult0low10
Fractures, Open0low10
Frozen Shoulder0low10
Fulminant Hepatic Failure with Cerebral Edema0low10
Functional Colonic Diseases0low10
Functional Gastrointestinal Disorders0low20
Fungal Diseases0low10
Fungal Infections0low10
Fungal Lung Diseases0low10
Fungal Skin Diseases0low10
Fungus Diseases0low10
Fungus Infections0low10
Gangrene0low20
Ganser Syndrome0low10
Garland-Moorhouse Syndrome0medium31
Gastric Acid Aspiration Syndrome0low10
Gastric Cancer0low10
Gastric Cancer, Familial Diffuse0low10
Gastric Neoplasms0low10
Gastroenteritis0low10
Gastrointestinal Diseases0low20
Gastrointestinal Disorders0low20
Gastrointestinal Disorders, Functional0low20
Gegenhalten0low30
Generalized Absence Seizure0low40
Generalized Absence Seizures0low40
Generalized Convulsive Status Epilepticus0low10
Generalized Headache0medium183
Generalized Tonic-Clonic Seizures0low40
Genetic Predisposition0low40
Genetic Predisposition to Disease0low40
Genetic Susceptibility0low40
Genome Instability0low10
Genome Stability0low10
Genomic Instability0low10
Genomic Stability0low10
Germinoblastoma0low10
Gestosis, EPH0low10
Giant Cell Glioblastoma0low10
Glaucoma0low10
Glaucoma, Angle Closure0low10
Glaucoma, Angle-Closure0low10
Glaucoma, Closed-Angle0low10
Glaucoma, Narrow-Angle0low10
Glaucoma, Uncompensated0low10
Glaucoma, Uncompensative0low10
Glioblastoma0low10
Glioblastoma Multiforme0low10
Glomerulonephritis0low10
Glomerulonephritis, Lupus0low10
Glucose Metabolic Disorder0low10
Glucose Metabolic Disorders0low10
Glucose Metabolism Disorder0low10
Glucose Metabolism Disorders0low10
Goat Diseases0low10
Gonorrhea0medium136
Gossypiboma0low40
Graft vs Host Disease0low10
Graft-Versus-Host Disease0low10
Graft-vs-Host Disease0low10
Gram-Negative Bacterial Infections0medium253
Gram-Positive Bacterial Infections0medium43834
Grand Mal Seizure Disorder0low10
Grand Mal Status Epilepticus0low10
Granulocytic Leukemia0low10
Granulocytic Leukemia, Chronic0low10
Granulocytopenia0low20
Granuloma0low30
Granuloma, Hodgkin0low10
Granuloma, Hodgkin's0low10
Granuloma, Hodgkins0low10
Granuloma, Malignant0low10
Granulomas0low30
Granulomatous Disease, Chronic0low10
Granulomatous Disease, Chronic, X-Linked0low10
Granulomatous Disease, Chronic, X-Linked, Variant0low10
Granulomatous Slack Skin0low10
Grawitz Tumor0low10
Grippe0low20
Group A Strep Infection0medium351
Group A Streptococcal Infection0medium351
Group A Streptococcal Infections0medium351
Group B Strep Infection0medium351
Group B Streptococcal Infection0medium351
Group B Streptococcal Infections0medium351
Growth Retardation, Facial Abnormalities, and Central Nervous System Dysfunction0low10
Haemolysis0low10
Haemolytic Anaemia0low10
Haemophilus Infections0low40
Haemophilus influenzae Infection0low40
Haemophilus influenzae Type b Infection0low40
Hallucination of Body Sensation0low30
Hallucinations0low30
Hallucinations, Auditory0low30
Hallucinations, Dissociative0low30
Hallucinations, Elementary0low30
Hallucinations, Formed, of People0low30
Hallucinations, Gustatory0low30
Hallucinations, Hypnagogic0low30
Hallucinations, Hypnapompic0low30
Hallucinations, Internal Body Sensation0low30
Hallucinations, Kinesthetic0low30
Hallucinations, Mood Congruent0low30
Hallucinations, Mood Incongruent0low30
Hallucinations, Olfactory0low30
Hallucinations, Organic0low30
Hallucinations, Reflex0low30
Hallucinations, Sensory0low30
Hallucinations, Somatic0low30
Hallucinations, Tactile0low30
Hallucinations, Verbal Auditory0low30
Hallucinations, Visual0low30
Hallucinations, Visual, Formed0low30
Hallucinations, Visual, Unformed0low30
Hand Dermatoses0low10
Hand Dermatosis0low10
Hansen Disease0low10
Hansen's Disease0low10
HbS Disease0low10
HDLDT10low10
Head Pain0medium183
Headache0medium183
Headache Disorders0low10
Headache Syndromes0low10
Headache, Cluster0medium275
Headache, Intractable0low10
Headache, Migraine0medium24572
Headache, Vascular0low10
Health Care Associated Infection0medium18019
Health Care Associated Infections0medium18019
Healthcare Associated Infections0medium18019
Hearing Impairment0low10
Hearing Loss0low10
Hearing Loss, Bilateral0low10
Hearing Loss, Transitory0low10
Heart Arrest0low10
Heart Attack0medium101
Heart Decompensation0low10
Heart Disease, Ischemic0low20
Heart Diseases0low40
Heart Disorders0low40
Heart Failure0low10
Heart Failure, Congestive0low10
Heart Failure, Left-Sided0low10
Heart Failure, Right-Sided0low10
Heart Septal Defects, Atrial0low10
Heart Valve Diseases0low40
Heart Valvular Disease0low40
Hemangioblastic Meningioma0low20
Hemangiopericytic Meningioma0low20
Hematologic Diseases0medium81
Hematologic Malignancies0low40
Hematologic Malignancy0low40
Hematologic Neoplasms0low40
Hematological Diseases0medium81
Hematological Malignancies0low40
Hematological Neoplasms0low40
Hematoma0low10
Hematopoietic Malignancies0low40
Hematopoietic Neoplasms0low40
Hemeralopia0low30
Hemicrania0medium183
Hemicrania Migraine0medium24572
Hemifacial Myokymia0low20
Hemifacial Spasm0low20
Hemiparesis0low10
Hemiplegic Migraine, Familial0medium75
Hemiplegic-Ophthalmoplegic Migraine0medium75
Hemoglobin S Disease0low10
Hemolysis0low10
Hemolytic Anemia0low10
Hemolytic Anemia, Acquired0low10
Hemopericardium0low10
Hemophilus Infections0low40
Hemorrhage0low20
Hemorrhage, Subarachnoid0low20
Hemorrhagic Necrotic Pancreatitis0low30
Hepatic Cancer0low50
Hepatic Cirrhosis0low40
Hepatic Cirrhosis, Experimental0low20
Hepatic Coma0low10
Hepatic Encephalopathy0low10
Hepatic Failure0low20
Hepatic Neoplasms0low50
Hepatic Stupor0low10
Hepatitis, Drug-Induced0low70
Hepatitis, Toxic0low70
Hepatobiliary Diseases0low10
Hepatobiliary Disorders0low10
Hepatocellular Cancer0low50
Hepatocellular Carcinoma0low20
Hepatocerebral Encephalopathy0low10
Hepatoma0low20
Hepatoma, Experimental0low20
Hepatoma, Morris0low20
Hepatoma, Novikoff0low20
Hepatomas, Experimental0low20
Hereditary Lymphedema0low10
Hereditary Lymphedema 10low10
Hereditary Lymphedema Type I0low10
Hereditary Oligophrenic Cerebello-Lental Degeneration0medium31
Hereditary Spinocerebellar Degenerations0medium31
Herniated Disc0low10
Herniated Disk0low10
Herpes Zoster0low10
Herpetic Facial Paralysis0low20
Hib Infection0low40
Hidradenitides, Suppurative0low10
Hidradenitis Suppurativa0low10
Hidradenitis, Suppurative0low10
HIE Syndrome0low10
HIES, Autosomal Dominant0low10
HIES, Autosomal Recessive0low10
High Cholesterol Levels0medium186
High Density Lipoprotein Deficiency, Tangier Type0low10
High Density Lipoprotein Deficiency, Type 10low10
High-Density Lipoprotein Deficiency, Tangier Type0low10
High-Density Lipoprotein Deficiency, Type I0low10
Hip Fractures0low10
Histamine Cephalgia0medium275
HIV0low10
HIV Coinfection0low120
HIV Infections0low120
HIV-Related Opportunistic Infections0low20
Hodgkin Disease0low10
Hodgkin Lymphoma0low10
Hodgkin Lymphoma, Adult0low10
Hodgkin's Disease0low10
Hodgkin's Lymphoma0low10
Hodgkins Disease0low10
Homologous Wasting Disease0low10
Horizontal Nystagmus0low10
Horton Syndrome0medium275
Horton's Syndrome0medium275
Hospital Infections0medium18019
Hospital-Acquired Condition0low20
HTLV-III Infections0low120
HTLV-III-LAV Infections0low120
Hughes Syndrome0low10
Human Flu0low20
Human Influenza0low20
Human Mammary Carcinoma0low20
Humeral Fractures0low20
Hydrocephalus0low50
Hydrocephalus Ex-Vacuo0low50
Hydrocephaly0low50
Hydrops0low20
Hydrops Fetalis0low10
Hydrops Fetalis Nonimmune0low10
Hydrops Fetalis, Idiopathic0low10
Hydrops Fetalis, Immune0low10
Hydrops Fetalis, Non-Immune0low10
Hydrops Fetalis, Nonimmune0low10
Hyper-beta-Lipoproteinemia0medium52
Hyper-IgE Recurrent Infection Syndrome, Autosomal Recessive0low10
Hyper-IgE Syndrome0low10
Hyper-IgE Syndrome, Autosomal Dominant0low10
Hyper-IgE Syndrome, Autosomal Recessive0low10
Hyper-Immunoglobulin E Syndrome, Autosomal Dominant0low10
Hyper-Immunoglobulin E Syndrome, Autosomal Recessive0low10
Hyper-Low Density Lipoproteinemia0medium52
Hyper-Low-Density-Lipoproteinemia0medium52
Hyperacusia0medium22
Hyperacusis0medium22
Hyperaldosteronism0low10
Hyperalgesia0low10
Hyperalgesia, Mechanical0low10
Hyperalgesia, Primary0low10
Hyperalgesia, Secondary0low10
Hyperalgesia, Tactile0low10
Hyperalgesia, Thermal0low10
Hyperalgesic Sensations0low10
Hyperalgia0low10
Hyperalgia, Mechanical0low10
Hyperalgia, Primary0low10
Hyperalgia, Secondary0low10
Hyperbetalipoproteinemia0medium52
Hyperbilirubinemia0low10
Hypercapnic Acute Respiratory Failure0low20
Hypercapnic Respiratory Failure0low20
Hypercholesteremia0medium186
Hypercholesterolemia0medium186
Hypercholesterolemia, Autosomal Dominant0medium52
Hypercholesterolemia, Autosomal Dominant, Type B0medium52
Hypercholesterolemia, Essential0medium52
Hypercholesterolemia, Familial0medium52
Hypercholesterolemic Xanthomatosis, Familial0medium52
Hyperemia0low10
Hyperesthesia0low10
Hyperesthesia, Tactile0low10
Hyperesthesia, Thermal0low10
Hyperesthetic Sensations0low10
Hyperimmunoglobulin E-Recurrent Infection Syndrome0low10
Hyperimmunoglobulin E, Recurrent Infection Syndrome0low10
Hyperimmunoglobulinemia E Syndrome0low10
Hyperkinetic Syndrome0low30
Hyperlipemia0medium72
Hyperlipidemia0medium72
Hyperlipidemias0medium72
Hyperlipoproteinemia0low10
Hyperlipoproteinemia Type 20medium52
Hyperlipoproteinemia Type II0medium52
Hyperlipoproteinemia Type IIa0medium52
Hyperlipoproteinemia Type IIb0medium52
Hyperlipoproteinemia, Type II0medium52
Hyperlipoproteinemia, Type IIa0medium52
Hyperlipoproteinemias0low10
Hypermetria0medium11
Hypernephroma0low10
Hyperplasia0low30
Hypersensitivity0low30
Hypersensitivity Angiitis0low10
Hypersensitivity Vasculitis0low10
Hypersensitivity, Contact0low10
Hypersensitivity, Drug0low60
Hypertension0medium91
Hypertension-Edema-Proteinuria Gestosis0low10
Hypertension, Portal0low10
Hypertensive Encephalopathy0low10
Hypertropia0low10
Hypoacusis0low10
Hypoglycemia0low20
Hypokalemia0low10
Hypomenorrhea0medium22
Hyponatremia0low10
Hypophosphatemia0low10
Hypoplastic Left Heart Syndrome0low10
Hypopotassemia0low10
Hypothermia0low30
Hypothermia, Accidental0low30
Hypothyroidism0low30
Hypoxemia0low40
Hypoxemic Acute Respiratory Failure0low20
Hypoxemic Respiratory Failure0low20
Hypoxia0low40
Iatrogenic Disease0low20
Icterus0low10
IDDM0low10
Idiopathic Acute Facial Neuropathy0low20
Idiopathic Fibrosing Alveolitis, Chronic Form0low10
Idiopathic Hydrops Fetalis0low10
Idiopathic Inflammatory Myopathies0low10
Idiopathic Inflammatory Myopathy0low10
Idiopathic Inflammatory Myositis0low10
Idiopathic Parkinson Disease0low30
Idiopathic Parkinson's Disease0low30
Idiopathic Pulmonary Fibrosis0low10
Idiopathic Pulmonary Fibrosis, Familial0low10
Idiopathic Ventricular Tachycardia0low10
Ileitis, Regional0low20
Ileitis, Terminal0low20
Ileocolitis0low20
Immune Diseases0low10
Immune Disorders0low10
Immune Hydrops Fetalis0low10
Immune System Diseases0low10
Immune System Disorders0low10
Immunologic Diseases0low10
Immunological Diseases0low10
Impairment, Light Touch Sensation0medium21
Impetigo0low10
Impetigo Contagiosa0low10
Incoordination0low20
Infant, Newborn, Diseases0medium11
Infant, Premature, Diseases0low40
Infarct0low20
Infarct of the Spleen0low10
Infarction0low20
Infarction, Cerebral0low10
Infarction, Cerebral, Left Hemisphere0low10
Infarction, Cerebral, Right Hemisphere0low10
Infarction, Left Hemisphere, Cerebral0low10
Infarction, Right Hemisphere, Cerebral0low10
Infection0low100
Infection and Infestation0low100
Infection, Bacterial0medium683
Infection, Central Nervous System, Protozoal0low10
Infection, Cross0medium18019
Infection, Dental Focal0low10
Infection, Mycobacterium avium-intracellulare0low50
Infection, Mycobacterium intracellulare0low50
Infection, Postoperative Wound0medium344
Infection, Surgical Wound0medium344
Infection, Wound0medium93
Infections0low100
Infections and Infestations0low100
Infections, Acinetobacter0low10
Infections, Actinobacillus0low10
Infections, Actinomyces0low10
Infections, Actinomycetales0low50
Infections, Actinomycete0low50
Infections, Atypical Mycobacterium0low240
Infections, Bacterial0medium683
Infections, Bacterial Eye0low70
Infections, Bacterial Ocular0low70
Infections, Bacterial, Central Nervous System0low30
Infections, Bacteroides0low20
Infections, Central Nervous System0medium41
Infections, Clostridium0medium193
Infections, Community-Acquired0medium574
Infections, Corynebacterium0low20
Infections, Dental Focal0low10
Infections, E coli0low30
Infections, Enterobacteriaceae0low10
Infections, Enterobacterial0low10
Infections, Enterovirus0low10
Infections, Erysipelothrix0low10
Infections, Escherichia coli0low30
Infections, Gram-Negative Bacterial0medium253
Infections, Gram-Positive Bacterial0medium43834
Infections, Haemophilus0low40
Infections, Hemophilus0low40
Infections, Hospital0medium18019
Infections, Klebsiella0low20
Infections, Listeria0low50
Infections, Meningococcal0low10
Infections, Mimae0low10
Infections, Mycobacterium0low80
Infections, Mycobacterium ulcerans0low20
Infections, Neisseriaceae0low30
Infections, Nocardia0medium321
Infections, Nosocomial0medium18019
Infections, Orthomyxoviridae0low10
Infections, Orthomyxovirus0low10
Infections, Pasteurella0low10
Infections, Pneumococcal0medium191
Infections, Prosthesis-Related0medium735
Infections, Protozoal, Central Nervous System0low10
Infections, Pseudomonas0low40
Infections, Respiratory0medium112
Infections, Respiratory Syncytial Virus0low10
Infections, Respiratory Tract0medium112
Infections, Salmonella0low20
Infections, Soft Tissue0medium7616
Infections, Staphylococcal0medium55627
Infections, Staphylococcal Skin0medium4210
Infections, Streptococcal0medium351
Infections, Streptococcus pneumoniae0medium191
Infections, Trichomonas0low10
Infections, Upper Respiratory0medium112
Infections, Upper Respiratory Tract0medium112
Infectious Arthritis0medium211
Infectious Diseases0low20
Infectious Diseases, Emerging0low20
Infectious Diseases, Re-Emerging0low20
Infectious Diseases, Reemerging0low20
Infectious Endophthalmitis0medium91
Infectious Myositis0low10
Infectious Pregnancy Complications0low30
Infectious Skin Diseases0medium174
Infectious Ventriculitis0low10
Infective Endocarditis0low40
Inflammation0medium121
Inflammation, Brain0medium71
Inflammatory Bowel Disease 10low20
Inflammatory Facial Neuropathy, Acute0low20
Inflammatory Muscle Diseases0low10
Inflammatory Myopathies, Idiopathic0low10
Inflammatory Myopathy0low10
Inflammatory Myopathy, Idiopathic0low10
Inflammatory Response Syndrome, Systemic0low20
Influenza0low20
Influenza in Humans0low20
Influenza, Human0low20
Inherited Spinocerebellar Degenerations0medium31
Injuries0medium61
Injuries and Wounds0medium61
Injuries, Blunt0low10
Injuries, Facial0low10
Injuries, Finger0low10
Injuries, Knee0low10
Injuries, Leg0low10
Injuries, Multiple0low20
Injuries, Nonpenetrating0low10
Injuries, Radiation0low10
Injuries, Spinal Cord0medium31
Injuries, Surgical0low10
Injuries, Wounds0medium61
Injury, Brain, Traumatic0low30
Innate Inflammatory Response0medium121
Insulin Resistance0low20
Insulin Resistance Syndrome X0low20
Insulin Sensitivity0low20
Insulin-Dependent Diabetes Mellitus 10low10
Intention Tremor0low20
Intermittent Tremor0low20
Internal Carotid Artery Diseases0low10
Interstitial Nephritis0low30
Interstitial Pneumonitis, Usual0low10
Intertrochanteric Fractures0low10
Intervertebral Disc Displacement0low10
Intervertebral Disk Displacement0low10
Intestinal Cancer0low10
Intestinal Neoplasms0low10
Intestines Cancer0low10
Intestines Neoplasms0low10
Intracranial Central Nervous System Disorders0medium51
Intracranial CNS Disorders0medium51
Intracranial Embolism0low20
Intracranial Extradural Abscess0medium51
Intracranial Meningeal Neoplasms0low10
Intracranial Meningioma0low20
Intracranial Neoplasms0low20
Intrahepatic Cholestasis0low10
Intraocular Pressure0low10
Intraoperative Complications0low10
Intraorbital Meningioma0low20
Intravascular Hemolysis0low10
Intravenous Drug Abuse0low10
Intraventricular Meningioma0low20
Invasiveness, Neoplasm0low10
Involuntary Quiver0low20
Iodamoebiasis0low10
Irregular Menses0medium22
Irregular Menstruation0medium22
Ischemia0low30
Ischemia, Cerebral0low20
Ischemia, Myocardial0low20
Ischemic Attack, Transient0low10
Ischemic Encephalopathy0low20
Ischemic Heart Disease0low20
Itching0low30
Jacksonian Seizure0low40
Jaundice0low10
Jaundice, Hemolytic0low10
Jerk Nystagmus0low10
Job Syndrome0low10
Job-Buckley Syndrome0low10
Job's Syndrome0low10
Joint Diseases0low50
Juvenile Absence Epilepsy0low10
Juvenile-Onset Diabetes0low10
Kahler Disease0low10
Keratitis0low10
Keratitis, Ulcerative0low20
Keskushermoston sairaudet@fi0low40
Kidney Cancer0low30
Kidney Diseases0medium104
Kidney Failure0low180
Kidney Failure, Acute0medium91
Kidney Failure, Chronic0medium195
Kidney Insufficiency0low180
Kidney Insufficiency, Acute0medium91
Kidney Neoplasms0low30
Kidney Scarring0low10
Klebsiella Infections0low20
Knee Injuries0low10
Koch's Disease0medium472
Kochs Disease0medium472
Lack of Coordination0low20
Lactic Acidosis0low250
Laryngeal Cancer0low10
Laryngeal Neoplasms0low10
Larynx Cancer0low10
Larynx Neoplasms0low10
Late Onset Alzheimer Disease0low10
Late Onset Cerebellar Ataxia0medium31
Latent Tuberculosis0low20
Latent Tuberculosis Infection0low20
LDL Receptor Disorder0medium52
Left Heart Hypoplasia Syndrome0low10
Left Heart Syndrome, Hypoplastic0low10
Left Hemisphere, Cerebral Infarction0low10
Left Hemisphere, Infarction, Cerebral0low10
Left Main Coronary Artery Disease0low30
Left Main Coronary Disease0low30
Left Main Disease0low30
Left Ventricular Apical Ballooning Syndrome0low10
Left-Sided Heart Failure0low10
Leg Injuries0low10
Leg Ulcer0low20
Leiomyoma0low10
Leiomyoma, Uterine0low10
Lemierre Disease0low10
Lemierre Syndrome0low10
Lemierre's Disease0low10
Lemierre's Syndrome0low10
Leprosy0low10
Leptomeningeal Neoplasms0low10
Leucocythaemia0low20
Leucocythemia0low20
Leukemia0low20
Leukemia L 12100low10
Leukemia L12100low10
Leukemia Model, Animal0low20
Leukemia, Acute Lymphoblastic0low30
Leukemia, Acute Myelogenous0low80
Leukemia, Acute Myeloid0low80
Leukemia, B Cell, Chronic0low30
Leukemia, B-Cell, Chronic0low30
Leukemia, Chronic Lymphatic0low30
Leukemia, Chronic Lymphocytic0low30
Leukemia, Chronic Lymphocytic, B-Cell0low30
Leukemia, Chronic Myelogenous0low10
Leukemia, Chronic Myeloid0low10
Leukemia, Experimental0low20
Leukemia, Granulocytic0low10
Leukemia, Granulocytic, Chronic0low10
Leukemia, Lymphoblastic0low30
Leukemia, Lymphoblastic, Acute0low30
Leukemia, Lymphoblastic, Acute, L10low30
Leukemia, Lymphoblastic, Acute, L20low30
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive0low30
Leukemia, Lymphoblastic, Chronic0low30
Leukemia, Lymphocytic, Acute0low30
Leukemia, Lymphocytic, Acute, L10low30
Leukemia, Lymphocytic, Acute, L20low30
Leukemia, Lymphocytic, Chronic0low30
Leukemia, Lymphocytic, Chronic, B Cell0low30
Leukemia, Lymphocytic, Chronic, B-Cell0low30
Leukemia, Lymphoid, Acute0low30
Leukemia, Monocytic, Chronic0low10
Leukemia, Myeloblastic, Acute0low80
Leukemia, Myelocytic0low10
Leukemia, Myelocytic, Acute0low80
Leukemia, Myelocytic, Chronic0low10
Leukemia, Myelogenous0low10
Leukemia, Myelogenous, Acute0low80
Leukemia, Myelogenous, Chronic0low10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive0low10
Leukemia, Myelogenous, Ph1 Positive0low10
Leukemia, Myelogenous, Ph1-Positive0low10
Leukemia, Myeloid0low10
Leukemia, Myeloid, Acute0low80
Leukemia, Myeloid, Acute, M10low80
Leukemia, Myeloid, Acute, M20low80
Leukemia, Myeloid, Chronic0low10
Leukemia, Myeloid, Ph1 Positive0low10
Leukemia, Myeloid, Ph1-Positive0low10
Leukemia, Myeloid, Philadelphia Positive0low10
Leukemia, Myeloid, Philadelphia-Positive0low10
Leukemia, Nonlymphoblastic, Acute0low80
Leukemia, Nonlymphocytic, Acute0low80
Leukemia, Pre-B-Cell0low10
Leukemias, Experimental0low20
Leukocytopenia0low20
Leukopenia0low20
Lewy Body Parkinson Disease0low30
Lewy Body Parkinson's Disease0low30
Libman-Sacks Disease0low10
Lichtheim's Sign0low10
Light Sensitivity0medium22
Light Touch Sensation Impairment0medium21
Light-Headedness0medium54
Lightheadedness0medium54
Lip Diseases0low20
Lipemia0medium72
Lipid Metabolism, Inborn Error0low30
Lipid Metabolism, Inborn Errors0low30
Lipidemia0medium72
Listeria Cerebritis0low30
Listeria Infections0low50
Listeria Meningoencephalitis0low30
Listeria monocytogenes Meningitis0low30
Listeriosis0low50
Liver Abscess0low30
Liver Cancer0low50
Liver Cancer, Adult0low20
Liver Cell Carcinoma0low20
Liver Cell Carcinoma, Adult0low20
Liver Cirrhoses, Experimental0low20
Liver Cirrhosis0low40
Liver Cirrhosis, Experimental0low20
Liver Diseases0medium103
Liver Dysfunction0medium103
Liver Failure0low20
Liver Fibrosis0low40
Liver Injury, Drug-Induced0low70
Liver Injury, Drug-Induced, Acute0low70
Liver Neoplasms0low50
Liver Neoplasms, Experimental0low20
Liver Steatosis0low10
Livor Mortis0low10
Lobar Pneumonia0medium193
Loeffler Syndrome0low10
Logagnosia0low10
Logamnesia0low10
Logasthenia0low10
Long QT Syndrome0medium32
Loudness Perception Disturbances0medium22
Loudness Recruitment0medium22
Low Back Ache0medium31
Low Back Pain0medium31
Low Back Pain, Mechanical0medium31
Low Back Pain, Posterior Compartment0medium31
Low Back Pain, Postural0medium31
Low Back Pain, Recurrent0medium31
Low Backache0medium31
Lower Back Pain0medium31
Lower Extremity Paresis0low10
Lumbago0medium31
Lung Abscess0low40
Lung Aspergillosis0low10
Lung Cancer0low10
Lung Diseases0low30
Lung Diseases, Fungal0low10
Lung Diseases, Obstructive0low10
Lung Inflammation0medium193
Lung Neoplasms0low10
Lupus Erythematosus Disseminatus0low10
Lupus Erythematosus, Systemic0low10
Lupus Glomerulonephritis0low10
Lupus Nephritis0low10
Lymphadenitis0low10
Lymphatic Diseases0low10
Lymphatism0low10
Lymphedema0low10
Lymphedema, Early-Onset0low10
Lymphedema, Hereditary, Ia0low10
Lymphoblastic Leukemia0low30
Lymphoblastic Leukemia, Acute0low30
Lymphoblastic Leukemia, Acute, Adult0low30
Lymphoblastic Leukemia, Acute, Childhood0low30
Lymphoblastic Leukemia, Acute, L10low30
Lymphoblastic Leukemia, Acute, L20low30
Lymphoblastic Leukemia, Chronic0low30
Lymphoblastic Lymphoma0low30
Lymphocyte Depletion Hodgkin's Lymphoma0low10
Lymphocyte-Rich Classical Hodgkin's Lymphoma0low10
Lymphocytic Leukemia, Acute0low30
Lymphocytic Leukemia, Chronic0low30
Lymphocytic Leukemia, Chronic, B Cell0low30
Lymphocytic Leukemia, Chronic, B-Cell0low30
Lymphocytic Leukemia, L10low30
Lymphocytic Leukemia, L20low30
Lymphocytic Lymphoma0low30
Lymphocytic Lymphoma, Diffuse, Well Differentiated0low30
Lymphocytic Lymphoma, Diffuse, Well-Differentiated0low30
Lymphocytic Lymphoma, Well Differentiated0low30
Lymphocytic Lymphoma, Well-Differentiated0low30
Lymphogranuloma, Malignant0low10
Lymphoma0low10
Lymphoma, B-Cell0low10
Lymphoma, Lymphoblastic0low30
Lymphoma, Lymphocytic0low30
Lymphoma, Lymphocytic, Diffuse, Well Differentiated0low30
Lymphoma, Lymphocytic, Diffuse, Well-Differentiated0low30
Lymphoma, Lymphocytic, Well Differentiated0low30
Lymphoma, Lymphocytic, Well-Differentiated0low30
Lymphoma, Lymphoplasmacytoid, CLL0low30
Lymphoma, Malignant0low10
Lymphoma, Small Lymphocytic0low30
Lymphoma, Small Lymphocytic, Plasmacytoid0low30
Lymphoma, Small-Cell0low30
Lymphoma, T Cell, Cutaneous0low10
Lymphoma, T-Cell, Cutaneous0low10
Lymphoplasmacytoid Lymphoma, CLL0low30
Macropsia0low30
Maculopapular Drug Eruption0low40
Maculopapular Exanthem0low40
Madura Foot0low50
Maduromycosis0low50
Major Depressive Disorder0low20
Major Motor Seizure Disorder0low10
Maladie du systu00E8me nerveux central@fr0low40
Malattie del sistema nervoso centrale@it0low40
Male Genitourinary Diseases0medium11
Male Urogenital Diseases0medium11
Malignancies, Hematologic0low40
Malignancy0medium121
Malignancy, Hematologic0low40
Malignant Cerebellar Neoplasms0low10
Malignant Meningeal Neoplasms0low10
Malignant Meningioma0low20
Malignant Neoplasm of Breast0low20
Malignant Neoplasms0medium121
Malignant Neoplasms, Brain0low20
Malignant Primary Brain Neoplasms0low20
Malignant Primary Brain Tumors0low20
Malignant Tumor of Breast0low20
Malignant Tumor of Urinary Bladder0low10
Malnourishment0low10
Malnutrition0low10
Mammary Cancer0low20
Mammary Carcinoma, Human0low20
Mammary Neoplasm, Human0low20
Mammary Neoplasms, Human0low20
Mandibular Diseases0low20
Marie Cerebellar Ataxia0medium31
Marie's Cerebellar Ataxia0medium31
Marinesco-Garland Syndrome0medium31
Marinesco-Sjogren Syndrome0medium31
Marinesco-Sjogren Syndrome-Hypergonadotrophic Hypogonadism0medium31
Marinesco-Sjogren Syndrome-Myopathy0medium31
Marinesco-Sjogren-Garland Syndrome0medium31
Marinesco-Sju00F6gren Syndrome0medium31
Massive Tremor0low20
Mastitis, Bovine0low10
Maternal Sepsis0low30
Maturity-Onset Diabetes0medium81
Maturity-Onset Diabetes Mellitus0medium81
Mechanical Allodynia0low10
Mechanical Hyperalgesia0low10
Mechanical Low Back Pain0medium31
Mechanical Strabismus0low10
Mediastinitis0low60
Mediastinum Inflammation0low60
Medication-Induced Dyskinesia0low10
Melancholia0medium72
Melancholia, Involutional0low20
MELAS0low10
MELAS Syndrome0low10
Memory Deficits0low10
Memory Disorder, Semantic0low10
Memory Disorder, Spatial0low10
Memory Disorders0low10
Memory Disorders, Age-Related0low10
Memory Loss0low10
Mendelson Syndrome0low10
Mendelson's Syndrome0low10
Meningeal Cancer0low10
Meningeal Neoplasms0low10
Meningeal Neoplasms, Benign0low10
Meningeal Neoplasms, Intracranial0low10
Meningeal Neoplasms, Malignant0low10
Meningeal Tumors0low10
Meningioma0low20
Meningiomas, Multiple0low20
Meningiomatosis0low20
Meningitides, Bacterial0medium361
Meningitis0low30
Meningitis, Bacterial0medium361
Meningitis, Listeria0low30
Meningitis, Pneumococcal0low60
Meningitis, Pneumococcal, Experimental0low60
Meningitis, Pneumococcal, Penicillin-Resistant0low60
Meningitis, Pneumococcal, Recurrent0low60
Meningitis, Streptococcus pneumoniae0low60
Meningitis, Tuberculous0low50
Meningococcal Disease0low10
Meningococcal Infections0low10
Meningoencephalitis0low30
Meningoencephalitis, Listeria0low30
Meningoencephalitis, Protozoal0low10
Meningotheliomatous Meningioma0low20
Menstrual Irregularities0medium22
Menstrual Irregularity0medium22
Menstruation Disorders0medium22
Menstruation Disturbances0medium22
Menstruation, Painful0medium11
Menstruation, Retrograde0medium22
Mental Deterioration0low10
Mental Disorders0low20
Mental Disorders, Severe0low20
Mental Illness0low20
Metabolic Cardiovascular Syndrome0low20
Metabolic Syndrome0low20
Metabolic Syndrome X0low20
Metabolic X Syndrome0low20
Metamorphopsia0low30
Metastase0low10
Metastases, Neoplasm0low10
Metastasis0low10
Metastasis, Neoplasm0low10
Microangiopathic Hemolytic Anemia0low10
Microangiopathy, Diabetic0low10
Microbial Superinvasion0low10
Microcystic Meningioma0low20
Microglossia0low30
Micropsia0low30
Middle Ear Effusion0low10
Middle Ear Inflammation0medium41
Migraine0medium24572
Migraine Aura without Headache0medium75
Migraine Disorders0medium24572
Migraine Headache0medium24572
Migraine Variant0medium24572
Migraine with Acute Onset Aura0medium75
Migraine with Aura0medium75
Migraine with Prolonged Aura0medium75
Migraine with Typical Aura0medium75
Migraine without Aura0medium75
Migraine, Classic0medium75
Migraine, Common0medium75
Migraine, Prolonged Aura0medium75
Mild Cognitive Impairment0low10
Mild Neurocognitive Disorder0low10
Milroy Disease0low10
Milroy's Disease0low10
Mimae Infections0low10
Minimal Brain Dysfunction0low30
Mitochondrial Diseases0low30
Mitochondrial Disorders0low30
Mitochondrial Electron Transport Chain Deficiencies0low30
Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes0low10
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes0low10
Mitochondrial Myopathy, Lactic Acidosis, Stroke-Like Episode0low10
Mitochondrial Respiratory Chain Deficiencies0low30
Mitral Incompetence0low10
Mitral Insufficiency0low10
Mitral Regurgitation0low10
Mitral Valve Incompetence0low10
Mitral Valve Insufficiency0low10
Mitral Valve Regurgitation0low10
Mixed Cellularity Hodgkin's Lymphoma0low10
Mixed Infection0low100
Mixed Oligodendroglioma-Astrocytoma0low10
Mixed Oligodendroglioma-Ependymoma0low10
MODS0low40
MODY0medium81
Moniliasis0low20
Monocytic Leukemia, Chronic0low10
Mononeuritis0low10
Mononeuritis Multiplex0low10
Mononeuropathies0low10
Mononeuropathy Multiplex0low10
Mononeuropathy Multiplex Syndrome0low10
Mononeuropathy, Diabetic0medium22
Monoparesis0low10
Moral Injury0low10
Moraxella Infections0low20
Moraxellaceae Infections0low20
Morbid Obesity0low60
Morbilliform Drug Reaction0low40
Morbilliform Exanthem0low40
Mucositis0low10
Mucoviscidosis0medium213
Multidirectional Nystagmus0low10
Multiple Injuries0low20
Multiple Myeloma0low10
Multiple Organ Dysfunction Syndrome0low40
Multiple Organ Failure0low40
Multiple Trauma0low20
Muscle Contraction0low20
Muscle Diseases, Inflammatory0low10
Muscle Disorders0medium31
Muscle Paresis0low10
Muscle Relaxation0low10
Muscle Rigidity0low30
Muscle Spasm0medium31
Muscle Spasticity0medium11
Muscle Weakness0low10
Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis0low20
Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis0low20
Muscular Atrophy0low10
Muscular Diseases0medium31
Muscular Dystrophies0low10
Muscular Dystrophy0low10
Muscular Paresis0low10
Muscular Spasm0medium31
Muscular Weakness0low10
Musculoskeletal Diseases0low20
MuSK MG0low20
MuSK Myasthenia Gravis0low20
Myasthenia Gravis0low20
Myasthenia Gravis, Generalized0low20
Myasthenia Gravis, Ocular0low20
Mycetoma0low50
Mycobacterium abscessus Infection0low240
Mycobacterium avium intracellulare Infection0low50
Mycobacterium avium-intracellulare Infection0low50
Mycobacterium Infections0low80
Mycobacterium Infections, Atypical0low240
Mycobacterium Infections, Nontuberculous0low240
Mycobacterium intracellulare Infection0low50
Mycobacterium tuberculosis Infection0medium472
Mycobacterium ulcerans Infection0low20
Mycoses0low10
Mydriasis0low10
Myeloblastic Leukemia, Acute0low80
Myelocytic Leukemia0low10
Myelocytic Leukemia, Acute0low80
Myelocytic Leukemia, Chronic0low10
Myelogenous Leukemia0low10
Myelogenous Leukemia, Acute0low80
Myelogenous Leukemia, Chronic0low10
Myelogenous Leukemia, Ph1-Positive0low10
Myeloid Leukemia0low10
Myeloid Leukemia, Acute0low80
Myeloid Leukemia, Acute, M10low80
Myeloid Leukemia, Acute, M20low80
Myeloid Leukemia, Chronic0low10
Myeloid Leukemia, Ph1-Positive0low10
Myeloid Leukemia, Philadelphia-Positive0low10
Myeloma-Multiple0low10
Myeloma, Multiple0low10
Myeloma, Plasma-Cell0low10
Myelomatosis0low10
Myelopathy, Traumatic0medium31
Myocardial Failure0low10
Myocardial Infarct0medium101
Myocardial Infarction0medium101
Myocardial Infarction, Anterior Wall0low10
Myocardial Ischemia0low20
Myocardial Preinfarction Syndrome0low10
Myoclonic Seizure0low40
Myoclonic Seizures0low40
Myodystrophica0low10
Myodystrophy0low10
Myopathic Conditions0medium31
Myopathies0medium31
Myopathies, Idiopathic Inflammatory0low10
Myopathy, Inflammatory0low10
Myopathy, Mitochondrial-Encephalopathy-Lactic Acidosis-Stroke0low10
Myopia0low20
Myositis0low10
Myositis, Focal0low10
Myositis, Infectious0low10
Myositis, Proliferative0low10
Naegleria fowleri Infection0low10
Naegleria fowleri Meningoencephalitis0low10
Nagana0low30
Nail Fungus0low10
Nausea0medium116
Nearsightedness0low20
Neck Ache0low10
Neck Pain0low10
Neckache0low10
Necrosis0medium111
Necrotizing Pancreatitis, Acute0low30
Necrotizing Pyelonephritis0low10
Neisseria gonorrhoeae Infection0medium136
Neisseriaceae Infections0low30
nemoci centru00E1lnu00EDho nervovu00E9ho systu00E9mu@cs0low40
Neointima0low30
Neointima Formation0low30
Neonatal Diseases0medium11
Neonatal Early-Onset Sepsis0low10
Neonatal Late-Onset Sepsis0low10
Neonatal Sepsis0low10
Neoplasia0medium121
Neoplasm0medium121
Neoplasm Invasion0low10
Neoplasm Invasiveness0low10
Neoplasm Metastases0low10
Neoplasm Metastasis0low10
Neoplasms0medium121
Neoplasms, Adrenal Gland0low10
Neoplasms, Benign0medium121
Neoplasms, Bladder0low10
Neoplasms, Bone0low10
Neoplasms, Brain0low20
Neoplasms, Brain, Benign0low20
Neoplasms, Brain, Malignant0low20
Neoplasms, Brain, Primary0low20
Neoplasms, Breast0low20
Neoplasms, Cerebellar0low10
Neoplasms, Cerebellar, Benign0low10
Neoplasms, Cerebellar, Malignant0low10
Neoplasms, Cerebellar, Primary0low10
Neoplasms, Colonic0low10
Neoplasms, Experimental0low20
Neoplasms, Experimental Liver0low20
Neoplasms, Gastric0low10
Neoplasms, Hematologic0low40
Neoplasms, Hematopoietic0low40
Neoplasms, Hepatic0low50
Neoplasms, Intestinal0low10
Neoplasms, Intracranial0low20
Neoplasms, Kidney0low30
Neoplasms, Laryngeal0low10
Neoplasms, Leptomeningeal0low10
Neoplasms, Liver0low50
Neoplasms, Lung0low10
Neoplasms, Meningeal0low10
Neoplasms, Prostate0low10
Neoplasms, Prostatic0low10
Neoplasms, Pulmonary0low10
Neoplasms, Stomach0low10
Neoplasms, Uterine0low10
Neoplasms, Uterus0low10
Neovascularization, Pathologic0low10
Neovascularization, Pathological0low10
Nephritis, Interstitial0low30
Nephritis, Lupus0low10
Nephritis, Tubulointerstitial0low30
Nephroid Carcinoma0low10
Nephrotic Syndrome0low10
Nerve Pain0low20
Nervous System Diseases0low50
Nervous System Disorders0low50
Nervous System Disorders, Ethanol-Induced0low10
Nervous System Poisoning0low50
Neural-Optical Lesion0low250
Neuralgia0low20
Neuralgia, Atypical0low20
Neuralgia, Diabetic0medium22
Neuralgia, Iliohypogastric Nerve0low20
Neuralgia, Ilioinguinal0low20
Neuralgia, Perineal0low20
Neuralgia, Sciatic0low10
Neuralgia, Stump0low20
Neuralgia, Supraorbital0low20
Neuralgia, Vidian0low20
Neuralgic Migraine0medium275
Neuroblastoma0low10
Neurodynia0low20
Neurogenic Inflammation0medium11
Neurogenic Muscular Atrophy0low10
Neurologic Disorders0low50
Neurological Disorders0low50
Neuropapillitis0low20
Neuropathic Pain0low20
Neuropathy of Tangier Disease0low10
Neuroses, Phobic0low10
Neuroses, Post-Traumatic0low10
Neuroses, Posttraumatic0low10
Neurosis, Depressive0medium72
Neurosis, Obsessive-Compulsive0medium11
Neurotoxic Disorders0low50
Neurotoxicity Syndromes0low50
Neurotoxin Diseases0low50
Neurotoxin Disorders0low50
Neurotrophic Muscular Atrophy0low10
Neutropenia0medium232
NIDDM0medium81
Nocardia asteroides Infection0medium321
Nocardia Infections0medium321
Nocardiosis0medium321
Nocturnal Teeth Grinding Disorder0low10
Nodular Lymphocyte-Predominant Hodgkin's Lymphoma0low10
Nodular Sclerosing Hodgkin's Lymphoma0low10
Non-Concomitant Strabismus0low10
Non-Convulsive Status Epilepticus0low10
Non-Epileptic Seizure0low40
Non-Epileptic Seizures0low40
Non-Fatigable Positional Nystagmus0low10
Non-Immune Hydrops Fetalis0low10
Nonconcomitant Strabismus0low10
Nonepileptic Seizure0low40
Nonepileptic Seizures0low40
Noninsulin-Dependent Diabetes Mellitus0medium81
Nonlymphoblastic Leukemia, Acute0low80
Nonlymphocytic Leukemia, Acute0low80
Nonne-Milroy Disease0low10
Nonne-Milroy Lymphedema0low10
Nonne-Milroy-Meige Disease0low10
Nonpenetrating Injuries0low10
Nonsustained Ventricular Tachycardia0low10
Nosocomial Infections0medium18019
Nuchal Rigidity0low30
Nutritional Deficiency0low10
Nystagmus, Pathologic0low10
Obesity0medium114
Obesity, Morbid0low60
Obesity, Severe0low60
Obsessive-Compulsive Disorder0medium11
Obstructive Hydrocephalus0low50
Obstructive Lung Diseases0low10
Obstructive Pulmonary Diseases0low10
Ocular Headache0medium183
Ocular Infections, Bacterial0low70
Olfactory Groove Meningioma0low20
Oligodendroblastoma0low10
Oligodendroglioma0low10
Oligodendroglioma, Adult0low10
Oligodendroglioma, Childhood0low10
Oligodendroglioma, Well-Differentiated0low10
Onychomycosis0low10
Ophthalmia0medium91
Opportunistic Infections0low60
Opportunistic Infections, AIDS-Related0low20
Opportunistic Infections, HIV-Related0low20
Optic Disc Disorders0low250
Optic Disk Disorders0low250
Optic Nerve Diseases0low250
Optic Neuritis0low20
Optic Neuropathy0low250
Orbital Cellulitis0low10
Organ Dysfunction Syndrome, Multiple0low40
Organ Failure, Multiple0low40
Organic Mental Disorders, Substance-Induced0low30
Orthomyxoviridae Infections0low10
Orthomyxovirus Infections0low10
Orthopedic Disorders0low20
Orthostasis0medium54
Orthostatic Headache0medium183
Osteitis0low10
Osteoarthritis0low50
Osteoarthritis of Knee0low20
Osteoarthritis of the Knee0low20
Osteoarthritis, Knee0low20
Osteoarthrosis0low50
Osteoarthrosis Deformans0low50
Osteolysis0low10
Osteomyelitis0medium556
Osteoporosis0low10
Osteoporosis, Age-Related0low10
Osteoporosis, Involutional0low10
Osteoporosis, Post-Traumatic0low10
Osteoporosis, Senile0low10
Ostium Secundum Atrial Septal Defect0low10
Otitis Media0medium41
Otitis Media with Effusion0low10
Otitis Media, Secretory0low10
Otitis Media, Serous0low10
Oxidative Phosphorylation Deficiencies0low30
Oxyesthesia0low10
Oxygen Deficiency0low40
Pachymeningitis0low30
Pain0medium168
Pain Sensation Diminished0medium21
Pain, Burning0medium168
Pain, Crushing0medium168
Pain, Menstrual0medium11
Pain, Migratory0medium168
Pain, Post-operative0low10
Pain, Postoperative0low10
Pain, Radiating0medium168
Pain, Splitting0medium168
Pancreatic Cystic Fibrosis0medium213
Pancreatic Diseases0medium21
Pancreatic Necrosis0low30
Pancreatic Parenchyma with Edema0low30
Pancreatic Parenchymal Edema0low30
Pancreatitis0low30
Pancreatitis Necrotising0low30
Pancreatitis Necrotizing0low30
Pancreatitis, Acute0low30
Pancreatitis, Acute Edematous0low30
Pancreatitis, Acute Necrotizing0low30
Pancytopenia0low80
Panic Attacks0medium21
Panic Disorder0medium21
Papillary Meningioma0low20
Papillary Renal Cell Carcinoma0low10
Papilloma0low10
Papilloma, Squamous Cell0low10
Papillomatosis0low10
Parageusia0low10
Paralysis Agitans0low30
Paraparesis0low10
Paraparesis, Cerebral0low10
Paraparesis, Chronic Progressive0low10
Paraparesis, Hypotonic0low10
Paraparesis, Spinal0low10
Paraphrenia, Involutional0low20
Parasagittal Meningioma0low20
Paresis0low10
Paresthesia0medium11
Paresthesia, Distal0medium11
Paresthesia, Painful0medium11
Parkinson Disease0low30
Parkinson Disease, Idiopathic0low30
Parkinson's Disease0low30
Parkinson's Disease, Idiopathic0low30
Parkinson's Disease, Lewy Body0low30
Parotiditis0medium11
Parotitis0medium11
Paroxysmal Atrial Fibrillation0low10
Paroxysmal Hemicrania0low10
Paroxysmal Nerve Pain0low20
Paroxysmal Supraventricular Tachycardia0low10
Partial Complex Epilepsy, Cryptogenic0low10
Partial Complex Epilepsy, Symptomatic0low10
Partial Fetal Alcohol Syndrome0low10
Partial Seizure0low40
Partial Seizures0low40
Passive Hyperemia0low10
Passive Tremor0low20
Pasteurella Infections0low10
Pasteurellosis0low10
Pathologic Angiogenesis0low10
Pathologic Constriction0low10
Pathologic Neovascularization0low10
Pediatric Respiratory Distress Syndrome0low30
Pelvic Pain0low10
Pemphigus0low10
Pemphigus Foliaceus0low10
Pemphigus Vulgaris0low10
Pendular Nystagmus0low10
Peri-Implantitis0low10
Periapical Periodontitis0medium21
Pericardial Effusion0low10
Pericarditis0low10
Pericementitis0low10
Pericoronitis0low10
Periimplantitis0low10
Perinatal Subarachnoid Hemorrhage0low20
Periodic Alternating Nystagmus0low10
Periodontitis0low10
Periodontitis, Acute Nonsuppurative0medium21
Periodontitis, Apical0medium21
Periorbital Headache0medium183
Peripancreatic Fat Necrosis0low30
Peripheral Angiopathies0low30
Peripheral Nerve Diseases0low220
Peripheral Nervous System Disease0low220
Peripheral Nervous System Diseases0low220
Peripheral Nervous System Disorders0low220
Peripheral Neuropathies0low220
Peripheral Vascular Diseases0low30
Peritoneal Diseases0low20
Peritonitis0low160
Permanent Nystagmus0low10
Peroperative Complications0low10
Persistent Atrial Fibrillation0low10
Persistent Ostium Primum0low10
Persistent Postsurgical Pain0low10
Persistent Tremor0low20
Pes Anserine Bursitis0low10
Petechiae0low20
Petit Mal Convulsion0low40
Petit Mal Epilepsy0low10
Petit Mal Status0low10
Pharyngeal Diseases0medium11
Pharyngitis0medium21
Pharynx Diseases0medium11
Pheochromocytoma0low10
Pheochromocytoma, Extra-Adrenal0low10
Phlegmon0medium133
Phobia, School0low10
Phobias0low10
Phobic Disorders0low10
Phobic Neuroses0low10
Phonophobia0medium22
Phorias0low10
Photophobia0medium22
Pill Rolling Tremor0low20
Pinprick Sensation Diminished0medium21
Plant Poisoning0low10
Plantar Ulcer0medium21
Plaque, Atherosclerotic0low10
Plasma Cell Myeloma0low10
Pleural Effusion0low20
Pleuropericarditis0low10
Pneumococcal Diseases0medium191
Pneumococcal Infections0medium191
Pneumonia0medium193
Pneumonia, Aspiration0low10
Pneumonia, Bacterial0medium5610
Pneumonia, Eosinophilic0low10
Pneumonia, Lobar0medium193
Pneumonia, Pneumococcal0medium81
Pneumonia, Staphylococcal0medium816
Pneumonia, Ventilator-Associated0medium236
Pneumonitis0medium193
PNS (Peripheral Nervous System) Diseases0low220
PNS Diseases0low220
Poisoning0low20
Poisoning, Blood0medium505
Poisoning, Nervous System0low50
Poisoning, Plant0low10
Polyarthritis0medium31
Polycystic Ovarian Syndrome0low10
Polycystic Ovary Syndrome0low10
Polycystic Ovary Syndrome 10low10
Polymenorrhea0medium22
Polymicrobial Infection0low100
Polyneuropathies0low10
Polyneuropathy, Acquired0low10
Polyneuropathy, Critical Illness0low10
Polyneuropathy, Familial0low10
Polyneuropathy, Inherited0low10
Polyneuropathy, Motor0low10
Polyploid0low10
Polyploid Cell0low10
Polyploidy0low10
Polytrauma0low20
Polyuria0low10
Portal-Systemic Encephalopathy0low10
Portosystemic Encephalopathy0low10
Position Sense Disorders0medium21
Positional Vertigo0medium31
Post Traumatic Stress Disorder0low10
Post-operative Pain0low10
Post-operative Pain, Acute0low10
Post-operative Pain, Chronic0low10
Post-surgical Pain0low10
Post-Traumatic Hydrocephalus0low50
Post-Traumatic Myelopathy0medium31
Post-Traumatic Stress Disorders0low10
Postabsorptive Hypoglycemia0low20
Postanginal Sepsis0low10
Posterior Cervical Pain0low10
Posterior Choroidal Artery Infarction0low10
Posterior Circulation Transient Ischemic Attack0low10
Posterior Fossa Meningioma0low20
Posterior Neck Pain0low10
Posterior Optic Neuritis0low20
Postmortem Changes0low10
Postoperative Complications0medium303
Postoperative Pain0low10
Postoperative Pain, Acute0low10
Postoperative Pain, Chronic0low10
Postoperative Wound Infection0medium344
Postprandial Hypoglycemia0low20
Postsurgical Pain0low10
Posttraumatic Stress Disorders0low10
Postural Low Back Pain0medium31
Pott Disease0low20
Pott's Disease0low20
Pott's Paraplegia0low20
Poultry Diseases0low50
Pre B-ALL0low10
Pre-B ALL0low10
Pre-B-Cell Leukemia0low10
Pre-Eclampsia0low10
Pre-Symptomatic Diseases0low10
Precancerous Conditions0low30
Precordial Catch0medium21
Precordial Catch Syndrome0medium21
Precursor B-Cell Lymphoblastic Leukemia0low10
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma0low10
Precursor B-Cell Lymphoblastic Lymphoma0low10
Precursor Cell Lymphoblastic Leukemia-Lymphoma0low30
Predisposition, Genetic0low40
Preeclampsia0low10
Preeclampsia Eclampsia 10low10
Pregnancy0low90
Pregnancy Complications0low10
Pregnancy Complications, Infectious0low30
Pregnancy Toxemias0low10
Pregnancy, Infectious Complications0low30
Premature Birth0low20
Premenstrual Syndrome0medium21
Premenstrual Tension0medium21
Preneoplastic Condition0low30
Preneoplastic Conditions0low30
Prescription Drug Abuse0low30
Presenile Alzheimer Dementia0low10
Pressure Sore0low20
Pressure Ulcer0low20
Presymptomatic Diseases0low10
Preterm Birth0low20
Primary Amebic Meningoencephalitis0low10
Primary Brain Neoplasms0low20
Primary Congenital Lymphedema0low10
Primary Cutaneous Nocardiosis0medium321
Primary Hyperaldosteronism0low10
Primary Hypothyroidism0low30
Primary Malignant Brain Neoplasms0low20
Primary Malignant Brain Tumors0low20
Primary Neoplasms, Cerebellum0low10
Primary Parkinsonism0low30
Primary Peritonitis0low160
Primary Senile Degenerative Dementia0low10
Prinzmetal Angina0low10
Prinzmetal's Angina0low10
Prolapsed Disc0low10
Prolapsed Disk0low10
Proprioceptive Disorders0medium21
Prostate Cancer0low10
Prostate Neoplasms0low10
Prostatic Cancer0low10
Prostatic Neoplasms0low10
Prosthesis Related Infection0medium735
Prosthesis-Related Infection0medium735
Prosthesis-Related Infections0medium735
Proteinuria-Edema-Hypertension Gestosis0low10
Protozoal Infections, Central Nervous System0low10
Protozoal Infections, Cerebral0low10
Protozoal Meningoencephalitis0low10
Pruritis0low30
Pruritus0low30
Psammomatous Meningioma0low20
Pseudoakathisia0medium22
Pseudodementia0low10
Pseudomembranous Colitis0low70
Pseudomembranous Enteritis0low70
Pseudomembranous Enterocolitis0low70
Pseudomonas aeruginosa Infection0low40
Pseudomonas Infections0low40
Pseudopsychosis0low10
Psychiatric Diagnosis0low20
Psychiatric Diseases0low20
Psychiatric Disorders0low20
Psychiatric Illness0low20
Psychobacter Infections0low20
Psychoses, Drug0low20
Psychoses, Substance-Induced0low20
Psychoses, Toxic0low20
Psychosis, Involutional0low20
PTSD0low10
Pulmonary Abscess0low40
Pulmonary Abscesses0low40
Pulmonary Aspergillosis0low10
Pulmonary Cancer0low10
Pulmonary Consumption0medium398
Pulmonary Cystic Fibrosis0medium213
Pulmonary Disease0low30
Pulmonary Disease, Chronic Obstructive0low30
Pulmonary Diseases0low30
Pulmonary Edema0low10
Pulmonary Edemas0low10
Pulmonary Embolism0low40
Pulmonary Embolisms0low40
Pulmonary Eosinophilia0low10
Pulmonary Eosinophilias0low10
Pulmonary Fibrosis, Idiopathic0low10
Pulmonary Fungal Diseases0low10
Pulmonary Fungal Infections0low10
Pulmonary Inflammation0medium193
Pulmonary Neoplasms0low10
Pulmonary Nocardiosis0medium321
Pulmonary Phthisis0medium398
Pulmonary Thromboembolism0low40
Pulmonary Thromboembolisms0low40
Pulmonary Tuberculoses0medium398
Pulmonary Tuberculosis0medium398
Pure Red-Cell Aplasia0low30
Purpura0low20
Pus0low10
Pyaemia0medium505
Pyelonephritis0low10
Pyelonephritis, Acute Necrotizing0low10
Pyemia0medium505
Pykno-Epilepsy0low10
Pyknolepsy0low10
Pyoderma Gangrenosum0low10
Pyogenic Sacroiliitis0low10
Pyohemia0medium505
Pyothorax0low10
Pyrexia0medium91
Pythiosis0low10
Pythiosis Insidiosi0low10
Pythium insidiosum Infection0low10
Pyuria0low10
Q Fever0low10
Query Fever0low10
Radiation Injuries0low10
Radiation Sickness0low10
Radiation Syndrome0low10
Raeder Paratrigeminal Syndrome0low10
Rash0low30
Rasmussen Encephalitis0medium71
Rasmussen Syndrome0medium71
Rasmussen's Syndrome0medium71
Reactive Hyperemia0low10
Reactive Hypoglycemia0low20
Reaven Syndrome X0low20
Rebound Nystagmus0low10
Recrudescence0medium3414
Recruitment, Loudness0medium22
Rectal Diseases0medium11
Rectal Disorders0medium11
Recurrence0medium3414
Recurrent Low Back Pain0medium31
Red-Cell Aplasia, Pure0low30
Refractory Anemia0low10
Regional Enteritis0low20
Relapse0medium3414
Renal Cancer0low30
Renal Carcinoma0low10
Renal Cell Cancer0low10
Renal Cell Carcinoma0low10
Renal Cell Carcinoma, Papillary0low10
Renal Collecting Duct Carcinoma0low10
Renal Disease, End-Stage0medium195
Renal Failure0low180
Renal Failure, Acute0medium91
Renal Failure, Chronic0medium195
Renal Failure, End-Stage0medium195
Renal Insufficiency0low180
Renal Insufficiency, Acute0medium91
Renal Neoplasms0low30
Research-Related Injuries0medium61
Respiratory Chain Deficiencies, Mitochondrial0low30
Respiratory Depression0low20
Respiratory Distress Syndrome0low30
Respiratory Distress Syndrome, Acute0low30
Respiratory Distress Syndrome, Adult0low30
Respiratory Distress Syndrome, Pediatric0low30
Respiratory Failure0low20
Respiratory Infections0medium112
Respiratory Insufficiency0low20
Respiratory Syncytial Virus Infection0low10
Respiratory Syncytial Virus Infections0low10
Respiratory Tract Infections0medium112
Rest Tremor0low20
Resting Tremor0low20
Retained Surgical Instruments0low40
Retained Surgical Items0low40
Retained Surgical Needle0low40
Retained Surgical Sponge0low40
Retained Surgical Tools0low40
Retention Disorders, Cognitive0low10
Reticulolymphosarcoma0low10
Retinal Diseases0low20
Retraction Nystagmus0low10
Retro-Ocular Headache0medium183
Retrobulbar Neuritis0low20
Retropharyngeal Abscess0low10
Rhabdomyolysis0medium11
Rheumatic Diseases0low10
Rheumatism0low10
Rheumatoid Arthritis0low20
Right Hemisphere, Cerebral Infarction0low10
Right Hemisphere, Infarction, Cerebral0low10
Right-Sided Heart Failure0low10
Rigidity, Decerebrate0low30
Rigidity, Decorticate0low30
Rigidity, Muscular0low30
Ritter Disease0low10
Ritter's Disease0low10
Rotary Nystagmus0low10
Rotational Nystagmus0low10
Runt Disease0low10
Sacroiliitis0low10
SAH (Subarachnoid Hemorrhage)0low20
Salmonella Infections0low20
Salmonella Infections, Animal0low20
Salmonellosis0low20
San Joaquin Valley Fever0low20
Sappinia diploidea Meningoencephalitis0low10
Sarcoidosis0low10
Sarcoma, Ewing0low10
Sarcoma, Ewing's0low10
Sarcoma, Germinoblastic0low10
Sarcomatoid Renal Cell Carcinoma0low10
SARS Coronavirus 2 Infection0low10
SARS-CoV-2 Infection0low10
Saturnine Tremor0low20
Scalded Skin Syndrome, Staphylococcal0low10
Schaumann Disease0low10
Schaumann Syndrome0low10
Schaumann's Syndrome0low10
Schizophrenia0medium31
Schizophrenic Disorders0medium31
Sciatic Neuralgia0low10
Sciatica0low10
Sciatica, Bilateral0low10
Sclerocystic Ovarian Degeneration0low10
Sclerocystic Ovaries0low10
Sclerocystic Ovary Syndrome0low10
Second Cranial Nerve Diseases0low250
Secondary Hypothyroidism0low30
Secondary Infection0low100
Secondary Infections0low100
Secondary Peritonitis0low160
Secondary Trigeminal Neuralgia0low20
Secretory Meningioma0low20
See-Saw Nystagmus0low10
Seizure0low40
Seizure Disorder0medium81
Seizure Disorder, Absence0low10
Seizure Disorder, Complex Partial0low10
Seizure Disorder, Grand Mal0low10
Seizure Disorder, Major Motor0low10
Seizure Disorder, Tonic Clonic0low10
Seizures0low40
Seizures, Auditory0low40
Seizures, Clonic0low40
Seizures, Convulsive0low40
Seizures, Epileptic0low40
Seizures, Focal0low40
Seizures, Generalized0low40
Seizures, Gustatory0low40
Seizures, Motor0low40
Seizures, Olfactory0low40
Seizures, Sensory0low40
Seizures, Somatosensory0low40
Seizures, Tonic0low40
Seizures, Tonic-Clonic0low40
Seizures, Vertiginous0low40
Seizures, Vestibular0low40
Seizures, Visual0low40
Semantic Memory Disorder0low10
Semiconsciousness0low10
Senile Dementia, Acute Confusional0low10
Senile Dementia, Alzheimer Type0low10
Senile Osteoporosis0low10
Senile Paranoid Dementia0low10
Senile Tremor0low20
Sensation Disorders0low10
Sensitivity and Specificity0medium551
Sensitivity, Contact0low10
Sensory Disorders0low10
Sepsis0medium505
Sepsis during Pregnancy0low30
Sepsis in Pregnancy0low30
Sepsis Syndrome0low20
Sepsis, Neonatal0low10
Septic Sacroiliitis0low10
Septic Shock0low90
Septicemia0medium505
Serotonin Syndrome0low380
Severe Sepsis0medium505
Sexually Transmitted Diseases0medium11
Sexually Transmitted Infections0medium11
Sharp Headache0medium183
Shingles0low10
Shock Lung0low30
Shock, Endotoxic0low90
Shock, Septic0low90
Shock, Toxic0low90
Short Bowel Syndrome0low10
Shortness of Breath0low10
Shoulder Adhesive Capsulitis0low10
Shoulder Pain0low10
Sick Headache0medium24572
Sickle Cell Anemia0low10
Sickle Cell Disease0low10
Sickle Cell Disorders0low10
Sickling Disorder Due to Hemoglobin S0low10
Side Effects of Drugs0medium174
Simple Partial Status Epilepticus0low10
Simple Pulmonary Eosinophilia0low10
Single Seizure0low40
Sinus Infections0low20
Sinusitis0low20
Skin and Subcutaneous Tissue Disorders0medium52
Skin Diseases0medium52
Skin Diseases, Bacterial0medium6522
Skin Diseases, Fungal0low10
Skin Diseases, Infectious0medium174
Skin Diseases, Staphylococcal0medium4210
Skin Fistula0low10
Skin Infections, Staphylococcal0medium4210
Skin Rash0low30
Skin Ulcer0low20
Sleep Bruxism0low10
Sleep Bruxism, Adult0low10
Sleep Bruxism, Childhood0low10
Sleep-Related Bruxism0low10
Slipped Disc0low10
Slipped Disk0low10
Small-Cell Lymphoma0low30
Soft Tissue Infections0medium7616
Somatic Sensation Disorders0medium21
Somatosensory Disorders0medium21
Sore Throat0medium21
Spasm0medium31
Spasm, Ciliary Body0medium31
Spasm, Generalized0medium31
Spasm, Hemifacial0low20
Spastic0medium11
Spatial Memory Disorder0low10
Special Senses Disorders0low10
Sphenoid Wing Meningioma0low20
Spinal Cord Contusion0medium31
Spinal Cord Injuries0medium31
Spinal Cord Laceration0medium31
Spinal Cord Transection0medium31
Spinal Cord Trauma0medium31
Spinal Diseases0low30
Spinal Extradural Abscess0medium51
Spinal Meningeal Neoplasms0low10
Spinal Meningioma0low20
Spinal Stenosis0low10
Spinning Sensation0medium31
Spino Cerebellar Degenerations0medium31
Spino-Cerebellar Degenerations0medium31
Spinocerebellar Degeneration0medium31
Spinocerebellar Degenerations0medium31
Spinocerebellar Diseases0medium31
Splenic Diseases0low10
Splenic Infarct0low10
Splenic Infarction0low10
Splenic Infarcts0low10
Spondylodiscitis0low40
Spondylodiskitis0low40
Spontaneous Ocular Nystagmus0low10
Sprains0low20
Sprains and Strains0low20
Squint0low10
SREDIu0160NJI u017DIVu010CANI SUSTAV, BOLESTI@hr0low40
Staphylococcal Diseases, Skin0medium4210
Staphylococcal Infections0medium55627
Staphylococcal Infections, Skin0medium4210
Staphylococcal Pneumonia0medium816
Staphylococcal Scalded Skin Syndrome0low10
Staphylococcal Scalded-Skin Syndrome0low10
Staphylococcal Skin Diseases0medium4210
Staphylococcal Skin Infections0medium4210
Staphylococcus aureus Infection0medium55627
Staphylococcus Aureus Pneumonia0medium816
Static Tremor0low20
Status Epilepticus0low10
Status Epilepticus, Complex Partial0low10
Status Epilepticus, Electrographic0low10
Status Epilepticus, Generalized0low10
Status Epilepticus, Generalized Convulsive0low10
Status Epilepticus, Grand Mal0low10
Status Epilepticus, Non-Convulsive0low10
Status Epilepticus, Simple Partial0low10
Status Epilepticus, Subclinical0low10
Status Lymphaticus0low10
Status Migrainosus0medium24572
STDs0medium11
Steatohepatitis0low10
Steatosis of Liver0low10
Stein-Leventhal Syndrome0low10
Stenosis0low10
Still Disease, Adult-Onset0low10
Still's Disease, Adult-Onset0low10
STIs0medium11
Stomach Cancer0low10
Stomach Neoplasms0low10
Strabismus0low10
Strabismus, Comitant0low10
Strabismus, Noncomitant0low10
Strains0low20
Streptococcal Infections0medium351
Streptococcus pneumoniae Infections0medium191
Streptozocin Diabetes0low30
Streptozotocin Diabetes0low30
Stress Cardiomyopathy0low10
Stress Disorder, Post Traumatic0low10
Stress Disorders, Post-Traumatic0low10
Stress Disorders, Posttraumatic0low10
Stricture0low10
Stroke0low50
Stroke, Acute0low50
Subacute Bacterial Endocarditides0low20
Subacute Bacterial Endocarditis0low20
Subacute Delirium0low10
Subarachnoid Hemorrhage0low20
Subarachnoid Hemorrhage, Aneurysmal0low20
Subarachnoid Hemorrhage, Intracranial0low20
Subarachnoid Hemorrhage, Spontaneous0low20
Subcortical Infarction0low10
Subdural Empyema0low30
Substance Abuse0low30
Substance Abuse, Intravenous0low10
Substance Addiction0low30
Substance Dependence0low30
Substance Use0low30
Substance Use Disorders0low30
Substance Withdrawal Syndrome0medium31
Substance-Induced Psychoses0low20
Substance-Related Disorders0low30
Subtrochanteric Fractures0low10
Sudden Visual Loss0low40
Suffering, Physical0medium168
SUNCT Syndrome0low10
Superinfection0low10
Superinvasion, Microbial0low10
Suppuration0low10
Suppurative Arthritis0medium211
Suppurative Hidradenitides0low10
Suppurative Hidradenitis0low10
Surgery-Induced Tissue Adhesions0low40
Surgical Adhesions0low40
Surgical Injuries0low10
Surgical Site Infection0medium344
Surgical Wound Dehiscence0low10
Surgical Wound Infection0medium344
Susceptibility, Disease0low40
Susceptibility, Genetic0low40
Swine Diseases0low60
Swine Influenza0low10
Sykdommer i sentralnervesystemet@no0low40
Symmetric Diabetic Proximal Motor Neuropathy0medium22
Symptom Cluster0low40
Symptomatic Nystagmus0low10
Symptomatic Partial Complex Epilepsy0low10
Symptomatic Tonic-Clonic Epilepsy0low10
Syndrome0low40
Syndrome X, Insulin Resistance0low20
Syndrome X, Metabolic0low20
Systemic Inflammatory Response Syndrome0low20
Systemic Lupus Erythematosus0low10
T-Cell Lymphoma, Cutaneous0low10
T-Lymphotropic Virus Type III Infections, Human0low120
Tachycardia, Ventricular0low10
Tactile Allodynia0low10
Tako-tsubo Cardiomyopathy0low10
Tako-tsubo Syndrome0low10
Takotsubo Cardiomyopathy0low10
Takotsubo Syndrome0low10
Tangier Disease0low10
Tangier Disease Neuropathy0low10
Tangier Hereditary Neuropathy0low10
Taste Disorder, Anterior Tongue0low10
Taste Disorder, Posterior Tongue0low10
Taste Disorder, Primary0low10
Taste Disorder, Primary, Bitter0low10
Taste Disorder, Primary, Salt0low10
Taste Disorder, Primary, Sweet0low10
Taste Disorder, Secondary0low10
Taste Disorder, Secondary, Bitter0low10
Taste Disorder, Secondary, Salt0low10
Taste Disorder, Secondary, Sweet0low10
Taste Disorders0low10
Taste Dysfunction0low10
Taste, Altered0low10
Taste, Distorted0low10
Taste, Metallic0low10
TB Meningitis0low50
TBI (Traumatic Brain Injury)0low30
TBIs (Traumatic Brain Injuries)0low30
Teeth Grinding Disorder, Nocturnal0low10
Temporary Nystagmus0low10
Texidor's Twinge0medium21
Textiloma0low40
Thermal Allodynia0low10
Thermal Sensation Disorders0medium21
Thoracoabdominal Aortic Aneurysm0low10
Throbbing Headache0medium183
Thrombocytopenia0medium566
Thromboembolism, Pulmonary0low40
Thromboembolisms, Pulmonary0low40
Thrombopenia0medium566
Thrombosis0low30
Thrombus0low30
Thyroid-Stimulating Hormone Deficiency0low30
Thyroiditis0low10
TIA (Transient Ischemic Attack)0low10
Tic Doloureux0low20
Tic Douloureux0low20
Tinea Unguium0low10
Tissue Adhesions0low40
Tongue Diseases0low30
Tonic Clonic Convulsions0low10
Tonic Clonic Seizure0low40
Tonic Seizure0low40
Tonic Seizures0low40
Tonic-Clonic Convulsion Disorder0low10
Tonic-Clonic Convulsion Syndrome0low10
Tonic-Clonic Seizure0low40
Tonic-Clonic Seizure Disorder0low10
Tonic-Clonic Seizure Syndrome0low10
Tonic-Clonic Seizures0low40
Tooth Discoloration0low30
Tooth Sensitivity0low10
Torulosis0low10
Toxemia Of Pregnancy0low10
Toxemias, Pregnancy0low10
Toxic Encephalitis0low50
Toxic Hepatitis0low70
Toxic Psychoses0low20
Toxic Shock0low90
Toxic Shock Syndrome0low90
Toxicity, Drug0medium174
Tracheoesophageal Fistula0low10
Transient Apical Ballooning Syndrome0low10
Transient Ischemic Attack0low10
Transient Ischemic Attack, Anterior Circulation0low10
Transient Ischemic Attack, Brain Stem0low10
Transient Ischemic Attack, Brainstem0low10
Transient Ischemic Attack, Carotid Circulation0low10
Transient Ischemic Attack, Posterior Circulation0low10
Transient Ischemic Attack, Vertebrobasilar Circulation0low10
Transient Ischemic Attacks, Crescendo0low10
Transitional Meningioma0low20
Transitory Hearing Loss0low10
Trauma0medium61
Trauma, Brain0low30
Trauma, Multiple0low20
Traumatic Brain Injury0low30
Traumatic Encephalopathy0low30
Tremor0low20
Tremor, Limb0low20
Tremor, Muscle0low20
Tremor, Neonatal0low20
Tremor, Nerve0low20
Tremor, Perioral0low20
Tremor, Rubral0low20
Tremor, Semirhythmic0low20
Trichomonas Infections0low10
Trichomoniasis0low10
Trifacial Neuralgia0low20
Trigeminal Autonomic Cephalalgias0low10
Trigeminal Nerve Diseases0low10
Trigeminal Nerve Disorders0low10
Trigeminal Neuralgia0low20
Trigeminal Neuralgia, Idiopathic0low20
Trigeminal Neuralgia, Secondary0low20
Trigeminal Neuropathy0low10
Trigeminal Neuropathy, Idiopathic0low10
Trochanteric Fractures0low10
Tropical Eosinophilia0low30
Tropical Eosinophilic Pneumonia0low10
Trypanosoma cruzi Infection0low30
Trypanosomiasis0low50
Trypanosomiasis, African0low30
Trypanosomiasis, South American0low30
TSH Deficiency0low30
Tubercular Meningitis0low50
Tuberculoses, Pulmonary0medium398
Tuberculosis0medium472
Tuberculosis Meningitis0low50
Tuberculosis, Drug-Resistant0medium997
Tuberculosis, Extensively Drug-Resistant0medium464
Tuberculosis, Extremely Drug-Resistant0medium464
Tuberculosis, MDR0medium997
Tuberculosis, Meningeal0low50
Tuberculosis, Multi-Drug Resistant0medium997
Tuberculosis, Multidrug-Resistant0medium997
Tuberculosis, Pulmonary0medium398
Tuberculosis, Spinal0low20
Tuberculous Hypertrophic Pachymeningitis0low50
Tubulointerstitial Nephritis0low30
Tumors0medium121
Tumors, Breast0low20
Type 1 Diabetes0low10
Type 1 Diabetes Mellitus0low10
Type 2 Diabetes0medium81
Type 2 Diabetes Mellitus0medium81
Typical Aura without Headache0medium75
u041Du0415u0420u0412u041Du041Eu0419 u0421u0418u0421u0422u0415u041Cu042B u0426u0415u041Du0422u0420u0410u041Bu042Cu041Du041Eu0419 u0411u041Eu041Bu0415u0417u041Du0418@ru0low40
u4E2Du67A2u795Eu7D4Cu7CFBu75BEu60A3@ja0low40
Ulcer0low10
Undernutrition0low10
Unidirectional Nystagmus0low10
Unilateral Blindness0low40
Unilateral Headache0medium183
Unipolar Depression0medium72
Unstable Angina0low10
Upper Extremity Paresis0low10
Upper Respiratory Infections0medium112
Upper Respiratory Tract Infection0medium112
Upper Respiratory Tract Infections0medium112
Urethritis0low20
Urinary Bladder Cancer0low10
Urinary Bladder Diseases0low10
Urinary Bladder Neoplasms0low10
Urinary Tract Diseases0low20
Urinary Tract Infections0low140
Urination Disorders0low10
Urologic Diseases0low20
Urological Diseases0low20
Usual Interstitial Pneumonia0low10
Uterine Cancer0low10
Uterine Neoplasms0low10
Uterus Cancer0low10
Uterus Neoplasms0low10
Valley Fever0low20
Valvular Heart Diseases0low40
Varicella0low10
Vascular Accident, Brain0low50
Vascular Diseases0low10
Vascular Diseases, Peripheral0low30
Vascular Headache0low10
Vascular Headaches0low10
Vascular Injuries0low20
Vascular System Injuries0low20
Vasculitis, Allergic Cutaneous0low10
Vasculitis, Hypersensitivity0low10
Vasculitis, Leukocytoclastic, Cutaneous0low10
Venereal Diseases0medium11
Venous Congestion0low10
Venous Engorgement0low10
Ventilator-Associated Pneumonia0medium236
Ventilatory Depression0low20
Ventricular Tachyarrhythmias0low10
Ventricular Tachycardia0low10
Vertebrobasilar Circulation Transient Ischemic Attack0low10
Vertebrogenic Pain Syndrome0low10
Vertex Headache0medium183
Vertical Nystagmus0low10
Vertigo0medium31
Vertigo, Brain Stem0medium31
Vertigo, Brainstem0medium31
Vertigo, Central Nervous System Origin0medium31
Vertigo, Central Origin0medium31
Vertigo, Constant0medium31
Vertigo, Essential0medium31
Vertigo, Intermittant0medium31
Vertigo, Paroxysmal0medium31
Vertigo, Peripheral0medium31
Vertigo, Subjective0medium31
Vestibular Diseases0low10
Viral Diseases0low10
Viral Infections0low10
Virus Diseases0low10
Virus Infections0low10
Visceral Steatosis0low10
Vision Disability0low30
Vision Disorders0low30
Visual Disorders0low30
Visual Impairment0low30
Vitamin D Deficiency0low10
Vomiting0medium21
Water Stress0low20
Weight Gain0low10
Weight Loss0low30
Weight Reduction0low30
Well-Differentiated Oligodendroglioma0low10
Wet Lung0low10
White Spot, Dental0low10
White Spots, Dental0low10
Withdrawal Symptoms0medium31
Word Deafness0low10
Wound Dehiscence, Surgical0low10
Wound Infection0medium93
Wound Infection, Postoperative0medium344
Wound Infection, Surgical0medium344
Wounds0medium61
Wounds and Injuries0medium61
Wounds and Injury0medium61
Wounds, Gunshot0low10
Wounds, Injury0medium61
Wounds, Multiple0low20
Wounds, Nonpenetrating0low10
X-Linked Chronic Granulomatous Disease0low10
Xanthomatous Meningioma0low20
XDR-TB0medium464
Zentralnervensystemkrankheiten@de0low40
Ziekte, centraalzenuwstelsel-@nl0low40
Zona0low10
Zoonoses0low20
Zoonotic Diseases0low20
Zoonotic Infections0low20
Zoonotic Infectious Diseases0low20
Zoonotic Spillover0low20
Zoster0low10

Research Highlights

Safety/Toxicity (111)

ArticleYear
Efficacy and safety of intranasal agents for the acute treatment of migraine: a systematic review and network meta-analysis.
The journal of headache and pain, Sep-18, Volume: 24, Issue: 1		2023
Prolonged use of linezolid in bone and joint infections: a retrospective analysis of adverse effects.
The Journal of antimicrobial chemotherapy, 11-06, Volume: 78, Issue: 11		2023
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxaci
Trials, Jun-06, Volume: 24, Issue: 1		2023
Real-world evaluation of linezolid-associated serotonin toxicity with and without concurrent serotonergic agents.
International journal of antimicrobial agents, Volume: 62, Issue: 1		2023
Efficacy and safety of tedizolid for the treatment of ventilated gram-positive hospital-acquired or ventilator-associated bacterial pneumonia in Japanese patients: Results from a subgroup analysis of a phase 3, randomized, double-blind study comparing ted
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, Volume: 28, Issue: 9		2022
Single Ascending-Dose Study To Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid in Healthy Adult Subjects.
Antimicrobial agents and chemotherapy, 04-19, Volume: 66, Issue: 4		2022
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections.
The Journal of antimicrobial chemotherapy, 05-29, Volume: 77, Issue: 6		2022
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
European heart journal, 04-06, Volume: 43, Issue: 14		2022
Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting system.
Expert opinion on drug safety, Volume: 20, Issue: 11		2021
Hematological side effect analysis of linezolid in MDR-TB patients with individual therapy.
Journal of basic and clinical physiology and pharmacology, Jun-25, Volume: 32, Issue: 4		2021
Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine.
The journal of headache and pain, May-17, Volume: 22, Issue: 1		2021
Residues and dietary intake risk assessments of clomazone, fomesafen, haloxyfop-methyl and its metabolite haloxyfop in spring soybean field ecosystem.
Food chemistry, Oct-30, Volume: 360		2021
Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, Volume: 105		2021
Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure Infections.
The Pediatric infectious disease journal, 03-01, Volume: 40, Issue: 3		2021
Safety and Tolerability of More than Six Days of Tedizolid Treatment.
Antimicrobial agents and chemotherapy, 06-23, Volume: 64, Issue: 7		2020
Multiple-dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral LCB01-0371 in Healthy Male Volunteers.
Clinical therapeutics, Volume: 40, Issue: 12		2018
The effect and safety of anacetrapib in the treatment of dyslipidemia: a systematic review and meta-analysis.
Postgraduate medicine, Volume: 130, Issue: 1		2018
Safety, tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic, LCB01-0371, in healthy male subjects.
The Journal of antimicrobial chemotherapy, Jan-01, Volume: 73, Issue: 1		2018
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
Cephalalgia : an international journal of headache, Volume: 38, Issue: 2		2018
Single- and Multiple-Dose Study To Determine the Safety, Tolerability, Pharmacokinetics, and Food Effect of Oral MRX-I versus Linezolid in Healthy Adult Subjects.
Antimicrobial agents and chemotherapy, Volume: 61, Issue: 4		2017
Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects.
Journal of medicinal chemistry, 04-13, Volume: 60, Issue: 7		2017
[Clinical efficacy and safety of vancomycin compared with linezolid for the treatment of neonatal gram-positive bacterial sepsis].
Zhonghua er ke za zhi = Chinese journal of pediatrics, Volume: 54, Issue: 9		2016
Can herbicide safeners allow selective control of weedy rice infesting rice crops?
Pest management science, Volume: 73, Issue: 1		2017
Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with heterozygous familial hypercholesterolemia.
Atherosclerosis, Volume: 249		2016
Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.
Expert opinion on drug metabolism & toxicology, Volume: 11, Issue: 12		2015
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment.
The European respiratory journal, Volume: 46, Issue: 5		2015
Discovery of a Teraryl Oxazolidinone Compound (S)-N-((3-(3-Fluoro-4-(4-(pyridin-2-yl)-1H-pyrazol-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide Phosphate as a Novel Antimicrobial Agent with Enhanced Safety Profile and Efficacies.
Journal of medicinal chemistry, Aug-27, Volume: 58, Issue: 16		2015
Safety, tolerability, and efficacy of GSK1322322 in the treatment of acute bacterial skin and skin structure infections.
Antimicrobial agents and chemotherapy, Volume: 58, Issue: 11		2014
Lipids, safety parameters, and drug concentrations after an additional 2 years of treatment with anacetrapib in the DEFINE study.
Journal of cardiovascular pharmacology and therapeutics, Volume: 19, Issue: 6		2014
Efficacy and safety of linezolid for the treatment of infections in children: a meta-analysis.
European journal of pediatrics, Volume: 173, Issue: 9		2014
New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile.
Journal of medicinal chemistry, Jun-12, Volume: 57, Issue: 11		2014
Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis.
Pain practice : the official journal of World Institute of Pain, Volume: 15, Issue: 2		2015
Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease.
The American journal of cardiology, Jan-01, Volume: 113, Issue: 1		2014
Cadazolid, a novel antibiotic with potent activity against Clostridium difficile: safety, tolerability and pharmacokinetics in healthy subjects following single and multiple oral doses.
The Journal of antimicrobial chemotherapy, Volume: 69, Issue: 3		2014
Comparative evaluation of serotonin toxicity among veterans affairs patients receiving linezolid and vancomycin.
Antimicrobial agents and chemotherapy, Volume: 57, Issue: 12		2013
Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Clinical therapeutics, Volume: 35, Issue: 10		2013
Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia.
Atherosclerosis, Volume: 230, Issue: 1		2013
Photocatalytic degradation of the herbicide clomazone in natural water using TiO2: kinetics, mechanism, and toxicity of degradation products.
Chemosphere, Volume: 93, Issue: 1		2013
Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, Volume: 17, Issue: 10		2013
Systematic identification of proteins that elicit drug side effects.
Molecular systems biology, Volume: 9		2013
Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections.
International journal of antimicrobial agents, Volume: 41, Issue: 6		2013
The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infections.
PloS one, Volume: 8, Issue: 3		2013
Clinical relevance of linezolid-associated serotonin toxicity.
The Annals of pharmacotherapy, Volume: 47, Issue: 3		2013
Safety of inhibition of cholesteryl ester transfer protein with anacetrapib: the DEFINE study.
Expert review of cardiovascular therapy, Volume: 10, Issue: 8		2012
Safety of CETP inhibition.
Current opinion in lipidology, Volume: 23, Issue: 6		2012
Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.
The European respiratory journal, Volume: 41, Issue: 6		2013
A reduced linezolid dosage maintains favorable efficacy with minimal hematologic toxicity in a methicillin-resistant Staphylococcus aureus-infected patient with renal insufficiency.
Scandinavian journal of infectious diseases, Volume: 45, Issue: 1		2013
A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections.
Antimicrobial agents and chemotherapy, Volume: 56, Issue: 11		2012
Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components.
Antimicrobial agents and chemotherapy, Volume: 56, Issue: 8		2012
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.
The Journal of antimicrobial chemotherapy, Volume: 67, Issue: 8		2012
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
The European respiratory journal, Volume: 40, Issue: 6		2012
Safety and efficacy of linezolid in 16 infants and children in Japan.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, Volume: 18, Issue: 4		2012
The safety and efficacy of linezolid and daptomycin as an additive in Optisol-GS against methicillin-resistant Staphylococcus aureus.
Cornea, Volume: 31, Issue: 5		2012
Immediate hematological toxicity of linezolid in healthy volunteers with different body weight: a phase I clinical trial.
The Journal of antibiotics, Volume: 65, Issue: 4		2012
Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data.
The Journal of antimicrobial chemotherapy, Volume: 67, Issue: 2		2012
Efficacy and safety of linezolid in the treatment of extensively drug-resistant tuberculosis.
Japanese journal of infectious diseases, Volume: 64, Issue: 6		2011
Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia.
American heart journal, Volume: 162, Issue: 4		2011
Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India.
The European respiratory journal, Volume: 39, Issue: 4		2012
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection.
Antimicrobial agents and chemotherapy, Volume: 55, Issue: 12		2011
Potential for linezolid-related blindness: a review of spontaneous adverse event reports.
Pharmacotherapy, Volume: 31, Issue: 6		2011
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Volume: 52 Suppl 7		2011
Linezolid: safety and efficacy in special populations.
The Journal of antimicrobial chemotherapy, Volume: 66 Suppl 4		2011
Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.
Antimicrobial agents and chemotherapy, Volume: 55, Issue: 5		2011
Efficacy and safety of linezolid in liver transplant patients.
Transplant infectious disease : an official journal of the Transplantation Society, Volume: 13, Issue: 4		2011
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.
Antimicrobial agents and chemotherapy, Volume: 55, Issue: 2		2011
Safety of anacetrapib in patients with or at high risk for coronary heart disease.
The New England journal of medicine, Dec-16, Volume: 363, Issue: 25		2010
Biomarker-assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosis.
Antimicrobial agents and chemotherapy, Volume: 55, Issue: 2		2011
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
Cephalalgia : an international journal of headache, Volume: 31, Issue: 3		2011
Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus.
American journal of surgery, Volume: 199, Issue: 6		2010
Efficacy and safety of linezolid in immunocompromised children with cancer.
Pediatrics international : official journal of the Japan Pediatric Society, Volume: 52, Issue: 5		2010
The safety of intraocular linezolid in rabbits.
Investigative ophthalmology & visual science, Volume: 51, Issue: 6		2010
Linezolid: a review of safety and tolerability.
The Journal of infection, Volume: 59 Suppl 1		2009
Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Volume: 15, Issue: 10		2009
Pure red cell precursor toxicity by linezolid in a pediatric case.
Journal of pediatric hematology/oncology, Volume: 31, Issue: 9		2009
Update on the safety of linezolid.
Expert opinion on drug safety, Volume: 8, Issue: 4		2009
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis.
The European respiratory journal, Volume: 34, Issue: 2		2009
Serotonin toxicity as a consequence of linezolid use in revision hip arthroplasty.
Orthopedics, Volume: 31, Issue: 11		2008
Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients.
American heart journal, Volume: 157, Issue: 2		2009
Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey.
Diagnostic microbiology and infectious disease, Volume: 62, Issue: 4		2008
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
The Journal of antimicrobial chemotherapy, Volume: 62 Suppl 1		2008
[Adverse effect optic neuropathy].
Medizinische Monatsschrift fur Pharmazeuten, Volume: 31, Issue: 6		2008
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.
Antimicrobial agents and chemotherapy, Volume: 52, Issue: 4		2008
Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
Headache, Volume: 48, Issue: 2		2008
The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancer.
The Journal of antimicrobial chemotherapy, Volume: 61, Issue: 2		2008
Linezolid: effectiveness and safety for approved and off-label indications.
Expert opinion on pharmacotherapy, Volume: 8, Issue: 14		2007
[Toxicity of recent and less recent drugs on the optic nerve. Does Viagra cause blindness?].
Bulletin de la Societe belge d'ophtalmologie, Issue: 304		2007
Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series.
Diagnostic microbiology and infectious disease, Volume: 59, Issue: 2		2007
Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse events induced by linezolid.
Antimicrobial agents and chemotherapy, Volume: 51, Issue: 7		2007
Tongue discoloration in an elderly kidney transplant recipient: Treatment-related adverse event?
The American journal of geriatric pharmacotherapy, Volume: 4, Issue: 3		2006
Bell's palsy associated with linezolid therapy: case report and review of neuropathic adverse events.
Pharmacotherapy, Volume: 26, Issue: 8		2006
Serotonin toxicity associated with the use of linezolid: a review of postmarketing data.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Jun-01, Volume: 42, Issue: 11		2006
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Mar-01, Volume: 42, Issue: 5		2006
The effectiveness and safety of oral linezolid for the primary and secondary treatment of osteomyelitis.
Journal of chemotherapy (Florence, Italy), Volume: 17, Issue: 6		2005
Linezolid-induced dyserythropoiesis: chloramphenicol toxicity revisited.
Internal medicine journal, Volume: 35, Issue: 10		2005
Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases.
Infection, Volume: 33, Issue: 3		2005
Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.
The Journal of infection, Volume: 52, Issue: 2		2006
Serotonin toxicity associated with concomitant use of linezolid.
The Annals of pharmacotherapy, Volume: 39, Issue: 5		2005
Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
Headache, Volume: 45, Issue: 1		2005
The safety and efficacy of linezolid in orthopaedic practice for the treatment of infection due to antibiotic-resistant organisms.
Expert opinion on drug safety, Volume: 3, Issue: 5		2004
Safety and tolerability of linezolid in children.
The Pediatric infectious disease journal, Volume: 22, Issue: 9 Suppl		2003
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Long-term Use (16)

ArticleYear
The Novel Oxazolidinone TBI-223 Is Effective in Three Preclinical Mouse Models of Methicillin-Resistant Staphylococcus aureus Infection.
Microbiology spectrum, 10-26, Volume: 10, Issue: 5		2022
Synergistic effect of serotonin 1A and serotonin 1B/D receptor agonists in the treatment of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats.
Experimental neurology, Volume: 358		2022
Long-term use of tedizolid for pulmonary nocardiosis.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, Volume: 28, Issue: 8		2022
Long-term use of liposomal nebulized amikacin and tedizolid for the treatment of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantation.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, Volume: 40, Issue: 9		2021
Safety, tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic, LCB01-0371, in healthy male subjects.
The Journal of antimicrobial chemotherapy, Jan-01, Volume: 73, Issue: 1		2018
Chronic Administration of Anacetrapib Is Associated With Accumulation in Adipose and Slow Elimination.
Clinical pharmacology and therapeutics, Volume: 102, Issue: 5		2017
Pharmacological issues of linezolid: an updated critical review.
Clinical pharmacokinetics, Volume: 49, Issue: 7		2010
Linezolid-associated optic neuropathy in a patient with ocular sarcoidosis.
Japanese journal of ophthalmology, Volume: 53, Issue: 4		2009
Linezolid for the treatment of patients with [corrected] mycobacterial infections [corrected] a systematic review.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, Volume: 11, Issue: 6		2007
[Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca, Volume: 73, Issue: 5		2006
Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
The Journal of antimicrobial chemotherapy, Volume: 58, Issue: 3		2006
Successful treatment of chronic bone and joint infections with oral linezolid.
Clinical orthopaedics and related research, Issue: 427		2004
Peripheral neuropathy associated with prolonged use of linezolid.
The Lancet. Infectious diseases, Volume: 4, Issue: 8		2004
Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain.
Cephalalgia : an international journal of headache, Volume: 24, Issue: 1		2004
Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
CNS drugs, Volume: 17, Issue: 11		2003
Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects.
Clinical pharmacology and therapeutics, Volume: 52, Issue: 4		1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (197)

ArticleYear
A pharmacokinetic-pharmacodynamic (PKPD) model-based analysis of tedizolid against enterococci using the hollow-fibre infection model.
The Journal of antimicrobial chemotherapy, 08-25, Volume: 77, Issue: 9		2022
Single Ascending-Dose Study To Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid in Healthy Adult Subjects.
Antimicrobial agents and chemotherapy, 04-19, Volume: 66, Issue: 4		2022
Pharmacokinetics and Pharmacodynamics of Tedizolid.
Clinical pharmacokinetics, Volume: 61, Issue: 4		2022
Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections.
Antimicrobial agents and chemotherapy, 11-17, Volume: 65, Issue: 12		2021
Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles - Formulation and Pharmacodynamic Assessment.
International journal of nanomedicine, Volume: 15		2020
Design, Synthesis, and Pharmacological Characterization of a Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics.
Journal of medicinal chemistry, 11-12, Volume: 63, Issue: 21		2020
Pharmacokinetics of tedizolid, sutezolid, and sutezolid-M1 in non-human primates.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Aug-01, Volume: 151		2020
Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients.
Clinical therapeutics, Volume: 42, Issue: 5		2020
Pharmacokinetic study and brain tissue analysis of Zolmitriptan loaded chitosan nanoparticles in rats by LC-MS method.
International journal of biological macromolecules, Jan-01, Volume: 142		2020
Metabolic profiles and pharmacokinetics of goitrin in rats through liquid chromatography combined with electrospray ionization-tandem mass spectrometry.
Biomedical chromatography : BMC, Volume: 33, Issue: 10		2019
Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis.
Clinical therapeutics, Volume: 41, Issue: 6		2019
Chiral separation and thermodynamic investigation of WCK 3023: A novel oxazolidinone antibacterial agent, application to pre-clinical pharmacokinetic study.
Biomedical chromatography : BMC, Volume: 33, Issue: 9		2019
Multiple-dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral LCB01-0371 in Healthy Male Volunteers.
Clinical therapeutics, Volume: 40, Issue: 12		2018
Pharmacokinetics and Pharmacodynamics of Anacetrapib in Black and White Healthy Subjects.
Journal of clinical pharmacology, Volume: 58, Issue: 12		2018
Pharmacokinetics and Skin Tolerability of Intracutaneous Zolmitriptan Delivery in Swine Using Adhesive Dermally Applied Microarray.
Journal of pharmaceutical sciences, Volume: 107, Issue: 8		2018
In vivo efficacy and pharmacokinetics of bi-aryl oxazolidinone RBx 11760 loaded polylactic acid-polyethylene glycol nanoparticles in mouse hematogenous bronchopneumonia and rat groin abscess caused by Staphylococcus aureus.
Nanomedicine : nanotechnology, biology, and medicine, Volume: 14, Issue: 4		2018
Non-clinical pharmacokinetic profiles of rovatirelin, an orally available thyrotropin-releasing hormone analogue.
Xenobiotica; the fate of foreign compounds in biological systems, Volume: 49, Issue: 1		2019
Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 01-01, Volume: 22, Issue: 1		2018
Safety, tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic, LCB01-0371, in healthy male subjects.
The Journal of antimicrobial chemotherapy, Jan-01, Volume: 73, Issue: 1		2018
Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.
Clinical pharmacokinetics, Volume: 57, Issue: 5		2018
Pharmacokinetics and Pharmacodynamics of Anacetrapib Following Single Doses in Healthy, Young Japanese and White Male Subjects.
Journal of clinical pharmacology, Volume: 58, Issue: 2		2018
Improving the pharmacokinetics and tissue distribution of pyrinezolid by self-assembled polymeric micelles.
Colloids and surfaces. B, Biointerfaces, Aug-01, Volume: 156		2017
Single- and Multiple-Dose Study To Determine the Safety, Tolerability, Pharmacokinetics, and Food Effect of Oral MRX-I versus Linezolid in Healthy Adult Subjects.
Antimicrobial agents and chemotherapy, Volume: 61, Issue: 4		2017
Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable antimicrobials against Staphylococcus aureus and Staphylococcus epidermidis.
The Journal of antimicrobial chemotherapy, 05-01, Volume: 72, Issue: 5		2017
Pharmacokinetic drug evaluation of anacetrapib for the treatment of dyslipidemia.
Expert opinion on drug metabolism & toxicology, Volume: 13, Issue: 2		2017
Pharmacokinetics of Tedizolid in Morbidly Obese and Covariate-Matched Nonobese Adults.
Antimicrobial agents and chemotherapy, Volume: 60, Issue: 8		2016
Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.
Arteriosclerosis, thrombosis, and vascular biology, Volume: 36, Issue: 5		2016
Intranasal Pharmacokinetic Data for Triptans Such as Sumatriptan and Zolmitriptan Can Render Area Under the Curve (AUC) Predictions for the Oral Route: Strategy Development and Application.
Journal of pain & palliative care pharmacotherapy, Volume: 30, Issue: 1		2016
Simultaneous determination of tedizolid and linezolid in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Feb-01, Volume: 1011		2016
Pharmacokinetic/pharmacodynamic research on three different infusion time regimens of linezolid in healthy Chinese volunteers.
International journal of clinical pharmacology and therapeutics, Volume: 53, Issue: 9		2015
Tedizolid Adsorption and Transmembrane Clearance during in vitro Continuous Renal Replacement Therapy.
Blood purification, Volume: 40, Issue: 1		2015
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.
The Journal of clinical investigation, Volume: 125, Issue: 6		2015
Assessment of the persistence of anacetrapib and evacetrapib concentrations using two pharmacokinetic modeling approaches.
Journal of clinical pharmacology, Volume: 55, Issue: 7		2015
Concentration-response studies and modelling of the pharmacodynamics of linezolid: Staphylococcus aureus versus Enterococcus faecium.
International journal of antimicrobial agents, Volume: 45, Issue: 1		2015
Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function.
Antimicrobial agents and chemotherapy, Volume: 59, Issue: 1		2015
Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, Volume: 21, Issue: 1		2015
Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation.
The Journal of antimicrobial chemotherapy, Volume: 70, Issue: 1		2015
Design, synthesis, and structure-activity and structure-pharmacokinetic relationship studies of novel [6,6,5] tricyclic fused oxazolidinones leading to the discovery of a potent, selective, and orally bioavailable FXa inhibitor.
Journal of medicinal chemistry, Sep-25, Volume: 57, Issue: 18		2014
Tedizolid population pharmacokinetics, exposure response, and target attainment.
Antimicrobial agents and chemotherapy, Volume: 58, Issue: 11		2014
Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment.
Antimicrobial agents and chemotherapy, Volume: 58, Issue: 11		2014
Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.
International journal of antimicrobial agents, Volume: 44, Issue: 3		2014
Single-dose linezolid pharmacokinetics in critically ill patients with impaired renal function especially chronic hemodialysis patients.
Biopharmaceutics & drug disposition, Volume: 35, Issue: 7		2014
Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Gal
Antimicrobial agents and chemotherapy, Volume: 58, Issue: 8		2014
Pharmacokinetic and pharmacodynamic evaluation of AZD5847 in a mouse model of tuberculosis.
Antimicrobial agents and chemotherapy, Volume: 58, Issue: 7		2014
Influence of renal and hepatic impairment on the pharmacokinetics of anacetrapib.
Journal of clinical pharmacology, Volume: 54, Issue: 11		2014
Population pharmacokinetic/pharmacodynamic analysis of the bactericidal activities of sutezolid (PNU-100480) and its major metabolite against intracellular Mycobacterium tuberculosis in ex vivo whole-blood cultures of patients with pulmonary tuberculosis.
Antimicrobial agents and chemotherapy, Volume: 58, Issue: 6		2014
Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection.
Journal of clinical pharmacology, Volume: 54, Issue: 9		2014
Potent fluorinated agelastatin analogues for chronic lymphocytic leukemia: design, synthesis, and pharmacokinetic studies.
Journal of medicinal chemistry, Jun-26, Volume: 57, Issue: 12		2014
Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, Volume: 22		2014
The emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristics.
Antimicrobial agents and chemotherapy, Volume: 58, Issue: 5		2014
Clinical population pharmacokinetics and toxicodynamics of linezolid.
Antimicrobial agents and chemotherapy, Volume: 58, Issue: 4		2014
Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Clinical and experimental pharmacology & physiology, Volume: 41, Issue: 6		2014
Cadazolid, a novel antibiotic with potent activity against Clostridium difficile: safety, tolerability and pharmacokinetics in healthy subjects following single and multiple oral doses.
The Journal of antimicrobial chemotherapy, Volume: 69, Issue: 3		2014
Simultaneous quantification of linezolid, tinidazole, norfloxacin, moxifloxacin, levofloxacin, and gatifloxacin in human plasma for therapeutic drug monitoring and pharmacokinetic studies in human volunteers.
Therapeutic drug monitoring, Volume: 35, Issue: 6		2013
Population pharmacokinetic analysis of linezolid in low body weight patients with renal dysfunction.
Journal of clinical pharmacology, Volume: 53, Issue: 9		2013
Pharmacokinetics and relative bioavailability evaluation of linezolid suspension and tablet formulations.
Drug research, Volume: 63, Issue: 9		2013
Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported
The Journal of antimicrobial chemotherapy, Volume: 68, Issue: 10		2013
Effects of Rifampin, a potent inducer of drug-metabolizing enzymes and an inhibitor of OATP1B1/3 transport, on the single dose pharmacokinetics of anacetrapib.
Journal of clinical pharmacology, Volume: 53, Issue: 7		2013
Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model.
Journal of chemotherapy (Florence, Italy), Volume: 25, Issue: 1		2013
Weight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: a Phase I pharmacokinetic and pharmacodynamic study.
Expert opinion on investigational drugs, Volume: 22, Issue: 3		2013
Pharmacokinetics of intravenous linezolid in moderately to morbidly obese adults.
Antimicrobial agents and chemotherapy, Volume: 57, Issue: 3		2013
Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model.
Antimicrobial agents and chemotherapy, Volume: 56, Issue: 11		2012
Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines.
Expert opinion on drug metabolism & toxicology, Volume: 8, Issue: 8		2012
Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in vivo preclinical pharmacokinetic study.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Jul-15, Volume: 901		2012
Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.
The Journal of antimicrobial chemotherapy, Volume: 67, Issue: 8		2012
Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Antimicrobial agents and chemotherapy, Volume: 56, Issue: 6		2012
Pharmacokinetics and pulmonary disposition of tedizolid and linezolid in a murine pneumonia model under variable conditions.
Antimicrobial agents and chemotherapy, Volume: 56, Issue: 6		2012
Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, Volume: 31, Issue: 9		2012
Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia.
The Journal of antimicrobial chemotherapy, Volume: 67, Issue: 5		2012
Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient.
Scandinavian journal of infectious diseases, Volume: 44, Issue: 8		2012
Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
British journal of clinical pharmacology, Volume: 74, Issue: 1		2012
Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model.
Antimicrobial agents and chemotherapy, Volume: 56, Issue: 3		2012
Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system.
Antimicrobial agents and chemotherapy, Volume: 56, Issue: 1		2012
Lack of an effect of anacetrapib on the pharmacokinetics of digoxin in healthy subjects.
Biopharmaceutics & drug disposition, Volume: 32, Issue: 9		2011
In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
International journal of antimicrobial agents, Volume: 38, Issue: 4		2011
The antistaphylococcal pharmacodynamics of linezolid alone and in combination with doxycycline in an in vitro dynamic model.
Journal of chemotherapy (Florence, Italy), Volume: 23, Issue: 3		2011
Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients.
International journal of antimicrobial agents, Volume: 38, Issue: 4		2011
Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysis.
Antimicrobial agents and chemotherapy, Volume: 55, Issue: 9		2011
Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin.
The American journal of the medical sciences, Volume: 342, Issue: 6		2011
Linezolid in the central nervous system: comparison between cerebrospinal fluid and plasma pharmacokinetics.
Scandinavian journal of infectious diseases, Volume: 43, Issue: 9		2011
Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.
The Journal of antimicrobial chemotherapy, Volume: 66 Suppl 4		2011
Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis.
Antimicrobial agents and chemotherapy, Volume: 55, Issue: 7		2011
In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model.
Antimicrobial agents and chemotherapy, Volume: 55, Issue: 7		2011
Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.
Antimicrobial agents and chemotherapy, Volume: 55, Issue: 5		2011
Pharmacokinetics of diphenylboroxazolidones of L-α-amino acids with activity on the CNS: quantification in rat DBS by UPLC-MS/MS.
Bioanalysis, Volume: 3, Issue: 4		2011
Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.
European journal of medical research, Nov-30, Volume: 15, Issue: 12		2010
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.
Antimicrobial agents and chemotherapy, Volume: 55, Issue: 2		2011
Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteers.
The Journal of infectious diseases, Sep-01, Volume: 202, Issue: 5		2010
Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.
Clinical pharmacokinetics, Volume: 49, Issue: 8		2010
Pharmacokinetics and distribution of linezolid in cerebrospinal fluid in children and adolescents.
The Pediatric infectious disease journal, Volume: 29, Issue: 9		2010
Unexpected effect of rifampin on the pharmacokinetics of linezolid: in silico and in vitro approaches to explain its mechanism.
Journal of clinical pharmacology, Volume: 51, Issue: 2		2011
Activity of linezolid in an in vitro pharmacokinetic-pharmacodynamic model using different dosages and Staphylococcus aureus and Enterococcus faecalis strains with and without a hypermutator phenotype.
Antimicrobial agents and chemotherapy, Volume: 54, Issue: 4		2010
Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 38, Issue: 3		2010
Pharmacokinetics of linezolid in septic patients with and without extended dialysis.
European journal of clinical pharmacology, Volume: 66, Issue: 3		2010
[Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
Pathologie-biologie, Volume: 58, Issue: 2		2010
Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.
British journal of clinical pharmacology, Volume: 68, Issue: 4		2009
Pharmacokinetic-pharmacodynamic modeling of the in vitro activities of oxazolidinone antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy, Volume: 53, Issue: 12		2009
Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines.
The Journal of antimicrobial chemotherapy, Volume: 64, Issue: 5		2009
Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model.
Antimicrobial agents and chemotherapy, Volume: 53, Issue: 10		2009
Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.
Antimicrobial agents and chemotherapy, Volume: 53, Issue: 9		2009
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (115)

ArticleYear
The Novel Oxazolidinone TBI-223 Is Effective in Three Preclinical Mouse Models of Methicillin-Resistant Staphylococcus aureus Infection.
Microbiology spectrum, 10-26, Volume: 10, Issue: 5		2022
Evaluation of Brain Targeting Potential of Zolmitriptan Mucoadhesive Nanoparticles for Intranasal Drug Delivery.
Pharmaceutical nanotechnology, Volume: 10, Issue: 2		2022
Simultaneous determination of a novel oxazolidinone anti-tuberculosis OTB-658 and its metabolites in monkey blood by LC-MS/MS.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Mar-15, Volume: 1167		2021
Design, Synthesis, and Pharmacological Characterization of a Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics.
Journal of medicinal chemistry, 11-12, Volume: 63, Issue: 21		2020
Evidence Associated with the Use of Oxazolidinones for the Treatment of Skin and Skin Structure Infections: A Retrospective Study.
Acta medica portuguesa, Jun-28, Volume: 32, Issue: 6		2019
Effect of Amorphous Nanoparticle Size on Bioavailability of Anacetrapib in Dogs.
Journal of pharmaceutical sciences, Volume: 108, Issue: 9		2019
Development of a Clinically Relevant Dissolution Method for Metaxalone Immediate Release Formulations Based on an IVIVC Model.
Pharmaceutical research, Jun-22, Volume: 35, Issue: 8		2018
Pharmacokinetics and Skin Tolerability of Intracutaneous Zolmitriptan Delivery in Swine Using Adhesive Dermally Applied Microarray.
Journal of pharmaceutical sciences, Volume: 107, Issue: 8		2018
Non-clinical pharmacokinetic profiles of rovatirelin, an orally available thyrotropin-releasing hormone analogue.
Xenobiotica; the fate of foreign compounds in biological systems, Volume: 49, Issue: 1		2019
Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation.
Drug development and industrial pharmacy, Volume: 44, Issue: 3		2018
Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.
Clinical pharmacokinetics, Volume: 57, Issue: 5		2018
Discovery of 3,5-Diphenyl-4-methyl-1,3-oxazolidin-2-ones as Novel, Potent, and Orally Available Δ-5 Desaturase (D5D) Inhibitors.
Journal of medicinal chemistry, 11-09, Volume: 60, Issue: 21		2017
Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.
International journal of pharmaceutics, Aug-30, Volume: 529, Issue: 1-2		2017
Improving the pharmacokinetics and tissue distribution of pyrinezolid by self-assembled polymeric micelles.
Colloids and surfaces. B, Biointerfaces, Aug-01, Volume: 156		2017
Single- and Multiple-Dose Study To Determine the Safety, Tolerability, Pharmacokinetics, and Food Effect of Oral MRX-I versus Linezolid in Healthy Adult Subjects.
Antimicrobial agents and chemotherapy, Volume: 61, Issue: 4		2017
Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable antimicrobials against Staphylococcus aureus and Staphylococcus epidermidis.
The Journal of antimicrobial chemotherapy, 05-01, Volume: 72, Issue: 5		2017
Intranasal Eutectic Powder of Zolmitriptan with Enhanced Bioavailability in the Rat Brain.
Molecular pharmaceutics, 09-06, Volume: 13, Issue: 9		2016
Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
Drug delivery, Volume: 23, Issue: 9		2016
Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Feb-01, Volume: 1011		2016
Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies.
Journal of liposome research, Volume: 26, Issue: 4		2016
Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives.
Current medicinal chemistry, Volume: 22, Issue: 38		2015
Discovery of a Teraryl Oxazolidinone Compound (S)-N-((3-(3-Fluoro-4-(4-(pyridin-2-yl)-1H-pyrazol-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide Phosphate as a Novel Antimicrobial Agent with Enhanced Safety Profile and Efficacies.
Journal of medicinal chemistry, Aug-27, Volume: 58, Issue: 16		2015
Drug in Adhesive Patch of Zolmitriptan: Formulation and In vitro /In vivo Correlation.
AAPS PharmSciTech, Volume: 16, Issue: 6		2015
Optimization of combinational intranasal drug delivery system for the management of migraine by using statistical design.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Apr-05, Volume: 70		2015
[Therapeutic Drug Monitoring of antiinfectives in intensive care medicine].
Deutsche medizinische Wochenschrift (1946), Volume: 139, Issue: 38		2014
Design, synthesis, and structure-activity and structure-pharmacokinetic relationship studies of novel [6,6,5] tricyclic fused oxazolidinones leading to the discovery of a potent, selective, and orally bioavailable FXa inhibitor.
Journal of medicinal chemistry, Sep-25, Volume: 57, Issue: 18		2014
Tedizolid population pharmacokinetics, exposure response, and target attainment.
Antimicrobial agents and chemotherapy, Volume: 58, Issue: 11		2014
Clinical experience with linezolid for the treatment of orthopaedic implant infections.
The Journal of antimicrobial chemotherapy, Volume: 69 Suppl 1		2014
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Volume: 20 Suppl 4		2014
Synthesis of stable isotope labeled anacetrapib, its major metabolites and [(14) C]anacetrapib.
Journal of labelled compounds & radiopharmaceuticals, Volume: 56, Issue: 12		2013
Pharmacokinetics and relative bioavailability evaluation of linezolid suspension and tablet formulations.
Drug research, Volume: 63, Issue: 9		2013
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
Journal of medicinal chemistry, Jun-13, Volume: 56, Issue: 11		2013
Linezolid in late-chronic prosthetic joint infection caused by gram-positive bacteria.
Diagnostic microbiology and infectious disease, Volume: 76, Issue: 1		2013
Oral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects?
The Journal of antimicrobial chemotherapy, Volume: 68, Issue: 3		2013
Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections.
Scandinavian journal of infectious diseases, Volume: 44, Issue: 7		2012
Tedizolid (TR-701): a new oxazolidinone with enhanced potency.
Expert opinion on investigational drugs, Volume: 21, Issue: 4		2012
Fast relief from migraine attacks using fast-disintegrating sublingual zolmitriptan tablets.
Drug development and industrial pharmacy, Volume: 38, Issue: 6		2012
Design, synthesis, and structure-activity relationship studies of highly potent novel benzoxazinyl-oxazolidinone antibacterial agents.
Journal of medicinal chemistry, Nov-10, Volume: 54, Issue: 21		2011
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Volume: 52 Suppl 7		2011
Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.
The Journal of antimicrobial chemotherapy, Volume: 66 Suppl 4		2011
Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis.
Antimicrobial agents and chemotherapy, Volume: 55, Issue: 7		2011
Model-based development of anacetrapib, a novel cholesteryl ester transfer protein inhibitor.
The AAPS journal, Volume: 13, Issue: 2		2011
Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.
European journal of medical research, Nov-30, Volume: 15, Issue: 12		2010
[Linezolide in paediatrics].
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, Volume: 17 Suppl 4		2010
Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteers.
The Journal of infectious diseases, Sep-01, Volume: 202, Issue: 5		2010
Preclinical and clinical evidence for the collaborative transport and renal secretion of an oxazolidinone antibiotic by organic anion transporter 3 (OAT3/SLC22A8) and multidrug and toxin extrusion protein 1 (MATE1/SLC47A1).
The Journal of pharmacology and experimental therapeutics, Sep-01, Volume: 334, Issue: 3		2010
Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 38, Issue: 3		2010
Linezolid: a review of safety and tolerability.
The Journal of infection, Volume: 59 Suppl 1		2009
Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.
Antimicrobial agents and chemotherapy, Volume: 53, Issue: 9		2009
Application of affinity selection/mass spectrometry to determine the structural isomer of parnafungins responsible for binding polyadenosine polymerase.
Journal of the American Chemical Society, Dec-10, Volume: 130, Issue: 49		2008
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
Lancet (London, England), Dec-20, Volume: 372, Issue: 9656		2008
Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics.
Bioorganic & medicinal chemistry letters, Dec-01, Volume: 18, Issue: 23		2008
Linezolid in children: recent patents and advances.
Recent patents on anti-infective drug discovery, Volume: 2, Issue: 1		2007
Burned rice straw reduces the availability of clomazone to barnyardgrass.
The Science of the total environment, Mar-25, Volume: 392, Issue: 2-3		2008
Experience with linezolid therapy in children with osteoarticular infections.
The Pediatric infectious disease journal, Volume: 26, Issue: 11		2007
Synthesis and biological evaluation of new N-linked 5-triazolylmethyl oxazolidinones.
European journal of medicinal chemistry, Volume: 43, Issue: 8		2008
Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 35, Issue: 10		2007
Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series.
Diagnostic microbiology and infectious disease, Volume: 59, Issue: 2		2007
[Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
Wiadomosci lekarskie (Warsaw, Poland : 1960), Volume: 59, Issue: 9-10		2006
[Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca, Volume: 73, Issue: 5		2006
Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model.
Spine, Oct-15, Volume: 31, Issue: 22		2006
Treatment of post-traumatic hand Staphylococcus aureus osteomyelitis with oral linezolid.
Journal of chemotherapy (Florence, Italy), Volume: 18, Issue: 4		2006
Quantification of metaxalone in human plasma by liquid chromatography coupled to tandem mass spectrometry.
Journal of analytical toxicology, Volume: 30, Issue: 4		2006
Effectiveness of linezolid and imipenem association in the treatment of severe community-acquired pneumonia in children: two case reports.
Scandinavian journal of infectious diseases, Volume: 38, Issue: 5		2006
Management of infections of osteoarticular prosthesis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Volume: 12 Suppl 3		2006
Early experience with linezolid for infections in orthopaedics.
Injury, Volume: 37, Issue: 9		2006
In vitro activity of linezolid and other antibiotics against Gram-positive bacteria from the major teaching hospitals in Kuwait.
Journal of chemotherapy (Florence, Italy), Volume: 17, Issue: 6		2005
Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.
PharmacoEconomics, Volume: 23, Issue: 9		2005
Oxazolidinones--a new class of broad-spectrum chemotherapeutics.
Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, Volume: 59, Issue: 2		2004
Absolute bioavailability and pharmacokinetics of linezolid in hospitalized patients given enteral feedings.
Antimicrobial agents and chemotherapy, Volume: 49, Issue: 9		2005
Role of linezolid in the treatment of orthopedic infections.
Expert review of anti-infective therapy, Volume: 3, Issue: 3		2005
Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
The Annals of pharmacotherapy, Volume: 39, Issue: 3		2005
Quantification of zolmitriptan in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Dec-25, Volume: 813, Issue: 1-2		2004
A review of linezolid: the first oxazolidinone antibiotic.
Expert review of anti-infective therapy, Volume: 2, Issue: 1		2004
[Linezolid, an agent from a new class of antibiotics].
Nederlands tijdschrift voor geneeskunde, Aug-07, Volume: 148, Issue: 32		2004
The safety and efficacy of linezolid in orthopaedic practice for the treatment of infection due to antibiotic-resistant organisms.
Expert opinion on drug safety, Volume: 3, Issue: 5		2004
[The role of linezolid in the therapy of infections caused by multiresistant gram-positive cocci].
Le infezioni in medicina, Volume: 12, Issue: 1		2004
Intranasal medications for the treatment of migraine and cluster headache.
CNS drugs, Volume: 18, Issue: 10		2004
Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Apr-15, Volume: 38, Issue: 8		2004
4,5-Disubstituted-1,3-oxazolidin-2-imine derivatives: a new class of orally bioavailable nitric oxide synthase inhibitor.
Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue: 2		2004
Treatment of gram-positive surgical sepsis: role of the oxazolidinones.
Journal of chemotherapy (Florence, Italy), Volume: 15, Issue: 4		2003
Predicting oral absorption of drugs: a case study with a novel class of antimicrobial agents.
Pharmaceutical research, Volume: 20, Issue: 8		2003
Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies.
Antimicrobial agents and chemotherapy, Volume: 47, Issue: 6		2003
Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.
The Journal of antimicrobial chemotherapy, Volume: 51 Suppl 2		2003
Quinupristin-dalfopristin and linezolid: evidence and opinion.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Feb-15, Volume: 36, Issue: 4		2003
Linezolid: an oxazolidinone antimicrobial agent.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, Dec-15, Volume: 59, Issue: 24		2002
The discovery of linezolid, the first oxazolidinone antibacterial agent.
Current drug targets. Infectious disorders, Volume: 1, Issue: 2		2001
[Antimicrobial and clinical effect of linezolid (ZYVOX), new class of synthetic antibacterial drug].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica, Volume: 120, Issue: 4		2002
Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog.
Xenobiotica; the fate of foreign compounds in biological systems, Volume: 32, Issue: 10		2002
Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections.
American family physician, Feb-15, Volume: 65, Issue: 4		2002
Oxazolidinone antibiotics.
Lancet (London, England), Dec-08, Volume: 358, Issue: 9297		2001
Linezolid absolute bioavailability and the effect of food on oral bioavailability.
Biopharmaceutics & drug disposition, Volume: 22, Issue: 3		2001
The oxazolidinones as a new family of antimicrobial agent.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Volume: 7 Suppl 4		2001
Linezolid--a review of the first oxazolidinone.
Expert opinion on pharmacotherapy, Volume: 2, Issue: 2		2001
[Emergency treatment of migraine attacks with particular reference to agonists of 5-HT1B/1D receptor].
Neurologia i neurochirurgia polska, Volume: 32 Suppl 6		1999
Oxazolidinones: a review.
Drugs, Volume: 59, Issue: 1		2000
[Clinical efficacy of zolmitriptan in migraine].
Neurologia (Barcelona, Spain), Volume: 13 Suppl 2		1998
[Mechanism of action of zolmitriptan].
Neurologia (Barcelona, Spain), Volume: 13 Suppl 2		1998
The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers.
British journal of clinical pharmacology, Volume: 46, Issue: 5		1998
The novel anti-migraine compound zolmitriptan (Zomig 311C90) has no clinically significant interactions with paracetamol or metoclopramide.
European journal of clinical pharmacology, Volume: 53, Issue: 3-4		1997
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (293)

ArticleYear
Efficacy and safety of intranasal agents for the acute treatment of migraine: a systematic review and network meta-analysis.
The journal of headache and pain, Sep-18, Volume: 24, Issue: 1		2023
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxaci
Trials, Jun-06, Volume: 24, Issue: 1		2023
The Novel Oxazolidinone TBI-223 Is Effective in Three Preclinical Mouse Models of Methicillin-Resistant Staphylococcus aureus Infection.
Microbiology spectrum, 10-26, Volume: 10, Issue: 5		2022
Clinical Pharmacology and Utility of Contezolid in Chinese Patients with Complicated Skin and Soft-Tissue Infections.
Antimicrobial agents and chemotherapy, 06-21, Volume: 66, Issue: 6		2022
Pharmacokinetics and Pharmacodynamics of Tedizolid.
Clinical pharmacokinetics, Volume: 61, Issue: 4		2022
Therapeutic drug monitoring of linezolid: HPLC-based assays for routine quantification of linezolid in human serum and cerebrospinal fluid.
European journal of hospital pharmacy : science and practice, Volume: 30, Issue: 6		2023
Thorough QT Study To Evaluate the Effect of Zoliflodacin, a Novel Therapeutic for Gonorrhea, on Cardiac Repolarization in Healthy Adults.
Antimicrobial agents and chemotherapy, 11-17, Volume: 65, Issue: 12		2021
Negative cross-resistance to clomazone in imazethapyr-resistant Echinochloa crus-galli caused by increased metabolization.
Pesticide biochemistry and physiology, Volume: 178		2021
Influence of the quality of capsule shell on the non-invasive monitoring of medicines using Terizidone as an example.
Journal of pharmaceutical and biomedical analysis, Sep-10, Volume: 204		2021
Evaluation of the Anti-Mycobacterial Activity of Newly Synthesized (S)-N-(3-(2-Fluoro-4'-(2-Amino-4-Thiazolyl)Biphenyl-4-Yl)-2-Oxo-1,3-Oxazolidie-5-Ylmethyl) Acetamide Derivative in Vitro and in Mycobacterium marinum-Infected Zebrafish.
Japanese journal of infectious diseases, May-24, Volume: 74, Issue: 3		2021
Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients.
Clinical therapeutics, Volume: 42, Issue: 5		2020
Neuropeptide S Displays as a Key Neuromodulator in Olfactory Spatial Memory.
Chemical senses, 04-17, Volume: 45, Issue: 3		2020
Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis.
Clinical therapeutics, Volume: 41, Issue: 6		2019
The Sterilizing Effect of Intermittent Tedizolid for Pulmonary Tuberculosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 11-28, Volume: 67, Issue: suppl_3		2018
Multiple-dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral LCB01-0371 in Healthy Male Volunteers.
Clinical therapeutics, Volume: 40, Issue: 12		2018
An evaluation of tedizolid for the treatment of MRSA infections.
Expert opinion on pharmacotherapy, Volume: 19, Issue: 13		2018
Clomazone influence soil microbial community and soil nitrogen cycling.
The Science of the total environment, Dec-10, Volume: 644		2018
Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 01-01, Volume: 22, Issue: 1		2018
Safety, tolerability and pharmacokinetics of 21 day multiple oral administration of a new oxazolidinone antibiotic, LCB01-0371, in healthy male subjects.
The Journal of antimicrobial chemotherapy, Jan-01, Volume: 73, Issue: 1		2018
Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.
Clinical pharmacokinetics, Volume: 57, Issue: 5		2018
Pharmacokinetics and Pharmacodynamics of Anacetrapib Following Single Doses in Healthy, Young Japanese and White Male Subjects.
Journal of clinical pharmacology, Volume: 58, Issue: 2		2018
Preclinical Evidence That 5-HT1B Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders.
The international journal of neuropsychopharmacology, 08-01, Volume: 20, Issue: 8		2017
Chronic Administration of Anacetrapib Is Associated With Accumulation in Adipose and Slow Elimination.
Clinical pharmacology and therapeutics, Volume: 102, Issue: 5		2017
Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable antimicrobials against Staphylococcus aureus and Staphylococcus epidermidis.
The Journal of antimicrobial chemotherapy, 05-01, Volume: 72, Issue: 5		2017
Pharmacokinetic drug evaluation of anacetrapib for the treatment of dyslipidemia.
Expert opinion on drug metabolism & toxicology, Volume: 13, Issue: 2		2017
Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones.
Expert opinion on drug metabolism & toxicology, Volume: 12, Issue: 5		2016
Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Feb-01, Volume: 1011		2016
Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies.
Journal of liposome research, Volume: 26, Issue: 4		2016
Disposition into Adipose Tissue Determines Accumulation and Elimination Kinetics of the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Mice.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 44, Issue: 3		2016
New treatment options for infections caused by increasingly antimicrobial-resistant Neisseria gonorrhoeae.
Expert review of anti-infective therapy, Volume: 14, Issue: 2		2016
Minimal systemic and high faecal exposure to cadazolid in patients with severe Clostridium difficile infection.
International journal of antimicrobial agents, Volume: 46, Issue: 5		2015
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.
Antimicrobial agents and chemotherapy, Volume: 59, Issue: 10		2015
Pharmacokinetic/pharmacodynamic research on three different infusion time regimens of linezolid in healthy Chinese volunteers.
International journal of clinical pharmacology and therapeutics, Volume: 53, Issue: 9		2015
Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases.
Scientific reports, Jul-14, Volume: 5		2015
Thinking outside the "bug": a unique assay to measure intracellular drug penetration in gram-negative bacteria.
Analytical chemistry, Apr-07, Volume: 87, Issue: 7		2015
Treatment of mediastinitis due to methicillin-resistant Staphylococcus aureus in a renal dysfunction patient undergoing adjustments to the linezolid dose.
Internal medicine (Tokyo, Japan), Volume: 54, Issue: 2		2015
Therapeutic drug monitoring: linezolid too?
Critical care (London, England), Sep-15, Volume: 18, Issue: 5		2014
In vitro resistance studies with bacteria that exhibit low mutation frequencies: prediction of "antimutant" linezolid concentrations using a mixed inoculum containing both susceptible and resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy, Volume: 59, Issue: 2		2015
Linezolid in the treatment of disseminated nontuberculous mycobacterial infection in anti-interferon-gamma autoantibody-positive patients.
The Southeast Asian journal of tropical medicine and public health, Volume: 45, Issue: 5		2014
Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function.
Antimicrobial agents and chemotherapy, Volume: 59, Issue: 1		2015
Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
Current opinion in infectious diseases, Volume: 27, Issue: 6		2014
Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, Volume: 21, Issue: 1		2015
Kinetics and thermodynamics of the sorption of furaltadone from aqueous solutions on magnetic multi-walled carbon nanotubes.
Water science and technology : a journal of the International Association on Water Pollution Research, Volume: 70, Issue: 6		2014
Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii.
Revista da Sociedade Brasileira de Medicina Tropical, Volume: 47, Issue: 4		2014
Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
International journal of antimicrobial agents, Volume: 44, Issue: 5		2014
[Therapeutic Drug Monitoring of antiinfectives in intensive care medicine].
Deutsche medizinische Wochenschrift (1946), Volume: 139, Issue: 38		2014
Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation.
The Journal of antimicrobial chemotherapy, Volume: 70, Issue: 1		2015
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin.
European heart journal, Jan-01, Volume: 36, Issue: 1		2015
Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.
International journal of antimicrobial agents, Volume: 44, Issue: 3		2014
Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study.
Critical care (London, England), Jul-10, Volume: 18, Issue: 4		2014
High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea.
Antimicrobial agents and chemotherapy, Volume: 58, Issue: 9		2014
Once-weekly dalbavancin versus daily conventional therapy for skin infection.
The New England journal of medicine, Jun-05, Volume: 370, Issue: 23		2014
Totally drug-resistant tuberculosis and adjunct therapies.
Journal of internal medicine, Volume: 277, Issue: 4		2015
Serotonin syndrome associated with metaxalone overdose.
Journal of medical toxicology : official journal of the American College of Medical Toxicology, Volume: 10, Issue: 4		2014
Tedizolid: a new oxazolidinone antimicrobial.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, Apr-15, Volume: 71, Issue: 8		2014
Population pharmacokinetic/pharmacodynamic analysis of the bactericidal activities of sutezolid (PNU-100480) and its major metabolite against intracellular Mycobacterium tuberculosis in ex vivo whole-blood cultures of patients with pulmonary tuberculosis.
Antimicrobial agents and chemotherapy, Volume: 58, Issue: 6		2014
Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, Volume: 22		2014
Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
Pharmacotherapy, Volume: 34, Issue: 5		2014
[The extraction technology of epigoitri from isatidis radix by supercritical CO2 fluid].
Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, Volume: 36, Issue: 7		2013
Duel-acting subcutaneous microemulsion formulation for improved migraine treatment with zolmitriptan and diclofenac: formulation and in vitro-in vivo characterization.
The AAPS journal, Volume: 16, Issue: 2		2014
Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease.
The American journal of cardiology, Jan-01, Volume: 113, Issue: 1		2014
Formulation and evaluation of chitosan-chondroitin sulphate based nasal inserts for zolmitriptan.
BioMed research international, Volume: 2013		2013
In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection.
The Journal of antimicrobial chemotherapy, Volume: 69, Issue: 3		2014
Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Clinical therapeutics, Volume: 35, Issue: 10		2013
Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients.
International journal of antimicrobial agents, Volume: 42, Issue: 4		2013
A rapid and sensitive HPLC assay of some concomitant anti-migraine drugs.
Journal of chromatographic science, Volume: 52, Issue: 7		2014
Linezolid decreases susceptibility to secondary bacterial pneumonia postinfluenza infection in mice through its effects on IFN-γ.
Journal of immunology (Baltimore, Md. : 1950), Aug-15, Volume: 191, Issue: 4		2013
Pharmacokinetics and relative bioavailability evaluation of linezolid suspension and tablet formulations.
Drug research, Volume: 63, Issue: 9		2013
Spectrofluorimetric determination of terbinafine hydrochloride and linezolid in their dosage forms and human plasma.
Journal of fluorescence, Volume: 23, Issue: 5		2013
The efficacy of triptans in childhood and adolescence migraine.
Current pain and headache reports, Volume: 17, Issue: 7		2013
Subtherapeutic linezolid concentrations in a patient with morbid obesity and methicillin-resistant Staphylococcus aureus pneumonia: case report and review of the literature.
The Annals of pharmacotherapy, Volume: 47, Issue: 6		2013
Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis.
Surgical infections, Volume: 14, Issue: 4		2013
Effects of Rifampin, a potent inducer of drug-metabolizing enzymes and an inhibitor of OATP1B1/3 transport, on the single dose pharmacokinetics of anacetrapib.
Journal of clinical pharmacology, Volume: 53, Issue: 7		2013
Can intermittent dosing optimize prolonged linezolid treatment of difficult multidrug-resistant tuberculosis?
Antimicrobial agents and chemotherapy, Volume: 57, Issue: 7		2013
High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.
The Journal of antimicrobial chemotherapy, Volume: 68, Issue: 9		2013
Serotonergic and adrenergic drug interactions associated with linezolid: a critical review and practical management approach.
The Annals of pharmacotherapy, Volume: 47, Issue: 4		2013
Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design.
Antimicrobial agents and chemotherapy, Volume: 57, Issue: 5		2013
A PET study with [11C]AZ10419369 to determine brain 5-HT1B receptor occupancy of zolmitriptan in healthy male volunteers.
Cephalalgia : an international journal of headache, Volume: 33, Issue: 10		2013
Weight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: a Phase I pharmacokinetic and pharmacodynamic study.
Expert opinion on investigational drugs, Volume: 22, Issue: 3		2013
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice.
Antimicrobial agents and chemotherapy, Volume: 57, Issue: 3		2013
Pharmacokinetics of intravenous linezolid in moderately to morbidly obese adults.
Antimicrobial agents and chemotherapy, Volume: 57, Issue: 3		2013
Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model.
Medical science monitor : international medical journal of experimental and clinical research, Volume: 18, Issue: 11		2012
Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, Volume: 16, Issue: 12		2012
Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.
The European respiratory journal, Volume: 41, Issue: 6		2013
A reduced linezolid dosage maintains favorable efficacy with minimal hematologic toxicity in a methicillin-resistant Staphylococcus aureus-infected patient with renal insufficiency.
Scandinavian journal of infectious diseases, Volume: 45, Issue: 1		2013
Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model.
Antimicrobial agents and chemotherapy, Volume: 56, Issue: 11		2012
Does resistance in severe infections caused by methicillin-resistant Staphylococcus aureus give you the 'creeps'?
Current opinion in critical care, Volume: 18, Issue: 5		2012
Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
Clinical therapeutics, Volume: 34, Issue: 8		2012
Metaxalone estimation in biological matrix using high-throughput LC-MS/MS bioanalytical method.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Aug-01, Volume: 902		2012
Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid.
The journal of trauma and acute care surgery, Volume: 72, Issue: 6		2012
In vitro activity and microbiological efficacy of tedizolid (TR-700) against Gram-positive clinical isolates from a phase 2 study of oral tedizolid phosphate (TR-701) in patients with complicated skin and skin structure infections.
Antimicrobial agents and chemotherapy, Volume: 56, Issue: 9		2012
Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin.
Anaesthesia and intensive care, Volume: 40, Issue: 3		2012
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.
The Journal of antimicrobial chemotherapy, Volume: 67, Issue: 8		2012
Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.
The Journal of antimicrobial chemotherapy, Volume: 67, Issue: 8		2012
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
The European respiratory journal, Volume: 40, Issue: 6		2012
Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Antimicrobial agents and chemotherapy, Volume: 56, Issue: 6		2012
Scaling adult doses of antifungal and antibacterial agents to children.
Antimicrobial agents and chemotherapy, Volume: 56, Issue: 6		2012
Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model.
Antimicrobial agents and chemotherapy, Volume: 56, Issue: 5		2012
Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers.
Antimicrobial agents and chemotherapy, Volume: 56, Issue: 5		2012
Tedizolid (TR-701): a new oxazolidinone with enhanced potency.
Expert opinion on investigational drugs, Volume: 21, Issue: 4		2012
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Interactions (39)

ArticleYear
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxaci
Trials, Jun-06, Volume: 24, Issue: 1		2023
In vitro antimicrobial combination testing of and evolution of resistance to the first-in-class spiropyrimidinetrione zoliflodacin combined with six therapeutically relevant antimicrobials for Neisseria gonorrhoeae.
The Journal of antimicrobial chemotherapy, 12-01, Volume: 74, Issue: 12		2019
Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer.
Antimicrobial agents and chemotherapy, Volume: 63, Issue: 3		2019
Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.
Expert opinion on drug metabolism & toxicology, Volume: 11, Issue: 12		2015
Potential drug interaction between warfarin and linezolid.
Internal medicine (Tokyo, Japan), Volume: 54, Issue: 5		2015
Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Gal
Antimicrobial agents and chemotherapy, Volume: 58, Issue: 8		2014
In vitro activity of fosfomycin in combination with linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus.
The Journal of antibiotics, Volume: 67, Issue: 5		2014
Secretory ranalexin produced in recombinant Pichia pastoris exhibits additive or synergistic bactericidal activity when used in combination with polymyxin B or linezolid against multi-drug resistant bacteria.
Biotechnology journal, Volume: 9, Issue: 1		2014
Antimicrobial activity of linezolid combined with minocycline against vancomycin-resistant Enterococci.
Chinese medical journal, Volume: 126, Issue: 14		2013
Serotonergic and adrenergic drug interactions associated with linezolid: a critical review and practical management approach.
The Annals of pharmacotherapy, Volume: 47, Issue: 4		2013
Probable drug-drug interaction leading to serotonin syndrome in a patient treated with concomitant buspirone and linezolid in the setting of therapeutic hypothermia.
Journal of clinical pharmacy and therapeutics, Volume: 37, Issue: 5		2012
Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms.
The Journal of antimicrobial chemotherapy, Volume: 67, Issue: 2		2012
Linezolid combined with trimethoprim-sulfamethoxazole therapy for the treatment of disseminated nocardiosis.
Journal of medical microbiology, Volume: 60, Issue: Pt 7		2011
Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy, Volume: 54, Issue: 12		2010
Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, Volume: 30, Issue: 1		2011
In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
International journal of antimicrobial agents, Volume: 35, Issue: 6		2010
[Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Mikrobiyoloji bulteni, Volume: 43, Issue: 2		2009
Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model.
Antimicrobial agents and chemotherapy, Volume: 53, Issue: 10		2009
Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients.
American heart journal, Volume: 157, Issue: 2		2009
Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.
Antimicrobial agents and chemotherapy, Volume: 53, Issue: 3		2009
Efficacy of linezolid alone and in combination with rifampin in staphylococcal experimental foreign-body infection.
The Journal of infection, Volume: 57, Issue: 3		2008
Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.
Antimicrobial agents and chemotherapy, Volume: 52, Issue: 10		2008
Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
The Journal of surgical research, May-15, Volume: 139, Issue: 2		2007
In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Volume: 19, Issue: 3		2006
Enhanced activity of rifalazil in combination with levofloxacin, linezolid, or mupirocin against Staphylococcus aureus in vitro.
The Journal of antibiotics, Volume: 59, Issue: 5		2006
In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy, Volume: 50, Issue: 7		2006
Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature.
Pharmacotherapy, Volume: 26, Issue: 2		2006
In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy, Volume: 49, Issue: 1		2005
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
Antimicrobial agents and chemotherapy, Volume: 48, Issue: 12		2004
In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
International journal of antimicrobial agents, Volume: 24, Issue: 4		2004
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
The Journal of antimicrobial chemotherapy, Volume: 52, Issue: 4		2003
In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organisms.
Antimicrobial agents and chemotherapy, Volume: 47, Issue: 6		2003
In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
The Journal of antimicrobial chemotherapy, Volume: 51, Issue: 4		2003
In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
Antimicrobial agents and chemotherapy, Volume: 47, Issue: 1		2003
AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strains.
Diagnostic microbiology and infectious disease, Volume: 43, Issue: 1		2002
Effects of the antimigraine compound zolmitriptan ('Zomig') on psychomotor performance alone and in combination with diazepam in healthy volunteers.
Cephalalgia : an international journal of headache, Volume: 18, Issue: 7		1998
Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90).
Cephalalgia : an international journal of headache, Volume: 17 Suppl 18		1997
Peripheral vascular effects and pharmacokinetics of the antimigraine compound, zolmitriptan, in combination with oral ergotamine in healthy volunteers.
Cephalalgia : an international journal of headache, Volume: 17, Issue: 6		1997
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]